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Genome-wide association studies have revealed an association between variation at the SLC4A7 
locus and blood pressure. SLC4A7 encodes the electroneutral Na+/HCO3
– co-transporter NBCn1 
which regulates intracellular pH (pHi) in a range of tissues, including vascular smooth muscle and 
endothelium. Notably, the SLC4A7 knockout mouse has been shown to have an altered blood 
pressure phenotype.  
 
This thesis presents a functional study of variants at this locus in primary cultures of vascular 
smooth muscle and endothelial cells. There were genotype-dependent differences in DNA-nuclear 
protein interactions by formaldehyde-assisted isolation of regulatory elements, electrophoretic 
mobility shift assays and DNA pulldown assays. Subsequently, there were also genotype-
dependent differences in SLC4A7 expression level and NBCn1 availability at the plasma membrane. 
In turn, SLC4A7 genotype is associated with Na+/HCO3
–-dependent steady-state pHi and recovery 
from intracellular acidosis. The genotypic effect on pHi regulation was independent of the 
calcineurin activity, or the amino acid substitution E326K resulting from a missense polymorphism. 
However, in the presence of Na+/H+ exchange activity, the SLC4A7 genotypic effect on net base 
uptake and steady-state pHi was detected only in vascular smooth muscle cells but not endothelial 
cells.  
 
The finding of a genotypic influence on SLC4A7 expression and pHi regulation in vascular smooth 
muscle cells provide an insight into the molecular mechanism underlying the association of 
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Hypertension is a common (affecting approximately 40% of adults) and major aetiological factor in 
cardiovascular, cerebrovascular and renovascular disease. It is estimated to cause up to 12.8% of 
global mortality and 3.7% of morbidity as calculated by disability-adjusted life years (WHO, 2009). 
Additionally, it has a major economic cost worldwide, estimated at around $USD 3.6 trillion 
(3,600,000,000,000) annually when all indirect costs of its complications are taken into account 
(Gaziano et al., 2009). It poses as a continuous graded risk factor, where a 20 mmHg increase in 
systolic blood pressure associated with a two-fold increase in risk of cardiovascular and 
cerebrovascular disease (Lewington et al., 2002). To compound the population health issue, up to 
30% of patients with hypertension are inadequately treated (Calhoun et al., 2008), identifying a 
need for novel therapeutic pathways.  
 
 
1.1. Blood pressure, genetics and GWAS (genome-wide association studies) 
Hypertension is a condition with strong contribution from both genes and their interaction with 
the environment. Studies on twins reared apart have suggested that the heritability for blood 
pressure is around the magnitude of 40% (Hong et al., 1994; Kupper et al., 2005), and GWAS has 
identified a number of candidate genes in the pathogenesis of hypertension (Levy et al., 2009; 
Newton-Cheh et al., 2009; Ehret et al., 2011; Kato et al., 2011; Wain et al., 2011; Franceschini et 
al., 2013; Ganesh et al., 2013; Tragente et al., 2013; Kato et al., 2015; as a selection of references 
fully reviewed as joint author in Cabrera et al., 2015). Our current understanding of the 
pathophysiology of hypertension has partially been aided by the knowledge gained from 
monogenetic hypertension, and to a lesser extent candidate gene analyses (Munroe et al., 2013). 
GWASs have aimed to go further to identify loci that contain DNA variants that are associated with 
more subtle blood pressure effects. However, these large observational studies can only identify 
association, and this does not necessarily mean causation, let alone any additional knowledge of 
an underlying molecular mechanism. Thus far, there have only been a small handful of published 
studies successfully determining the molecular mechanism underpinning the effects of the SNPs 
associated with blood pressure from GWAS (Cabrera et al., 2015). This section will summarise 





Within the UMOD (uromodulin) locus, the lead GWAS SNP (rs13333226) is a good example of a 
marker being in high linkage disequilibrium (LD) with the proposed causal SNP (rs4293393). The 
latter polymorphism is predicted by position weight matrices to be part of a glucocorticoid 
response element that is lost in the presence of the C (protective) allele. Concordantly, luciferase 
assays showed that the T (risk) allele resulted in higher promoter activity as compared to the 
protective allele in three in vitro experimental cell lines. This supports the finding of increased 
UMOD transcript levels in human nephrectomy samples of those with the risk haplotype. The 
physiological relevance of these findings is further emphasised by the authors’ in vivo human 
studies identifying a salt-sensitive hypertensive phenotype with the risk genotype. The risk 
genotype was associated with an elevated diastolic BP in a cohort of 471 never-treated 
hypertensive patients, and within experimental subgroups, the loop diuretic furosemide produced 
larger natriuretic and diastolic BP lowering effects (Trudu et al., 2013). 
 
Another example of alterations in regulatory elements is the SNP rs5068 at the NPPA locus which 
was shown to differentially interact with the inhibitory microRNA miR-425 by co-transfection 
experiments, where miR-425 reduced the expression of the NPPA plasmid containing the risk (T) 
allele, but not with the protective (G) allele plasmid. This is concordant with the hypothesis that 
the risk allele reduces gene expression with deleterious effect on blood pressure regulation (Arora 
et al., 2012). The role of miRNA also appears to be important in regulating gene expression 
relating to the rs4846049 locus, positioned at the 3’-end of the MTHFR gene (encoding 5,10-
methylenetetrahydrofolate). A common coding polymorphism (C677T) has previously been 
associated with hyperhomocysteinaemia (Frosst et al., 1995), and in turn, blood pressure (Yang et 
al., 2014). A luciferase assay demonstrated that miR-149 inhibited the gene expression in the 
vector carrying the protective (T) allele, but not the risk (G) allele. This result was further 
supported with the observation that the peripheral blood mononuclear cells of coronary heart 
disease patients with the T/T genotype has lower 5,10-methylenetetrahydrofolate expression as 
compared to risk-carrying G/G heterozygotes (Wu et al., 2013). 
 
The potential of one SNP altering transcription factor binding has also been considered. The SNP 
rs3918226 in the promoter region of the NOS3 gene was predicted to alter a putative binding site 
for transcription factors of the ETS (E-twenty six) family. A luciferase reporter study demonstrated 
that the T (risk) allele was associated with lower transcriptional activity when tested in HeLa and 




expression of eNOS, the gene product of NOS3, would be a risk factor for hypertension. However, 
there was neither functional confirmation of the predicted interaction with ETS, nor replication in 
a cell line better reflective of those relevant to blood pressure regulation.  
 
In addition to identifying local effects of SNPs, there is also a drive to determine potential trans-
acting regulators; i.e. SNPs that are associated with expression levels of genes that map far away, 
even on different chromosomes. The SNP rs653178 at the ATNX2-SH2B3 locus has shown 
extensive disease pleiotropy including blood pressure levels, but it is still unclear which, if any, of 
the local genes ATNX2 (encodes ataxin-2) or SH2B3 (SH2B adapter protein-3) may be a causative 
gene in blood pressure regulation. However, rs653178 (located at 12q24) has been shown to be 
associated with the expression of CRIP1 (at 14q32.33) and RAB11FIP1 (at 8p11.22) (Rotival et al., 
2011). This gives rise to two more proteins as possible candidate regulatory proteins in blood 
pressure control, with little known about them in this context. 
 
The limited reports so far of successful follow-ups to GWAS hits in a polygenetic disease with 
modest individual contributions to an individual blood pressure measurement emphasises the 
complexities and challenges facing the research in this thesis. 
 
 
1.2. SLC4A7 and blood pressure GWAS 
A large-scale international GWAS identified a locus emcompases the SLC4A7 gene, positioned at 
the 3p24.1 genomic region, as one of several novel loci associated with blood pressure (Ehret et 
al., 2011). The lead GWAS SNP, rs13082711, showed a significant association with diastolic blood 
pressure, but not reaching genome-wide significance with systolic blood pressure (p=3.8×10-9 and 
1.5×10-6 respectively). To better describe the locus and the SNPs in strong linkage disequilibrium, 
the SNP Annotation and Proxy Search (SNAP, Broad Institute) is able to annotate this from 
HapMap data (Johnson et al., 2008) (Figure 1, Appendix 1 for full dataset). This rs13082711 SNP is 
located 40kb upstream from the 5’ end of the SLC4A7 gene and is in strong linkage disequilibrium 
(LD, r2>0.8) with 92 other SNPs spanning a genomic region of 136kb in the CEU (Utah residents 
with Northern and Western European ancestry from the Centre d'Etude du Polymorphisme 
Humain collection) population, with SLC4A7 being the only gene within this region (Broad 
Institute, http://www.broadinstitute.org/mpg/snap/ldsearch.php). Of these 93 SNPs, only 4 are 




In comparison, the YRI (Yoruba in Ibadan, Nigeria) population had fewer SNPs in strong LD based 
on the same pre-specified r2>0.8 cut-off. Notably, a third panel data provided includes the 
combined CHB+JPT panel, comprising of Han Chinese in Beijing, China and Japanese in Tokyo, 
Japan, despite being two very different populations. With this atypical panel, there is a larger 
spread of SNPs spanning 250kb, including 18 additional SNPs, of which 8 are 5’-end of the gene, 8 
are 3’-end of the gene and 2 are intronic. These SNPs did not span any other genes, and did not 
reveal any characteristics of interest based on the tools below.  
 
In context, there are currently 441 known common (defined as having a minor allele frequency of 
>0.01) SNPs in the region of SLC4A7. Of these, 2 are within 500 bp upstream of the gene, 2 within 
the 5’-UTR (untranslated region), 10 within the 3’-UTR, 6 are synonymous exonic, 3 are non-
synonymous, and 418 are intronic. Of course, these numbers will likely increase with discoveries 






Figure 1: Linkage disequilibrium plots at rs13082711 based on data across the CEU, YRI, and a 
mixed panel of CHB and JPT populations 
Linkage disequilibrium plots at the blood pressure-associated (rs13082711) based on HapMap3 
(release 2) data across the CEU, YRI, and a mixed panel of CHB and JPT populations 
(http://www.broadinstitute.org/mpg/snap/ldplot.php). Position along chromosome 3 is matched 
on the three plots. An LD of r2 > 0.8 (dashed lines) is marked as strong linkage disequilibrium within 




Since GWAS can only identify associations within large populations and cannot infer causality, 
further studies are required to determine if, and potentially which, polymorphisms can have an 
effect on gene expression and protein activity, and subsequently on cellular and organ 
phenotypes. 
 
The SLC4A7 gene, encodes the electroneutral sodium/bicarbonate co-transporter NBCn1. This 
symporter functions to co-transport Na+ and HCO- ions in a one-to-one ratio (therefore 
electroneutral) in the intracellular direction. Amongst the cells that express NBCn1 are tissues that 
are important for blood pressure control – vascular smooth muscle cells (VSMCs) (Damkier et al., 
2006; Boedtkjer et al., 2008), endothelial cells (Damkier et al., 2006; Boedtkjer et al., 2008; 
Boedtkjer et al., 2011) and the renal salt- and water-concentrating cells of the medullary thick 
ascending loop of Henle cells (Vorum et al., 2000; Damkier et al., 2007; Boedtkjer et al., 2008).  
 
This protein has also been demonstrated to have an important role in controlling intracellular pH 
(pHi) (Boedtkjer et al., 2008), where an in vivo mouse SLC4A7 gene trap model reduced NCBn1 
expression, decreased resting pHi and reduced the sodium- and bicarbonate-dependent rate of 
recovery from ammonium chloride-prepulse induced intracellular acidosis (Figure 2). A recent 
study showed SLC4A7-/- knockout mice had an attenuated response to angiotensin II (Ang II) and 
nitric oxide synthase inhibition in raising blood pressure, although these mice had higher blood 








Figure 2: Sodium- and bicarbonate-dependent pHi recovery in wildtype and NBCn1
LacZ/LacZ gene 
trap/knockout mice (Boedtkjer et al., 2008) 
 
This chapter will initially introduce the potential for pHi to be an important factor in blood 
pressure regulation (Sections 1.4 to 1.8), but the potential role of intracellular sodium will also be 
considered (Section 1.15).  
 
 
1.3. Intracellular pH (pHi) regulation - NBCn1 and other acid-base transporters 
Intracellular pH is regulated by a range of membrane-bound transporters. The relative importance 
of the different transporters would depend on the expression profile in the varying tissues. In 
general, the main transporters responsible for maintaining an pHi suitable for cellular functioning 
are NHEs (Na+/H+ exchanger) and NBCs (Na+/HCO3
− co-transporter). They function to alkalinize (or 
reduce the acidity of) the cytosol by H+ extrusion or by importing HCO3
- respectively. A limited 
number of cell types utilise NDCBEs (Na+-dependent Cl−-HCO3
− exchanger), by using the inwardly 
directed electrochemical Na+ gradient established by Na+/K+-ATPase pumps. Where anaerobic 
metabolism occurs, MCTs (monocarboxylate/H+ co-transporters) may also play a role. Although 
may be viewed that intracellular milieu may tend towards acidosis due to the byproducts of 
cellular metabolism, there are other transporters that acidify the cell. These include AEs (anion 
exchangers) that imports extracellular Cl- in exchange for cytosolic HCO3
−, or less likely PMCAs 
(plasma membrane Ca2+-ATPase), which exchanges cytosolic Ca2+ for extracellular H+. The latter 
may therefore decrease pHi in response to stimuli that elevate intracellular Ca
2+. These 







Figure 3: Cartoon identifying different classes of pHi regulators 
There are multiple members within each class of transporter, and the relative importance depends 
on cell type. NHE, Na+/H+ exchanger; NBC, Na+/HCO3
− co-transporter; NDCBE, Na+-dependent Cl−-
HCO3
− exchanger; AE, anion exchanger; PMCA, plasma membrane Ca2+-ATPase; MCT, 
monocarboxylate/H+ co-transporters; CA, carbonic anhydrase; NKA, Na+/K+-ATPase pumps; LDH, 
lactate dehydrogenase; pHc, cytosolic pH; pHo, outside/extracellular pH. (Adapted from Casey et 
al., 2010) 
 
As well-regulated pHi is crucial for cellular function, it would not be surprising to find 
compensatory mechanisms in a system with in-built redundancies. However, several 
pharmacological studies suggest otherwise. Non-selective pharmacological inhibition of all 
sodium-bicarbonate co-transporters (NBCs) with the small molecule S0859 reduces the pHi of cat 
myocytes by 0.2 (De Giusti et al., 2010). This is also reflected by pharmacological agents inhibiting 
other acid-base transporters in human vascular smooth muscle in vitro, with both EIPA (5-(N-ethyl-
N-isopropyl)amiloride) inhibiting NHE and DIDS (4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid)  
inhibiting the anion exchanger, decreasing pHi by 0.1 separately (Weissberg et al., 1987; Aalkjaer 
and Cragoe, 1988). Altogether, this may suggest that despite multiple acid-base transporters 
having a role in maintaining pHi, modulation of just one of these proteins may be sufficient to alter 
pHi, and potentially cellular phenotype. 
 
It could be argued that the short-term pharmacological in vitro studies would not account for 




models provide better evidence of longer-term reduction in NBCn1 activity. Despite the SLC4A7-/- 
knockout mouse demonstrating an increased NHE1 activity in mesenteric endothelial cells, this 
does not fully compensate for the absence of NBCn1 function, resulting in a persisting reduction in 
pHi (Boedtkjer et al., 2011). This suggests that changes in NBCn1 activity alone may be sufficient to 
alter intracellular acid-base regulation. Interestingly, the SLC9A1-/- (NHE1) knockout mice did not 
demonstrate a reduction in resting pHi, but still has the hypotensive phenotype (Boedtkjer et al., 
2012). The observation that knockout mice for a variety of acid-base transporters demonstrate 
persisting phenotypes ( 









































↑ BP at rest, but ↓ 
hypertensive response 
to AngII or L-NAME 
(Boedtkjer et al., 2011) 
↑ BP (Groger et al., 
2011) 
↓ BP (Boedtkjer et al., 
2012) 











recovery (Boedtkjer et 
al., 2011) 
 ↓ pHi recovery, but 




et al., 2012) 
 
Arterial pH No change (Chen et al., 
2012) 
Metabolic acidosis 
(Groger et al., 2011) 
No change (Bell et al., 
1999) 
Metabolic acidosis 








 (Boedtkjer et al., 2011) 
 
↓ myogenic tone 
(Thomsen et al., 2014) 








(Boedtkjer et al., 2012). 
↓ hypoxia-induced 
pulmonary ↑BP (Yu et 
al., 2008). 
 
Endothelium ↓ NO-mediated 
relaxation (Boedtkjer et 
al., 2011) 
 ↓ NO-mediated 




(Boedtkjer et al., 2012) 
 
Renal  Increased urine volume 
(Groger et al., 2011) 
↓transepithelial 
absorption rate (Good 
et al., 2004) 
Salt-wasting (Ledoussal 
et al., 2001) 
GI tract ↓ duodenal HCO3
- 
secretion (Chen et al., 
2012) 
No change in duodenal 
HCO3
-
 flux (Chen et al., 
2012) 
 GI hypertrophy 
(Schultheis et al., 1998) 
Hormone 
profile 
 ↓ renin, 
↓aldosterone, ↑ ANP 
(Groger et al., 2011) 
 ↑renin, ↑aldosterone 





et al., 2011) 




Table 1: Selected NBC and NHE knockout mice traits 
Where multiple publications applicable, earliest is referenced. L-NAME, l-arginine methyl ester; 
ROCK, rho kinase; NAd, noradrenaline; ANP, atrial natriuretic peptide. Empty cells denote currently 
unknown phenotype. Yellow cells, likely secondary adaptive changes. 
 
Another key concept is that pHi is a dynamic variable. pHi falls in response to a variety of 
vasocontrictive stimuli such as angiotensin II, noradrenaline, endothelin-1 and cellular 




and Wray; 1993b). Changes in NBCn1 expression or activity will impact on the rate of recovery, 
even if there was an absence of changes in baseline pHi. This is supported by the observation that 
NBCn1-mediated Na+/HCO3
– co-transport protects vascular smooth muscle cells against 
intracellular acidification during contractions (Boedtkjer et al., 2006; Danielsen et al., 2013). 
 
 
1.4. Possible mechanisms of pHi affecting blood pressure – vascular smooth muscle 
Consistent with the hypothesis that pHi affects vascular function, intracellular acidosis has been 
previously demonstrated to reduce VSMC contractility, and the converse is also true to 
intracellular alkalosis (Austin and Wray, 1993a; Horie et al., 1995; Boedtkjer et al., 2011). As 
intracellular acidification of VSMCs lowers rho-kinase-dependent VSMC Ca2+ sensitivity (Boedtkjer 
et al., 2011; Boedtkjer et al., 2012), the improved ability to eliminate the contraction-induced 
intracellular acid load may contribute to the higher peripheral resistance of hypertensive patients 
through increased rho-kinase activity. Consistent with the effect of sustained intracellular 
acidification on VSMC Ca2+ sensitivity, knockout of NBCn1 lowers noradrenaline-induced 
contractions of mesenteric arteries (Boedtkjer et al., 2011) and myogenic responses of pressurized 
middle cerebral arteries (Thomsen et al., 2014) after endothelial blockade without affecting VSMC 
membrane potential or [Ca2+]i. 
 
Notably, studies in the early 1990s using rat mesenteric arteries, a fall of pHi by 0.1 generated by 
the weak acid butyrate can reduce ex vivo contractility by around 10%, with the converse also true 
intracellular alkalosis induced by the weak base trimethlyamine (Austin and Wray, 1993a). This 
suggests that modest changes in pHi, well within potential pharmacological modulation of NBCn1 
activity/expression (see Section 1.3), may have an effect on overall peripheral vascular resistance. 
Additionally, cariporide (NHE1 inhibitor) which reduces pHi, reversed the hypertensive response to 
the mineralocorticoid agonist deoxycorticosterone acetate (Young and Funder, 2003). In turn, 
SLC4A7-/- knockouts, mimicking long-term pharmacological inhibition of NBCn1 reduced the 
hypertensive and vascular reactivity to angiotensin II (Boedtkjer et al., 2011). 
 
There is also evidence that changes in acid-base transport function and/or pHi impact in vitro 
VSMC proliferation (Wu et al., 2008), migration and viability (Brenninkmeijer et al., 2011), and 
medial wall thickness (Boedtkjer et al., 2012a). NBCn1 plays a key role for VSMC migration and 




filopodia, which can explain the decelerated directional migration of VSMCs from NBCn1 knockout 
mice (Boedtkjer et al., 2016). Altered NBCn1 activity could therefore modify vascular remodeling 
with long-term impact on peripheral resistance. 
 
 
1.5. Possible mechanisms of pHi affecting blood pressure – endothelial function 
Intracellular pH also appears to have an impact on endothelial function (Besse et al., 2006; 
Boedtkjer et al., 2011). In SLC4A7-/- knockout mice, endothelial function was impaired as compared 
to wildtype mice. This was demonstrated by differences in acetylcholine-stimulated NO levels, L-
NAME (NO-synthase inhibitor, N-nitro-L-arginine methyl ester)-sensitive L-arginine conversion and 
ex vivo acetylcholine-dependent relaxation. Due to the already diminished NO-tone, these mice 
were also resistant to the blood pressure raising effect of NO-synthase inhibition (Boedtkjer et al., 
2011). Similarly, myogenic tone in cerebral arteries of these mice did not increase as much as 
wildtypes following treatment with L-NAME. Importantly, there were no differences in membrane 
potential or [Ca2+]i between arteries from NBCn1 knockout and wild-type mice, and it was shown 
that that NO production and  -kinase-dependent Ca2+ sensitivity were similarly reduced at low pHi 
in pressurized mouse middle cerebral arteries (Thomsen et al., 2014). 
 
Intracellular pH has also been shown to impact on the expression of gene products important in 
hypertension. In the endothelial cells, this includes the vasoactive peptide endothelin (Cukiernik et 
al., 2004) and nitric oxide synthase, the enzyme responsible for the generation of another 
vasoactive substance nitric oxide (Fleming et al., 1994; Thomsen et al., 2014).  
 
 
1.6. Possible mechanisms of pHi affecting blood pressure – combined effects of vascular 
smooth muscle and endothlial function 
While these studies provide evidence of how the vascular smooth muscle and endothelium may 
respond to changes in pHi independent of each other, this may not be representative of the in vivo 
interaction between the two cell types. There is however only limited studies utilizing both cell 
types concurrently. The use of whole-animal knockout models (Boedtjker et al., 2011) is 





As expressed in Section 1.5, the potential impact of endothelial pHi on overall vasculature may be 
in part via the release of vasoactive substances which may be assayed in isolated endothelial cells. 
However, when in its native form, there are myoendothelial gap junctions that allow the spread of 
cellular hyperpolarization and the subsequent vasorelaxation.  In ex vivo preparations of mouse 
mesenteric arteries, alkalinisation of the endothelium (from an average pHi of 7.24 up to greater 
than 7.5) inhibited acetylcholine-induced vasorelaxation. This effect was NO-synthase 
independent, but was abolished by gap junction inhibitors or normalisation of pHi by NHE 
inhibition (cariporide). Furthermore, dye transfer from endothelial cells to VSMCs was inhibited by 
the endothelial alkalinisation caused by the removal of CO2/HCO3
-, as was an endothelium-derived 
hyperpolarization of vascular smooth muscle cells (Boedtkjer et al., 2013).  
 
One study on the pulmonary arteries of heartworm-free dogs demonstrated that ammonium 
chloride-induced, and thus intracellular alkalosis-related, ex vivo vasoconstriction was 
independent of endothelial function, achieved either by manual denudation or indomethacin. 
Similarly, whole-organ ex vivo preparations of isolated perfused lungs of male Sprague-Dawley rats 
showed that ammonium chloride induces an increase in pulmonary artery pressures similar to that 
predicted based on isometric tension studies of artery segments (Krampetz and Rhoades, 1991). 
While this might suggest that the effect on the vascular smooth muscle is dominant, this is with 
the caveat of deriving evidence of an ex vivo model, and with a relatively underused animal model 
as well as the pulmonary circulation. This is later supported by the finding that the intracellular 
acidification of whole endothelium-intact mouse mesenteric small arteries induced by the nominal 
absence of CO2/HCO3
- diminished the response to sustained (2 hours) norepinephrine-induced 
contractions as compared to the presence of CO2/HCO3
-. This was despite the absence of effect of 
CO2/HCO3
- -free conditions on intracellular Ca2+ (Boedtkjer et al., 2006). 
 
As pHi may have an impact on the release of a range of vasoactive substances, together with 
alteration in myoendothelial gap junctions, it makes the interpretation of isolated systems very 
difficult. Additionally, it is feasible that different vascular beds may have different dominant 






1.7. Possible mechanisms of pHi affecting blood pressure – renal salt- and water- handling 
Although NBCn1 is known to be expressed in the medullary thick ascending loop of Henle, the 
overall impact on salt- and water-handling is complicated. As NBCn1 is positioned basolaterally in 
the medullary thick ascending loop of Henle (mTAL) (Praetorius et al., 2004), at first glance it may 
seem logical that knockout mice would have reduced Na+-flux from the blood to lumen, thus Na+-
preserving. Alternatively, better parallels might be drawn with SLC9A1-/- (encoding NHE1) and 
SLC9A3-/- (encoding NHE3) knockout mice. Just like the SLC4A7-/- knockouts, they all lead to 
reduced intracellular Na+ and HCO3
-, but a key difference in that NHE1 is positioned basolaterally 
and NHE3 is apical. Despite the difference in localization, and thus the overall flux of Na
+, both 
these knockout models are salt-resistant (or salt-wasting), suggesting the overall impact of 
intracellular acidosis might be more important than that of sodium flux. In SLC9A3-/- knockouts, 
one of the key findings is that the NKCC2 co-transporter (which is the target of loop diuretics) is 
down-regulated (Brooks et al., 2001; Amlal et al., 2003), thus demonstrating a salt- and water- 
wasting phenotype consistent with loop diuretic treatment. In SLC9A1-/- knockout mice, NHE3 
expression was down-regulated (Good et al., 2004), although not much is known of its effect on 
NKCC2. 
 
In the absence of data on salt-loading of SLC4A7-/- knockout mice, nor a renal-specific conditional 
knockout, the overall impact on the salt-and-water handling capabilities remains under 
speculation. A further caveat is that the murine nephron is not completely analogous to that of 




1.8. Possible mechanisms of pHi affecting blood pressure – other tissues 
Due to the expression profile of NBCn1, three further tissues should be considered as potential 
contributors to potential mechanisms affecting blood pressure – the heart, gastrointestinal tract 
and neural tissue.  
 
Within the heart, NBCn1 has been shown to be expressed in the atria, and mRNA is also present in 
the ventricles (Boedtkjer et al., 2008). Like vascular smooth muscle, the cardiac muscle appears to 
be similarly responsive to pHi, even though it is striated muscle instead. Correspondingly, 




cardiomyocytes, and intracellular acidosis with a decrease in tension (Bountra and Vaughan-Jones, 
1989). Additionally, intracellular acidosis was also associated with a decline in spontaneous Ca2+ 
spark rate (Balnave and Vaughan-Jones, 2000). If an increase in cardiac contractility increases 
cardiac output (as cardiac output = stroke volume x heart rate), this theoretically may result in an 
increase in blood pressure (as mean arterial pressure = cardiac output x systemic vascular 
resistance + central venous pressure). However, the effect of changes in cardiac contractility 
would perhaps be nullified by other homeostatic factors. 
 
NBCn1 is expressed on the mucosal surface in various sections of the gastrointestinal tract, where 
it is found basolaterally (Praetorius et al., 2001; Boedtkjer et al., 2008). While there is no published 
data on the impact of SLC4A7-/- knockout on gastrointestinal function, it is worth bearing in mind 
that the SLC9A3-/- knockout mice lacking the apical NHE3 results in a diarrhoeal state, volume 
depletion and subsequently lower blood pressure (Ledoussal et al., 2001). 
 
Within the central nervous system, NBCn1 has been shown to be expressed throughout the 
cerebrum and cerebellum (Boedtkjer et al., 2008), but very little is known about which specific cell 
types and anatomical regions they are expressed, let alone how the expression impacts neuronal 
function. The limited knowledge available shows that pHi is a factor in the frequency of action 
potentials of trigeminal cells in vitro, where intracellular acidification reduces the activity, and 
conversely intracellular alkalosis increases the frequency of action potentials (Hwang et al., 2011).   
Due to the complex nature of neural regulation of blood pressure, in the absence of tissue-specific 
knockouts, the exact contribution of NBCn1 in each tissue type is difficult to tease out. 
 
 
1.9. NBCn1 splice variants and impact on function  
The SLC4A7 gene spans over 110,000 bp and contains 28 exons, introducing the possibility of 
multiple splice variants. Additionally, exons 1 and 2 pose as two potentially different transcription 
initiation sites (designated MEAD and MERF respectively based on the initial four amino acids). In 
combination with the two possible start codons, there are four cassettes identified, leading to 32 
theoretical combinations, the key isoforms are identified in Figure 4. Thus far, only 21 full length 
variants have been identified, with a further 6 truncated variants, albeit in mRNA transcripts and 
not fully explored in protein form. Based on experimental in vitro work on Xenopus laevis oocytes, 




an effect on surface NBCn1 protein abundance and intrinsic bicarbonate transport activity (Yang et 
al., 2009). Of note, the non-synonymous SNP rs3755652 (see Section 3.6 for more details) is 
located within Cassette II.  
 
 
Figure 4: Representative diagram of motifs within NBCn1 of first 8 variants discovered 
Representative diagram of the alternative transcription starts points, cassettes, transmembrane 
domains, conserved/variable regions in relation to NBCn1 isoforms (Adapted from Boron, 2009) 
 
The in vitro relevance of splice variants is further emphasized by the observation that the splice 
Cassette II can bind calcineurin, as demonstrated in A7r5, a fibroblastic cell line derived from 
Rattus norvegicus thoracic aorta smooth muscle cells. In turn, calcineurin inhibitors were able to 
attenuate the expected activity of NBCn1 in murine mesenteric arteries, after either 
depolarization or norepinephrine-induced contractions (Danielsen et al., 2013). Any finding with 
regards to animal models needs to be taken in context of any differences in the amino acid 
sequences. As indicated in Figure 5, within the Cassette II splice itself, there are 11 amino acid 
differences between the human and rat sequences or varying predicted significance. Furthermore, 






Figure 5: Differences in amino acid sequences of human and rat NBCn1 Cassette II 
Homo sapiens (NCBI Ref Sequence: NP_003606.3) and Rattus norvegicus (NCBI Ref Sequence: 
NP_478118.1). Colour coded amino acids indicate different amino acids between the species, 
graded by Grantham (1974) classes of severity – green, conserved; yellow, moderate; red, radical. 
Grey indicates the extra amino acid in the human sequence. The E326K amino acid change of 
interest in humans is underlined. 
In addition to the possibility of Cassette II binding calcineurin, it is suggested that this results in a 
conformational change of the domain (Gill et al., 2014). This may relate to the finding that 
Cassette II also appears to contribute to protein trafficking to the cytoplasmic membrane. In 
Xenopus laevis oocytes injected with SLC4A7 RNA, the transcript without Cassette B (NBCn1-E) 
demonstrated an earlier peak to maximal protein expression and conductance as compared to the 
transcript with Cassette II (NBCn1-B) (Yang et al., 2009). The impact of the absence of Cassette II 
resulting in higher surface abundance was again observed in cDNA-injected oocytes. However, the 
absence of Cassette II was also observed to be associated with lower intrinsic co-transporter 
activity, so having no overall impact on functional expression (Liu et al., 2013). 
 
The finding of the role of calcineurin (which is itself also a phosphatase) may be consistent with 
the findings that increasing phosphatase activity tended to increase NBCn1 activity and in turn, 
reducing phosphatase activity tended to decrease NBCn1 activity - albeit a study in the HeLa 
experimental cell model (Hong et al., 2013). There is further in vivo evidence of a role of 
calcineurin interacting with NBCn1, where 9 days treatment of male Wistar rats with 
subcutaneous tacrolimus (calcineurin inhibitor) reduces the renal expression of NBCn1 (Mohebbi 
et al., 2009). This is of course accepting the complicated pharmacological effects of tacrolimus, not 
just on renal tissue. Further discussion of the potential calcineurin-NBC interactions is expanded 
upon in the section on post-translational modifications in Section 1.10 below. 
 
Another reasonable source of information could have been from sequences homologous to the 
splice cassette. However, as indicated by the summarized findings of the BLAST (Basic Local 





_LOC=blasthome) in  
Figure 6, even the closely related members of the SLC4 family (anion exchangers 1, 2, and 3, 
electroneutral sodium-bicarbonate co-transporter and sodium-driven chloride-bicarbonate 
exchanger) or the functionally relevant SLC9 family of sodium-hydrogen exchangers did not have 
any homology with the splice cassette. In fact, there are no known proteins with significant 
homology with the splice cassette (Appendix 2 for full BLAST results). This limits the ability to 




Figure 6: BLAST protein alignments of NBCn1 and other selected acid-base regulators 
BLAST (Basic Local Alignment Search Tool; http://blast.ncbi.nlm.nih.gov/Blast.cgi, NCBI) protein 
alignments of NBCn1-B (full length), NBCn1-E (without Cassette II), other members of the SLC4 
family as well as selected acid-base regulators. 
 
Thus, if there is an allele-dependent difference in RNA splicing, it poses a potential mechanism for 
the polymorphism to have an overall impact on pHi, either by total protein abundance, intrinsic 






1.10. Post-translational modifications and examples from other NBCs  
The function or activity of a protein may be affected by various post-translational modifications. 
Whilst there is a multitude of different potential modifications, there has already been some 
evidence of the impact of phosphorylation and glycosylation on the family of sodium-bicarbonate 
co-transporters, mainly on NBCe1 for which NBCn1 shares some homology (Boron et al., 2009, 
also see  
Figure 6). This may be particularly relevant to the blood pressure-associated SNP, as it marks a 
non-synonymous polymorphism resulting in an amino acid change positioned within a series of 
serine or threonine residues (both being sites of phosphorylation and glycosylation). As the 
mechanism of adding a phosphate or glycosyl group to an amino acid is typically enzymatic with 
the requirement for a surrounding consensus binding sequence (see Section 3.8), theoretically the 
amino acid change can alter any propensity to these modifications. 
Phosphorylation is the modification of an amino acid by the addition of a phosphate group (PO4
3-). 
There are multiple kinases potentially responsible for phosphorylation, which typically occurs on 
serine, threonine, tyrosine, and less commonly, histidine residues. For phosphorylation to occur, a 
kinase-specific consensus sequence usually is closely matched to the amino acid sequence at the 
phosphorylation site (Rust and Thompson, 2011). As indicated earlier in Section 1.9, there is 
already the potential for calcineurin (a.k.a. protein phosphatase 3) to regulate NBCn1 function. 
 
The phosphorylation status of the NBCe1 Ser1026 residue appears to have a role in modulating its 
stoichiometry, shifting between 3:1 and 2:1 (HCO3
- : Na+ ratio). 8-Br-cAMP-stimulated PKA-
dependent phosphorylation of that amino acid results in the change to the 2:1 stoichiometry, and 
this shift was removed in mutant proteins with an (non-phosphorylatable) Ala1026 residue. 
Furthermore, Asp1026 mutants (mimics the negative charge of a phosphorylated serine residue 
retains a 2:1 function regardless of 8-Br-cAMP stimulation. However it is worth noting that not all 
phosphorylation sites have an observed effect on co-transporter function, as generating the N-
terminus T49A or T49D mutants in NBCe1 did not have an impact (Gross et al., 2003). 
 
A similar dependence on phosphorylation was also noted with NBCn1. Dephosphorylation by 
exposure to PP1 (protein phosphatase 1) or IRBIT (an inositol 1,4,5-trisphosphate receptor-binding 
protein which recruits PP1) resulted in an increased activity. Conversely, dephosphorylation by 
inhibitors of PP1 (I2 and tautomycin), a dominant-negative IRBIT mutation (IRBITΔPEST, reducing 




kinase, resulting in phosphorylation of proteins) reduced NBCn1-A activity (Hong et al., 2013). 
Furthermore, protein kinase A (PKA) also resulted in reduced NBCn1 activity (Loiselle et al., 2004). 
The same pattern of regulation was also found with these pharmacological challenges with NBCe1 
(Shirakabe et al., 2006; Yang et al., 2011; Hong et al., 2013). Overall, it may suggest that NBCs may 
be more active in the dephosphorylated state. 
 
Further supporting evidence might be inferred from studies on NHE1 and NHE3. With these 
antiporters, they also appear to be regulated by phosphorylation, but in the opposite direction – 
where the activity is increased in the phosphorylated state ( 
Table 2) (Pang et al., 2001; Pang et al., 2002; Pang et al., 2004; Misik et al., 2005; Ammar et al., 
2006; Epting et al., 2006; Esteva-Font et al., 2007; Matsushita et al., 2007; Zaun et al., 2008; Di 
Sole et al.; Matsushita et al., 2011; Liu et al., 2013). Of course, care should be taken when 
interpreting this and extrapolating towards the potential interaction with calcineurin A. 
Particularly, as the research represented in  
Table 2 combines outputs from only 12 groups. Additionally, any summary of results in such a 
manner should be taken in context of possible publication and confirmation biases. 
 
 
Table 2: Summary of studies on the impact of phosphorylation state on NBC and NHE activity 
Studies grouped into overall experimental challenge. Each cell may represent more than one study. 
Orange cells – increased activity; blue cells - decreased activity; black cells - no change; empty cells 
– no studies so far. “+ Co-IP” denotes that in addition to change in activity, there is evidence of 
protein-protein interaction by co-immunoprecipitation. * denotes the presence of multiple studies 
across there CHP proteins (CHP1, CHP2 and CHP3). Full details and references in Appendix 3.  
PKA, Protein Kinase A; SPAK, Ste20-related proline/alanine-rich kinase; I2, Protein Phosphatase 
Inhibitor-2; Tauto, Tautomycin; CHP, calcium-binding protein; CsA, ciclosporin A; FK506, tacrolimus; 






Glycosylation is the modification of an amino acid by the addition of a glycosyl group. There are a 
range of mechanisms and cellular locations by which glycosylation occurs, but this is beyond the 
scope of this thesis. For glycosylation to occur, a consensus sequence usually is typically matched 
to the amino acid sequence at the glycosylation site (Chauhan et al., 2013), although thought not 
to be as strict as for phosphorylation. 
 
NHE3 is an example of a transporter that is regulated by glycosylation. Treating cultured renal 
proximal tubule cells LLC-PK1 with tunicamycin, an inhibitor of N-glycosylation, reduced the 
presence of glycosylated NHE3 at the membrane, and for the non-glycosylated NHE3 to be 
retained away from the membrane. This in turn resulted in reduced NHE activity, either measured 
by acid-stimulated 22Na+ uptake, or sodium-dependent pHi recovery from acid load (Soleimani et 
al., 1997). NCBE (the sodium-coupled bicarbonate exchanger encoded by SLC4A10, and also 
known as NBCn2) was found to be glycosylated, as the apparent molecular weight decreased 
following the removal of N-glycosylation modifications by N-glycosidase F treatment. To assess the 
physiological impact of these glycosylation modifications, a triple mutant generated by converting 
the N-glycosylation target asparagine to the non-glycosylatable glutamine (N677Q/N687Q/N697Q) 
residues was generated, resulting in significantly reduced protein expression in Xenopus laevis 
oocytes. Accordingly, the triple mutant did not demonstrate any measurable co-transporter 
function (Chen et al., 2008). On the other hand, despite finding NBCe1 to be glycosylated, the non-
glycosylated triple mutant (N592Q/N597Q/N617Q) did not show any changes in co-transporter 
activity in Xenopus laevis oocytes (Choi et al., 2003). However, none of these protein variants 
occur in a homologous sequence or domain/regions as the E326K variants in NBCn1.  
 
 
1.11. Protein trafficking and examples from other pHi regulators 
To fulfill the role as an pHi regulator by bicarbonate transport, NBCn1 should be, at least 
classically, positioned on the plasma membrane. However, it has already been observed that 
NBCn1 is predominantly located on the membrane, although with some intracellular signal from 
confocal microscopy (Lauritzen et al., 2010), with the function of the intracellular localization 
being currently yet unknown. Interestingly, changes in trafficking and/or protein activity have 
been noted with non-synonymous polymorphisms or mutations in SLC4A1 (Quilty et al., 2001), 




(Loganathan and Casey, 2014). However, these variants are typically in the transmembrane 
domains, and not in the analogous N-terminal region like the NBCn1 E326K variation. 
 
As already explored in Section 1.9, the E326K amino acid change occurs in a region where protein-
protein interaction can occur, with potential conformational changes. This may suggest a potential 
allele-dependent difference in protein trafficking. With changes in cellular localization, it may be a 
potential mechanism for the polymorphism to have an overall impact on pHi. 
 
 
1.12. Inducibility of NBCn1 (and other acid-base co-transporters)  
NBCn1, and other regulators of pHi, is feasibly spatially and temporally dynamic. There is a body of 
evidence indicating that the expression profiles of NBCn1 and other pHi  regulating co-transporters 
change in response to various challenges. It appears that in general, intracellular acidosis induces 
expression of these co-transporters ( 
Table 3), be it generated by ammonium chloride (Laghmani et al., 1997; Kim et al., 1999; Kwon et 
al., 2002; Amlal et al., 2004; Praetorius et al., 2004; Jakobson et al., 2004; Nowik et al., 2008; Lee 
et al., 2010), hydrogen chloride (Karim et al., 2002, Kim et al., 2003; Park et al., 2010) or chronic 
hypercapnia (Kanaan et al., 2007; Orlowski et al., 2013). Conversely, intracellular alkalosis appears 
to downregulate expression (Kim et al., 1999; Amlal et al., 2001; Praetorius et al., 2004). As pHi 







Table 3: Summary of studies on the impact of altering pH on expression of acid-, base-, sodium- 
transporters of channels 
Studies in vascular, endothelial, renal and neuronal cells are listed in chronological order from left-
to-right after grouping into overall experimental challenge. Each column represents one 
experimental condition. Experimental model abbreviation M – mice, R – rat, X – experimental cell 
line, * - in vitro study. Red cells - acidosis increased expression / alkalosis decreased expression; 
black cells – no change; empty cells – not assessed in study. There were no studies indicating that 
acidosis reduced expression or alkalosis increased expression. Full details and references in 
Appendix 4. 
Notes: Summaries such as this table are subject to publication bias. 
 
 
Additionally, exposure to activators of the renin-angiotensin-aldosterone axis (RAAS) appears to 
induce the expression or increase the activity of NBCs and NHEs ( 
Table 4). This includes induction by angiotensin II (Matsui et al., 1995; Ye et al., 1996; Sandmann et 
al., 2001; Baertz et al., 2002; Kwon et al., 2003; Epting et al., 2006; Li et al., 2008; De Giusti et al., 
2009) and aldosterone / corticosteroids (Ebata et al., 1999; Alzamora et al., 2000; Muto et al., 




al., 2005; Musch et al., 2008), as well as reversal of the induction by their respective antagonists 
(Alzamora et al., 2000; Sandmann et al., 2001; Nielsen et al., 2002; Baetz et al., 2002; Michea et 
al., 2005; Miyata et al., 2005; Epting et al., 2006; Yamamoto et al., 2007; Li et al., 2008; Musch et 
al., 2008; De Giusti et al., 2009). The one study that did not follow this pattern was by Muto et al. 
(2000), who demonstrated that short-term dexamethasone exposure (3 hours) with cultured rat 








Table 4: Summary of studies on the impact of RAAS activation on expression of acid-, base-, 




Studies in vascular, endothelial, renal and neuronal cells are listed in chronological order from left-
to-right. Each column represents one experimental condition. Experimental model abbreviation C – 
cat, H – human, M – mice, R – rat, X – experimental cell line, * - in vitro study. Red cells – increased 
expression by RAAS activation, blue cells – decreased expression, orange cells – increased transport 
function; black cells – no change, empty cells – not assessed in study. Full details and references in 
Appendix 5. 
Notes: (1) Earlier studies (predating cloning of NBCn1) describe any Na+- dependent pHi recovery as 
NHE. (2) Studies on the acid or base flux cannot differentiate between the NHE isoforms as well as 
between the NBC isoforms. (3) Summaries such as this table are subject to publication bias. 
 
There is less information and no clear pattern observed when NBCs or NHEs are knocked-out/-
down when compared to changes in pH or challenges via the renin-angiotensin-aldosterone axis, 
(Brooks et al., 2001; Amlal et al., 2003; Lauritzen et al., 2010; Boedtkjer et al., 2011; Groger et al., 
2011; Chen et al., 2012) ( 
Table 5). However, it is notable that in the very few studies on changes in gene expression after 
disruption of SLC4A7 expression, no impact was observed for NBCe1, NHE1 and NHE3 expression 
(Lauritzen et al., 2010; Chen et al., 2012). This should be taken with the usual caveat that with 
detection by protein immunoblots, these studies may not have sufficient sensitivity to identify 
subtle but yet physiologically significant changes. Additionally, there may be cell-specific 







Table 5: Summary of studies on the impact of NBC / NHE knockouts or knockdown on expression of 
acid-, base-, sodium- transporters or channels 
Studies in vascular, endothelial, renal and neuronal cells are listed in chronological order from left-
to-right. Each column represents one experimental condition. Red cells – increased expression by 
the knockout, blue cells – decreased expression, black cells – no change, empty cells – not assessed 
in study. Full details and references in Appendix 6. 
 
It is conceivable that the impact of functional SNPs at the SLC4A7 locus acts by altering the 
inducibility of gene expression over and above the basal level, such as changing the propensity of 
transcription factor to bind the altered consensus sequence.  
 
A note of caution should be stated when comparing studies across different animal species, 
particularly when involving a range of different acid-base regulators. This is because the relative 
contributions of NBC and NHE in regulating cardiomyocyte pHi have been shown to vary with 
species assessed (Yamamoto et al., 2005). Additionally, results from HEK293 cell lines should 
always be interpreted with caution. Whilst they were initially derived from the embryonic human 




most of the cells have been shown to have a hypotriploid karyotype, with most cells having 64 
chromosomes, but some with more (European Collection of Cell Cultures, n.d.). It is unlikely that 
HEK293 cells have cellular function similar to human cells, let alone that of human kidneys.  
 
 
1.13. Observational studies of pHi in hypertension 
There is already previous research into pHi and hypertension. In the experimental murine model of 
hypertension, the spontaneously hypertensive rat (SHR), resting pHi  in resistance arterioles was 
more alkaline as compared to Wistar-Kyoto wildtypes (Izzard and Heagerty, 1989a). There is 
evidence that this difference is amiloride-dependent, thus suggestive of increased NHE activity in 
SHR. However, the contribution of the DIDS-dependent component, reflecting anion exchanger 
activity was not different between SHR and WKY wildtypes (Izzard and Heagerty, 1989b). It is 
important to recognize that in the late 1980s, the function of NBCs would not have been 
investigated. However, this was further examined to show that SHR did indeed have increased pHi  
recovery in the absence of HCO3
-, better supporting the finding of increased NHE activity in SHR 
(Foster et al., 1992). On the other hand, this still predates the cloning of NBCs, and thus no direct 
investigation on whether NBCs contribute to the differences in baseline pHi between the 
hypertensive and normotensive animal models are known. With such observational data, it is 
difficult to establish causality. It is possible that the increased NHE activity predisposes to a 
hypertensive phenotype, or that hypertension induces secondary changes which includes 
upregulation of acid extruders. Alternatively, this data also does not exclude a spiral where 
increased NHE expression predisposes to hypertension which in turn upregulates NHE. 
 
However, the converse seems to apply to circulating blood cells. The lymphocytes of SHR were 
more acidotic than that of wildtype controls (Batlle et al., 1990). This was consistent with 
observations that untreated hypertensive patients had more acidotic pHi erythrocytes as 
compared to treated hypertensive patients and normotensive subjects (Resnick et al., 1987). 
Interestingly, there were no observed differences with platelets (Sagnella et al., 1999). The 
differences between the findings in resistance arterioles and circulating blood cells may however 





Thus far, the large majority of supportive evidence presented is dependent on animal models, and 
particularly the knockout mouse model. It is worth emphasising that the mouse NBCn1 protein has 
up to 80 different amino acids within its sequence, and is also 1 amino acid shorter ( 
Figure 7). These differences are typically conserved across murine species, and it is currently 
unknown whether any of these differences have any functional impact.  
 
 
Figure 7: Comparing human and mouse NBCn1 amino acid sequences 
Comparison made between the human full-length MERF-start NBCn1 protein (NCBI Reference 
Sequence: NP_003606.3) and the predicted mouse full length MERF-start NBCn1 protein (NCBI 
Reference Sequence: XP_011243051). Amino acids in red represent differences between the two 
species. Amino acid in grey is absent from the mouse NBCn1. 
Sequences bold and underlined indicate 11 regions predicted by NCBI as transmembrane regions. 
NOTE: This needs to be taken in context - that the absence of known crystallised structure, NBCn1 
is widely thought to contain 10 to 14 transmembrane regions, and that both N- and C-termini are 
intracellular, indicating an even number of transmembrane regions (Boron et al., 2009). The 326 
amino acid in this sequence is represented as 326E. 
 
Alongside this, it is essential to consider the human data, all in vivo and in vitro, experimental and 
observational, whilst recognising the limitations of these data. With regards to observational data, 
resistance arteries from subcutaneous fat biopsies from fourteen hypertensive subjects and 
fourteen normotensive controls showed no difference in baseline pHi. However, the biopsies of 
normotensive controls showed the expected intracellular acidification when treated with 
noradrenaline, but this is significantly attenuated in hypertensive patients’ biopsies. Furthermore, 




NHEs) and DIDS-induced intracellular acidosis (by inhibiting the HCO3
-/Cl- exchanger) (Izzard et al., 
1991). This leaves room for the discrepancy to be accounted for by a sodium-bicarbonate 
transporter. However, this study was also conducted prior to in-depth characterisation of NBCs, 
thus their contribution currently cannot be deduced. 
 
 
1.14. Limited human in vivo experience with modulation of pHi 
There has also been some clinical experience with inhibitors of pHi regulators, in the guise of the 
NHE1 inhibitor cariporide as a postulated therapy in ischaemic heart disease and high-risk 
coronary artery bypass grafting. This included two large randomised controlled trials – GUARDIAN, 
n=3000 (Boyce et al., 2004) and EXPEDITION, n=6000 (Mentzer et al., 2008). Both the clinical trials 
reported reduced cardiac events, but the larger EXPEDITION trial reported an increase in mortality, 
predominantly due to cerebrovascular accidents (strokes). Neither trials report data on blood 
pressure changes, except for a statement that “changes observed in blood pressure, pulse, ECG 
parameters, and laboratory evaluations that included hematology, electrolytes, and metabolism 
were not considered clinically relevant”. While this might suggest that pharmacological 
modulation of pHi may not have a strong impact on managing hypertension, it should be recalled 
that NHEs and NBCs may have different expression profiles, different inducibility, and that the 
finding of Izzard et al. (1991), that altered pHi regulation in hypertensive patients is not explained 
by NHEs, leaving a possibility of NBCs being a dominant factor. Furthermore, these studies were 
conducted in the acute phase of ischaemic events, where the regulation of blood pressure would 
be managed by the clinical teams, potentially removing any signal that might have been present. 
 
In a smaller, but better controlled context, amiloride was infused into forearms of 28 healthy 
volunteers undergoing venous occlusion plethysmography (Pickkers et al., 1999). Amiloride, in 
addition to its well-known effect of inhibiting ENaC (epithelial sodium channel), is also reported to 
inhibit NHE (Besterman et al., 1985). In this setting, amiloride reduced the angiotensin II-induced 
vasoconstriction, and was itself vasodilatory in high concentrations (Pickkers et al., 1999), 
suggesting pharmacological modulation of pHi impacts on human vascular function in vivo. Whilst 
this effect was initially attributed to the effect on NHE1, it is now complicated by the identification 
of ENaC in vascular smooth muscle (Drummond et al., 2004) and endothelial cells (Kusche-Vihrog 






1.15. NBCn1 and intracellular sodium (Na+i) – an alternative mechanism? 
Whilst there is biological plausibility for genetic polymorphism in SLC4A7 exerting an influence on 
blood pressure regulation via pHi, the impact of the concomitant sodium flux should also be 
considered. 
 
Some observational evidence can be seen in both animal models and humans. Red blood cells and 
cultured aortic vascular smooth muscle cells from SHR were found to have higher intracellular Na+ 
as compared to wildtype (Losse et al., 1984). Similar findings were identified in the red blood cells 
of untreated hypertensive patients having higher intracellular sodium concentrations as compared 
to healthy adults (Cooper et al., 1989), but with the caveat that all 217 participants were black 
Americans, limiting the generalisability. Interestingly, intracellular Na+ of red blood cells 
demonstrated a negative correlation with the response to calcium-channel blockers in 17 African 
Americans (M’Nuyamba-Kabangu et al., 1988).  
 
With this observation that hypertensive patients have higher intracellular sodium levels, it is 
interesting to note that potent vasoconstrictors do not only result in intracellular acidification as 
explored in Section 1.3, but an elevated [Na+]i in vascular smooth muscle cells after exposure to 
angiotensin II (Johnson et al., 1991), vasopressin and endothelin-1 (Neylon et al., 1994). This 
makes the interpretation of the observational evidence more complicated as it opens up the 
possibility of the association between intracellular sodium and blood pressure as due to 
confounding factors, rather than a causative relationship.  
 
Unlike the impact of pHi, the impact of intracellular sodium on vascular reactivity is more difficult 
to tease out experimentally. Unlike intracellular acidosis and alkalosis caused by weak acids and 
alkali which can diffuse through the plasma membrane, generating changes in intracellular sodium 
concentrations often requires manipulation of a co-transporter, thus a change in concentrations of 
another ion as well. 
 
Ouabain is a Na+/K+-ATPase inhibitor with secondary effects on reducing Na+/Ca2+ exchanger 
activity. When used to challenge rat mesenteric arteries, it increased intracellular sodium from 11 
mM to 65 mM without a change in the tone of rat mesenteric arteries, but did potentiate 




depolarization (Mulvany et al., 1984). As the potentiation was not reversed by the calcium channel 
blockers felodipine or D600, it was proposed that the effect was mediated via depolarisation of 
the cell membrane, but the contribution via intracellular sodium cannot be fully excluded. There is 
also some in vivo evidence with ouabain. Local infusion induced an elevation of vascular resistance 
utilising venous occlusion forearm plethysmograph in 15 normotensive subjects. Unlike the study 
with ex vivo rat mesenteric arteries, this effect was completely abolished when combined with 
nifedipine (Robinson et al., 1983). Once again, it is difficult to isolate the contribution of 
intracellular sodium, from all the other changes in intracellular ions, pHi and membrane potential. 
 
Another method of experimentally increasing intracellular sodium is by introducing a sodium 
ionophore (such as callipeptin A or gramicidin), which allows the influx of Na+ ions due to the 
electrochemical gradient. Callipeltin A, while increasing [Na+]i, provokes vasoconstriction in guinea 
pig aortic rings. This effect was inhibited by amiloride, but not the calcium channel blocker, 
verapamil (Trevesi et al., 2004). A different sodium ionophore gramicidin, was also demonstrated 
to induce hyperplasia in SHR vascular smooth muscle cells (Osanai et al., 1996). This provides an 
association with intracellular sodium and a hypertensive phenotype for vascular smooth muscle 
cells, but like experiments with ouabain, it is still difficult to separate the effect of intracellular 
sodium and the change in membrane potential. 
 
Whilst pHi and [Na
+]i appears inextricably linked, any increased activity of NBCn1 is likely to result 
in both intracellular alkalosis and increased intracellular sodium – both of which has evidence 
towards increased peripheral vascular resistance. Although it may be near impossible to define 
which (or both) is the primary cause, this does not affect the assessment of SLC4A7 as a candidate 
gene in hypertension. 
 
 
1.16. NBCn1 and intracellular lead (Pb2+i) – an alternative mechanism? 
This thesis will concentrate on the potential impact of the blood pressure associated SNPs on 
NBCn1, and mainly via pHi. However, it should be borne in mind that twin studies have identified 
that the genetic region around SLC4A7 is associated with intracellular lead concentrations of 
erythrocytes (Whitfield et al., 2007; Whitfield et al., 2010). A major caveat is that the peak genetic 
region (within the 1-LOD score confidence interval of this peak) spans 15 Mb, and contains 62 




most biologically plausible candidate, other genes within the region may be responsible through 
other mechanisms. 
 
The role of Pb2+i
 with relation to SLC4A7 and blood pressure may have some support through a 
longitudinal cohort study identified that blood Pb2+ was a significant predictor of blood pressure 
independent of confounders. Additionally, over the course of 11 years where the exposure to 
environmental lead in Copenhagen was markedly reduced, the individual’s reduction in blood Pb2+ 
levels were also predictive of a reduction in their blood pressure (Moller and Kristensen, 1992). 
However, in a cross-sectional study in Birmingham with industrial lead exposure of the early 
1980s, this effect was much weaker (Maheswaren et al., 1993). The American NHANES (National 
Health and Nutrition Examination Survey) study including 16,222 participants demonstrated a 
positive correlation between blood Pb2+ levels and blood pressure, although the finding was more 
apparent in Black Americans as compared with White and Mexican-Americans (Scinicariello et al., 
2011). These observational studies are backed by experimental evidence where Pb2+ reduced the 
endothelium-dependent acetylcholine relaxation of aortic rings ex vivo (Zhang et al., 2007) and rat 
tail arteries in vivo (Silveria et al., 2010). Whilst this could be of relevance, it is essential to 
recognize that the genetic association is with intracellular lead concentrations, whereas the 
observational and experimental data associated with blood pressure is with extracellular lead 
levels.  
 
Although feasible, there is thus far no evidence to support suggestions that intracellular lead levels 
impacting on blood pressure regulation or direct experimental evidence linking NBCn1 and Pb2+i. 
With this, there is still more supportive evidence of SLC4A7 acting via pHi or [Na
+]i, as opposed to 
Pb2+i
 to result in altered risks of hypertension. It is important to note that the cell culture media 
used for this thesis is in the nominal absence of Pb2+ (http://www.sigmaaldrich.com/life-
science/cell-culture/learning-center/media-formulations/dme.html and 
http://www.sigmaaldrich.com/life-science/cell-culture/learning-center/media-
formulations/medium-199.html), suggesting that any observed differences is unlikely to be Pb2+-
dependent. 
1.17. Pleitropy of SLC4A7 – association with cancer and addiction 
Interestingly, SLC4A7 also demonstrates pleiotropy with an association with breast cancer 
susceptibility (Ahmed et al., 2009; Chen et al., 2012). Notably, the SNP associated with cancer 




blood pressure-associated SNP, and is only in weak LD (r2 < 0.2) (Figure 8). SLC4A7 demonstrates 
strong biological plausibility as a candidate gene as intracellular alkalosis has already been 
associated with cancer cell growth and survival in vitro (Pedersen et al., 2006). More recently, 
rs4973768 has been associated with volume density of breast cancer in African-American women 
(Keller et al., 2015), although the authors accept the need for further validation, particularly with 
the apparent ethnicity-specificity of the findings. 
 
This link is strengthened by the finding that S0859, inhibiting NBCs non-selectively, reduces the in 
vitro growth of the HCT116 (human colonic carcinoma) cell line (Hulikova et al., 2011), and that 
NBCn1 expression is up-regulated in biopsies of primary human breast carcinomas (Lee et al., 
2014) and somatic mutations in SLC4A7 have been identified to up to 5% of breast, pancreatic, 
lung, colonic and endometrial cancers (Gorbatenko et al., 2014). On the other hand, the non-
selective NBC inhibitor S0859 did not have a clear impact on MCF-7 (human breast cancer) cell line 
in vitro survival (Lauritzen et al., 2010). To date, there are no published studies on the potential 






Figure 8: Linkage disequilibrium plots at rs13082711 and rs497376 SNPs 
Linkage disequilibrium plots at the blood pressure-associated (rs13082711) and breast cancer 
susceptibility-associated (rs4973768) SNPs based on HapMap3 (release 2) data for the CEU 
population (http://www.broadinstitute.org/mpg/snap/ldplot.php). Position along chromosome 3 is 
matched on both plots. An LD of r2 > 0.8 (dashed lines) is marked as strong linkage disequilibrium 
within the loci.   
 
Whilst there is no strong positional link between the two different GWAS loci to suggest that they 
share a common molecular genetic mechanism, there is still strong biological support that both 
affect its disease susceptibility via NBCn1 and pHi regulation. Additionally, it appears that 




common to both diseases. A lesson worth considering from the field of cancer is that a gene-by-
environment (GxE) interaction analysis identified the rs4973768 as having a suggestive (non-
genome-wide significant) interaction with ever-smoker status (Barrdahl et al., 2014). Whilst the 
authors linked this with the potential interplay with Pb2+, it is important to recognize that it does 
not reach a genome-wide level of significance, and the caveats expressed above in Section 1.16 
still apply. Thus far, the blood pressure-associated rs13082711 is not known to GxE interactions 
with regards to smoking status (Sung et al., 2015) but larger scale studies are in progress. 
 
With these developments, there may still be much to learn from evidence derived from rs4973768 
with regards to hypertension. 
 
Other than an association with malignancies, a case-control study of 1158 individuals from three 
populations indicated that rs3278, an intronic SNP within SLC4A7, was associated with criteria for 
dependence on at least one substance of abuse (Ishiguro et al., 2007). Although rs3278 and 
rs13082711 having genomic loci that spans a similar region, none of the SNPs are in LD with the 
other loci (r2 < 0.2) (Figure 9). Unlike the impact of pHi in malignancies, little is known of its impact 






Figure 9: Linkage disequilibrium plots at the rs13082711 and rs3278 SNPs 
Linkage disequilibrium plots at the blood pressure-associated (rs13082711) and addiction 
susceptibility-associated (rs3278) SNPs based on HapMap3 (release 2) data for the CEU population 
(http://www.broadinstitute.org/mpg/snap/ldplot.php). Position along chromosome 3 is matched 
on both plots. An LD of r2 > 0.8 (dashed lines) is marked as strong linkage disequilibrium within the 
loci.   
 
 
1.18. Other BP-associated SNPs in the region - Chinese GWAS identifying rs820430 as 
independent risk SNP  
In addition to rs13082711, a newer GWAS investigating blood pressure genetics in a Chinese 
population (11,816 in discovery meta-analysis, 69,146 in replication cohort) identifed rs820430 as 
a new and independent SNP associated with blood pressure, where this time, only systolic blood 




under 11kb from each other, both 5’ of SLC4A7 (Figure 10). It is notable that the prevalence of the 
rs13082711 risk allele was >20% in the ICBP (Ehret et al., 2011) cohort, but only 2% in the 
HapMap-CHB, perhaps accounting for the failed detection in the Lu cohort as a risk SNP. 
Importantly, the two SNPs, rs13082711 and rs820430, are not in LD (r2 = 0.06 in HapMap-JPY+CHB, 
and 0.19 in HapMap-CEU populations). Although these are two independent signals, whether both 
SNPs (additively or synergistically), one or actually none impacts on SLC4A7 expression or NBCn1 
function is not possible to be determined based purely on the GWAS. The lack of clues of how 




Figure 10: Linkage disequilibrium plots at the rs13082711 and rs820430 SNPs 
Linkage disequilibrium plots at the Ehret et al., 2011 (rs13082711) and Le et al., 2014 (rs820430) 
blood pressure-associated SNPs based on HapMap3 (release 2) data for the CHBJPT population 
(http://www.broadinstitute.org/mpg/snap/ldplot.php). Position along chromosome 3 is matched 
on both plots. An LD of r2 > 0.8 (dashed lines) is marked as strong linkage disequilibrium within the 




1.19. Considerations of NBCn1 as pharmacological target  
The widespread expression profile of NBCn1 (Boedtkjer et al., 2008) would raise the potential for 
adverse effects based on the impact on other tissues. This is exemplified by developmental 
abnormalities observed with the SLC4A7-/- knockout mouse is similar to Usher’s Syndrome, with 
developmental abnormalities in photoreceptor cells together with reduction of auditory brainstem 
responses between one and four months, with resultant hearing and sight impairment (Bok et al., 
2003).  
 
Additionally, SLC4A7-/- knockouts demonstrate non-Mendelian inheritance, with a breeding pair of 
two SLC4A7+/- heterozygotes produces only 18% SLC4A7-/- homozygotes as opposed to the 
expected 25%, suggesting some selection pressures, although maintaining equal gender 
distributions (Boedtkjer et al., 2011). However, there does not appear to be a significant selection 
pressure exerted by the blood-pressure associated SNP rs13082711, as it appears that its 
genotype frequency does not deviate from Hardy-Weinberg equilibrium in a number of 
populations (see Section 3.2). 
 
On the other hand, knockout mice can be crude models to predict potential pharmacological 
inhibition of the NBCn1 protein, due to the constitutive absence of the function of the protein of 
interest. While constitutive knockouts may affect maturing organs, pharmacological agents used in 
adults should not impact on tissue maturation. Additionally, gene knockout exerts the equivalent 
of full pharmacological antagonism, whereas pharmacological agents can behave as partial 
antagonists or even as perhaps partial agonist. Additionally, the current published SLC4A7-/- 
knockout model is not tissue-selective. Pharmacological agents may have the possibility of tissue-
specific targeting, or at least limiting the crossing of the blood-brain barrier. 
 
The only NBC inhibitor developed thus far is S0859, but is not selective between the different NBC-
subtypes. Additionally, it has been shown to have a very strong affinity to components in plasma, 
and as a result showed no effect on isolated murine tissues at concentrations up to 50 μM (Larsen 
et al., 2012). While S0859 may be a useful in vitro tool, there is currently no small molecule close 






1.20. Summary of background 
From the recent literature, SLC4A7 appears to be a biologically plausible candidate gene for blood 
pressure regulation. A genetic locus encompases the gene has been identified as being associated 
with levels of diastolic blood pressure. Additionally, SLC4A7-/- knockout mice demonstrate a blood 
pressure phenotype that appears to be resistant to hypertensive stressors. This follows the overall 
understanding of pHi being important in the function of tissues relevant to hypertension. There is 
also some evidence of altered pHi regulation in the hypertensive population.  
 
 
1.21. Hypothesis and aims 
The blood-pressure associated SNP rs13082711 may exert its effect by one or more genetic 
mechanisms, and via pHi regulation (Figure 11). This may impact on a variety of tissue types, but 
this project concentrates in vascular smooth muscle and endothelial cells. 
 
 
Figure 11: Schema of hypothesized potential mechanisms via which the blood pressure related SNP 
(rs13082711) exerts its effect 
LD, linkage disquilibrium; TFBS, transcription factor binding site; ESE, exonic splicing enhancers; 
ANGII, angiotensin II. 




Using in vitro cell lines relating to blood pressure regulation, the work in this thesis aims to 
investigate the impact of the blood pressure-associated SNP at the SLC4A7 locus or the SNP(s) in 
strong LD on: 
1. DNA-nuclear protein interactions at the SLC4A7 locus, 
2. NBCn1 expression and localization, and 





2. Methods and materials 
 
2.1. Tissue culture and cell lines  
2.1.1. Principles - Choice of cell lines  
Human umbilical artery smooth muscle cells (HUASMC) 
There are several commonly used vascular smooth muscle cell lines for tissue culture, all grown as 
adherent cultures. However, the necessity of comparing genotypes / haplotypes in most of the 
experiments conducted for this thesis limits the potential of experimental cell lines such as the BD 
(Berlin Drukrey) IX rat embryonic aortic vascular smooth muscle A7r5 or A10. Additionally, 
knowledge gained from animal cell lines can occasionally be difficult to extrapolate to human 
disease. 
 
On the other hand, there are many commercial suppliers of primary human vascular smooth 
muscle cell lines, including derived from aorta, coronary artery, pulmonary and umbilical arteries. 
These are likely to be derived from a very small of donors, and thus not achieving the aim of 
assessing a population of different genotypes / haplotypes. 
 
The issues highlighted above indicates that to be able to assess the necessary number of samples 
of different genotypes / haplotypes, an in-house supply of primary cells lines needs to be 
generated. Whilst human coronary arteries may occasionally be excised in coronary artery bypass 
grafting, the availability of samples is rare, and even if available would represent a wide range of 
disease states. Umbilical cords then becomes an ideal source of primary cell lines, as they are 
widely available, non-diseased and would otherwise be regarded as clinical waste. A further 
advantage of utilising umbilical cords is the less potential for co-morbidities to affect cellular 
phenotype as in the case of coronary arteries following bypass grafting – by definition diseased 
vessels. 
 
There are a couple of counter-arguments against the use of HUASMCs. These primarily center on 
the nature of umbilical cords being conduit arteries (i.e. not resistance vessels), carriers 
deoxygenated blood (unlike systemic arteries) and are of embryonic origin (i.e. not adult arteries). 




resistance vessels, and the use of pulmonary arteries would not be applicable for research into 
systemic hypertension.  
 
Human umbilical vein endothelial cells (HUVEC) 
The rationale for utilizing HUVECs as the endothelial cell line of choice is similar to that of 
HUASMCs above. For the same reasons requiring heterogeneity of samples, the mouse yolk sac 
endothelial cell line (C166) and the simian virus 40-transfected immortalised human dermal 
microvascular endothelial cells (CDC/EU.HMEC-1) is not feasible. Although primary endothelial cell 
lines, especially HUVECs are available commercially, they are also likely to be from a small pool of 
donors. As above, umbilical cords are also a ready source of primary endothelial cells. However, 
the same counter-arguments also apply in the case of HUVECs, with the added caveat that they 
are derived from veins, instead of artery, but notably carry oxygenated blood. Like the HUASMCs, 
HUVECs are adherent cell cultures. 
 
MCF-7  
MCF-7 cells are a commercially-available adherent epithelial cell line initially isolated from the 
metastatic pleural effusion from human breast adenocarcinoma, and is typically used as a 
transfection host (ATTC; http://www.lgcstandards-atcc.org/products/all/HTB-
22.aspx?geo_country=gb). For this thesis, it is a reasonable positive control for the gene 
expression of several genes of interest (e.g. SLC4A7, NEK10). As a cancer cell line with multiple 
mutations, no further interpretation is made of the profile and relative quantity of gene 
expression, as it is not a comparable cell line for the work in this thesis. 
 
A10 cells 
A10 cells are a commercially-available adherent myoblastic cell line initially isolated from the 
medial layer of the embryonic Rattus norvegicus (DBIX strain) thoracic aorta (Kimes and Brandt, 
1976), and is typically used as a transfection host and has characteristics of smooth muscle cells 
including expression of myokinase and creatine phosphokinase (ATCC; http://www.lgcstandards-
atcc.org/products/all/CRL-1476.aspx?geo_country=dk). For this thesis, it was utilised as a 







HEK293 cells  
HEK293 cells are a commercially-available adherent epithelial cell line which may act as a positive 
control for the expression of several genes of interest (e.g. SLC4A7, NEK10 and TFAP2C). Results 
from HEK293 cell lines should however be interpreted with caution. Whilst they were initially 
derived from embryonic kidney cells, they have expression profiles similar to neuronal tissue 
(Shaw et al., 2002). Additionally, most of the cells have been shown to have a hypotriploid 
karyotype, with most cells having 64 chromosomes, but some with more (European Collection of 
Cell Cultures, n.d.). Thus, no further interpretation is made of the profile and relative quantity of 
gene expression, as it is not a comparable cell line for the work in this thesis. For this thesis, it was 
utilised as a transfection host, to provide an easily transfectable cell from a human source, albeit 
an experimental cell line. 
 
NIH Swiss 3T3 cells 
3T3 cells are a commercially-available adherent fibroblast cell line derived from embryonic 
fibroblasts from NIH Swiss mice. These cells were used purely as an experimental model, and were 
not intended to be extrapolated to vascular smooth muscle or endothelial cell function. 
Additionally, most of the cells have been shown to have a hypertriplod karyotype, with most cells 
having 68 chromosomes (note diploid number of chromosomes is 20), but some with more 
(Leibiger et al., 2013).  
 
CD8+ T-lymphocytes (cDNA kind gift from Dr S Nadkarni) 
CD4+ T-lymphocytes isolated by flow cytometry from human peripheral blood is used as a positive 
control for EOMES gene expression (McLane et al., 2013). 
 
cDNA from renal nephrectomies (kind gift from Professor P Munroe) 
A limited collection of cDNA derived from the non-diseased pole of renal carcinoma 
nephrectomies were gifted by Professor Munroe. This had a restricted role in the thesis for several 
reasons: 
- Kidneys are highly heterogeneous organs, with a multitude of cell types. As the surgical 
samples could not be obtained uniformly, they are likely to have significant variations in the 





- Although designated as the non-disease pole, this is a macroscopic label, and was not 
histologically examined to consider whether there are microscopic regions of tumours.  
- There are no provisions for a larger sample size, and any attempts at establishing primary 
cultures were not feasible. 
 
2.1.2. Principles - Tissue culture 
The conduct of tissue culture required sterile conditions. This included the use of Class II laminar 
flow biological safety cabinets, single-use sterile pipettes and flasks, autoclaved liquids, sterile 
reagents, and where necessary sterile-filtered using a 0.22 µm filter (Milipore, SLGVV255F). Waste 
from such cultures needed to be treated with broad-spectrum disinfectants (e.g. Virkon®, Du Pont) 
which have anti-viral, anti-fungal and anti-bacterial properties. For all centrifugation steps, cells 
were spun down at low speeds (1,000g) to maintain cell viability. 
 
As the work conducted for this thesis utilised adherent cells, they needed to be detached from the 
tissue culture surface with minimal damage, either harvesting for experiments, or for subculturing. 
In most instances, unless stated, harvesting cells for experiments was conducted with single-use 
cell lifters. For subculturing, there are several enzymatic options, one of which is trypsin. Trypsin is 
a serine protease and is able to hydrolyse proteins. It functions to cleave peptide chains mainly at 
the carboxyl- side of lysine or arginine residues, unless when followed by proline. As trypsin is able 
to undergo autolysis, they were stored at cold temperatures when not in use. Conversely, to 
optimise enzymatic efficiency, it was warmed to 37oC when in use and was prepared at a pH of ~8. 
Once the cells have lifted off the tissue culture surface, it can be inactivated with serum (either 
fetal bovine, bovine calf or human). 
 
While in use in a tissue culture system, trypsin digests extracellular proteins, primarily to detach 
adherent cells from the tissue culture surface. In addition to digesting adhesion proteins, it will 
also interact with most of the other membrane-bound proteins. This is particularly relevant for the 
current study, as trypsin would also degrade the membrane-bound protein of interest, NBCn1. 
Thus, for experiments that require intact NBCn1 proteins, it is essential that cell lifters were used 
for harvesting the cells for protein assays. 
 
Primary cells used for the experiments in this thesis were younger than 7th passage. This is 




confounding the ability to draw physiologically relevant conclusions. For example, as 
demonstrated with  baboon femoral artery endothelial cells, most cells become senescent by the 
30th population doubling, with around a 50% reduction in eNOS protein levels, but no significant 
changes in E-selectin, VCAM-1 and ICAM-1 expression (Shi et al., 2004). 
 
Where indicated, serum-free media was used to induce synchronised cell arrest of the cultured 
cells (Pardee, 1974). Even if there may be some dispute on whether if cells arrest at a specific 
point within the G1 phase of a cell cycle or not (Cooper, 2003), this provides a standardized state of 
the cells to conduct experiments. Additionally, the presence of serum may breakdown 
pharmacological challenges – for example, angiotensin II has a very short half-life in serum, 
approximately 16 seconds in the circulatory system of the rat (Al-Merani et al., 1978). The dose of 
external challenges used are planned to be as close to circulating physiological levels as possible, 
ranging from 10 to 100 ρg/ml for angiotensin II, and 1 to 16 ρM for norepinephrine (Bergeron et 
al., 2001). 
 
A large part of the work conducted for this required the establishment of primary cell lines, both 
of vascular smooth muscle and endothelial cells. This can be achieved by using adherent explants 
(such as with vascular smooth muscle cells) where the tissue is dissected and placed opposing a 
tissue culture surface for cells to grow onto. Alternatively, this can be through enzymatic digestion 
(such as with endothelial cells) where collagenase type I was used to lift the endothelial cells off 
the luminal surface, and this was then seeded onto an appropriate cell culture surface. 
 
The work in this thesis also requires preservation of cell lines for future utilization, for which the 
cells are stored as low temperatures. While ultra-low temperature freezers (-80oC) are appropriate 
in the short term, storage in liquid nitrogen storage tanks (less than -180oC) virtually stops the 
biological activity of the cells, allowing safe storage.  
 
The main damage to cells during cryopreservation occurs during the freezing stage. There are 
several contributory reasons. Firstly, solutes are excluded as ice crystals grow in freezing water, 
causing them to become very concentrated in the remaining liquid water, potentially damaging 
cells with osmotic pressures. Secondly, when tissues are cooled slowly, water molecules migrate 
out of cells. This forms ice outside of the cells, and may cause mechanical damage to the cell 




the cell can cause damage directly. Finally, and perhaps most importantly, intracellular ice 
formation can be fatal to cells. 
 
To counter the potential damage by freezing, dimethyl sulfoxide (DMSO) was used in tissue culture 
as a cryoprotectant. When added prior to the freezing process, it reduces ice formation and 
thereby prevents cell death during the freezing process. This protective effect needs to be 
balanced against the intracellular toxicity of DMSO – and 10% v/v is a typical concentration in 
cryopreservation media. To further enhance survival through the cryopreservation process, the 
cooling is slow and controlled, with the optimal rate of being lowered at 1oC per minute (Mazur, 
1984). 
 
A further complication is the necessity to slowly dilute out the DMSO from the cells upon re-
warming the cells by adding the resuspending media in a dropwise manner (Weed and Jenkins, 
1979). Unlike the cooling period, cells survive the cryopreservation process better when warmed 
up rapidly (Mazur, 1984). 
 
2.1.3. Human umbilical cord specimens - Ethical approval and exclusion criteria 
The work conducted for this thesis had ethical approval (Protocol No.: Plaque-WHRI-01; NRES ref: 
08/ H0704 / 140 dated 21st January 2009 (Appendix 7a); AM04 Substantial Amendment dated 8th 
March 2012 (Appendix 7b) and further expanded with AM05 Minor Amendment dated 01 Jan 
2013 (Appendix 7c). 
 
Umbilical cords were obtained from The Royal London Hospital, Barts and The London NHS Trust, 
Whitechapel Road, Whitechapel, London E1 1BB, which is one of the three listed Clinical Source 
Centers. As per the ethical approval, all tissue samples were fully anonymous and devoid of 
patient clinical data before distribution to the recipient analysis groups. 
 
In brief, prior to the placenta being discarded by the clinical team, the umbilical cord was cut and 
placed into a specimen pot filled with Hanks’ Balanced Salt Solution (HBSS), and kept at 4oC before 
transfer to the named Study Centre.  
 
Exclusion criteria for the study includes known infective status of the mother (e.g. viral hepatitis B 




only one cord will be assessed) and stillbirths. Pre-eclampsia was not a pre-stated exclusion 
criteria based on the ethical approval, but the umbilical cords were also not collected. 
 
2.1.4. Materials 
Medium 199 (M199) (Sigma, D5671) supplemented with 15% v/v fetal bovine serum (FBS) 
(Appleton Woods, FB021), 2.5 µg/ml human beta-endothelial cell growth factor (Sigma, E1388), 
2.25 mg/ml endothelial cell growth supplement from bovine neural tissue (Sigma, E2759), 1.25 
mg/ml thymidine (Sigma, 89270), 5,000 units/ml heparin from porcine intestinal mucosa (Sigma, 
H3393), 2 mM glutamine (Sigma, G7513), 100 units/ml penicillin (Sigma, P0781) and 100 µg/ml 
streptomycin (Sigma, P0781), hereby in this thesis termed “supplemented M199”. Where stated, 
“unsupplemented M199” denotes Medium 199 without any additives. 
 
Dulbecco’s Modified Eagle Medium (DMEM) (Sigma, M4530) supplemented with 15% v/v FBS, 0.5 
ng/ml human epidermal growth factor (ProSpec, CYT-217), 2 ng/ml human fibroblast growth 
factor (ProSpec, CYT-218), 5 µg/ml human insulin (ProSpec, CYT-270), 2mM glutamine, 100 
units/ml penicillin and 100 µg/ml streptomycin, hereby in this thesis termed “supplemented 
DMEM”. Where stated, “unsupplemented DMEM” denotes Dulbecco’s Modified Eagle Medium 
without any additives. When culturing HEK293 or A10 cells, DMEM was supplemented with 10% 
v/v FBS, 2mM glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin, hereby in this thesis 
termed “DMEM+10%FBS”. 
 
Phosphate buffered saline (PBS) was formulated initially at 10x concentration using 80g NaCl, 2g 
KCl, 14.4g Na2HPO4 and 2.4g KH2PO4 dissolved into 800ml distilled-deionised water. This was 
adjusted to pH 7.4 (with concentrated HCl or NaOH) and the volume adjusted to 1 L using distilled-
deionised water. This solution was later diluted to 1x working concentration (1 part 10x PBS, 9 
parts distilled-deionised water) and autoclaved for sterility. The final concentration is 137 mM Na+, 
2.7 mM K+, 139.7 mM Cl-, 10 mM PO4
3-. 
 
Physiological saline solution (PSS) was formulated initially at 10x concentration using 64.28 g NaCl, 
3.73 g KCl, 4.07 g MgCl2, 23.83 g HEPES, 8.4 g NaHCO3, 0.68 g KH2PO4, 1.82 g EDTA
 
 dissolved into 
1L distilled-deionised water. This solution was later diluted to 1x working concentration and 
autoclaved separately from glucose and CaCl2 (which is added to reach the final concentration of 




Hanks’ Balanced Salt Solution (HBSS) had a final formulation of 138 mM NaCl, 5.33 mM KCl, 4 mM 
NaHCO3, 1.26 mM CaCl2, 0.5 mM MgCl2, 0.44 mM KH2PO4, 0.41 mM MgSO4, 0.3 mM Na2HPO4
 and 
5.6 mM glucose.  
 
Cryopreservation media consisted of 70% v/v FBS, 20% v/v basal media (either unsupplemented 
DMEM for HUASMCs or unsupplemented M199 for HUVECs) and 10% v/v DMSO, constituted just 
prior to use. 
 
Specific reagents used in tissue culture systems for various experiments are discussed in their 
respective methods sections. All are sterile when used in cell culture systems. Unless stated, all 
materials were warmed to 37oC prior to use. 
 
2.1.5. Methods 
Derivation of primary human umbilical artery vascular smooth muscle cell (HUASMC) lines  
The following protocol was adapted from Leik et al., 2004, and conducted in a designated Class II 
laminar flow biological safety cabinets specifically reserved for primary cultures. In summary, the 
umbilical cord was kept moist in a petri dish filled with PSS. It was then dissected to expose the 
umbilical arteries (usually two per cord, but occasionally one), which then using forceps, the outer 
fascia and adventitia was peeled off to reveal the underlying tunica media. These arteries were 
then trimmed to approximately 6 to 8 cm, and transferred to a new petri dish with fresh PSS. The 
arteries were dissected longitudinally and any remaining intravascular blood clots were flushed 
away. The arteries were then cut further into sections of approximately 3mm in length. These 
small sections were washed twice with PSS, and once with unsupplemented DMEM. The residual 
wash solutions were removed, and the sections were transferred to a T-25 flask pre-coated with 
0.2% w/v gelatin. The tissue culture flask was then placed upright in the tissue culture incubator to 
allow further draining of wash media, which would otherwise reduce attachment and formation of 
explants. After two hours, the media that has drained from the artery segments was removed 
from the tissue culture flask, and replaced with supplemented DMEM while being careful not to 
displace the attached segments. Primary cells usually appear after seven days. From then on, the 
culture media was replaced every two to three days. Once the tissue sections detach, they are 






Derivation of primary human umbilical vein endothelial cell (HUVEC) lines  
The following protocol was adapted from Jaffe et al. (1973), and was conducted in a designated 
Class II laminar flow biological safety cabinets specifically reserved for primary cultures. In 
summary, the umbilical vein was identified, and cannulated using at 18G cannula at one end, and 
clamped in position. Through this cannula, the umbilical vein was washed with 50ml of Hanks’ 
Balanced Salt solution (HBSS), removing the intraluminal clots. Following the wash, 0.2% w/v type I 
collagenase (Sigma, C9891) diluted in HBSS was introduced via the cannula. When the collagenase 
started to drip out the distal end, the cord was clamped on both ends. Further type I collagenase 
was injected until the vein was significantly distended. On average, a 15 cm section of umbilical 
vein required 15 to 20ml of collagenase. The cord was then incubated with collagenase and 
clamped in situ for ten minutes at 37oC with gentle massaging of the cord at the start. 
 
Following the incubation the distal clamp was released and the fluid collected in a 50ml sterile 
centrifuge tube. The vein was further flushed with 30 to 35ml of PBS until to a final volume of 
50ml. The solution, now containing the HUVECs, was centrifuged slowly, at 1,000g for 10 minutes 
at room temperature. The supernatant was carefully discarded, and the cell pellet resuspended in 
supplemented M199. The cells are then plated in T-75 flasks pre-coated with 0.2% w/v gelatin. The 
culture media was changed the next day to remove non-adherent cells. Subsequently, the culture 
media was replaced every two to three days until suitable for further subculture. Confluency was 
typically achieved in 6 to 8 days with “cobblestone appearance” on optical microscopy. 
 
General maintenance 
All tissue culture procedures were conducted in sterile conditions, and where required, in a Class II 
laminar flow biological safety cabinets. The culture media was replaced every two to three days 
unless the cells required subculturing or were suitable for the start of an experimental protocol. 
Tissue culture was conducted in a humidified incubator kept at 37oC and 5% CO2. Cellular 
morphology and growth was regularly monitored. 
 
Subculturing (passaging) cells 
When the cells reached 80-90% confluency, they were suitable for subculturing, if required. The 
adherent cells were initially washed with PBS, and the wash solution is subsequently fully 
removed. A volume of trypsin (Sigma, T4049) just enough to cover the cell culture surface (350 µl 




humidified cell culture incubator – approximately 2 minutes for HUASMCs, 30 seconds for HUVECs. 
The cell culture surface was then observed under the optical microscope for cell detachment. 
Once the cell detachment is confirmed, supplemented media (DMEM for HUASMCs, M199 for 
HUVECs, defined in Section 2.1.4) was added at a sufficient volume for further cell culture flasks. 
The new tissue culture flasks were pre-coated with 0.04% w/v porcine skin gelatin (Sigma, G1890). 
 
Cryopreservation and subsequent resuscitation of cryopreserved cell lines 
When the cells were suitable for cryopreservation, the flask was washed with PBS, and all the 
residual wash solution aspirated. Then a volume of trypsin just sufficient to cover the tissue 
culture surface was added. This was allowed to incubate in the cell culture incubator for the cell 
type-dependent time, until cell detachment is observed on the optical microscope. Once the cells 
have detached, supplemented media (DMEM for HUASMCs, and M199 for HUVECs) was added to 
neutralise the trypsin. This cell suspension was collected into a 15ml centrifuge tube, and slow 
centrifuged at 1,000g for 5 minutes at room temperature. The supernatant is discarded, and the 
cell pellet was resuspended with cryopreservation media (see Materials above). A confluent T-25 
flask contained sufficient number of cells for 1ml of cryopreservation media, and in turn sufficient 
for resuscitation into a new gelatin pre-coated T-25 flask in the future. Once resuspended, the 
cells were transferred into cryovial(s) (Thermo Scientific, 5000-0020), which is then placed in a 
cryopreservation container (Thermo Scientific, 5100-0001) filled with isopropanol. This container is 
initially transferred to ultra-low temperature (-80oC) freezers, with the container controlling the 
decline in temperature. Once at -80oC, usually left overnight, it is then suitable to be transferred to 
liquid nitrogen storage tanks. 
 
To resuscitate cryopreserved cells, the cryovials were transferred from its storage on dry ice to the 
relevant cell culture areas. It was then rapidly warmed up by a water bath set at 37oC. Once it has 
reached the desired temperature, usually after 10 minutes, the cell suspension within the cryovial 
was transferred into a 15ml centrifuge tube. Unsupplemented media (DMEM for HUASMCs, and 
M199 for HUVECs) was added, initially drop-by-drop, to dilute out the DMSO. The final volume 
added is 10x that of the cryopreservation media. This cell suspension was then slow centrifuged at 
1,000g for 5 minutes at room temperature. The supernatant was discarded, and the cell pellet 
resuspended with the appropriate supplemented media (DMEM for HUASMCs, and M199 for 





2.2. DNA isolation from cells or tissues 
2.2.1. Principles 
DNA isolation with isopropanol is based on the insolubility of DNA in isopropanol (and ethanol). 
The first step is lysing the cells, usually with lysis buffers containing detergents or surfactants to 
aid disruption of the lipid membrane. Cell lysis can be aided by physical methods such as 
sonication or using the vortex mixer.  
 
When extracting DNA from tissue samples with connective tissue, digestion with Proteinase K is 
required. Proteinase K is a broad-spectrum endopeptidase / serine protease with broad activity 
over a wide range of pH as well as an optimal temperature of 50oC to 60oC. Proteases and RNases 
may also be used to remove proteins and RNAs respectively from the sample as potential 
contaminants. Alternatively, treating with high concentrations of sodium chloride precipitates out 
the proteins in the sample. Sodium chloride “salts out” the proteins as the sodium ions attract 
water molecules away from interacting with the hydrophilic / charged sections of proteins. In turn, 
the hydrophobic portions of the proteins become relatively stronger than hydrophilic interactions. 
This results in protein molecules coagulating by forming hydrophobic interactions with each other.  
 
DNA is highly soluble in water, primarily due to its polar and negatively charged phosphate 
backbone. Due to its polarity, it forms a hydration shell when dissolved in water. On the addition 
of isopropanol, which is much less polar than water, this removes the hydration shell and allows 
the phosphate groups to form stable ionic bonds with positive ions in the solution, usually with 
sodium ions in the lysis buffer. This precipitate can be further washed with ethanol. Eventually, 
when the ethanol is evaporated, the DNA pellet can be dissolved with nuclease-free water. 
 
Alternatively, commercial kits with mini-columns are available for DNA extraction. 
 
2.2.2. Methods 
Isopropanol / ethanol method 
The samples were initially mixed with 500 µl lysis buffer (10mM Tris pH 8.0, 10mM EDTA pH 8.0, 
100mM NaCl, 0.5% w/v sodium dodecylsulfate), with pipette mixing. This is sufficient for up to 107 
cells from tissue culture. However, pieces of tissue up to 20 mg required additional digestion by 
400 µg Proteinase K (Sigma, P2308) added to the lysis buffer and incubated overnight at 55oC with 




At this stage, isolation of DNA from either cell pellets or digested tissue samples required the same 
steps. Following cell lysis, 250 µl of 5M NaCl is added and mixed on the roller shaker for 5 minutes 
at room temperature. This precipitates the proteins, and was separated from the soluble DNA by 
fast centrifugation at 13,000g for 7 minutes at room temperature.  
 
The supernatant with the soluble DNA is transferred to a new microcentrifuge tube, to which 500 
µl of isopropanol is added. This was mixed for 2 minutes on a roller shaker at room temperature. 
At this stage, the DNA is precipitated and collected by fast centrifugation at 13,000g for 5 minutes 
at room temperature. The supernatant was discarded, and the DNA pellet was washed with 70% 
v/v ethanol and once again pelleted by fast centrifugation at 13,000g for 2 minutes at room 
temperature. The supernatant was removed, and the residual ethanol was left to air-dry. 
 
Once dry, the DNA pellet was dissolved with 50 µl of nuclease-free water and incubated at 55OC 
for 10 minutes. The DNA concentration and purity was then measured using a spectrophotometer 
(Nanodrop® ND-1000, Thermo Fisher Scientific Inc., USA). For a sample that is free of 
contaminants, DNA is expected to have an A260/A280 ratio (ratio of absorbance of ultraviolet light at 
wavelengths of 260 nm and 280 nm respectively) of approximately 2.0, where A260 typically 
reflects nucleic acid content. If the ratio is much lower, it may indicate the presence of proteins, 
phenols or other contaminants that absorb strongly at or near 280 nm. A secondary measure of 
nucleic acid purity is that of the A260/A230 ratio, commonly expected to be around 2.0 to 2.2. In the 
presence of excess EDTA, carbohydrates, phenols and guanidine HCl, all absorbing ultraviolet light 
at around 230 nm, the sample will reveal a reduced A260/A230 ratio. 
 
During the studies conducted for this thesis, this method produced a larger quantity of DNA and of 
higher purity as compared to commercial kits, albeit was more time consuming. 
  
 
2.3. RNA isolation and reverse transcription into cDNA (complementary DNA) 
2.3.1. Principles – RNA isolation 
There are several methods that are commonly used for extracting total cellular RNA. This includes 
the phenol-chloroform extraction method, as first described in 1987 (Chomczynski et al., 1987) as 





RNA isolation – column-based  
Column-based nucleic acid purification is a solid phase extraction method to quickly purify nucleic 
acids. It also has the benefit compared to phenol-chloroform based methods as it does not use 
hazardous materials. 
 
This method relies on nucleic acids binding to the solid phase (usually silica) depending on the pH 
and the salt content of the lysis buffer. There are typically three stages. First, a buffer is added to 
lower the pH, then the appropriate solute content thus allowing the sample to bind the silica 
column. The lysis buffer also often contains a denaturing agent such as guanidine hydrochloride, 
which denatures proteins including RNases. 
 
The column is then washed, usually containing a higher percentage of ethanol, several times. 
Finally, the column can be eluted with buffer or water. 
 
RNA isolation – liquid-liquid extraction technique 
Acid guanidinium thiocyanate-phenol-chloroform extraction is a liquid–liquid extraction technique 
that is able to separate out RNA from other cellular components. This method typically takes 
longer than column-based systems, but usually provides higher purity and recovery of RNA. 
Additionally, standard RNA columns are unsuitable for purification of short (<200 nucleotides) RNA 
species, such as siRNA, miRNA, gRNA and tRNA. 
 
The lysis buffer for this method, amongst others, includes both guanidinium thiocyanate and 
phenol. The former denatures proteins, including RNases, and separates rRNA from ribosomal 
proteins, while the latter is a solvent with poor solubility. Following the addition of chloroform, 
these solvents separate into two phases with different colours. The clear, upper aqueous phase 
contains nucleic acids and the lower phase containing the proteins dissolved in phenol and the 
lipids dissolved in chloroform. With the introduction of acidic conditions, RNAs remains in the 
aqueous phase, whilst DNA partitions into the organic phase.  
 
The aqueous phase can then be used for further isopropanol precipitation. Like DNA, isopropanol 
precipitates RNAs by removing its hydration shell and allows the phosphate groups to form stable 




Eventually, when the ethanol is evaporated, the RNA pellet can be dissolved with nuclease-free 
water. 
 
2.3.2. Principles - Reverse transcription 
First strand synthesis primers 
There are two main options for primers in first strand synthesis – oligo(dT) and random primers.  
 
Oligo(dT) primers are based on targeting the poly-adenosine tail present in mRNA. They are 
usually either oligo(dT)12-18 (a mixture of 12-mer to 18-mer thymidines), oligo(dT)20 (a homogenous 
mixture of 20-mer thymidines) or anchored oligo(dT) primers which anneals at the 3’-UTR/polyA 
junction. 
 
An advantage of oligo(dT) primers is that it targets the poly-adenine tail present only in mRNA – 
which significantly increases the specificity of the amplification. However, as this also means all 
reverse transcription is initiated at the 3’ end, the difficult secondary structure may interfere with 
complete cDNA synthesis. Additionally, a commonly used internal control in real-time quantitative 
PCR, 18S rRNA (ribosomal RNA), does not have a poly-A tail. Thus, if 18S is to be used as an 
internal control, oligo(dT) primers should not be used. 
 
Random primers are oligonucleotide sequences synthesized entirely randomly. Commonly these 
primers are six (hexamers) or fifteen nucleotide long (pentadecamers). This gives a numerous 
range of sequences that have the potential to anneal at many random points on a RNA sequence 
and act as primers to commence first strand cDNA synthesis. 
 
This potential to anneal and act as a primer at many points of an RNA sequence allows it to be 
good for synthesizing large pools of DNA. Additionally, as first strand synthesis starts throughout 
the RNA molecule, it does not have the same issues with non-polyadenylated RNAs. 
 
2.3.3. Method 
RNA isolation – Acid guanidinium thiocyanate-phenol-chloroform extraction technique 
The liquid-liquid method used for RNA isolation was based on the TRI reagent (acid guanidimium 





reagent.html) and is summarized as below. 
 
As TRI reagent (Sigma, T9424) is not compatible with plastic tissue culture flasks, cells were initially 
isolated by cell lifters and centrifugation into a cell pellet. 1 ml of TRI reagent was used to process 
up to 107 cells, therefore suitable for either a confluent T-25 or T-75 flask. The cell lysate was 
homogenized by pipette and vortex mixing. The cell lysates were then centrifuged at 13,000 g for 
10 minutes at 4oC to pellet the insoluble material such as plasma membranes, polysaccharides, 
and high molecular mass DNA. The supernatant contained RNA and protein, and was transferred 
into a fresh microcentrifuge tube.   
 
To ensure complete dissociation of nucleoprotein complexes, the samples were allowed to stand 
for 5 minutes at room temperature. Then, 200 µl of chloroform : isoamyl alcohol (24:1 v/v) (Sigma, 
C0549) was added and mixed vigorously with a vortex mixer for 15 seconds. This mixture was 
allowed to stand for 2–15 minutes at room temperature before centrifugation at 13,000g for 15 
minutes at 4oC. The centrifugation separates the mixture into 3 phases - a red lower organic phase 
(containing protein), an interphase (containing DNA), and a colorless upper aqueous phase 
(containing RNA). 
 
The aqueous phase containing RNA was then transferred into to a fresh microcentrifuge tube. 
Then, 500 µl of isopropanol is added to the sample, vortex mixed, and allowed to stand for 10 
minutes at room temperature to precipitate the RNA. The mixture was then centrifuged at 
13,000g for 10 minutes at 4oC to pellet the RNA precipitate. The supernatant was discarded, and 
the RNA pellet washed with 1 ml of 70% v/v ethanol. The suspension was then centrifuged at 
13,000g for 10 minutes at 4oC to pellet the RNA precipitate again.  
 
The wash ethanol was discarded, and the RNA pellet allowed to air dry for 5–10 minutes by air-
drying. However, the RNA pellet should not completely dry out, as this greatly decrease its 
solubility. The pellet was then dissolved in nuclease-free water and pipette-mixed, and if required, 
incubated at 55–60 °C for 10–15 minutes.  
 
As part of optimization, the RNA sample was also run on an agarose gel demonstrating the 28S, 





Figure 12: Agarose gel electrophoresis of RNA isolated using the acid guanidinium thiocyanate-
phenol-chloroform extraction technique 
Thick bands represent the 28S, 18S and 5S RNA species, whereas the smear is the expected sizes for 
total cellular RNA. No appreciable genomic DNA signal seen 
 
RNA isolation – column method 
The column method used for total cellular RNA isolation for this thesis utilised Nucleospin RNA II 
columns (Macherey-Nagel, 740955), and the protocol is summarized below. This column is able to 
process up to 5x106 cells, which equated to a 25cm2 tissue culture surface area (T-25 flask). 
 
To lyse cell pellets, 350 μl Buffer RA1 and 3.5 μl beta-mercaptoethanol was added to each sample 
in a microcentrifuge tube and vortex mixed. This cell lysate was then transferred into the 
NucleoSpin Filter, and centrifuged at 13,000g for 1 minute at 4oC. This step filters the lysate and 




To ensure RNA binding to the spin columns, 350 µl of 70% v/v ethanol was added to adjust RNA 
binding conditions, and pipette mixed. The mixture was then transferred into the Nucleospin RNA 
II Column, and centrifuged at 13,000g for 1 minute at 4oC. This resulted in RNA binding to the 
column. The flowthrough was discarded. The silica membrane was desalted by adding 350 µl of 
Membrane Desalting Solution B, and centrifuged at 13,000g for 1 minute at 4oC with the 
flowthrough discarded. 
 
To digest any contaminating DNA, a DNase reaction mixture (90 µl rDNase Reaction Buffer and 10 
µl rDNase) was dropped onto the silica membrane and left for 15 minutes at room temperature. 
To wash the silica, 200 µl Buffer RA2 was added to the column, and centrifuged at 13,000g for 30 
seconds at 4oC with the flowthrough discarded. After that, 600 µl Buffer RA3 was added to the 
column, and centrifuged at 13,000g for 30 seconds at 4oC with the flowthrough discarded. The 
final wash was conducted with 250 µl Buffer RA3 added to the column, and centrifuged at 13,000g 
for 2 minutes at 4oC with the flowthrough discarded. To dry the silica, the column was further 
centrifuged at 13,000g for 1 minute at 4oC and the flowthrough discarded. 
 
To elute the RNA, 40 µl of RNase-free water was added to the silica membrane and centrifuged at 
13,000g for 2 minutes at 4oC with the flowthrough collected. The eluate was quantified by a 
spectrophotometer. 
 
RNA yield and purity quantification 
The RNA content and purity was quantified using a spectrophotometer. For a sample free of 
contaminants, RNA is expected to have an A260/A280 ratio (ratio of absorbance of ultraviolet light at 
wavelengths of 260nm and 280nm respectively) of approximately 2.0, where A260 typically reflects 
nucleic acid content. If the ratio is much lower, it may indicate the presence of proteins, phenols 
or other contaminants that absorb strongly at or near 280nm. A secondary measure of nucleic acid 
purity is that of the A260/A230 ratio, commonly expected to be around 2.0 to 2.2. In the presence of 
excess EDTA, carbohydrates, phenols and guanidine HCl, all absorbing ultraviolet light at around 









The reverse transcription conducted for the work in this thesis utilises the M-MLV (Moloney 
murine leukemia virus) reverse transcriptase (Promega, M170), and the manufacturer’s protocol is 
summarized below. 
 
The protocol was optmised for the reverse transcription of 1000 ng of RNA. This was added to an 
RNase-free microcentrifuge tube together with 0.1 ng random primers (Promega, C1181), and 
made up to a final volume of 10 µl with nuclease free water. This was heated to 70oC in a 
thermocycler (PTC-0225, Peltier DNA Engine Tetrad) for 5 minutes, and immediately returned to 
4oC on an ice bath. To this mixture, reagents were added to achieve a final concentration of 1x M-
MLV reaction buffer (50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2 and 10 mM DTT), 1 mM 
dNTPs together with 200 units of M-MLV reverse transcriptase. The reaction was made up with 
nuclease-free water to a final volume of 25 µl. This reaction mixture was returned to the 
thermocycler, kept at 25oC for 5 minutes, followed by 42oC for 90 minutes and finally 70oC for 15 
minutes. 
 
Subsequent PCRs are conducted as per Section 2.5. 
 
Positive and negative controls 
For end-point RT-PCR, the following controls should be utilised: 
- No template control – whereby a signal indicates cDNA contamination within the PCR system. 
- RT negative control (i.e. RNA sample underwent the same process of reverse transcription, 
but with the reverse transcriptase enzyme replaced with water) – whereby a signal indicates 
potential cDNA or genomic DNA contamination of the template. 
- Positive control (cDNA of a sample that is known to express the RNA of interest) – whereby 
the absence of a signal indicates a failed reaction. 
 
 
2.4. Genotyping by KASP™ (Kompetitive Alelle Specific PCR) method 
2.4.1. Principles – Genotyping overview 
Most estimates place the overall frequency of polymorphisms within the human genome at 1 in 




variations (GRCh37, Ensembl genome browser release 68, July 2012; 
http://jul2012.archive.ensembl.org/Homo_sapiens/Location/Genome?r=1:1-1000000). 
 
The current definition of a genetic polymorphism is the occurrence in the same population, of two 
or more alleles at one locus, each with appreciable frequency (typically 1%). These variations are 
not de novo mutations, but are actively and steadily maintained by natural selection, in contrast to 
transient polymorphisms where a form is progressively replaced by another. By this definition, 
genetic polymorphisms include single nucleotide polymorphisms (SNPs), insertion-deletion (Indel) 
and variable tandem number repeats (VTNR). Whilst accepting the importance of the other types 
of polymorphisms, the scope of this thesis only includes SNPs. 
 
Current methods of genotyping SNPs include restriction fragment length polymorphism 
identification (RFLPI), random amplified polymorphic detection (RAPD), amplified fragment length 
polymorphism detection (AFLPD), polymerase chain reaction (PCR), DNA sequencing, allele specific 
oligonucleotide (ASO) probes, and hybridization to DNA microarrays. Most of these methodologies 
can be viewed as either enzyme-based, or hybridization-based. Enzyme-based methods utilize a 
range of enzymes, including nucleases (restriction fragment length polymorphism) and DNA 
polymerases (PCR-based methods where the primer or product interacts with a reporter/quencher 
system). Hybridization-based methods often include probes that are complementary to the allele-
specific sequence of interest, linked together with a reporter/quencher system. 
 
DNA sequencing, such as Sanger sequencing used in this thesis, also provides genotype data, and 
is often regarded as the gold standard. Currently, the main limitation is the cost per unit, as 
compared to the other methods. 
 
2.4.2. Principles – KASPTM methodology 
The genotyping method used for this thesis was the KASP™ method (Applied Bioscience). It is an 
endpoint genotyping technology based on fluorescence and associated quenchers, as summarized 
in Figure 13. It has the benefit of being able to be conducted on 96-, 384- and 1536-well plate 














The assay consists of two key mixtures – the master mix, and the primer mix. The master mix 
consists of the DNA polymerase and appropriate buffers to catalyze the polymerase chain 
reaction, and two distinct FRET (Förster resonance energy transfer) cassettes. These cassettes 
contain a double-stranded oligonucleotide with a fluorescent dye on one 5’-end, and a quencher 
on the complementary 3’-end. Whilst annealed together, there is no detectable fluorescent signal, 
but when separated, the signal is detectable. The primer mix includes two allele-specific forward 
primers and one common reverse primer that are designed by the proprietary primer design 
program PrimerPicker™ (Applied Bioscience), with an algorithm set, at least in part, for a Tm 
between 63oC to 66oC. The 5’-end of the primers contain an allele-specific sequence that 
corresponds to that of the corresponding fluorescence-tagged oligonucleotide, but does not relate 
to the sequence around the SNP of interest. It is however noteworthy that, the source code for the 
PrimerPicker™ is proprietary. 
 
When the PCR occurs, the allele-specific primer binds and elongates. This generates a first PCR 
strand that includes the allele-specific tail corresponding to the designated fluorescent dye. During 
subsequent PCR rounds, the complementary sequence to the fluorescent tagged oligonucleotide is 
generated, allowing it to anneal, and be separated from its quencher. Thus, this allows allele-
specific fluorescence to be detected.  
 
The fluorescent data is viewed graphically (see Figure 14 as example), and genotypes can then be 






Figure 14: Representative figure of a KASP genotyping assay 
Distinct clusters are identified to indicate homozygotes (red and blue circles) and heterozygotes 
(green circle). No template controls are located at near the point of origin (black circle). Where 
present, samples not in clusters are also unclassified. 
 
KASP (Kompetitive Allele Specific PCR) methodology – advantages and limitations 
The main advantage of the KASP methodology compared to other genotyping methods is based on 
a lower cost-per unit, as well as the flexibility to conduct low- to high-throughput studies, 
particularly compared to restriction enzyme-based, or DNA sequencing. There is a marginal cost-
benefit compared to other FRET-dependent technologies such as TaqMan® (Life Technologies). 
 
Limitations are based on the principle that samples are assayed in bulk and results are dependent 




non-uniform, or of insufficient quality, there is a potential for poor clustering on the fluorescence 
scatterplot. Additionally, there is anecdotal evidence based on the experience of the research 
team suggesting that some SNPs and their surrounding sequences are not suitable. The gold-
standard currently applied to genotyping is that of DNA sequencing. As shown here, the KASP 
assays used have a high concordance with the gold standard, as well as inter-batch concordance 
(Results Section 4.1.). 
 
2.4.3. Methods  
At first, the DNA template was stamped into a 384-well plate. Each well was plated with either 5ng 
DNA or left empty as to be a designated NTC (no template control). As the “dry template” method 
was used, this was left in a 37oC oven for the liquid to evaporate overnight, leaving the DNA left at 
the bottom of the well. 
 
The Reaction Mix was made by combining in a 1:63 ratio of Assay Mix (12 nM of each allele-
specific primer and 30 nM of the common primer) and the Buffer Mix (KASPar master mix with 
added 0.15 mM MgCl2 to achieve a final concentration of 1.8mM). 2.5 µl of this Reaction Mix was 
added to each well. The plate was then sealed with an optically-clear adhesive film to prevent 
evaporation. The reaction mixture was placed into a thermocycler and the program in  
Table 6 was used. 
 
 Temperature Duration 
Initialisation step (Hot Start) 94oC 15 minutes 
First 10 cycles Denaturing step 94oC 20 seconds 
Annealing and 
elongation step 
61oC to 55oC (dropping 
0.6oC per cycle) 
1 minute 
Next 26 cycles Denaturing step 94oC 20 seconds 
Annealing and 
elongation step 
55oC 1 minute 
 
Table 6: Thermocycler program for KASP assays 
 
The plates were cooled to 4oC prior to reading on a FRET-capable plate reader (7900HT Fast Real-
Time PCR System, Applied Biosystems). FAM (6-Carboxyfluorescein) and VIC (structure unknown, 
Applied Bioscience proprietary compound) probes were used for this thesis, and their excitation 




Table 7.  
Fluorophore Excitation (nm) Emission (nm) 
VIC 535 556 
FAM 485 520 
 
Table 7: Excitation and emission wavelengths for the utilised fluorophores 
 
If further cycles were required to achieve tight clusters, a further 3 cycles of 94oC denaturing for 20 
seconds and annealing/elongation for 1 minute at 57oC and cooled to 4oC prior to reading. This 
was repeated as necessary. 
 
Analysis of results by SDS (Sequence Detection Systems, Applied Biosystems) software 
The results from the plate reader was obtained in a *.sds file. This was analysed by the SDS v2.4.1 
software (Applied Biosystems, USA). Manual calling was utilised to identify clusters of samples 
based on their florescence levels for the respective probes. An example is shown in Figure 14. A 
successful call rate at 95% and above was regarded as an adequate assay. 
 
 
2.5. Polymerase chain reaction (PCR) and subsequent analyses 
2.5.1. Principles - PCR 
The polymerase chain reactions are able to amplify a single copy of a piece of DNA (or PCR 
amplicon) across several orders of magnitude, generating thousands to millions of copies of the 
original sequence (Saiki et al., 1985). This method relies on an enzyme, DNA polymerase, which is 
able to extend nucleotide sequences with an open 3’-end with a complementary strand present. 
To successfully complete a reaction to copy, there are several steps, and different temperatures 
that are required. This means a thermal cycler is required to create cycles of repeated heating and 
cooling. The main components of the reaction are a DNA (or PCR amplicon) template, Taq 
polymerase enzyme, primers, deoxynucleoside triphosphates (dNTPs), divalent cations (generally 
Mg2+ as co-enzymes) and buffer solutions. Their relevance will be explained in each step. 
 
Before the temperature of the reaction starts to cycle, some DNA polymerases require “hot-start” 
heat activation. In these instances, it undergoes an initialization step, with temperatures (usually 





In the first step (denaturing step), the two strands of the DNA double helix are physically 
separated at a high temperature in a process called DNA melting by disrupting the hydrogen bonds 
between the complementary bases, which results in two single-stranded DNA molecules. This is 
often set at a temperature greater than 90oC. 
 
With the second step (annealing step), the temperature is lowered and the two DNA strands 
become templates for complementary primers to anneal to. The optimal temperature is 
dependent on the primer and complementary template. In sequences with higher GC (guanine or 
cytosine nucleotides) content have the potential to form stronger hydrogen bonds with the 
template, and this generally require higher annealing temperatures. The annealing temperature 
ranges from 50oC to 65oC, and is empirically determined (see Section 2.5.3), but is typically about 
3–5 oC below the Tm (primer melting temperature) of the primers used. Stable DNA–DNA hydrogen 
bonds are formed when the primer sequence very closely matches the template sequence, and 
the DNA polymerase is able to combine with the primer-template interaction. Nowadays, almost 
all PCR amplifications utilises a heat-stable DNA polymerase (such as Taq polymerase, an enzyme 
that was initially isolated from the Thermus aquaticus bacteria, but is now typically bulk produced 
from pTaq cloned in E. coli). 
 
During the third step (elongation step), the DNA polymerase synthesizes a new DNA strand 
complementary to the template strand by adding dNTPs that are complementary to the template 
in 5' to 3' direction, by condensing the 5'-phosphate group of the dNTPs with the 3'-hydroxyl group 
at the end of the nascent (extending) DNA strand. This step is set at a temperature which is 
optimal for the DNA polymerase, typically between 70oC and 75oC. The buffer solution enhances 
the stability of the polymerase and provides a suitable chemical environment for optimum 
enzymatic activity. Magnesium acts as a co-factor for the polymerase enzyme, and increases the 
enzymatic activity, thus increasing the concentration increases sensitivity, but decreases 
specificity. The duration of this step is dependent on the predicted size of the PCR amplicon. As 
Taq polymerase extends by approximately 1,000 base pairs per minute, this is also the 
approximate time used. 
 
The final elongation step is often performed, and is maintained at the same temperature as all 
previous elongation steps, but for a longer duration (usually between 5 to 15 minutes). This is to 




As PCR progresses, the DNA generated is itself used as a template for replication, setting in motion 
a chain reaction in which the DNA template is exponentially amplified. Typically, PCR protocols 
consist of a series of 25-40 repeated temperature cycles. Once again, this is established empirically 
for each reaction.  
 
2.5.2. Principles - Primer design 
A PCR primer is a single-stranded oligonucleotide that is able to hybridize with complementary 
stands of the DNA template, and thus identify the region to be copied. An appropriate pair of 
primers is used to amplify each region that it flanks. There are several considerations during 
primer design: 
- Primer length between 18-30 bases  
o Longer primers do not necessarily improve specificity, but risks secondary structures 
and formation of primer dimers  
- (Predicted) primer melting temperatures (Tm) between 55°-70°C 
o A simple prediction is calculated from Tm = 4(G + C) + 2(A + T) 
oC 
o However, the actual Tm is more complicated. Tm is also influenced by the 
concentration of electrolytes within the reaction. There is a range of online tools that 
uses more complex algorithms, for example 
www.basic.northwestern.edu/biotools/oligocalc.html. 
o In practice, the range of acceptable Tm is broad enough that post-design optimisation 
is able to determine the optimal annealing temperature. 
- (Predicted) Tm difference between forward and reverse primers of less than 5
oC 
o Pairs of primers with a large difference in Tm may result in inadvertent preferential 
amplification of the most efficiently primed product strand, and lead to a reduction in 
yield or even no amplification. 
- GC content of 50-60% and good 3′ stability 
o In addition to the absolute number of G or C bases, the position also appears to 
matter. If present at the 3′ end of primers (GC clamp), it helps to promote correct 
binding at the 3′ end due to the stronger hydrogen bonding of G and C bases. 
However, when present as sequences in the middle of the primer may disrupt stable 






- No secondary structures 
o Nucleic acids natural fold into secondary structures, particularly at lower 
temperatures. The stability of these template secondary structures depends largely 
on their free energy and melting temperatures. If these secondary structures in the 
oligonucleotides are stable even above the annealing temperatures, then the primers 
are unable to bind to the template DNA, and the yield of PCR product is significantly 
reduced. There are a range of online tools that are able to predict the secondary 
structures of primers, for example 
http://www.premierbiosoft.com/primerdesign/index.html. 
- No self-complementarity 
o Self-complementarity can result in hairpin formation with just four GC base pairs in 
the stem and three bases in the loop. If primers form hairpins, they are not available 
for to anneal to their target regions. There are a range of online tools that is able to 
predict the secondary structures of primers, for example 
http://www.premierbiosoft.com/primerdesign/index.html. 
- No complementarity to other primers in the reaction 
o Complementarity between the two primers, especially at the 3′ ends, can lead to the 
formation of primer-dimers.  
- No long runs with the same base of greater than 4 pairs 
o As this would otherwise lead to an increased risk of overall misalignment of primer 
and template. 
- Depending on the polymerase enzyme, some are not able to reliably replicate beyond 2,000 
base pairs. 
There are several online programs to assist in primer design. This includes Primer3web 
(http://primer3.ut.ee/). 
 
Whilst a 17-mer or longer primer should be complex enough so that the likelihood of annealing to 
sequences other than its chosen target is low it is important to ensure that portions of the primer 
do not have sequence or cross-homology with regions other than the desired target. Computer 
programs such as BLAST (Basic Local Alignment Search Tool, 
http://blast.ncbi.nlm.nih.gov/Blast.cgi) can be used to find any other regions of similarity within a 
genome. If there is significant homology with other sections of the genome, it increases the 




Primer design for RT-PCR 
When designing primer pairs for RT-PCR, to amplify cDNA, at least one of the primers should span 
an intron-exon border or the pair to be placed in two different exons. This would allow 
differentiation of amplification of cDNA from that of genomic DNA ( 
Table 8). Of course, this is not possible with intronless genes. 
 
Template cDNA  Genomic DNA 
Both primers within one exon Amplifies with expected 
amplicon size 
Amplifies with expected 
amplicon size 
One primer spanning intron-
exon border 
Amplifies with expected 
amplicon size 
May amplify, depending on the 
3’-end of the primer 
interaction with the template 
Both primers on differing 
exons (spanning at least one 
intron) 
Amplifies with expected 
amplicon size 
Amplifies with larger than 
expected amplicon size (and 
might not amplify if too large 
an intron) 
 
Table 8: Designing RT-PCR primers 
 
2.5.3. Principles - Reaction optimization and controls 
As laid out above, there are two variables for the polymerase chain reaction that are often 
determined empirically – annealing temperature and Mg2+ concentration. The range of annealing 
temperatures is often 4oC either side of the lower Tm out of the two primers. The range for Mg
2+ 
concentration is typically between 1mM to 4mM, with starting experiments typically at 
2mM.Lowering the annealing temperature or increasing the Mg2+ concentration increases the 
sensitivity of the reaction, but increases the chances of non-specific products. Conversely, to 
increase the specificity of the reaction (for example when there are non-specific products already 
present), the annealing temperature can be increased or the Mg2+ concentration reduced – but 
potentially reducing yield of the desired amplicon.  
 
In certain circumstances, nested PCR can be conducted to reduce non-specific products or increase 
sensitivity in reactions with a low yield. This procedure involves two sets of primers, used in 
successive polymerase chain reactions. The second pair of primers is designed to amplify a region 






Polymerase chain reactions should be conducted with: 
- positive controls (known samples that produce an amplicon with the reaction) whereby an 
absence of an amplicon indicates a faulty reaction, 
- negative controls (no template in the reaction) whereby any detected amplicon indicates 
contamination of the reaction, and  
- in the case of RT-PCR, an RT-negative control (where the RNA is processed without the 
reverse transcriptase reaction) whereby any detected amplicon suggests contamination of the 
RNA sample. 
 
2.5.4. Principles - Agarose gel electrophoresis 
Detection of PCR products is typically conducted with agarose gel electrophoresis made in Tris-
Acetate-EDTA (TAE) or Tris-Borate-EDTA (TBE) buffers.  
 
The quantity (w/v percentage) of agarose determines the pore size to sieve the electrophoresed 
PCR products, with the higher percentage resulting in smaller pores, and better separation over 
smaller amplicon sizes. The 2% w/v agarose gels used for this thesis have a good separation of 
products between 100 and 1,200 bp. To separate larger products, such as in the cloning / 
mutagenesis process, 0.7% w/v gels were used. 
 
TAE and TBE buffers are chosen as these solutions are slightly basic, keeping the PCR amplicons 
deprotonated and soluble in water. Additionally, EDTA is a chelator of divalent cations, particularly 
Mg2+ which is also a co-factors for many enzymes, including contaminant nucleases, thus providing 
protection against enzymatic degradation. 
 
The samples are loaded near the cathode end of the gel. With the net negative charge of the 
sugar-phosphate backbone of the PCR amplicons, when an electric field is introduced, it induces 
the nucleic acids to migrate towards the anode. The separation of these fragments is dependent 
on the mobility of different sized molecules passing through the gel. Longer molecules experience 
more resistance within the gel, thus they migrate more slowly across the gel, and the converse is 
true for smaller molecules. The gel is run until the bromophenol front, which approximates to the 





There are several nucleic acid stains that aid detection. Previously, ethidium bromide was 
commonly used as it intercalates between double stranded DNA, and fluoresces under ultraviolet 
light. However, due to its mechanism of action, it deforms DNA and affects DNA replication, thus 
potentially mutagenesis. Newer and larger molecules such as GelRed™ and SYBR® Green work 
similarly, are more sensitive in detecting double stranded DNA, and are marketed as being less 
toxic by virtue of being less likely to enter cells. To approximate the sizes of PCR amplicons, a DNA 
ladder of known sizes is electrophoresed in parallel to the samples.  
 
2.5.5. Principles - Isolation of PCR products 
If the PCR amplicons are required for downstream processes, such as sequencing, enzymatic 
processing, cloning and microarray analyses, they need to be purified of unincorporated primers, 
left-over dNTPs, salts, and enzymes. This can be performed straight from the PCR product, or from 
excised bands of an agarose gel. 
 
If the sample is being extracted from an agarose gel, it is initially melted before it is bound on a 
silica membrane within a spin column. The bound DNA is washed with and ethanol-based 
solutions and the cleaned DNA can be eluted in the buffer of choice, such as nuclease-free water, 
TAE or TBE. Most manufacturers of commercial columns claim that up to 95% of PCR products, 
between 100 bp and 10 kb, can be reclaimed in this process. Furthermore, they would claim that 




The PCR template could be genomic DNA, complementary DNA (cDNA) as derived from reverse 
transcription of RNA, formaldehyde-derived chromatin-associated DNA, or PCR amplicons for 
nested PCRs.  
 
Polymerase chain reaction 
The reaction mix was kept at 0oC using an ice bath to inhibit any polymerase activity. The final 
concentration of the reagents within the reaction include 400 µM primers, 80 µM dNTPs, variable 
Mg2+ (see Table 21 for reaction specific concentration), 1x reaction buffer and 2.5 units of Taq 
polymerase (Sigma, D1806). The final volume of the reaction was made up to 25 µl using nuclease-




Table 9). After the reaction, the samples were held at 4oC until agarose gel electrophoresis.  
 
 Temperature Duration 
Initialisation step (Hot Start) 95oC 5 minutes 
35 cycles Denaturing step 95oC 1 minute 
Annealing step Variable (see Section 
2.21.2 for primer pair-
specific conditions) 
1 minute 
Elongation step 72oC 30 seconds 
Final elongation step 72oC 10 minutes 
 
Table 9: Thermocycler program for end-point PCR 
 
 
Agarose gel electrophoresis 
2% w/v agarose powder was suspended in 1x TBE buffer (89 mM Tris-base, 89 mM boric acid, 2 
mM EDTA pH 8.0; where the 10x preparation is adjusted to pH 8.3), and brought to the boil to 
dissolve the agarose. This was let to cool at room temperature, and before the gel forms, GelRed™ 
(Biotium, 41003) was added to achieve a final 1x concentration. The resultant mixture was poured 
into horizontal gel casts with the appropriate comb in place to create the sample wells. The gel is 
suitable for use once it solidifies and reaches room temperature. 
 
Just before electrophoresis, 6x DNA Loading Buffer (60% v/v glycerol, 60 mM Tris-HCl pH 8.0, 6 
mM EDTA pH 8.0, 0.06% w/v bromophenol blue) was added to the PCR products to achieve a final 
concentration of 1x. Electrophoresis was conducted in a horizontal electrophoresis tank filled with 
1x TBE. The samples are loaded in the wells placed at the cathode end of the tank. The quantity 
loaded is dependent on the size of the wells created. A 100 bp DNA ladder (New England Biolabs, 
N3231L) was electrophoresed in parallel. 
 
Once the bromophenol blue front reaches approximately three-quarters, the gel was visualised by 
an ultraviolet transilluminator which also captures a digital image (GelDoc-It Imager, Ultra-Violet 
Products Ltd., UK). In semi-quantitative analyses, the intensities of the signals were quantified by 
the public domain, Java-based image processing program ImageJ. 
 
 




Isolation of PCR products was conducted using the Wizard® SV Gel and PCR Clean-Up System 
(Promega, A9281), and the protocol is summarised as follows. 
 
When isolating PCR amplicons from an excised gel piece, Membrane Binding Solution was added 
to the gel slice in a microcentrifuge at a ratio of 1 µl for every 1 mg of agarose gel. This was then 
incubated in a water bath equilibrated to 50oC to 65oC until it dissolved. When isolating PCR 
amplicons from the reaction mixture, add an equal volume of Membrane Binding Solution to the 
PCR amplification. 
 
For both sample types, the mixture can now be loaded into the SV mini-column assembly. This was 
then centrifuged for 1 minute at 13,000g at room temperature. The flow-through was discarded, 
and 700 µl of Membrane Wash Solution was added.  This was then centrifuged for 1 minute at 
13,000g at room temperature. The flow-through is again discarded, and a second wash of 500 µl of 
Membrane Wash Solution was added to the mini-column assembly.  This was then centrifuged for 
5 minute at 13,000g at room temperature. The flow-through was discarded again, and the mini-
column was re-centrifuged to allow evaporation of any residual ethanol. 
 
Once the residual ethanol has evaporated, the PCR products was eluted by adding 50 µl of 
nuclease-free water to the mini-column, and incubated at room temperature for 1 minute. The 
eluate was collected by centrifugation of the mini-column for 1 minute at 13,000g at room 




2.6. Allelic expression imbalance analysis 
2.6.1. Principles 
The allelic expression imbalance analysis method used in this study utilises sequencing 
chromatographs of genomic DNA and cDNA of heterozygotes at the SNP of interest to assess any 
allele-dependent levels of RNA (i.e. cDNA). The relative chromatograph peak heights at the SNP 
could be a good indicator of relative expression levels of each allele. However, due to the nature 
of the Sanger sequencing method, the peak heights are not just dependent on other quantity of 
the allele present, but also the position of the SNP and the surrounding nucleotides. With this, the 





This method has an advantage of being internally controlled, where both alleles are exposed to 
the same intracellular environment, unlike qPCR (Section 2.7). On the other hand, it is not able to 
easily differentiate between isotypes or comparisons across different cell types. 
 
Sanger sequencing 
Sanger sequencing utilises the chain-termination method, and requires a single-stranded DNA (or 
PCR amplicon) template, a primer, DNA polymerase, deoxynucleoside triphosphates (dNTPs), and 
modified di-deoxynucleoside triphosphates (ddNTPs). The template, primer, polymerase and 
dNTPs work similarly to that in a standard PCR with cycling temperatures. However, the ddNTPs is 
the key variation, as once incorporated, they terminate elongation of the chain. They have chain-
terminating properties as these nucleotides lack a 3'-OH group required for the formation of a 
phosphodiester bond. The ddNTPs may be radioactively or fluorescently labeled for detection in 
automated sequencing machines. 
 
The processed sample is divided into four separate sequencing reactions, containing all four of the 
standard deoxynucleotides (dATP, dGTP, dCTP and dTTP) and the DNA polymerase. To each 
reaction only one of the four dideoxynucleosides (ddATP, ddGTP, ddCTP, or ddTTP) is added. 
Following rounds of template DNA extension from the bound primer, the resulting DNA fragments 
are heat denatured and separated by size. The relative positions of the different bands among the 
four lanes, from bottom to top, are then used to read the DNA sequence. In the past, separation 
may be conducted on a denaturing polyacrylamide-urea gel, and radiolabelled-ddNTPs detected 
by autoradiography. With modern DNA sequencers typically utilise capillary electrophoresis for 
size separation and detection is based on fluorescent dye-labelled ddNTPs. The data output is 
usually shown as fluorescent peak trace chromatograms. 
 
Allelic imbalance analysis by PeakPicker 
As peak-heights along a chromatogram vary depending on sample, base type and position, the 
absolute values are not fully representative of the relative abundance of any one allele. With this, 
the PeakPicker software (McGill University and Génome Québec Innovation Centre, California; 
previously available at http://genomequebec.mcgill.ca/EST-HapMap) was used to determine 
relative allele ratios from paired genomic DNA and cDNA samples, as first published in 2005 (Ge et 




were normalized to the peak-heights of the adjacent non-polymorphic positions. The software 
utilises the same adjacent positions across the whole dataset, analyzed simultaneously. The input 
files for PeakPicker are the raw sequence files from ABI (Applied Biosciences, USA) sequencers 
(*.ab1 file), whist the output of this software are normalized peak-heights (arbitrary units) for each 
allele at the polymorphism.  
 
Utilizing validated software such as PeakPicker allows for more uniform quantification and 
removes potential of observer bias. However, it should be recognised that these normalized peak-
heights is at most semi-quantitative as it is not linearly correlated with nucleic acid copy numbers. 




Another method of determining allele-associated mRNA expression levels is to compare the qPCR 
Ct values (number of PCR cycles to reached a defined level of signal) of different genotypes. A 
proposed benefit of qPCR over allelic imbalance analyses is that it allows comparisons across the 
three genotypes, potentially determining if there is an additive, or perhaps a dominant, model 
present. Unlike allelic imbalance, qPCR also allows comparison of haplotypes. 
 
However, this is balanced against the experimental context of allelic imbalance comparisons. In 
this setting, the cellular environment in a heterozygotic cell line is the same for both alleles. This 
reduces the significant variability and potentially confounding factors that would otherwise cloud 
the overall picture of qPCR results. This also provides the logistical advantage of being able to 
conduct paired statistical analyses, which in general reduces the number of experiments required 




Sanger sequencing was conducted by an in-house commercial service at the Genome Centre, 
Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ. Samples (greater 
than 10 µl, typically at 10 ng/µl) together with primers (2 µl at 10 mM) were delivered to the 





Allelic imbalance analysis by PickPicker 
The PeakPicker software (McGill University and Génome Québec Innovation Centre, California; 
previously available at http://genomequebec.mcgill.ca/EST-HapMap) was used to determine 
relative allele ratios from heterozygotes of interest. Once the raw sequencing data was available, it 
is uploaded into the program ( 





Figure 15: PeakPicker analysis of chromatographs conducted in parallel 
Each row of nucleotide sequence represents one uploaded sample. The chromatograph at the 
bottom is that set as “reference sequence”. 
 
After uploading the sequences, the SNP of interest is selected, and the program was prompted to 
automatically select surrounding peaks of the same nucleotides to allow for normalisation to the 
peak-heights of the adjacent non-polymorphic positions ( 






Figure 16: PeakPicker analysis of the “reference sequence” 
Red and blue dots indicate selection of the SNP of interest. The values in the box highlighted on the 
right represent the measure peak-heights at the specified positions. 
 
After the program conducts the analysis, the normalised peak-heights (arbitrary units) are listed 








Figure 17: PeakPicker output of normalised peak-heights 
The highlighted box lists the normalised peak-heights (arbitrary units) is listed for each sample. 
 
 
2.7. qRT-PCR (quantitative reverse transcription-polymerase chain reaction) 
2.7.1. Principles - History 
Before the age of the automated real-time PCR system, attempts were made to provide 
quantitation using end-point PCR and ethidium bromide staining, for which one of the first reports 
is that from Wang and colleagues (Wang et al., 1989). Then, the target mRNA is co-amplified with 
a known internal standard in one reaction. A standard curve could be generated with varying the 
number of cycles, or serial-diluting the templates. The slope of the curves, as compared to the 
known internal standard would provide the relative quantification.  The real-time PCR systems 
that we know now bear significant resemblance to this precursor technique, except for: 
 replacing the ethidium bromide staining with either fluorescent-quencher tagged probes or 




 replacing the standard curve with an automated process with fluorescence readings at each 
cycle, and detecting a threshold fluorescent signal is reported, instead of a manually 
generated standard curve. 
Each of these factors will be explored below. 
 
2.7.2. Principles - Detection systems 
Intercalators 
Initially techniques for measuring real-time PCR products utilised intercalator dyes. These dyes 
(such as SYBR® Green I) behave similarly to ethidium bromide and GelRed™, but instead of binding 
the major or minor grooves of double-stranded DNA, these dyes intercalate with DNA instead. The 
key difference between dyes like SYBR® Green I, and other intercalators is that they do not inhibit 
polymerase chain reactions. These intercalators also have an increased fluorescence when bound 
to double-stranded DNA. As the PCR progresses, more amplicons are created which allows more 
SYBR Green I dye to bind double-stranded DNA, and results in an increased fluorescence intensity 
proportional to the amount of PCR product produced.  
 
An advantage with the intercalator system is that multiple dye molecules bind to a single PCR 
amplicon, increasing the sensitivity for detecting amplification products. On the other hand, this 
multiple dye binding means the amount of signal is dependent on the mass of double-stranded 
DNA produced in the reaction. Thus, if the amplification efficiencies are the same, amplification of 
a longer product will generate more signal than a shorter one. A further advantage is that it is 
relatively cheaper than fluorogenic probe-based methods (see below). 
 
The primary disadvantage of the SYBR Green I dye chemistry is that it binds to any double-
stranded DNA. With this, it can also bind to nonspecific double-stranded DNA or oligonucleotide 
sequences, including primer dimers, resulting in either an inflated quantification, or in some cases, 
a false positive. This can be limited by initially conducting end-point PCR reactions to confirm 
specificity of the PCR primers, and melting curve analyses. 
 
Fluorogenic-labelled probes 
Another common method uses fluorogenic-labeled probes and the 5' nuclease activity of Taq DNA 
polymerase. An example of this is the TaqMan® probe-based expression assays. It requires two 




quencher dye on the 3' end. While the probe is intact, the proximity of the quencher dye greatly 
reduces the fluorescence emitted by the reporter dye by fluorescence resonance energy transfer 
through space. As the PCR continues, the Taq DNA polymerase cleaves the probe, and separates 
the reporter dye from the quencher dye, increasing the reporter dye signal. As this also removes 
the probe from the target strand, primer extension continues to the end of the template strand 
without inhibition of the overall PCR process. With each further cycle, more probes are cleaved, 
producing an increased fluorescent signal. 
 
The advantage of the fluorogenic-labelled probes centers around the increased specificity, as the 
probe only binds a specific sequence. Additionally, the probes can be labelled with different 
reporter dyes allowing the possibility of duplex studies, allowing an internal control. Finally, unlike 
that of intercalator dyes, the one probe to one amplicon ratio means that there is no dependence 
on amplicon size for the overall signal, allowing for more flexibility when designing primers and 
probes. 
 
The primary disadvantage of the TaqMan® probe-based chemistry is that the synthesis of different 
probes is required for different sequences. The requirement for a short amplicon (80 to 150 bp) to 
fit three binding sequences (a ~20 bp forward primer, a ~20 bp reverse primer and a ~30 bp probe) 
makes primer design in a predefined area difficult. Although usually not an issue, the ratio of one 
fluorescent probe to one amplicon means the fluorescent signal may not be as greatly amplified as 
intercalators. 
 
Passive reference dyes 
Passive reference dyes are commonly used in qPCR to normalize for non-PCR related fluorescence 
signal variation. As the passive reference dyes do not take part in the reaction, the detectable 
fluorescence remains constant throughout the numerous PCR cycles. This provides an internal 
reference to which the reporter dye signal can be normalized. This normalization is typically 
automatically considered with newer real-time PCR systems, and is taken as a ratio (Rn = Reporter 
fluorescence / Passive Reference fluorescence). The use of a passive reference is best for 
normalizing well-to-well optical variations caused by bubbles. It also may help, to a very limited 







The automated real-time PCR systems now allow a high-throughput, sensitive and accurate gene 
quantitation assay. The assay uses fluorescent signals, either by fluorescent DNA intercallators or 
fluorophore-tagged probes (described above), and an instrument capable of measuring 
fluorescence in real-time. 
 
During each extension step (when either the DNA intercallator is able to bind double-stranded 
amplicons or fluorescent-probes have already been cleaved), the fluorescence value of the PCR is 
assessed and plotted in an amplification plot as exemplified in Figure 18 (Heid et al., 1996). The 
reaction initially demonstrates a baseline phase, with minimal change in detectable fluorescence 
signal. At a certain number of amplicon copies, the signal rapidly increases into the exponential 
phase, then the linear phase and finally (after a large number of cycles), the plateau phase.  
 
The threshold value is calculated by the analysis software as a set number of standard deviations 
(usually 10) above the mean of the baseline emissions calculated from the initial cycles (usually 1 
to 15). Once the threshold is chosen, the point at which the amplification plot crosses the 
threshold is defined as Ct (threshold cycle). Ct is reported as the cycle number at this point, 




Figure 18: qPCR amplification plot 
Example amplification plot (Heid et al., 1996). ΔRQ (also termed ΔRn, or Delta Rn) is the 
normalization of ratio of the fluorescence emission intensity of the reporter dye to the fluorescence 





As identified by various reports, the Ct value is predictive of the quantity of input target (Figure 19, 
Heid et al., 1996). Depending on the PCR efficiency, each decrease in Ct of one cycle equates to an 
x-fold increase in template quantity. In a theoretical 100% efficient PCR system, this equates to a 




Figure 19: qPCR log-linear relationship 
Example of the log-linear relationship between input template (x-axis) and threshold cycle (y-axis) 
(Heid et al., 1996). 
 
As the work in this thesis concentrates on relative differences in gene expression, the above 
relative quantification is applicable. Absolute quantification adds a further layer of complexity of 
relating the PCR signal to a standard curve, and is neither used, nor further discussed in this thesis. 
 
2.7.3. Principles - Analysis 
One way of analyzing and presenting relative quantification qPCR data is the 2-ΔΔCt method (Livak 
and Schmittgen, 2001), and refers to the change in expression of a target gene in a sample (or 
population) relative to another. This method utilises an internal control gene to normalize for the 
amount of RNA/cDNA added to the reaction. Standard housekeeping genes such as GAPDH, β-
actin and 18S rRNA are often used. Theoretically, a difference of ddCt of x equates to a 2
x-fold 









A key reason for conducting qRT-PCR studies, in addition to supporting the initial findings of the 
allelic imbalance experiments on allele-dependent mRNA levels, is to assess any potential 
differences in SLC4A7 isoforms based on genotype. Original intentions to use a duplex design were 
excluded as the positioning of probes and primers would lead to potential duplicated and thus 
non-specific signals. The eventual primer design utilised a common forward primer. The amplicons 
of the reaction detecting either isoform were similar in size (near 100 bp) to aid comparable PCR 




Figure 20: Schematic of primers used for SYBR® Green qPCR. 
To detect the longer transcript (above), only the FOR and REV1 primers are used, and the position 
of REV2 is illustrated only to show the relative sizes of PCR amplicons. For the shorter SLC4A7 
transcript (below), only the FOR and REV2 primers are used. 
 
End-point PCR using these pairs of primers confirmed that there were no non-specific signals, no 
primer-dimers, and the absence of the larger (394 bp) product when using FOR and REV2 primers 
(Figure 21). This indicates the two different pairing of primers is appropriate to specifically amplify 






Figure 21: Endpoint PCR with primers used for SYBR® Green qPCR. 
Endpoint PCR with primer pairs detecting the variants with (left) and without (right) the 372 amino 
acid exon 7 (equating to the 124 amino acid Cassette II). There were neither non-specific products 
nor primer-dimers present. 
 
If required, magnesium and primer concentrations could be varied to optimize the signal while 
eliminating non-specific products as well as primer-dimers. However, the staring concentrations of 
3 mM Mg2+ and 400 nM of each primer produced the appropriate results on end-point PCR, and 
thus did not require further optimization. 
 
Quantitative polymerase chain reaction (qPCR) 
The qPCR was conducted in 384-well plates with the SYBR® Green system (Applied Biosystems, 
4309155) with 5 µl for each reaction. For each reaction, 2.5 µl of 2x  SYBR® Green PCR Master Mix, 
0.2 µl of each forward and reverse (10 mM) primer to reach a final concentration of 400 nM each 




SYBR® Green PCR Master Mix already contains 6 mM Mg2+, to reach a final concentration of 3 mM 
in each reaction. 
 
All reactions were conducted in duplicate, together with duplicates of the housekeeping gene (18S 
ribosomal RNA).  
 
The 384-well plate was placed into a real-time PCR system (Applied Biosystems 7900HT Fast Real-
Time PCR System) and the thermocycler program in  
Table 10 was used. 
 
 Temperature Duration 
Initialisation step (Hot Start) 95oC 10 minutes 
40 cycles Denaturing step 95oC 15 seconds 
Annealing and 
elongation step 
60oC 1 minute 
 
Table 10: Real-time PCR program for qPCR 
 
Control / housekeeping gene expression 
18S ribosomal RNA was used as the control housekeeping gene to normalize for RNA/cDNA 
quantity in the reaction. The pre-designed TaqMan probe and primer set (4333760F) was used 
according to the manufacturer’s protocol. 
 
Analysis of results by SDS (Sequence Detection Systems, Applied Biosystems) software 
The results from the plate reader was obtained in a *.sds file. This was analyzed by the SDS v2.4.1 
software (Applied Biosystems, USA). Ct values were automatically calculated based on population-
dependent threshold levels.  
 
 
2.8. Protein isolation 
2.8.1. Principles 
Methods and components of lysis buffers for protein isolation depend ultimately on the end use. 







(a) Total cellular protein isolation for SDS-PAGE 
Isolation of total cellular protein is predominantly based on surfactants. Surfactants are 
amphiphilic, which is to say that they have both hydrophilic and hydrophobic groups. This allows 
them to disrupt lipid membrane layers, thus freeing up intracellular and membrane-bound 
proteins. Typical surfactants used are SDS (sodium dodecyl sulphate), Triton X-100, CHAPS (3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate), NP-40 (nonyl 
phenoxypolyethoxylethanol) or Nonidet P-40 (octyl phenoxypolyethoxylethanol). Mechanical 
disruption with sonication, dounce homogenizers, vortex mixers or syringe-and-needle methods 
could also be further used.  
 
(b) Protein isolation for co-immunoprecipitation 
The basis of co-immunoprecipitation requires the retention of protein-protein interactions. Thus, 
lysis buffers containing milder detergents such as NP-40 or Nonidet P-40 were utilised as they 
have a lower propensity to interrupt protein-protein interactions. Unlike total cellular protein 
isolation, mechanical disruption is not utilised as it may promote disruption of protein-protein 
interactions, particularly sonication. Alternatively, other protocols utilise formaldehyde to form 
protein-protein crosslinks, which is maintained during, and reversed after immunoprecipitation by 
heating. 
 
(c) Nuclear extract isolation for electrophoretic mobility shift assays (EMSA) 
Isolation of nuclear extracts occurs in two stages with first the cytosolic lysis buffer followed by a 
nuclear lysis buffer. Initially, a cytosolic extract is derived when the plasma membrane is lysed 
without lysing the nuclear membrane. The cytosolic lysis buffer is often hypotonic, resulting in 
cellular swelling and disruption of the plasma membrane but not the nuclear membrane. Milder 
detergents such as NP-40 or Nonidet P-40 is utilised as they have an effect on the plasma 
membrane and not nuclear membrane. After the use of the cytosolic lysis buffer, the sample 
undergoes centrifugation separating out the cytosolic fraction (supernatant) and nuclei (pellet). 
The resultant pellet is lysed with a non-ionic, non-denaturing nuclear lysis buffer. The end-use in 







Figure 22: Fractionation of cytosolic and nuclear extracts 
Ponceau S staining of cytosolic and nuclear extracts (both 20 µg per lane) showing different 
banding patterns. 
 
(d)  Subcellular protein fractionation 
Isolation of membrane proteins takes advantage of the differences in the sedimentation 
coefficient of various cellular compartments. Typically, the larger and denser the particle, the 
higher the sedimentation coefficient, and in practical terms, forms pellets with centrifugation at 
lower speeds. 
 
Initially, the cells are lysed with a non-ionic, hypotonic lysis buffer. The non-ionic nature of the 
lysis buffer results in maintained lipid bilayers, thus nuclei, large complexes of cytoskeleton, 
mitochondria, lysosomes, peroxisomes, vesicles, and importantly, large fragments of the plasma 
membrane, remains intact. The cell homogenate is centrifuged at progressively higher speeds to 




A first low speed centrifugation (approximately 1,000g) pellets out whole cells, nuclei and large 
insoluble proteins complexes. A further centrifugation at medium speeds (approximately 10,000g) 
pellets out mitochondria, lysosomes and peroxisomes. A final ultracentrifugation at fast speeds 
(approximately 100,000g) pellets out vesicles and the cellular lipid membrane. The resultant 
supernatant contains the soluble cytosolic proteins (Figure 23). 
 
A key limitation to this method is that the 10,000g fraction contains the whole mixture of cellular 
organelles. If there is an interesting signal in this fraction, it is not possible to determine which 
subcellular location it is derived from. Alternatives, or more precisely complementary methods, 
would include immunocytochemistry (Section 2.16) and flow cytometry, although they would also 




Figure 23: Differential fractionation of cellular proteins 
Representative Ponceau S staining of subcellular fractionation by progressively higher speed 







(e)  Protease inhibitors 
Proteases are found in cells, and thus also present in cell lysates, independent of lysis method. 
There are broadly six groups of proteases – serine proteases, threonine proteases, cysteine 
proteases, aspartate proteases, glutamic acid proteases and metalloproteases – for which the 
names identify the mechanism to cleave the peptide bond. Metalloproteases are typically 
inhibited by the EDTA within most lysis buffers, as it chelates the necessary metal ions. With the 
remaining proteases, there are a variety of protease inhibitors with varying specificities for 
different protease classes. With this, usually a cocktail of different inhibitors are required.  
 
Particular care should be taken when handling and storing protease inhibitors, as several (such as 
phenylmethylsulfonyl fluoride) have a short half-life in aqueous solution and are even shorter with 
temperatures above 4oC. With this, the cocktails should be kept at -20oC before use. 
 
2.8.2. Methods 
(a) Total cellular protein isolation for SDS-PAGE 
Cells from a confluent T-25 flask (25 cm2 surface area) with an approximate cell count of 2.5 
million HUVECs or HUASMCs were used for whole-cell protein extraction. The cell culture media is 
removed from the T-25 flask, and subsequently the adherent cells were washed twice with ice-
cold PBS. Following removal of the PBS wash, 200 µl of RIPA buffer (50 mM Tris pH7.4, 150 mM 
NaCl, 0.5% w/v sodium deoxycholate, 1% v/v NP-40, 0.1% w/v sodium dodecylsulfate) with 
protease inhibitor mixture was added. The volume of RIPA buffer was scaled-up or –down 
dependent on the tissue culture surface area. Single-use cell lifters were used to detach the 
adherent cells from the cell culture surface. The resultant cell suspension was transferred to a 2 ml 
microcentrifuge tube. This was rested on ice for 30 minutes with cell disruption using a needle and 
syringe. Following cell lysis, the sample was centrifuged at 13,000g for 10 minutes at 4oC. The 
supernatant was kept as the cell lysate, and the cell debris pellet discarded. 
  
(b) Protein isolation for co-immunoprecipitation 
Cells from a confluent T-75 flask (75 cm2 surface area) with an approximate cell count of 7.5 
million HUASMCs were used for co-immunoprecipitation. The cell culture media was removed 
from the T-75 flask, and subsequently the adherent cells were washed twice with ice-cold PBS. 
Following removal of the PBS wash, 500 µl of IP lysis buffer (25 mM Tris HCl pH 7.2, 150 mM NaCl, 




lifters were used to detach the adherent cells from the cell culture surface. The resultant cell 
suspension was transferred to a 2 ml microcentrifuge tube. This was agitated on a roller shaker for 
30 minutes in the cold room (4oC). Following cell lysis, the sample was centrifuged at 13,000g for 
10 minutes at 4oC.  
 
(c) Nuclear extract isolation for electrophoretic mobility shift assays (EMSA) 
Cells from a confluent T-75 flask (75 cm2 surface area) with an approximate cell count of 7.5 
million HUVECs or HUASMCs were used for nuclear extract isolation. The cell culture media is 
removed from the T-75 flask, and subsequently the adherent cells are washed twice with ice-cold 
PBS. Following removal of the PBS wash, 500 µl of hypotonic lysis buffer (10 mM HEPES pH 7.9, 10 
mM KCl, 0.1 mM EDTA, 0.004% v/v NP-40), with protease inhibitor mixture was added. The 
volume of lysis buffer was scaled-up or -down dependent on the tissue culture surface area. 
Single-use cell lifters were used to detach the adherent cells from the cell culture surface.  
 
The resultant cell suspension was transferred to a 2 ml microcentrifuge tube. This was agitated on 
a roller shaker for 30 minutes in the cold room (4oC). Following cell membrane disruption, the 
sample was centrifuged at 13,000g for 3 minutes at 4oC. The supernatant was kept as the 
cytoplasmic fraction, and the cell debris pellet contains unlysed nuclei. 
 
The nuclei pellet is lysed with the nuclear lysis buffer (20 mM HEPES pH 7.9, 400 mM NaCl, 1 mM 
EDTA, 10% v/v glycerol), with protease inhibitor mixture. The nuclei were disrupted using a needle 
and syringe, and placed roller shaker for 2 hours in the cold room (4oC). Then, the sample was 
centrifuged at 13,000g for 5 minutes at 4oC. The supernatant nuclear fraction was retained, and 
the insoluble debris is discarded. 
 
(d)  Subcellular protein fractionation 
Cells from a confluent T-75 flask (75 cm2 surface area) with an approximate cell count of 7.5 
million were used for membrane protein preparations. The cell culture media was removed from 
the T-75 flask, and subsequently the adherent cells are washed twice with ice-cold PBS. Following 
removal of the PBS wash, 500 µl of homogenization buffer (10 mM Tris HCl pH 7.2, 1 mM EDTA pH 
8.0, 250 mM sucrose), with protease inhibitor mixture was added. Single-use cell lifters were used 





The cell homogenates was transferred to a microcentrifuge tube and centrifuged at 900g for 10 
minutes at 4oC. The pellet is kept as the nuclear (and cell debris) fraction and dissolved in 50 µl of 
RIPA buffer (50 mM Tris pH7.4, 150 mM NaCl, 0.5% w/v sodium deoxycholate, 1% v/v NP-40, 0.1% 
w/v sodium dodecylsulfate) with protease inhibitor mixture.  
 
The subsequent supernatant was transferred into a fresh microcentrifuge tube and centrifuged at 
10,000g for 5 minutes at 4oC. The pellet is kept as the mitochondrial (and lysosomes / 
peroxisomes) fraction and dissolved in 50 µl of RIPA buffer with protease inhibitors.  
 
The subsequent supernatant was again transferred into a fresh microcentrifuge tube and 
centrifuged at 100,000g for 60 minutes at 4oC. The pellet is kept as the membrane fraction and 
dissolved in 50 µl of RIPA buffer with protease inhibitors. The supernatant is kept as the 
cytoplasmic fraction. 
 
If the cytoplasmic fraction was not of a sufficient concentration, it was concentrated using the 





Figure 24: Cartoon of subcellular protein fractionation by differential centrifugation 
By sequentially increasing the centrifugational speed, the proteins are separated by their 
sedimentation coefficient. The large nuclei are the first to be isolated, followed by organelles and 
then membrane-bound proteins. Being very small, free cytosolic proteins are not able to be isolated 
at these centrifulational speeds. This method was utilized to assess the presence of NBCn1 that is 





(e)  Protease inhibitors 
Protease inhibitors were made into individual stocks of 100x stock solution of 100mM 
phenylmethanesulfonyl fluoride (PMSF) (Sigma, P7626), 200 µM leupeptin hemisulfate (Sigma, 
L2884), 150 µM pepstatin A (Sigma, P2465) and 15 µM aprotinin (Sigma, A1153). When preparing 
for use, equivolumes of each protease inhibitor was combined for a 25x stock concentration. This 
was used in a 24:1 (sample : protease inhibitor) ratio to achieve the final concentration of 1x. 
 
 
2.9. Bicinchoninic acid assay for sample protein quantification 
2.9.1. Principles 
Bicinchoninic acid (BCA) assays are based on alkaline solutions of copper salts. Under alkaline 
conditions, cupric ions (Cu2+) chelate with the peptide bonds, and this reduces the cupric ion to 
cuprous ions (Cu+). The cuprous ions are then able to chelate with bicinchoninic acid forming a 
bicinchoninic acid-cuprous ion complex that absorbs light at a wavelength of 562nm. The 
formation of the cuprous ions and the subsequent complex with BCA is proportional to the 
amount of protein, and particularly influenced by asparginine, histidine, cysteine, tyrosine, and 
tryptophan side chains due to their reducing potential (Smith, 1985). These reactions are also 
temperature-dependent, and are conducted between 37oC and 60oC to increase the sensitivity of 
the assay. BCA assays are routinely conducted with samples of known protein concentrations, 
forming standard curves. 
 
When using this assay, caution should be exercised to ensure the components of the lysis buffer 




Protein quantification was conducted using the bicinchoninic acid (BCA) assay. The protocol for 
the commercial kit (Pierce, 23225) was used and summarised as follows. 
 
For every reaction, 200 µl of Reagent A was mixed with 4 µl of Reagent B to form the working 
reagent. 200 µl of this mixture was added to 10 µl of protein sample (or standard / blank) in 96-
well plates. The resultant mixture was mixed on a plate shaker for 30 seconds, and then incubated 




absorbance read at 570nm on a microplate spectrophotometer (MRX-TC Revelation, Dynex 
Technologies). Although the optimal absorbance is 562nm, the kit manufacturers noted that a 
wavelength between 540nm to 590nm is acceptable. 
 
A standard curve is prepared of 0 (blank), 0.125, 0.25, 0.5, 0.75, 1, 1.5 and 2 mg/ml bovine serum 
albumin (BSA) diluted in the respective lysis buffer was prepared in parallel with the samples. A 
quadratic best-fit line was plotted with BSA standards with known concentrations to provide a 
reference for the samples with unknown concentrations (Figure 25). 
 
 
Figure 25: Representative bicinchoninic acid assay standard curve 
Absorbance plotted on x-axis and protein standard BSA (bovine serum albumin) plotted on the y-




2.10. SDS-PAGE (Sodium dodecylsulfate polyacrylamide gel electrophoresis) and 
immunoblotting (Western Blotting) 
2.10.1. Principles 
SDS-PAGE electrophoresis 
SDS-PAGE electrophoresis was used for a variety of experiments, including progression to Western 
protein immunoblotting, as well as separation of proteins in DNA-pull down assays (Section 2.11). 
This method separates proteins from a mixture based on their molecular weight. There has been 




Burnette, Stark and Towbin groups in the late 1970s and early 1980s (Towbin et al., 1979; Renart 
et al., 1979; Burnette, 1981). 
 
This method utilises protein samples that are denatured with heat and the surfactant sodium 
dodecylsulfate (SDS) and a reducing agent such as 2-betamercaptoethanol or dithiothreitol (DTT). 
The SDS coats the linearised protein, resulting in a negatively charge, overcoming the native 
charge of the protein. Denatured protein samples were loaded onto polyacrylamide gels, and an 
electrical current applied. The negatively-charged, SDS-coated proteins (anions) would migrate 
towards the positive (anode) electrode.  
 
The polymerised acrylamide within the SDS-PAGE gel forms a meshwork for which the proteins 
would migrate across. The higher the percentage (volume per volume) of acrylamide results in 
increased cross-linking and denser meshwork – allowing greater resolution between smaller 
proteins. Conversely, the lower the acrylamide content allows greater resolution between larger 
proteins. For most SDS-PAGE gels in this thesis, either 6% or 8% separating gels were used 
depending on sizes of the proteins of interest. Mobility across the gel is dependent on the 
conformation, size and charge of the molecule. However, due to the denaturing and linearization 
of the protein together with the SDS coat, the effect of native conformation and charge no longer 
is a significant factor (See Section 2.14. for comparison with native gels). This allows the separation 
whereby the smaller proteins, with a larger charge-to-mass-ratio, would move faster than the 
larger proteins.  
 
The discontinuous Laemmli buffer system employs different buffer ions and pH in the gel and in 
the electrode reservoirs. Samples are loaded onto a “stacking” non-restrictive large pore gel 
(lower pH of 6.8 and lower polyacrylamide concentration) which overlays a smaller pore 
“resolving” gel (higher pH of 8.3 to 9.0 and higher polyacrylamide concentration). This allows 
stacking of proteins at the interphase before final separation, so that relatively large volumes of 
dilute protein samples can be applied with greater resolution. 
 
As the protein itself within the samples is not visible on a SDS-PAGE gel, the rate of mobility is 
monitored by commercial pre-stained protein standards, marking out a range of protein sizes. 




maintains its blue colour in the alkaline environment of the gel, and travels in a front that 
approximates to 5 to 10 kDa. 
 
After electrophoretic separation, the proteins are electrotransferred onto polyvinylidene fluoride 
(PVDF) membranes, which are hydrophobic and binds protein with high affinity. This membrane 
was preferred to the alternative, nitrocellulose, due to the superior binding capacity, particularly if 
SDS is used in the transfer buffer. PVDF membranes also have the additional benefit for being able 
to be processed in downstream applications such as protein sequencing. The buffers during 
electrotransfer need to be kept cool in face of the current that is applied through it, to prevent 
buffer breakdown and the subsequent loss of transfer efficiency. 
 
Following electrotransfer, the membrane can proceed to be used for immunoblotting, or Ponceau 
S staining for DNA-pulldown studies. 
 
Immunoblotting 
Immunoblotting allows the identification of specific (or as specific as the antibody allows – see 
later) proteins electrotransferred onto membranes. It typically utilises signal amplification via 
secondary antibodies and a further enzymatic step before signal detection. 
 
Once the proteins are electrotransferred to the PVDF or nitrocellulose membrane, a “blocking” 
step is often conducted. This typically utilises non-fat milk available commercially from food 
stores, or purified proteins (such as bovine serum albumin). Application of these proteins occupies 
the regions of the membrane that has not had sample proteins transferred over from the gel. If 
this is not performed, the primary antibody used in later steps may bind the membrane itself 
(independent of the target protein of interest) resulting in increased background signal. 
 
Once “blocked”, the membrane is incubated with a primary antibody that has been raised against 
the protein of interest. Most antibodies however are raised against an epitope, typically a shorter 
sequence of amino acids from the protein of interest. This leads to the possibility of non-specific 
signals where other proteins may mimic the epitope, thus also binding the primary antibody. This 
incubation step is typically conducted overnight at 4oC, but may also be at room temperature over 




antibody step can compete for binding of the antibody, hence reducing or removing the signal, 
thus identifying “specific” bands. 
 
To amplify the signal, a secondary antibody is utilised. The secondary antibody is raised to target a 
portion of the primary antibody, typically the Fc region (fragment crystallisable region, or more 
colloquially known as the tail of the antibody). This is usually a conserved sequence for any 
particular species, as opposed to the Fab (antigen-binding fragments) region, which allows 
consistent and cross-assay use. The signal amplification occurs as for every one primary antibody 
bound to the membrane, more (often estimated to be in the region of 10 to 20) secondary 
antibodies can bind the protein-primary complex. 
 
The secondary antibody is usually labelled with an enzyme such as HRP (horseradish peroxidase) 
or alkaline phosphatase, although fluorescent-labelled secondary antibodies are also occasionally 
used for protein immunoblots. Labelling with an enzyme further amplifies the signal, as the bound 
enzymes are able to catalyse large quantities of substrate to the signal-generating products. This 
thesis utilises enhanced chemiluminescence with the horseradish peroxidase / luminol / hydrogen 
peroxide / p-coumaric acid combination. 
 
Enhanced chemiluminescence 
When the luminol is exposed to an activating oxidant, in this case hydrogen peroxide, it can 
undergo chemical reactions via several different intermediates to emit a low intensity blue glow. 
This reaction is catalysed by the horseradish peroxidase attached to the secondary antibodies, 
allowing specificity of the signal. The p-coumaric acid serves as the enhancer for the reaction, 
improving the light signal. 
 
This end-product of signal amplification allows for detection of very low protein abundance in 
samples. However, the light emission has a short half-life (in the order of minutes), and so needs 
to be exposed to an autoradiography film within the appropriate time window. 
 
Ponceau S staining 
Ponceau S is part of a family of azo dyes. It is a reversible colloidal stain that can be used on PVDF, 
nitrocellulose and cellulose acetate membranes. Ponceau S has an overall negative charge, and 




protein. Thus, protein-bound sections of the membrane are coloured pink/red, and sections 
without protein unstained. This allows visualisation of efficiency of the electrotransfer, as well as 
identifying any specific bands of proteins in the sample. Staining can be reversed by mild alkaline 
or water washes without detriment to subsequent processes such as immunoblotting or mass 
spectrometry. 
 
Other stains are also applicable, such as colloidal metals (typically gold or silver) or other diazo 
dyes (e.g. amido black). These methods are typically more sensitive but with slightly more complex 
experimental protocols or unlike Ponceau S, or is not reversible to a state of use in downstream 
studies. 
 
Advantages and limitations of protein immunoblotting 
Protein immunoblots are well-established in protein studies. It enables identification of proteins 
within a sample with relative ease. It also allows semi-quantitative assessment of relative amounts 
of the protein of interest present in different samples. 
 
It is however limited by the sensitivity and specificity of the antibody. Whilst conducting a 
competitive blockade of the primary antibody using the immunising epitope can somewhat helps 
identify immunoblot bands specific to the protein of interest, it still may identify other proteins 
containing similar epitopes.  
 
Additionally, like most assays that have an output dependent on signal intensity on an 
autoradiograph, with a non-linear relationship with the quantity of protein present, the method of 
quantifying protein immunoblots is only semi-quantitative. 
 
Another drawback is the limited number of samples that can be assessed concurrently. The 
inherent variability in the assay output signal, dependent on the efficiencies of the electrotransfer, 
primary and secondary antibodies, and the enhanced chemiluminescence reaction, meaning that 
comparing across two blots / autoradiographs is technically challenging. 
 
2.10.2. Methods 
Whole-cell protein extraction 





See Section 2.9.2 
 
Preparation of protein samples for SDS-PAGE electrophoresis 
Following quantification of the protein samples, 20 µg of protein was used and diluted with the 
above RIPA / PI mixture to 20 µl, followed by 5 µl of a 5x loading buffer (200 mM Tris pH 6.8, 10% 
w/v sodium dodecylsulfate, 20% v/v glycerol, 5% v/v beta-mercaptoethanol, 0.05% w/v 
bromophenol blue). This mixture was heated to 80oC for 2 minutes to denature the proteins for 
the work in this thesis, although a higher temperature and longer duration may be required for 
other proteins. These samples were then loaded into the wells of SDS-PAGE gels. 
 
Casting of SDS-PAGE gels 
Polyacrylamide gels were made based on the Laemmli discontinuous buffer system consisting of a 
lower separating gel and an upper stacking gel. The content of the SDS-PAGE gels were dependent 
on the size of the protein of interest. For the work in this thesis, separating gels of 8% or 10% 
acrylamide was used. The volume prepared to cast one separating gel of 8.6 cm width x 6.7 cm 
height x 0.1 cm thickness was 6 ml, using the Mini-PROTEAN Casting System (Biorad, 165-8000).  
 
The formulation for separating gels included the variable w/v percentage of acrylamide: (w/v) bis-
Acrylamide (37.5:1 stock) to suit the gel, 0.375 M Tris pH 8.8, 0.1% w/v sodium dodecyl sulfate 
(SDS), 0.1% w/v ammonium persulfate (APS) and 0.1% w/v tetramethylethylenediamine (TEMED).  
 
Once the separating gel mixture was placed into the casting system, 1 ml of butanol was added 
atop the separating gel to ensure a level gel. They were set aside for the acrylamide to polymerise 
for 30 minutes. Following this, the 2 ml per stacking gel (formulation below) was added to the 
formed separating gel and the plastic well combs were fixed in place. The formulation for 
separating gels included the variable w/v percentage of acrylamide: (w/v) bis-Acrylamide (37.5:1 
stock) to suit the gel, 0.375 M Tris pH 6.8, 0.1% w/v sodium dodecyl sulfate (SDS), 0.1% w/v 
ammonium persulfate (APS) and 0.1% w/v tetramethylethylenediamine (TEMED). These gels were 
cast up to 48 hours before use and kept moist with distilled-deionised water at 4oC. Alternatively, 






Separation of proteins with SDS-PAGE electrophoresis 
The gel casts were assembled into the Mini-PROTEAN Tetra Cell system (Biorad, #165-8000), and 
filled with 1x running buffer (0.1% w/v sodium dodecyl sulphate, 25 mM Tris-base, 192 mM 
glycine). Electrophoresis was conducted initially at 80 V, until the bromophenol blue front is 
compressed at the stacking-separating gel interface. At that point, electrophoresis was conducted 
at the higher voltage of 140V. This continued until the appropriate separation of pre-coloured 
standard proteins is visualised, usually lasted approximately 100 minutes. 
 
Electrotransfer of proteins from SDS-PAGE gel to PVDF membrane 
Following completion of the electrophoresis above, the SDS-PAGE gel was carefully lifted off the 
glass casting system, and opposed against a methanol-activated PVDF membrane. This was 
sandwiched by a single Whatman® qualitative Grade 1 filter paper on either side, and further 
sandwiched by manufacturer-provided sponges. This construct was placed in the mini-gel holder 
cassette, and placed within the Mini Trans-Blot module. Electrophoresis using Towbin transfer 
buffer (20% v/v methanol, 25 mM Tris-base, 192 mM glycine) was conducted at 60 V for 150 
minutes at 4oC. Successful transfer was visualised with the transfer of the pre-coloured standard 
protein ladder onto the PVDF membrane. 
 
Immunoblotting 
The PVDF membrane was placed in a plate shaker incubated with blocking buffer comprising 5% 
(w/v) non-fat milk (Marvel, Premier Foods) in TBS-Tween (150 mM NaCl, 50 mM Tris adjusted to 
pH 7.4, 0.5% w/v Tween) for 1 hour at room temperature to block potential non-specific binding of 
antibodies. In experiments with high background signal, such as immunoblotting for calcineurin A, 
the alternative blocking buffer comprising 3% w/v BSA (Sigma, A9418) in TBS-Tween was used. 
Following blocking, the membrane is incubated with the primary antibody (varying dilutions in the 
blocking buffer, see Section 2.22) with agitation, overnight at 4oC. This was then washed with TBS-
Tween thrice for 10 minutes each on a plate shaker for gentle agitation. After washing, the 
membrane was incubated with the corresponding HRP (horseradish peroxidise)-labelled secondary 
antibody (varying dilutions in blocking buffer, see Section 2.22) with agitation, for 1 hour at room 
temperature. This was again washed with TBS-Tween thrice for 10 minutes each on a plate shaker 







The PVDF membrane with the protein - primary antibody – HRP-labelled secondary antibody is 
suitable for enhanced chemiluminescence detection. One part of luminol / p-coumaric acid 
solution (2.5 mM luminol, 0.4 mM p-coumaric acid, 0.1 M Tris pH 8.5) and one part stabilised 
hydrogen peroxide (0.02% hydrogen peroxide, 0.1 M Tris pH 8.5) is mixed, and 2 ml is applied to 
sufficiently cover 100 cm2 (10 cm x 10 cm membrane). Following 5 minutes incubation at room 
temperature, the membrane is exposed to an autoradiograph film (CL-XPosure Film, 
Thermoscientific, 34089) in a dark room, and developed (Konica-Minolta). The developed film is 
later scanned (Hewlett-Packard) for digital storage and quantification. 
 
Analysis 
In semi-quantitative analyses, the intensities of the autoradiograph signals were quantified by the 
public domain, Java-based image processing program ImageJ. 
 
Ponceau S staining 
Ponceau S is a sodium salt diazo dye that stains protein bound sections of the membrane red. It 
has the added advantage of being reversible with no significant deleterious effect on downstream 
processes. Once a PVDF (or nitrocellulose) membrane was ready for staining, it was placed within 
the staining solution (0.1% w/v Ponceau S, 40% v/v isopropanol, 10% v/v acetic acid), and gently 
agitated for 10 minutes on a plate shaker at room temperature. The staining solution was 
discarded, and the membrane washed with de-staining solution (45% v/v isopropanol, 10% v/v 
acetic acid) for 5 minutes per wash. The washes were repeated as necessary until the protein 
bands are clear. To fully reverse the staining, the membrane was washed in distilled-deionised 
water, and repeated as necessary. This is mainly an optional step for confirmation of adequate 
protein transfer, but occasionally for specifically comparing protein bands in different samples. 
 
 
2.11. DNA pull-down assays  
2.11.1. Principles 
DNA pull-down assays can be utilised to determine in vitro DNA-nuclear protein interactions, as 
summarized in Figure 26. It relies on a labelled sequence of double-stranded oligonucleotides or 
polymerase chain reaction amplicons. The label is often a high affinity tag such as biotin that forms 




The labelled probe is incubated with nuclear proteins, either in the form of crude whole nuclear 
extracts or specific (often recombinant) proteins. In the case of biotin-labelled probes, a 
streptavidin coated bead is used to provide a heavier anchor to allow separation from unbound 
proteins. The beads are often agarose bead-based which requires slow centrifugation, or magnetic 
bead-based, which allows separation without centrifugation. 
 
Once the bead - streptavidin - biotin - DNA probe - nuclear protein complex is isolated, it 
undergoes several washes to reduce non-specific binding. The proteins are then eluted with 
heating. As the protein of interest may be low in abundance, it may be necessary to concentrate 
the eluate.  
 
 
Figure 26: Cartoon outlining the DNA-pull down process 
Initially the streptavidin-coated agarose beads, biotin-labelled double-stranded oligonucleotides 
and nuclear extracts are incubated together to allow for the relevant DNA-nuclear protein to occur. 
Subsequently, the beads are isolated by centrifugation and the unbound proteins removed. Finally, 




These samples are then suitable for separation using SDS-PAGE or 2D-electrophoresis, and further 
identification. 
 
Advantages, limitations and complementary methodologies 
Like most other studies in determining DNA-nuclear protein interactions, there are significant 
advantages and limitations to each method. The key advantage of DNA-pulldown assays are based 
on the ability to enrich low abundance targets and the ability to isolate intact DNA-nuclear protein 
complexes that are compatible with downstream processes such as immunoblotting, amino acid 
sequencing and mass-spectrometry. 
 
A major limitation is that the assay is conducted in an artificial in vitro environment which may not 
necessarily mimic that of an intracellular or nuclear milieu, notwithstanding the added 
complexities of epigenomic control. An additional concern is that DNA probes may be prone to 
non-specific binding, particularly with longer probes. This may result in false-positives, thus the 
requirement for complementary methods. 
 
Whilst DNA-pulldown assays can indicate whether a DNA sequence may interact with nuclear 
proteins in vitro, results need to be concordant with other assays. One such method is the 
chromatin immunoprecipitation (ChIP) assay, which utilises the crosslinking of the DNA-nuclear 
protein complex in chromatin, and antibodies to proteins of interest to pull-down DNA fragments 
which the protein is bound to. ChIP has the additional advantage of the DNA-nuclear protein 
interaction occurring within a cellular system as opposed to DNA-pulldown, occurring purely 
within an experimental context. 
 
Concentrating proteins by acetone precipitation  
Acetone precipitation, like most other methods of protein precipitation utilising organic solvents 
such as trichloroacetic acid (TCA), is based on hydrophobic aggregation within a solution. Acetone 
is able to dehydrate the shells of water on a protein in solution. This produces hydrophobic 
surfaces on proteins, whereby if they are present in sufficient numbers, aggregates can start to 
form. As this method relies on the proteins “finding each other”, it is also a time-dependent 
process. These aggregates are protein precipitates that can be separated from solution by 





Acetone, like TCA, is also a protein denaturant at room temperature. Thus the process is 
conducted on ice, or kept at -80Co when incubating. Unlike TCA, acetone is not an acid, and thus 
does not require further steps of acetone washes or pH titration when the protein precipitate is 
dissolved in the relevant SDS-PAGE buffer. 
 
SDS-PAGE electrophoresis 
See Section 2.10.1 
 
N-terminal amino acid sequencing 
N-terminal sequencing uses a chemical process based on the technique initially developed by Pehr 
Edman. During the chemical reaction, the N-terminal amino acid reacts with phenylisothiocyanate 
(PITC), this derivatization process results in a phenylthiohydantoin (PTH) - amino acid link. This 
amino acid is then sequentially removed while the rest of the peptide chain remains intact. Each 
derivatization process is a cycle, and each cycle removes a new amino acid. The amino acids are 
sequentially analysed by mass spectrometry to give the sequence of the protein or peptide (Jacobs 
and Niall, 1975). Samples that are suitable for this method of analysis include PVDF-membrane 
bound gel electrophoresis separated proteins, high-performance liquid chromatograph-separated 
tryptic digest fragments or purified proteins. A typical successful analysis requires 100 picomoles 
of purified protein. 
 
However, the N-terminus is reported to be “blocked”, by formyl, acetyl or pyroglutamyl groups in 
approximately 60 to 70% of eukaryotic proteins. These N-terminal modifications prevents the 
derivatization process, and thus does not produce a successful sequencing analysis. These blocks 
can also occur during isolation of the protein. 
 
2.11.2. Methods 
Nuclear protein isolation and bicinchoninic acid (BCA) assay quantification 
See sections 2.8.2 and 2.9.2 
 
Oligonucleotide annealing 
Commercial single-stranded oligonucleotides were suspended in annealing buffer (10 mM Tris pH 
8.0, 50 mM NaCl, 1 mM EDTA) to an initial concentration of 200 mM. Equimolar quantities of 




minutes with a thermocycler. This was left to cool at room temperature over an hour, and could 
be stored at -20oC. 
 
DNA pulldown 
The protocol was based on the manufacturer’s recommendations 
(http://www.sigmaaldrich.com/content/dam/sigma- 
aldrich/docs/Sigma/Product_Information_Sheet/1/s1638pis.pdf), and is summarised below. For 
every reaction, 50 µl of straptavidin-conjugated agarose beads mixture (Sigma, S1638) was 
centrifuged at 4,000g for one minute at room temperature. The preservative supernatant was 
discarded and the beads were washed with 100 µl of Binding/Washing buffer (10 mM Tris pH 7.0, 
1 mM EDTA, 2 M NaCl). The wash was repeated twice. 1 nmol of double-stranded oligonucleotides 
were immobilised onto the beads by incubating with the beads with 100 µl of Binding/Washing 
buffer for 15 minutes on a roller mixer at room temperature. 
 
Following biotin-straptavidin interaction, the bead-oligonucleotide complex was centrifuged 
4,000g for one minute at room temperature, and the supernatant discarded. The beads were 
further washed once with 100 µl of Binding/Washing buffer, and twice with incubation buffer (50 
mM Tris pH 7.0, 1 mM EDTA, 100 mM KCl, 5% v/v glycerol, 0.1% v/v Triton-X100) supplemented 
with protease inhibitors. All centrifugation steps for the washes were conducted at 4,000g for one 
minute at room temperature. 
 
The bead-oligonucleotide complex was incubated with 250 µl of nuclear extract (2 µg/µl) and 250 
µl of incubation buffer for 30 minutes on a roller mixer at room temperature. Following 
incubation, the bead-oligonucleotide-protein complex was formed, and the sample was 
centrifuged 4,000g for one minute at room temperature, and the supernatant kept as a reference 
sample. The bead-oligonucleotide-protein complex was washed twice with 500 µl of nuclear 
extract buffer (20 mM HEPES pH 7.9, 400 mM NaCl, 1 mM EDTA, 10% v/v glycerol) supplemented 
with protease inhibitors. All centrifugation steps for the washes were conducted at 4,000g for one 
minute at room temperature. Supernatant from the washes were also kept as reference samples. 
 
The washed bead-oligonucleotide-protein complex is then suitable for elution. 100 µl of 2x 
Laemmli buffer (4% w/v sodium dodecyl sulfate, 20% w/v glycerol, 120 mM Tris pH 6.8) 




complex, and incubated for 10 minutes at 70oC with occasional agitation. The sample was then 
centrifuged at 4,000g for one minute at room temperature. 
 
Acetone precipitation 
In these studies, the final quantity of nuclear extracts used was 2,000 µl, in other words, four of 
the above 500 µl reactions. The combined protein eluate in Laemlli buffer was added to cold 
acetone (-20°C), in a 1:4 ratio, to an acetone-compatible tube. This mixture was kept for 24 hours 
at -80oC with occasional vortex mixing. 
 
The sample was then centrifuged at 13,000g for 10 minutes at 4oC. The supernatant was decanted 
and disposed as per safety protocols. The residual acetone was left to evaporate from the 
uncapped tube in a fume hood at room temperature for 30 minutes. The pellets were not over-
dried, as this could have hindered dissolution. In this protocol, the pellet was resuspended in 20 µl 
of RIPA buffer (50 mM Tris pH7.4, 150 mM NaCl, 0.5% w/v sodium deoxycholate, 1% v/v NP-40, 
0.1% w/v sodium dodecylsulfate). In general, the buffer of choice is dependent on the 
downstream process. Recent literature suggest that acetone precipitation is at least, if not more, 
efficient as triacetic acid precipitation in murine samples (Fic et al., 2010). 
 
Control sample 
As the agarose beads have the ability to bind proteins themselves, control samples were run as 
above, but in place of the oligonucleotides, the same volume of annealing buffer with 
oligonucleotides was added. 
 
SDS-PAGE electrophoresis, electrotransfer and Ponceau staining 
See Section 2.10.2 
 
N-terminal amino acid sequencing 
Following identification of specific bands from the pull down (i.e. neither present in the final wash 
nor control sample), these were excised and assessed with N-terminal amino acid sequencing 








The basis of co-immunoprecipitation requires the retention of protein-protein interactions. Thus, 
lysis buffers containing milder detergents such as NP-40 or Nonidet P-40 were utilised as they 
have a lower propensity to interrupt protein-protein interactions. Unlike total cellular protein 
isolation, mechanical disruption is not utilised as it may promote disruption of protein-protein 
interactions, particularly sonication. Alternatively, other protocols utilise formaldehyde to form 
protein-protein crosslinks, which is maintained during, and reversed after immunoprecipitation by 
heating. 
 
After isolation of the proteins in their native and complexed conformations, they are 
immunoprecipitated using specific antibodies targeted against the protein of interest. The protein-
antibody complex is then pulled down by agarose beads, which provides a heavier anchor to allow 
separation from unbound proteins.  
 
Once the bead - antibody - protein complex is isolated, it undergoes several washes to reduce non-
specific binding. The proteins are then eluted with heating in a loading buffer including a reducing 
agent (such as beta-mercaptoethanol or dithiothreitol) to break the protein-protein interactions.  
 




The main limitation of co-immunoprecipitation assays stem from the antibodies available. Most 
commercial antibodies are raised to a linear epitope, which may not be easily recognised when in 
native conformation. Additionally, the target region for the antibody may also be involved any 
potential protein-protein interaction, thus shielded from immunoprecipitation.  
 
Additionally there are limitations with regards to quantification of results. As with other analytical 
systems with a final output dependent on signal intensity, immunoblotting a co-






The protocol was based on a recent study identifying the protein-protein interaction between 
NBCn1 and calcineurin A (CnA) (Danielsen et al., 2013).  
 
Protein isolation was conducted with IP lysis buffer (25 mM Tris HCl pH 7.2, 150 mM NaCl, 1 mM 
EDTA pH 8.0, 1% v/v NP-40), with protease inhibitor mixture. After quantification, 20 µl of protein 
was set aside as “input” samples.  
 
500 µl of protein, topped up to 1 ml with IP lysis buffer, was incubated with 2 ng of rabbit anti-
NBCn1 polyclonal IgG (Abcam, ab82335) or 2 ng of the negative control, normal rabbit IgG (Santa 
Cruz, sc-2027) overnight on a roller mixer at 4oC.  
 
Following overnight incubation, the samples were incubated with 20 µl of Protein A/G PLUS-
Agarose beads (Santa Cruz, sc-2003) for 3 hours on a roller mixer at 4oC. The samples were 
centrifuged at 1,000g for 5 minutes at 4oC, and the supernatant discarded. The beads were 
washed three times with 1ml of IP buffer (25 mM Tris HCl pH 7.2, 150 mM NaCl, 1 mM EDTA pH 
8.0), each time the samples centrifuged at 1,000g for 5 minutes at 4oC, and the supernatant 
discarded. After discarding the supernatant from the final wash, 50 µl of Co-IP Loading Buffer (62.5 
mM Tris-HCl pH 6.8, 10% v/v glycerol, 10% w/v sodium dodecylsulfate, 100 mM dithiothreitol) was 
added to the beads and incubated at 95oC for 2 minutes. After elution, the samples were 
centrifuged at 1,000g for 5 minutes at room temperature, and the supernatant saved as the co-
immunoprecipitation sample. Bromophenol blue was added to the sample to achieve a final 
concentration of 0.02% w/v. 
 
The samples were analysed by SDS-PAGE as described in Section 2.10. 
 
 
2.13. Isoelectric focusing 
2.13.1  Principles 
Isoelectric focusing utilises a pH gradient, as first described by Hoch and Barr (1955) with paper 
electrophoresis, and has been developed further to utilize an electrophoretic gel. With this, the 
sample components migrate towards the anode or the cathode depending on the pH of the gel 




compounds with a spectrum of isoelectric points, thus forming a gradient under the influence of 
an electric field. As they have high buffering capacities, the pH at the region does not change with 
the migration of proteins within the gel. Additionally, due to their hydrophilic nature, they do not 
bind proteins.  
 
Upon electrophoresis, proteins come to a rest within the gradient where their net charges are 
zero, also known as their isoelectric points (pI). Should a protein diffuse away from its pI, it would 
gain a charge and migrate back which provides the focusing effect. As the proteins become highly 
concentrated at their pI, this results in a high sensitivity for detection, and small charge differences 
can be differentiated. There is flexibility in the choice of pH gradients within the gels, which allows 
improvement of resolution by using narrower gradients.  
 
As indicated in Section 3.9, the non-synonymous SNP rs3755652 results in an amino acid change 
from the negatively charged glutamic acid to the positively charged lysine (E326K). Prediction tools 
suggest that this amino acid change alters the pI of NBCn1 by approximately 0.1. 
 
2.13.2.  Methods 
Protein isolation 
Whole-cell protein extraction with RIPA buffer, and protein quantification was conducted at the 
same as with SDS-PAGE studies (see Sections 2.8.2 and 2.9.2.). The desired quantity of proteins 
was acetone precipitated (see Section 2.11.2), and re-suspended in urea / thiourea / CHAPS buffer 
(6 M urea, 2 M thiourea and 2% w/v CHAPS). Just before electroseparation, 5x loading buffer (with 
a final 1x concentration of 10% v/v glycerol, 20 mM lysine, 20 mM arginine, 20 mM DTT, 0.001% 
w/v bromophenol blue) was added. 
 
Casting of isoelectric focusing gels 
An isoelectric focusing gel (pH 3-10) was casted using the Mini-PROTEAN Casting System. The final 
concentrations of the components are 5% (w/v) Acrylamide : Bis-Acrylamide (37.5 : 1), 2% (w/v) 3-
10 ampholytes, 0.1% (w/v) APS, 0.1% (w/v) TEMED and 8 M urea. The plastic well combs were 







Separation of proteins by isoelectric focusing 
The gel casts were assembled into the Mini-PROTEAN Tetra Cell system. The inner chamber was 
filled with the cathode buffer (20 mM lysine, 20 mM arginine), and the outer chamber filled with 
anode buffer (70 mM phosphoric acid). Electrophoresis was conducted initially at 100 V for 60 
minutes, then 250 V for 60 minutes and finally at 400 V for 90 minutes. When the proteins have 
reached their respective isoelectric points on the gel, the current eventually drops to zero, 
indicating the focusing is complete. The module was kept at 10oC throughout at the experiment. 
 
Electrotransfer of proteins from isoelectric focusing gel to PVDF membrane, immunoblotting and 
enhanced chemiluminescence 
These steps were performed as the same with SDS-PAGE gels (see Section 2.10.2). 
 
 
2.14. Electrophoretic mobility shift assays (EMSA) 
2.14.1. Principles 
The regulation of gene expression is in a large part based on DNA-nuclear protein and RNA-protein 
interactions. DNA-nuclear protein interactions may take the form of transcription factor binding to 
DNA elements, up- or down-regulating gene expression. Additionally, DNA-histone interactions are 
a significant epigenetic regulator of gene expression. Histone proteins combine to form 
nucleosomes, which in turn binds segments of DNA to form closed condensed chromatin. This 
results in downregulation of the corresponding DNA regions that is spooled around the 
nucleosome. RNA-protein interactions may occur at various points post-transcription, including 
control of splicing by spliceosomes, polyadenylation by polynucleotide adenylyltransferase, and 
effects on mRNA stability, localization and translation. This section will only discuss EMSAs as a 
tool to investigate DNA-nuclear protein interactions. 
 
EMSAs utilize the differences in charge-to-size ratios of unbound and protein-bound double-
stranded oligonucleotides (Fried and Crothers, 1981; Garner and Revzin, 1981). As proteins need 
to retain its native conformation to be able to interact with oligonucleotides (or DNA sections), the 
protein extraction (see Section 2.8), protein-oligonucleotide reaction buffers and separating gel 





These oligonucleotides are labelled to be able to detect non-protein bound and protein bound 
species. This section describe in detail the biotin / streptavidin / horseradish peroxidase method 
(Li et al., 2004), but variations include biotin / streptavidin / alkaline phosphatase, digoxigenin 
(Denkin et al., 2004) or phosphorus-32 (32P), as well as nucleic acid stains of unlabeled 
oligonucleotides (Förster-Fromme and Jendrossek, 2010; Bussmann et al., 2010). The advantages 
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Cost Moderate Moderate Moderate High Low 
 







Figure 27: Streptavidin-alkaline phosphatase method of detecting labelled oligonucleotides 
Note relatively poor signal-to-noise ratio as compared to the biotin-streptavidin-horseradish 





Figure 28: Nucleic acid staining method of detecting EMSA with PCR products 
Note relatively poor signal-to-noise ratio (200 ng 369 bp PCR template approximates to 1.2x10-12 
moles) as compared to the biotin-streptavidin-horseradish peroxidase using only 10-14 moles of 
biotin-labelled oligonucleotides. Also there is smearing of the shifted products from 5ng nuclear 




In the absence of protein binding, double-stranded oligonucleotides have a strong negative charge 
due to their sugar-phosphate backbone, whilst still being small. This results in rapid mobility when 
exposed to an electrophoretic force attracting it towards the anode. In the presence of protein-
binding the oligonucleotide-protein complex will be larger and have a smaller charge as most DNA-
binding proteins carry an overall positive charge. This results in a smaller charge-to-size ratio and 
thus retards its mobility in an electrophoretic field. A difference in mobility can be visualized as 
two separate bands when the label is appropriately probed.  
 
The reaction mixture is combined with variable quantities of nuclear proteins, labeled 
oligonucleotide probes and unlabeled competitor probes. Unlabeled competitor probes serve to 
determine whether any shifted signals are specific. Addition of poly(dI.dC) functions as a non-
specific competitor to increase the specificity of the assay. In supershift experiments, the addition 
of an antibody targeted against specific nuclear proteins may produce a further increase in size 
with no significant change to charge, thus further reducing it complex’s electrophoretic mobility.  
 
This reactions mixture is then electrophoresed in a non-denaturing gel, and electrotransferred 
onto a nylon membrane, as this membrane is more suitable for retaining nucleic acids. The 
transferred oligonucleotides are then crosslinked with oven drying and 254nm ultraviolet light. 
Following crosslinking the biotin-labelled oligonucleotide can be detected by a variety of methods. 
The work in this thesis uses a commercial streptavidin-linked horseradish peroxidase kit, the 
LightShift® Chemiluminescent EMSA Kit (ThermoScientific).  
 
Limitations 
As with other analytical systems with a final output dependent on signal intensity, EMSAs would at 
best, allow only semi-quantitative comparisons. Another important consideration when 
interpreting EMSAs is that the DNA-nuclear protein interaction is conducted within a purely 
artificial experimental context. This reaction environment may not necessarily mimic that of an 
intracellular or nuclear milieu, notwithstanding the added complexities of epigenomic control.  
 
Complementary methods 
EMSAs can indicate an in vitro interaction between a nuclear protein and a short segment of 
double-stranded oligonucleotide, but further complementary methods may be required to 




This technique utilises the crosslinking of the DNA-nuclear protein complex in chromatin, and 
antibodies to proteins of interest to pull-down DNA fragments which the protein is bound to. ChIP 
has the additional advantage of the DNA-nuclear protein interaction occurring within a cellular 
system as opposed to EMSAs, occurring purely within an experimental context. 
 
A further alternative, not used in this thesis, is the DNase footprinting assay which can be used to 
identify the specific binding site of a protein to DNA in vitro. This technique utilises short 
fragments of labeled DNA (or PCR product), and an agent that cleaves the fragments into even 
smaller fragments. When a protein that can bind the DNA template is introduced into the reaction, 
it will protect the DNA it is bound to from the cleavage agent, thus identifying the “footprint” or 
the binding site of the protein. 
 
2.14.2. Variations – Western-Electrophoretic mobility shift assay (WEMSA) 
Some variants of the method combine western blotting together with EMSAs, gaining the name 
Western-Electrophoretic mobility shift assay (WEMSA) (Deckmann et al., 2012). This utilises the 
same binding conditions and native gel electrophoresis as EMSAs, but have the added component 
of electrotransfer to either a PVDF or nitrocellulose membrane for detecting specific proteins with 
their respective targeted antibodies. The principle of varying electrophoretic mobilities still 
applies. An unbound protein, being large and carrying relatively low charge, will not be particularly 
mobile in a native gel. On the other hand, a DNA-oligonucleotide complex will have significantly 
larger negative charge with only a small gain in size, thus increasing its electrophoretic mobility. 
 
2.14.3. Methods 
Nuclear extract isolation and bicinchoninic acid (BCA) assay quantification 
See sections 2.8.2 and 2.9.2 
 
Oligonucleotide annealing 
Commercial single-stranded oligonucleotides were suspended in annealing buffer (10 mM Tris pH 
8.0, 50 mM NaCl, 1 mM EDTA) to an initial concentration of 200 mM. Equimolar quantities of 
forward and reverse single-stranded oligonucleotides are mixed and heated to 95oC for 2 minutes 






Electrophoretic mobility shift reactions 
The reaction mixture (10 mM Tris pH 7.5, 50 mM NaCl, 1 mM EDTA, 5% v/v glycerol, 0.5 mg/ml 
poly(dI.dC), 1 mM phenylmethanesulfonylfluoride, 1 µg/ml leupeptin, 1 µg/ml aprotinin, 1 µg/ml 
pepstatin) was combined with variable quantities of nuclear proteins, labeled antibody, unlabeled 
competitor antibodies and supershift antibodies. Unless where specified, quantities of nuclear 
proteins were 10 µg (2 µg/µl), labelled oligonucleotides were 10 femtomoles (10-14 moles), 
unlabeled competitor oligonucleotides were 100 femtomoles (10-13 moles). Accounting for the 
variable volumes of reactants, the final volume totals 20 µl. The reaction occurs at room 
temperature for 30 minutes. At the end of the reaction, 2 µl of 10x loading buffer (10 mM Tris pH 
7.5, 1 mM EDTA, 50% v/v glycerol, 0.001% w/v bromophenol blue) is added.  
 
When required for supershift assays, 1 or 5 ng of the antibody (rabbit anti-AP2γ IgG antibody, 
Santa Cruz, sc-8977 X; goat anti-PHOX2A IgG antibody, Santa Cruz, sc-13229 X; or rabbit anti-ZAC1 
IgG antibody, Santa Cruz, sc-22811 X) was added into the reactions, while maintaining the overall 
volume at 20 µl. The rationale for selecting these antibodies is discussed in results (Results Section 
4.3.3). 
 
Non-denaturing gel electrophoresis 
For EMSAs, electrophoresis was conducted using a vertical 6% polyacrylamide gel (6% w/v 37.5:1 
acrylamide:bisacrylamide, 0.5x Tris-Borate-Edetate (TBE) buffer, 0.001% w/v ammonium 
persulphate (APS) and 0.001% v/v tetramethylethylenediamine (TEMED)). The running buffer was 
0.5x TBE. Although APS is important for the polymerization reaction, may interfere with protein-
oligonucleotide binding. Thus, it was electrophoresed away from the gel by a “pre-run” before the 
samples are applied. TBE buffer was used as they are effective keeping DNA or oligonucleotides 
soluble and protect from enzymatic degradation.  
 
The separating electrophoresis was conducted in 0.5x TBE buffer at 100 V at 40C, until the 
bromophenol blue front, approximating the electrophoretic mobility of free unbound 
oligonucleotides, is three-quarters down the gel. 
 
Electrotransfer to nylon membrane and crosslinking 
Following electrophoresis, the oligonucleotides are electrotransferred onto a nylon membrane at 




of the bromophenol blue front. The oligonucleotides were then crosslinked on to the membrane 
with oven drying for 30 minutes, followed by 254nm ultraviolet light at a dose of 0.12 J/cm2 
(Biolink BLX-254E).  
 
Detection of biotin-labeled oligonucleotides 
The studies conducted for this thesis used the LightShift® Chemiluminescent EMSA Kit (#89880, 
ThermoScientific), for which the manufacturer’s recommended protocol is summarized below. 
 
For each membrane, 20 mL of Blocking Buffer was added and incubated at room temperature for 
15 minutes with gentle shaking on a plate shaker. After blocking, the solution was discarded and 
replaced with a solution containing 66.7 µl of Stabilized Streptavidin-Horseradish Peroxidase 
Conjugate and 20 mL Blocking Buffer with a further incubation for 15 minutes with gentle shaking 
on a plate shaker. The membrane was then washed four times with 20 mL of 1x Wash Solution. 
Each wash lasted 5 minutes at room temperature with gentle shaking on a plate shaker.  
 
Following washing, the membrane was transferred to a new container and 30 mL of Substrate 
Equilibration Buffer was added, with a further incubation at room temperature for 5 minutes on a 
plate shaker. After the equilibration step, the membrane was again transferred to a new container 
and exposed to a Substrate Working Solution containing 6 mL Luminol / Enhancer Solution and 6 
mL Stable Peroxide Solution. This was incubated at room temperature for 5 minutes without 
agitation. 
 
The membrane was then removed from the Working Solution and an edge of the membrane was 
blotted on a paper towel for 2-5 seconds to remove excess buffer without allowing the membrane 
to become dry. The membrane was then exposed to an autoradiograph in the dark room and 
developed. The exposure time was adjusted to obtain the desired signal. 
 
In semi-quantitative analyses, the intensities of the signals were quantified by the public domain, 
Java-based image processing program ImageJ. 
 
Western-Electrophoretic mobility shift assay (WEMSA) 
WEMSAs were conducted similar to EMSAs until the stage of electrotransfer. Electrotransfer and 




2.15. Chromatin immunopreciptation (ChIP) and formaldehyde-assisted isolation of 
regulatory elements (FAIRE) assays 
2.15.1. Principles 
ChIP and FAIRE assays allow the identification of DNA sequences that are protein-bound within the 
cell nucleus. They are both based on the ability of formaldehyde to form reversible DNA-nuclear 
protein crosslinks, which are resistant to shearing damage or denaturing when exposed to 
ultrasound pulses. Conversely, sequences of DNA that is not interacting with proteins will not form 
crosslinks and thus not protected from shearing damage. Formaldehyde initially interacts with the 
amine structure of nucleotides (e.g. guanine, adenine or cytosine) to form a methylol structure, 
followed by a Schiff base (protein-N=CH2). This Schiff base forms the basis of the cross-link with an 
amine group of an amino acid on the interacting protein.  
 
For ChIP assays, the isolated sheared chromatin undergoes immunoprecipitation with an antibody 
against a specific (nuclear) protein with beads providing an anchor to precipitate out of solution. 
The DNA sequence of interest within the immunoprecipitated complex can be released following 
sodium hydroxide elution, de-crosslinking by heating and enzymatic digestion of residual proteins 
(Gilmour and Lis, 1984). These DNA fragments can form templates for end-point of quantitative 
PCR. Alternatively, FAIRE analyses of the chromatin preparation alone provides an overall 
assessment of which DNA sequences are protein/nucleosome-bound, as exemplified in Figure 67 






Figure 29: Cartoon showing sequence of steps in a modified protocol to FAIRE. 
The protocol identifies preferentially protein/nucleosome-bound alleles of SNPs (SNP1) as 
compared to polymorphisms has no impact (SNP2) (Significantly adapted from Smith et al., 2011). 
 
In the work for this thesis, the DNA fragments are amplified by PCR, and the amplicons analysed 
with Sanger sequencing to assess allelic imbalances (see Section 2.6.2). 
 
Limitations 
Whilst FAIRE and ChIP utilises the same principle of formaldehyde crosslinking of chromatin, their 
main limitations actually contrast with each other.  
 
FAIRE is non-specific in identifying DNA-nuclear protein interactions. In other words, the assay 
would be sensitive in identifying any DNA-nuclear protein interaction, but identity of the 
interacting protein would not be identified. Conversely, ChIP would be more specific to the 




cells for chromatin isolation. The additional limitation is the difficulty in predicting the exact 
identify of the protein interacting with the DNA. As identified in Section 3.4, the process of 
predicting transcription factor binding has its flaws. 
 
These studies gain strength when conducted in parallel with other studies aiming to determine the 
regulatory elements of gene transcription, such as electrophoretic mobility shift assays (Section 
2.14) or luciferase assays. 
 
2.15.2. Method 
Formaldehyde crosslinking and DNA shearing 
While the cells were still adherent to the tissue culture flasks, formaldehyde (stock 37% w/v) was 
added to the culture medium to achieve a final concentration of 1% w/v. For the purpose of the 
studies in this thesis, an 80-90% confluent T-25 flask (25 cm2 surface area) was sufficient. This was 
left to incubate for 10 minutes in room temperature to allow DNA-nuclear protein cross-linking. 
Following this, glycine (stock 1.25 M) was added to achieve a final concentration of 125 mM to 
quench the residual formaldehyde. This was left at room temperature for 5 minutes, and then 
place on ice. 
 
The culture media was then removed, and the cells washed with ice cold (4oC) PBS containing 
protease inhibitors twice. A cell lifter was then used detach the adherent cells from the tissue 
culture surface area and collected into a microcentrifuge tube. The cells were pelleted by slow 
centrifugation, at 1,000g for 4 minutes at 4oC, and the supernatant discarded. 
 
The cells were then resuspended in ChIP Lysis Buffer (50 mM Tris pH 8.0, 10 mM EDTA, 1% w/v 
sodium dodecylsulfate) with protease inhibitors. To aid cell lysis, the suspension was pipette 
mixed and incubated on ice for 10 minutes. The DNA in the sample was then exposed to a probe 
sonicator (Jencons Scientific, 690-024) for three pulses of 10 seconds. This was optimised for 
HUASMCs and the particular probe sonicator to result in sheared DNA of lengths between 200 and 
800 base pairs (Figure 30) – optimal for polymerase chain reactions. At this stage, for ChIP assays, 
the samples proceed to immunoprecipitation. For FAIRE assays, the samples do not undergo 






Figure 30: ChIP / FAIRE optimization of probe sonication 
DNA smear (200ng per lane) with increasing duration of probe sonication of formaldehyde cross-
linked chromatin. Probe sonication for 30 to 40 seconds provided the optimal sheared DNA sizes of 
approximately 150 to 800 base pairs.   
 
Immunoprecipitation of chromatin 
The sonicated lysates were then diluted with 800 µl of ChIP Dilution Buffer (16.7 mM Tris pH 8.0, 
1.2 mM EDTA, 150 mM NaCl, 1.1% v/v Triton X-100, 0.01% w/v sodium dodecylsulfate), together 
with the immunoprecitating antibody (in this thesis, 10 μg Rabbit Anti-Pol II IgG antibody; Santa 
Cruz, sc-9001) is added. The sample incubated overnight at 4oC on a roller shaker. Following that, 
20 µl Protein A/G PLUS-Agarose (Santa Cruz, sc-2003) was added to the sample and incubated 
again for 3 hours at 4oC on a roller shaker to collect the DNA-protein-antibody complex. The 
agarose beads were pelleted by slow centrifugation, at 1,000g for 4 minutes at 4oC, and the 
supernatant discarded. 
 
This was followed by four separate washes of 1ml: 
• Low salt buffer (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 150 mM NaCl, 0.1% w/v sodium 




• High salt buffer (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 500 mM NaCl. 0.1% w/v sodium 
dodecylsulfate, 1% v/v  Triton X-100);  
• LiCl buffer (250mM lithium chloride, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1% v/v NP-40, 1% 
w/v sodium dodecylcholate);  
• TE buffer (20 mM Tris-HCl pH 8.0, 1 mM EDTA). 
 
For each of the washes, the agarose beads were pelleted by slow centrifugation, at 1,000g for 4 
minutes at 4oC, and the supernatant discarded. 
 
The DNA-nuclear protein complex was eluted from the agarose by adding 200 µl Elution Buffer (1% 
w/v sodium dodecylsulfate, 100 mM NaHCO3) and incubated at room temperature for 30 minutes 
on a roller shaker. The agarose beads were then separated from the eluate by centrifugation at 
1,000g for 4 minutes at room temperature. The supernatant was collected as the DNA-nuclear 
protein complex eluate. The sample then undergoes de-crosslinking. 
 
De-crosslinking 
De-crosslinking of either ChIP or FAIRE samples requires adding of 8 µl of 5 M sodium chloride to 
the 200 µl sample. This was incubated at 65oC for 4 hours to reverse the DNA-nuclear protein 
crosslinks. To digest the residual proteins, proteinase K was used (addition of 20 μg proteinase K, 
10 µl 0.5 M EDTA, 20 µl 1 M Tris pH 6.5), and incubated at 45oC for 1 hour. The DNA fragments 
were then suitable for isolation by DNA extraction columns. 
 
Isolation of DNA fragments 
The DNA fragments were isolated using the Wizard® SV Gel and PCR Clean-Up System (Promega, 
A9281) (See Section 2.5.6) 
 
Polymerase chain reaction and Sanger sequencing 
See Section 2.6.2 
 
Control samples 
For negative controls, parallel reactions are conducted, but instead of the primary antibody of 
interest, the same quantity of isotype control normal IgG from the same animal (in this thesis, 10 






Immunocytochemistry allows the identification of proteins down to a cellular level, and particular 
if used in combination with high-magnification confocal microscopy. Due to the requirements of 
fluorescent microscopy, cells are often cultures on a coverslip, but occasionally on tissue culture 
surfaces may be suitable. Adherent cells usually require a coated surface for successful adherence. 
The process of immunocytochemistry has similar principles to that of immunoblotting (Section 
2.10.1). It requires the fixation of proteins (and cells), “blocking” to reduce background signal, and 
signal amplification with labelled antibodies.  
 
Fixation plays several critical roles; to stabilize cell morphology and tissue architecture, 
disable proteolytic enzymes, strengthen samples to withstand further processing and staining, as 
well as protect samples against decomposition. Chemical fixatives work by either crosslinking or 
precipitating sample proteins. Care should be taken on the duration of exposure to the fixation 
agent, as prolonged fixation can mask target antigens or prevent antibody accessibility. No single 
fixative is ideal for all tissues, samples or antigens. Each fixative procedure must therefore be 
optimized to balance adequate fixation without altering the antigen or disturbing the endogenous 
location and the cellular detail of the tissue.  
 
The most widely used chemical fixative is formaldehyde, which crosslinks primary amines on 
proteins and nucleic acids to form partially-reversible methylene bridges (see Section 2.15.1). 
Cross-linkers are better at preserving the cellular structure, but may reduce the antigenicity of 
some cell components. Alternatively, precipitating fixatives include organic solvent such as 
ethanol, methanol and acetone. They precipitate large protein molecules and are good for 
cytological preservation. These reagents have the added actions of also permeabilizing cells as 
they strip the lipid membrane. However, these reagents, requiring cold incubation, and typically 
causes cell shrinkage. Notably, both fixation types may denature protein antigens. 
 
To evaluate intracellular (and if the experiment is not purely to assess membrane-bound proteins), 
the cells must be permeabilized to ensure free access of the antibody to its antigen. If the cells are 
permeabilized by the choice of fixatives, this can be conducted using detergents that disrupt the 




concentration and duration of applying the permeabilisation buffer should be optimised as excess 
application of detergents can also remove the protein of interest. 
 
Following permeabilisation, a blocking step is conducted reduce non-specific antibody binding to 
the cell culture surface, and thus background signal. Blocking agents are typically a 2–10% w/v 
solution of bovine serum albumin or addition of a 5–10% v/v solution of serum (ideally from the 
species in which the secondary antibodies were raised).  
 
To achieve a fluorescent signal indicating the presence of a protein of interest, antibodies are 
used. Typically, immunofluorescence utilises primary-secondary antibody immunolabelling. Like in 
Western blots (Section 2.10.1) the primary antibody is raised against the protein of interest, and 
the secondary antibody if raised against the Fc section of the primary antibody. The difference as 
compared to Western blots, the primary antibody needs to be able to recognise the native 
conformation of the protein (as opposed to just the linearized amino acid epitope as the minimum 
sufficient criteria for Western blots) and the secondary protein is labelled with a fluorescent 
probe. Less commonly, directly fluorescent dye-conjugated primary antibodies can be useful in 
highly abundant targets, most protein targets require further signal amplification using primary 
and secondary antibodies. 
 
To be able to identify the position of the protein of interest relative to sub-cellular structures, the 
main options are double immunofluorescence and/or counterstaining via non-antibody based 
techniques. To identify the nucleus, nucleic acid stains such as DAPI (4',6-diamidino-2-
phenylindole) or Hoescht dyes bind the minor groove of double-stranded DNA (hence localising to 
nuclei), and when bound, it has a maximum fluorescence emission at 461 nm, in the blue spectra. 
To identify the plasma membrane, the commonly used counterstain is fluorophore-labelled wheat 
germ agglutinin. Wheat germ agglutinin is a lectin and has a high affinity for the membrane-
associated N-acetylglucosamine. To identify the cytoskeletal structures, the commonly used 
counterstain is fluorophore-labelled phalloidin. Phalloidin is derived from a fungal toxin and has a 
strong affinity for F-actin. With both the flourophore-labelled wheat germ agglutinin and 
phalloidin, the absorbance/emission wavelengths are dependent on the conjugated fluorophore. 
Alternatively, antibodies that specifically target certain organelles or cell types might be used as 





Whenever more than one fluorophore is used, it is important that there is no significant overlap in 









Advantages, limitations and complementary methods 
Immunocytochemistry has the advantage over protein immunoblots with the ability to localise the 
protein of interest to a particular region of the cell. Confocal microscopy has the added benefit of 
increased optical resolution and contrast due to being able to take images from one focal plane, 
and even reconstruct 3-D images.  
 
Similar to protein immunoblots, the technique is only as good as the primary antibody used. This 
introduces the possibility of low sensitivity or specificities, especially as not all proteins are able to 
appropriately detect the native conformation. Additionally, protein-protein interactions within the 
cellular environment may block the target epitope of the antibody, limiting its ability to detect the 
protein. A further limitation is that, unlike protein immunoblots, there is no way of identifying 
different protein sizes and therefore different isoforms (unless the antibody is isoform-specific). 
 
The quantification of immunofluorescence images is also complicated. Firstly, the signal is not 
directly proportional to protein quantity and therefore it is at best, semi-quantitative. There is also 
the difficulty of selecting appropriate cells to obtain images from, as this may potentially lead to 
biased selections.  
 
2.16.2. Materials 
Tris buffered saline (TBS – final concentration 20 mM Tris, 150 mM NaCl) was formulated initially 
at 10x concentration with 24 g Tris-HCl, 5.6 g Tris-base and 8 g NaCl dissolved into 900 ml distilled-
deionised water. This was adjusted to pH 7.6 (with concentrated HCl or NaOH) and the volume 
adjusted to 1 L using distilled-deionised water. This solution is later diluted to 1x working 
concentration (1 part 10x TBS, 9 parts distilled-deionised water) and further adjusted to pH 7.6. 
 
The fixative, 4% (w/v) formaldehyde was constituted from 37% (w/v) formaldehyde (Sigma, 
252549) diluted in serum-free media (unsupplemented DMEM for HUASMCs and unsupplemented 
M199 for HUVECs). The permeabilisation buffer was 0.1% Triton X-100 (v/v) (Sigma, T8787) diluted 
in TBS. The wash buffer was constituted with 1% FBS v/v in TBS. The blocking buffer was 
constituted with 10% FBS v/v in TBS. DAPI was diluted to final concentration of 300 nM in TBS. 
 





2.16.3  Methods  
Cells (HUASMC or HUVEC) were grown on coverslips in a 6-well plate pre-coated with 0.2% (w/v) 
porcine skin gelatin. Once the cells were between 60 to 80% confluent, the coverslips were 
suitable for immunocytochemistry. The coverslips were rinsed in wash buffer, followed by 
incubation with the fixative 4% w/v formaldehyde in TBS for 10 minutes at room temperature. The 
coverslips were again rinsed in wash buffer. Where indicated, this was the stage where the 
coverslip was incubated with permeabilisation buffer for 10 minutes at room temperature 
followed by rinses with wash buffer. The coverslip was then incubated with blocking buffer for 2 
hours at room temperature. Once again, the coverslips were rinsed and then incubated in the 
primary antibod(ies) of interest, diluted in blocking buffer (see  
Table 13 below for concentrations) for 1 hour at room temperature. At this stage, parallel control 
studies were conducted with normal (untargeted) antibodies of the same isotype/host as the 
primary antibody of interest. 
 
Following incubation with the primary antibod(ies), the coverslips were rinsed in wash buffer, and 
incubated in the corresponding secondary antibod(ies) diluted in blocking buffer (see  
Table 13 for concentrations) for 1 hour at room temperature in a humidified chamber. The 
coverslips were then rinsed in TBS, and then incubated with 300nM DAPI for 10 minutes at room 
temperature. The coverslips were then given a final rinse in deionised-distilled water. Once the 
coverslips were air-dried, they were mounted on glass microscope slides (VWR, 631-0110) using 
fluorescence mounting medium (Dako, S3023). To seal the coverslips onto the microscope slide, 
nail varnish was applied to the edges of the coverslip. 
 
Antigen Primary antibody Control (for primary) 
antibody 
Secondary antibody 
NBCn1 Rabbit IgG anti-human 
NBCn1 5μg/ml       (Abcam, 
ab82335) 
Rabbit normal IgG 5μg/μl 
(Santa Cruz, sc-2027) 
Donkey polyclonal Secondary 
Antibody to Rabbit IgG - H&L 
Alexa Fluor® 594 2μg/μl 
(Abcam, ab150076)        
Ex: 590nm, Em: 617nm 
VE-Cadherin Mouse IgG anti-human VE-
Cadherin 2μg/ml (Abcam, 
ab7047) 
Mouse normal IgG 2μg/μl 
(Santa Cruz, sc-2025) 
Goat polyclonal Anti-Mouse 
IgG - H&L Alexa Fluor® 488 
2μg/ml (Abcam, ab150113)        
Ex: 495nm, Em: 519nm 
 
Table 13: Antibodies used for immunocytochemistry 





The slides were initially visualised on an inverted fluorescent microscope (EVOS® FL Cell Imaging 
System, Life Technologies), using the DAPI (Ex: 357 nm, Em: 447 nm), GFP (Ex: 470 nm / Em: 510 
nm) and Texas Red® (Ex: 585 nm, Em: 624 nm) light cubes as recommended by the manufacturers 
for the respective fluorophores. Following this the slides were viewed on the ZEISS confocal 
microscope with filters for the respective wavelengths. Digital images were obtained from the 
microscopy for analysis. 
 
Analysis 
Digital images were quantified by the public domain, Java-based image processing program 
ImageJ. Channel-specific signals, matching the fluorophore of interest, were used. A line was 
created across a single cell, and the signal profile for each fluorophore was determined. The two 
peaks for membrane-specific proteins (e.g. VE-Cadherin) were used to identify the cell membrane. 
The mean signal of NBCn1 at the membrane was compared to the mean cytoplasmic signal (See 
Results Figure 88). 
 
 
2.17. Collagen gel contractility assay 
2.17.1. Principles 
Collagen gel contractility assays (CGCs) provide an option in assessing in vitro cell contraction. One 
of the earliest descriptions of this methodology was by Bell and colleagues using human foreskin 
fibroblasts. They showed that the contraction, as visualized by a reduction in collagen gel size, 
occurs over the duration of days, and the extent of contraction was time- and cell-number 
dependent (Bell et al., 1979). Over the years, this method has been adapted for a range of cell 
types including cardiac fibroblasts, airways smooth muscle, vascular smooth muscle, and 
particularly relevant to this thesis, vascular smooth muscle cells derived from human umbilical 
arteries (Sainio et al., 2010). The basis of the assay is that of a collagen matrix. When kept cool in 
acidic conditions, collagen does not polymerise easily. A collagen gel is formed through 
polymerization when the pH is brought up 7-8 and allowed to warm up in the humidified 
environment of a tissue culture incubator. Further added into this mixture are the cells dissociated 
by typsin, and the basal media.  
 
The polymerization takes up to 60 minutes, and a further layer of media is overlaid on the gel to 




previous morphology, and in fact form a more contractile phenotype in a three-dimensional 
matrix. There is however, no clear standardized protocol in the literature, but at least a working 
range is established. 
 
Once fully formed, collagen gels provide a platform to assess cellular responses to various 
pharmacological stimuli and comparing cells of different populations or patient groups 
(Matsumoto et al. 2007; Ihalainen et al., 2007).  
 
Advantages, limitations and competing methodology 
The advantages and limitations of CGCs should be viewed relative to the two main alternatives - 



























 Collagen gel contractility 
assays 
Small vessel wire 
myography 




(+) Derived from otherwise 
discarded umbilical cords 
(-) Discarded samples from 
abdominal surgery, which is 
not always viable for 
experiments 
(-) Invasive muscle or 
buttock biopsies procedures 
and therefore  difficult to 
recruit volunteers 
(-) Invasive, thus difficult to 





Already approved through 
NRES ref: 08/ H0704/140; 
Amendment 4 
Requires further Research 
Ethics Committee approvals  
Requires further Research 




(±) In vitro response, out of 
context of continuous, 
circumferential  vessels, and 
absence of endothelial cells 
(±) Ex vivo response, and 
difficult to standardize 
across different human 
samples 
(+) In vivo localized response 





(+) Due to tissue culture 
techniques and relatively 
small cell number required, 
numerous experiments can 
be conducted 
(-) Samples from surgery or 
biopsies tend to be small, 
and do not allow replicates. 
Additionally, limited by 
number of wire myographs 
available. 
(-) Time intensive 
procedures, thus limited 





(+) Large range possible, 
including pharmacological 
agents not licensed for 
human use, manipulation of 
gene expression such as 
siRNA, shRNA and 
overexpression plasmids. 
(±) Able to use the range of 
pharmacological agents, but 
difficult to manipulate gene 
expression while retaining 
tissue viability 
(-) Only a limited range of 
pharmacological agents 
would be suitable, often not 




(-) Days (+) Seconds to minutes (+) Seconds to minutes 
Cost (+) No fixed costs and low 
variable cost  
(±) High fixed cost, but low 
variable costs 
(-) High fixed and variable 
costs 
 
Table 14: Considerations in deciding methodology of choice assessing VSMC contraction 
 (+), (±) and (-) denotes author’s views on relative advantages and disadvantages. 
 
In context of a study that compares genotypes, especially one with a minor genotype frequency of 
less than 5%, the need for a large population is paramount. Additionally the number and type of 
planned experiments also favours the in vitro method of assessing vascular smooth muscle 
contractility. Although sometimes regarded as the “gold standard” in assessing vascular response, 




the inability to challenge the physiological system of choice, as it would be inappropriate to aim to 
intravenously infuse agents that changes intracellular or extracellular pH in vivo. 
 
2.17.2. Methods 
A 250 µl mixture of collagen gel with HUASMCs was dispensed into each well of a 48-well plate. 
The final formulation of the collagen gel mixture was 1x DMEM (from 10x solution, Sigma), 1.5 
mg/ml rat tail collagen type I (Sigma, C3867), 1.25x106 cells/ml, 2 mM glutamine, 40 mM sodium 
bicarbonate and 20 mM sodium hydroxide (optimised to achieve a final solution pH of 8). While 
preparing this mixture, all components were kept on ice to prevent early collagen polymerisation. 
 
Once dispensed into the wells, the plate was place in the humidified cell culture incubator for 30 
minutes to polymerise. Following polymerisation, the gels were overlaid with 250 µl of 
unsupplemented DMEM and left to incubate for 24 hours. After 24 hours, the gels were manually 
and gently detached from the walls of the well. Once detached, the appropriate pharmacological 
challenge could be used. 
 
At pre-determined time-points, digital images (Ivanov et al., 2005) were obtained with a specially-
fabricated camera housing case to ensure a fixed height and light exposure when obtaining images 
by a 14 megapixel digital camera (Nikon, S3100). The digital images were analysed using the public 
domain, Java-based image processing program ImageJ to calculate the gel surface area as a 
percentage of total well surface area. 
 
 
2.18. Cloning, mutagenesis and bacterial transformation 
2.18.1. Principles 
Background 
Mutagenesis and overexpression plasmids provide an important tool in molecular biology. 
Although used in a wide variety of settings, in the context of this study, it was utilised to 
investigate the impact of amino acid changes, and even splice variants, on protein function. There 
were many essential studies leading up to a functional insert, the earliest report of the process 
bearing resemblance to current protocols was described in Cohen et al. (1973). Cohen and 
colleagues managed to insert DNA encoding antibiotic resistance into unrelated plasmids, using 




vector together. Subsequent transformation into otherwise antibiotic-susceptible bacteria with 
the newly generated plasmid conferred it with newly-acquired antibiotic-resistance. Since then, 
the understanding of the range of restriction enzymes and the use of standardised vectors have 
made molecular cloning a key tool in research. Furthermore, improvements in transfection 
technologies (see Section 2.19), have allowed the use of expression plasmids in a range of cell 
lines. 
 
The current range of expression plasmids includes those that are untagged or tagged. Untagged 
inserts will express the protein in its native form, with no added moieties. Tags can take several 
forms, primary classified by the added function. These include affinity-tags (to aid isolation, such 
as polyhistidine-tags), epitope-tags (to aid antibody detection, such as HA- and myc-tags), 
chromatography-tags (to aid separation, such as FLAG-tags) and fluorescent-tags (to aid 
visualisation or quantification, such as GFP-tags). Despite these advantages of a tagged protein, 
the tag itself can be sizable, and has the theoretical potential to modulate the function of the 
protein of interest. As the work in this thesis prioritises a functioning protein in vivo, an untagged 
vector is preferred.  
 
In vitro site-directed mutagenesis 
There are several methods to achieve mutagenesis within an expression plasmid. The method 
used for this thesis is based on complementary mutagenic primers ( 
Figure 31). These primers are able to anneal to the plasmid, but introduces the desired mutation, 
typically in the middle of the primer set. Following PCR with high-fidelity Taq polymerase, there is 
the combination of the new daughter plasmids that contain the mutation, as well as the original 
parental plasmids with the unwanted original sequence. The system then exploits the methylated 
and hemi-methylated nature of parental plasmids that has been produced in most bacteria. The 
methylation-sensitive DpnI endonuclease enzyme has restriction site that recognises the target 
sequence 5’-Gm6A^TC-3’ (methylated sixth carbon of the adenine) sites, but not unmethylated 5’-
GATC-3’ sequences. Thus it only digests the parental plasmid, leaving the mutated daughter 
sequences undigested. The remaining plasmid is then suitable for bacterial transformation. It is 
worth noting that plasmid DNA from most E. coli strains (which are dam+) is methylated and is a 
suitable template for mutagenesis by this method. However, plasmid DNA derived from the dam– 






Figure 31: Cartoon overview of in vitro site-directed mutagenesis 
Adapted from http://www.chem.agilent.com/library/usermanuals/Public/200523.pdf 
 
An alternative to in vitro site-directed mutagenesis is PCR-drive overlap extension (Heckman and 
Pease, 2007), which is described below for sequence deletion.  
 
Deletion by PCR-driven overlap extension 
This method has been previously described by Heckman and Pease (2007), utilising a two-step 
procedure. To generate a deletion from the original sequence, deletion primers are designed to 
“jumping” the deleted sequence by matching 15 base pairs either side of the desired deletion. The 
reverse primer is then designed to be complementary to the forward primer (Figure 32, A).  The 
first step generates two PCR fragments, which contain segments of overlap with each other (B). 
The second step aims to hybridise the two fragments (C), exploiting the region of overlap to form a 
larger product after PCR (D). This method can also be used to generate mutations or insertions, 






Figure 32: Cartoon overview of deletion by PCR-driven overlap extension 
The grey box indicates the region to be deleted. The split primers DFOR and DREV are actually 
continuous, but represented as split only to demonstrate which sequences they are complementary 
to. Blue vertical bars identify complementary sequences at the region of overhang extension. 




E. coli, which is typically used for propagating plasmids, is not naturally transformable. Their ability 
to take up DNA, also known as competency, must be induced and is now commonly based on the 
early description by Mandel and Higa (1970). This method is typically by heat-shocking, often 
assisted by divalent and multivalent cations (for example Ca2+, Mg2+, Mn2+, Rb+ or hexaamine 
cobalt(III)). It is likely that a major reason for the lack of ability to take up DNA in its natural state is 
its lipid bilayer cell membrane. The cell membrane is negatively charged on the external surface, 
as is the overall charge of plasmids due to the phosphate backbone. With this, the cations are 




repellent forces of the two. This is further assisted by heat-shocking the bacteria. The rapid change 
in temperature (but not too high as to damage the cell) is proposed to temporarily alter the 
fluidity of the membrane, allowing the DNA molecule to enter the cell.  
 
In uncommon circumstances that the standard heat-shock does not induce transformation, 
electroporation is another method of promoting competence (Wirth et al., 1989). The cells are 
briefly shocked with an electric field, temporarily creating gaps in the cell membrane through 
which the DNA molecule enters. This permeability is a temporary phenomenon as the cell's 
membrane-repair mechanisms can seal up the hole.  
 
Once transformed, the bacteria are typically plated on a selective agar plate, whereby an antibiotic 
(e.g. ampicillin or kanamycin) which the plasmid carries resistance against is added. With this, only 
bacteria with the antibiotic-resistance sequences can grow. However, this may be growth of 
empty vectors, or abnormal inserts. The growth is promoted by the presence of typtone (peptides 
derived from the tryptic digest of casein) and yeast extracts, which are also a source of amino 
acids and peptides 
 
Further selection can be aided by the β-galactosidase Blue-White screening which requires 
addition of the chromogenic substrate X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) 
to the agar plate. This screening takes advantage of the characteristic of E.coli producing β-
galactosidase in the presence of lactose by activation of the lacZ operon. However, host E. coli 
strains are containing lacZΔM15 mutation produces β-galactosidase which are inactive on its own. 
When transfected with a plasmid vector, which typically codes for the first 146 amino acids of β-
galactosidase (also inactive on its own), it complements the mutated host enzyme to activate it. 
Thus, transfection with a native vector plasmid results in the β-galactosidase hydrolysing X-gal to 
form 5-bromo-4-chloro-indoxyl, which spontaneously dimerizes to produce an insoluble blue 
pigment.  However, if the DNA insert is placed within the multiple cloning sites of the vector lacZ 
sequence, this will disrupt the production of an active β-galactosidase, and the colony will remain 
white in colour. 
 
Once the colony is selected, it can be propagated in liquid culture, which continues to contain the 
antibiotic to maintain selectivity. The volume of the culture will depend on the eventual quantity 




Cryopreservation of bacterial cultures in glycerol stocks 
Although plasmids can be re-transformed into more bacteria, there is an advantage of freezing the 
transformed bacteria, particularly as it takes a shortened time to produce a large quantity of 
plasmids. Hollander and Nell (1954) aimed to find a solution to the concern of damage to bacteria 
when frozen. They found that freezing conditions supplemented with 15% v/v glycerol significantly 
preserved survival of bacterial after multiple freeze-thaw cycles. The glycerol method also 
maintained its original bacterial characteristics, which in this case was the virulence of Treponema 
pallidum and syphilitic lesions in rabbits. 
 
Like DMSO in cryopreservation of primary cell lines (see Section 2.1), glycerol is proposed to 
function as a cryopreservant by depressing the freezing point of the cells, serving to encourage 
greater dehydration of the cells, and minimises the solution effects as discussed previously. 
Glycerol is less toxic than DMSO to cells, but is also less penetrating. Thus glycerol is better for 
simpler cells such as bacteria, and DMSO for more complex cells such as in primary cell cultures.  
 
Plasmid isolation 
The transformed bacteria is usually pelleted from liquid culture, and re-suspended in an RNase-
containing formulation to prevent bacterial RNA contaminating the final product. The Tris in the 
solution provides a pH buffer, and the EDTA chelates divalent cations to prevent activity of 
DNases. It is then lysed, typically with sodium dodecylsufate as the surfactant. The presence of 
sodium hydroxide not just aids in lysing the cells, but also denatures plasmids and genomic DNA by 
breaking hydrogen bonds into single stranded DNA (ssDNA). Following a short incubation, the 
mixture is neutralised, typically with potassium acetate. The small circular plasmid DNA is more 
easily re-natured, but the huge genomic DNA cannot easily re-anneal, thus staying as single-
stranded DNA. This allows for the selection of plasmids by staying in solution, whereas the single-
stranded genomic DNA precipitate out with the sodium dodecylsulfate and denatured cellular 
proteins due to hydrophobic interactions, which in turn can easily be separated by centrifugation. 
 
At this point, there are two main options. The plasmid DNA in solution can be extracted by the 
phenol/chloroform method, or by affinity chromatography-based methods. In the former, the 
plasmid DNA will be isolated in the upper aqueous phase, and can be purified in the same manner 
as TRIzol-based RNA extraction (see Section 2.3.1). The work in this thesis utilises commercial 




certain pH or electrolyte conditions (as during the equilibration and wash phases), and releases 
the plasmid with other conditions (such as during the elution phase). Once eluted, the plasmid can 
be precipitated by isopropanol and washed with ethanol. 
 
2.18.2. Methods 
Cloning from HA-tagged SLC4A7 plasmid into untagged vector 
The expression plasmids used were cloned originally from a HA-tagged human SLC4A7 plasmid 
kindly gifted by Dr K Witkowska. The vector which was to be used was pcDNA3.1(+). The known 
restriction sites of the SLC4A7 insert was assessed using the online tool NEBCutter 
(http://nc2.neb.com/NEBcutter2/) to search for one which did not coincide with that of the vector 
(Figure 33).  
 
 
Figure 33: Restriction enzyme selection for pcDNA3.1(+)  
pcDNA3.1(+) restriction enzyme map (A) and NEBCutter output for full length SLC4A7 insert (B) 
The only restriction enzymes identified as being present on the pcDNA3.1(+) map and the SLC4A7 




Primers were designed with the sequence including a 5’ extended segment GAAAAA (green 
below), followed by the desired restriction site (AAGCTT for HindIII, and GGTACC for KpnI; red 
below) and the subsequent 18 to 20 base pairs. This resulted in the following primer sequences: 
- Forward with HinIII site (CFOR): GAAAAAAAGCTTATGGAAAGATTTCGTCTGG 
- Reverse with KpnI site (CREV): GAAAAAGGTACCCTATAATGAAGTTTCAGCA 
Note that the underlined ATG and CTA sequences represent the start codon and the reverse 
complement of the stop codon (TAG). 
 
As the primers had an estimated Tm of 65
oC, thus the PCR reaction was initially conducted at 
annealing temperatures of 68oC. However, due to the low product yields, optimisation identified 
an annealing temperature of 54oC was ideal.  
 
The PCR reaction utilised a high-fidelity Q5® High Fidelity DNA polymerase (New England BioLabs, 
M0491S). The reaction mix was kept at 0oC using an ice bath to inhibit any early polymerase 
activity. The final concentration of the reagents within the reaction included 10 ng of template, 
100 µM primers, 1x reaction master mix buffer (which included the optimised concentrations of 
Taq enzyme, dNTPs and Mg2+). The final volume of the reaction was made up to 20 µl using 
nuclease-free water. The reaction was placed into a thermocycler, and the following program was 
used as based on the manufacturer’s recommendations ( 
Table 15). 
 
 Temperature Duration 
Initialisation step (Hot Start) 98oC 5 minutes 
35 cycles Denaturing step 98oC 10 seconds 
Annealing step 54oC 30 seconds 
Elongation step 72oC 5 minutes (>1 minute 
per 1kb of PCR 
product) 
Final elongation step 72oC 10 minutes 
 
Table 15: Thermocycler program for cloning of SLC4A7 
 
The products were electrophoresed on a 0.7% w/v agarose gel. Once resolved, the desired PCR 
product (Figure 34, 3666bp) was excised and extracted as described above (Section 2.5.6), and the 




length PCR products from primary cell line (HUVEC) cDNA was unsuccessful, perhaps due to the 
relatively low concentrations of target template. 
 
 
Figure 34: Endpoint PCR of cloning products 
Endpoint PCR with primer pairs amplifying the full length SLC4A7 cDNA (3666 bp) from a HA-
tagged plasmid (lane 3), with non-specific products around 400bp. No products amplified with 
primary cell line cDNA (lane 2).   
 
Once purified, the PCR products were digested with HindIII and KpnI enzymes simultaneously. To 
achieve near complete digestion, NEBuffer 2 was chosen ( 
Figure 35). This process was also performed with the pcDNA3.1(+) vector. The final reaction 
included either 1 µg SLC4A7 insert or 10 µg pcDNA3.1(+), 1x NEBuffer 2, 150 units of HindIII 
enzyme (New England BioLabs, R0104) and 350 units of KpnI enzyme (New England BioLabs, 
R0142), made up to a final volume of 50 µl with nuclease-free water. The different quantities of 
enzyme were based on the relative activities in NEBuffer 2, and that this reached the maximal 
volume of enzyme mixture as 10% of the final volume, due to its glycerol content. The reaction 










Figure 35: Results of NEB Double Digest Finder  
The NEB Double Digest Finder (https://www.neb.com/tools-and-resources/interactive-
tools/double-digest-finder) identifying NEBuffer 2 as the optimal buffer for concomitant use of 
HindIII and KpnI. 
 
The digested vector was electrophoresed on a 0.7% w/v agarose gel. Once resolved, the 
electrophoretic pattern of an undigested plasmid typically shows three bands, representing the 
different electrophoretic mobilities of the different conformations – relaxed, circular and 
supercoiled. After restriction enzyme digestion, this is now a single band of a linear plasmid ( 
Figure 37 later). The digested plasmid band was excised and extracted as described above (see 
Section 2.5.5), and the concentration quantified measured using a spectrophotometer. 
 
The digested vector was subsequently dephosphorylated. The reaction included 1 µg digested 
vector, 1 unit of calf intestinal phosphatase (New England BioLabs, M0290S), a final concentration 
of 1x NEBuffer 2, and made up to a final volume of 50 µl with nuclease-free water. The reaction 
mix was incubated at 37oC for one hour. 
 
The digested insert, together with the digested and dephosphorylated vector were then ligated 
together. The reaction consisted of 10 ng of pcDNA3.1(+) vector, and equimolar (14.8 ng) quantity 
of the SLC4A7 insert, a final concentration of 1x reaction buffer and 10,000 units of T4 DNA Ligase 
(New England BioLabs, M0202) and made up to a final volume of 20 µl with nuclease-free water. 
The reaction mix was incubated at 4oC for 72 hours. Alternatively, the reaction can be conducted 
at room temperature for 24 hours. A negative control plate is conducted concurrently, using only 
digested vector but without insert, also treated with T4 DNA ligase as above. Note that although 
the reaction was successful at a 1:1 molar ratio of insert to vector, alternative ratios commonly 
used are 3:1, 5:1 and 10:1. 
 
Transformation 
In preparation for the bacterial transformation process, selective bacterial agarose plate was made 




g/l tryptone, 5 g/l yeast extract and 5 g/l sodium chloride. Each 100-mm petri dish required 
approximately 20 ml of the mixture. The mixture was sterilised by autoclaving to a temperature of 
121oC for 15 minutes. When cooling after autoclaving, at a temperature less than 40oC, ampicillin 
was added to achieve a final concentration of 100 µg/ml. The mixture was then poured into 
individual plates. Once set, they are pre-warmed in the incubator at 37oC prior to plating of 
bacteria. 
 
Prior to transformation of chemically competent cells (in the work for this thesis, either XL10 Gold 
or JM109), SOB medium (Super Optimal Broth) was created with a final concentration of 10 g/l 
tryptone, 5 g/l yeast extract, 0.584 g/l NaCl, 0.186 g/l KCl. This was autoclaved to 121oC for 15 
minutes to achieve sterility. To create the final SOB medium, concentrated sterile-filtered MgCl2 
was added to achieve a final concentration of 10 mM. To create a SOC (Super Optimal Broth with 
Catabolite repression), concentrated sterile-filtered glucose was added to achieve a final 
concentration of 20 mM. Magnesium and glucose are not autoclaved with the rest of the solution 
and at the high temperatures, they could react with tryptic peptides. 
 
To transform the chemically competent cells, they were brought to thaw slowly from -80oC 
storage on ice. Once thawed, 5 µl of the ligated mixture was added to the 50 µl aliquot of cells in a 
14 ml round-bottomed polypropylene culture tube. This was mixed gently, without pipette mixing 
or vortex mixing. The mixture was incubated on ice for 30 minutes. Following this, the cells were 
heat shocked at 42oC in a water bath for 30 seconds. The reaction mixture was then immediately 
returned to incubate on ice for 2 minutes. After the 2 minutes, 250 µl of pre-warmed (37oC) SOC 
media was added to the reaction and shaken horizontally on a shaking incubator at 37oC for 1 
hour, rotating at 225 rpm. Following this incubation, the mixture was then spread on the pre-
warmed selective plate. The plates were placed inverted in the 37oC bacterial incubator overnight, 
for a maximum of 16 hours to prevent overgrowth. 
 
The next day ( 
Figure 36), for singular colonies were picked and immersed into 2.5 ml of SOB medium in a 14 ml 
round-bottomed polypropylene culture tube supplemented with ampicillin to reach a final 
concentration of 100 µg/ml, and incubated in a shaking incubator at 37oC for 24 hours, rotating at 
250 rpm. After the 24 hours, if required, a glycerol stock of the bacterial culture was made by 




dry ice or liquid nitrogen, to be stored at -80oC. The remaining mixture of bacterial cells was 
pelleted with centrifugation at 8,000 g for 10 minutes at 4oC. 
 
 
Figure 36: Bacterial growth on petri dishes after ligation of cloning insert and vector 
No growth observed on negative control plate with only digested vector treated with T4 DNA ligase 
as above (left), and 8 visible colonies with ligated insert and vector in a 1:1 ratio (right). 
 
Plasmid isolation and purification 
Plasmid purification was conducted using the column method from commercial kits. The protocol 
for the Mini-Prep commercial kit (Invitrogen, K2100-03) was used and summarised as follows. 
When purifying larger quantities, the Midi-prep (Invitrogen, K2100-04) was used, which follows 
the same principle, but using different volumes (protocol not summarised here). 
 
Before the start of the purification process, the column resin was prepared by allowing 2 ml of 
equilibration buffer (EQ1; 0.1 M sodium acetate pH 5.5, 0.6 M NaCl, 0.15% v/v Triton X-100) to 
flow through the column, with the flow-through discarded. The harvested cells within the 
ultracentrifuge tube were then re-suspended with 400 µl of Resuspension Buffer containing RNase 
(R3; 50 mM Tris-HCl pH 8.0, 10 mM EDTA, 20 mg/ml RNase A), and then lysed with 400 µl of Lysis 
Buffer (L7; 0.2 M NaOH, 1% w/v SDS). This was allowed to settle for 5 minutes with occasional 
inversion of the ultracentrifuge tube. Following lysis, 400 µl of Precipitation Buffer (N3; 3.1 M 




temperature. The pelleted precipitant was discarded, and the resultant supernatant was allowed 
to flow through the column. The flow-through from this step is discarded. The resin membrane, 
containing the plasmids were washed twice with two 2.5 ml of Wash Buffer (W8; 0.1 M sodium 
acetate pH 5.0, 825 mM NaCl), once again with the flow-through discarded. The column is then 
transferred to be place upon a collection microcentrifuge, and the plasmids are then eluted with 
900 µl of Elution Buffer (E4; 100 mM Tris-HCl pH 8.5, 1.25 M NaCl).  
 
The plasmids within the eluent was then precipitated with 630 µl of ice-cold isopropanol, and 
pelleted by centrifugation at 16,000 g for 30 minutes at 4oC.  The supernatant was discarded, and 
the pellet washed with 1 ml of ice-cold 70% ethanol. Once again, the washed plasmids were 
pelleted by centrifugation, this time at 16,000 g for 5 minutes at 4oC.  The supernatant was 
discarded, and the pellet left to air-dry. Once dried, the pellet was resuspended 50 µl TE buffer (10 
mM Tris-HCl pH 8.0, 0.1 mM EDTA). The concentration of the purified plasmid was quantified 
using a spectrophotometer. 
 
Restriction mapping 
To conduct restriction mapping of plasmids with an approximate indication of success in 
transformation with the insert present, a reaction mix of 200 ng plasmid, 1x NEBuffer 2, 150 units 
of HindIII enzyme and 350 units of KpnI enzyme, made up to a final volume of 20 µl with nuclease-
free water was incubated at 37oC for 16 hours. The digestion products were then electrophoresed 








Figure 37: Gel electrophoresis of plasmids before and after KpnI/HindIII digestion 
Both lanes without restriction enzyme treatment (lanes 1 and 3) demonstrate the classical triple 
banding reflecting the three conformations of relaxed, supercoiled and circular plasmids. In the 
KpnI/HindIII treated samples, the vector (lane 4) shows only one product, whereas plasmid S1G, 
named in experimental order) contains the vector, as well as the full length insert. 
 
Mutagenesis by site-directed in vitro mutagenesis 
Site-directed in vitro mutagenesis was conducted using the QuikChange II Site-Directed 
Mutagenesis Kit (Agilent, #200523), and the protocol is summarised as follows. 
 
Primers were designed as per manufacturer’s recommendations, where the desired mutation is in 





Figure 38: Design rationale for mutagenic primers  
Black sequences denotes the complementary sequences of the initial SLC4A7 plasmid at the 
equivalent of rs3755652 (underlined). Red sequences denotes the mutagenic primer sequences, 





The mutagenesis consisted of a final concentration of 1x reaction buffer, 10 ng plasmid template, 
100 ng of both primers, 2 % v/v proprietary dNTP mix, and 2.5 U of PfuUltra HF DNA polymerase, 
made up to a final volume of 50 µl with nuclease-free water. The reaction was placed into a 




 Temperature Duration 
Initialisation step (Hot Start) 95oC 30 seconds 
16 cycles Denaturing step 95oC 30 seconds 
Annealing step 55oC 1 minute 
Elongation step 68oC 10 minutes (>1 minute 
per 1kb of PCR 
product) 
 
Table 16: Thermocycler program for in vitro site-directed mutagenesis 
 
Following the amplification of the mutated plasmids, 1 µl of 10 U/µl DpnI restriction enzyme was 
added to each reaction tube. This was pipette mix, and heated at 37oC for 1 hour to digest the 
parental (methylated, non-mutated) plasmid. 
 
Transformation of XL10-Gold supercompentent cells were conducted as described above, except 
for the addition of 2 µl of the provided 2-betamercaptoethanol to the 50 µl aliquots of cells just 
prior to mixing with the mutated molecule. 
 
Sequence deletion by PCR-driven overlap extension 
PCR-driven overlap extension was based on the protocol described in Heckman and Pease (2007). 
Primers were designed to span (and omit) the spliced Exon 7. In other words it included the 15 
final base pairs of Exon 6, and the first 15 base pairs of Exon 8 in consecutive order (Figure 32 
above). These primers were used in concert with the aforementioned cloning primers in two steps. 
 
The first of the two steps includes two separate high-fidelity PCRs; one between the forward 
cloning primer (CFOR), and the reverse deletion primer (DREV) to generate the first fragment (PCR1). 
The other reaction is between the reverse cloning primer (CREV) and forward deletion primer (DFOR) 




polymerase as before. In this instance, the final concentration of the reagents within the reaction 
included 100 ng of original full-length SLC4A7 plasmid, 100 µM of each primer, 1x reaction master 
mix buffer (which includes the optimised concentrations of Taq enzyme, dNTPs and Mg2+). The 
final volume of the reaction was made up to 50 µl using nuclease-free water. The reaction was 
placed into a thermocycler using the following program ( 
Table 17). 
 
 Temperature Duration 
Initialisation step (Hot Start) 98oC 5 minutes 
35 cycles Denaturing step 98oC 10 seconds 
Annealing step 54oC 30 seconds 
Elongation step 72oC 3 minutes (>1 minute 
per 1kb of PCR 
product) 
Final elongation step 72oC 10 minutes 
 
Table 17: Thermocycler program for step 1 of sequence deletion by PCR-driven overlap extension 
 
The products of the two PCR reactions were then run on a 0.7% w/v agarose gel ( 
Figure 39, Lanes 4 and 5). Upon resolution, the desired PCR1 and PCR2 products (777 bp and 2548 







Figure 39: End-point PCR of sequence deletion by PCR-driven overlap extension (Step 1) 
Lane 1 was a positive control using the HA-tagged plasmid as template. Lanes 2 and 3 were 
parallel attempts at mutagenesis by overlap extension (not described further). Lanes 4 and 5 were 
PCR1 and PCR2 products respectively. There were multiple non-specific products, and only the 
products of the correct sizes were extracted. All products yielded >750 ng DNA, and had the 
sequences confirmed by Sanger sequencing. 
 
The second step combines the two PCR products as templates, together with the flanking cloning 
primers, utilising the overhang to form deleted products. Once again, using the Q5® High Fidelity 
DNA polymerase kit, the final concentration of the reagents within the reaction include 100 ng of 
both PCR1 and PCR2, 100 µM of each CFOR and CREV primer, 1x reaction master mix buffer (which 
includes the optimised concentrations of Taq enzyme, dNTPs and Mg2+). The final volume of the 
reaction was made up to 50 µl using nuclease-free water. The reaction was placed into a 








 Temperature Duration 
Initialisation step (Hot Start) 98oC 5 minutes 
35 cycles Denaturing step 98oC 10 seconds 
Annealing step 54oC 30 seconds 
Elongation step 72oC 5 minutes (>1 minute 
per 1kb of PCR 
product) 
Final elongation step 72oC 10 minutes 
 
Table 18: Thermocycler program for step 2 of sequence deletion by PCR-driven overlap extension 
 
The PCR reaction products were run on a 0.7% w/v agarose gel ( 
Figure 40). The desired smaller product (3270 bp) was then excised from the gel, purified (see 
Section 2.5.5) and quantified measured using a spectrophotometer. This PCR product now forms 




Figure 40: End-point PCR of splicing by PCR-driven overlap extension (Step 2) 
Lane 1 was a positive control using the HA-tagged plasmid as template. Lanes 2 was the parallel 




sequence deletion by overlap. Lanes 3 and 5 are no template controls. There were multiple non-
specific products, and only the products of the correct sizes were extracted. All products yielded 
>250 ng DNA, and had the sequences confirmed by Sanger sequencing. 
As confirmation of the plasmids used for this thesis, plasmids S1G, U1 and Z3A (all named in 
chronological experimental order), together with vector control, underwent restriction enzyme 





Figure 41: Restriction mapping of plasmids 
200 ng of plasmid DNA were digested overnight with KpnI and HindIII. SLC4A7 inserts of S1G, U1 
and Z3A plasmid sequences were confirmed by Sanger sequencing. Note that the indicated 
fragments lengths are approximate, as does not account for the restriction enzyme sites 
overhangs. 
 
Original plasmid name Characteristics Functional name 
pcDNA3.1(+) No change Vec 
S1G Full SLC4A7 insert (into pcDNA3.1(+) via 
HindIII and KpnI restriction sites) with A 
allele at position 976 (AAG codon) 
326K 
U1 SLC4A7 insert (into pcDNA3.1(+) via HindIII 
and KpnI restriction sites) with deletion of 
base pairs 751 to 1122 
Spl 
Z3A Full SLC4A7 insert (into pcDNA3.1(+) via 
HindIII and KpnI restriction sites) with G 
allele at position 976 (GAG codon) 
326E 
 






All plasmids had their sequences confirmed by Sanger sequencing (see Section 2.6.2). 
 
 
Reviving transformed bacterial from cryopreservation in glycerol stock 
To revive transformed bacterial from frozen glycerol stocks, 50 ml of SOB media with 100 µg/ml 
ampicillin was initially prepared as above in a conical flask, and left to cool to 37oC. Once cooled, 
the glycerol stock was scraped with a sterile pipette tip, and immediately left immersed in the 
SOB/ampicillin. The vial containing the glycerol stock was always kept frozen by being place on dry 
ice throughout. The conical flask was then incubated in a shaking incubator overnight, rotating at 







Transfection describes the process of introducing nucleic acids (DNA, RNA, siRNA, plasmids etc.) 
into eukaryotic cells, as opposed to transformation which refers to process involving non-
eukaryotic cells (e.g. bacteria). Typically, it also excludes virus-driven methods, referred to as viral 
transduction.  
 
There are now a wide variety of methods of transfection. An early but still commonly used, 
relatively cheap and simple method is calcium phosphate transfection, as initially described by 
Graham and Van der Eb (1973). By mixing the various components containing calcium, phosphate 
and DNA, precipitates form and are allowed to reach the cells. Although the precise mechanism is 
unclear, the precipitates are presumed to be taken up by the cells via endocytosis. Whilst useful, 
the calcium phosphate transfection method has several limitations, not least the range of cell lines 
that it can be successfully transfect. A concern that often occurs with calcium phosphate 
transfections is the variability in transfection efficiencies from experiment-to-experiment. It is also 
unclear whether the uptake of the precipitates significantly alters the intracellular milieu in 





A common alternative is lipofection. This is a lipid-mediated method of DNA transfection into 
living cells, which one of the first descriptions was by Fraley et al. (1980). Most lipofection 
methods currently use proprietary molecules, and thus no further information is readily available. 
In general they utilise cationic lipids, having a positively charged polar head group and a non-polar 
lipid chain tail. Once again, the exact mechanism is unknown, but it is presumed that it is based on 
the electrostatic interactions between the positively charged cationic head and the negatively 
charged phosphate backbone of plasmid DNA. In turn the amphiphilic nature of the cationic lipid 
then forms a lipid bilayer containing the DNA, in other words a liposome. The outer cationic head 
of the liposome is then able to interact and merge with the anionic lipids present on the plasma 
membrane, allowing the DNA contents to be internalised. Lipofection is very efficient with 
majority of cell lines, but still fails in some. It is also relatively more expensive. 
 
Electroporation utilises an electric field placed across cell in suspension to enhance uptake of DNA 
macromolecules across the plasma membrane, with an early description by Neumann et al., 
(1982). Since then, the method has been refined, and standardised electroporators are 
commercially available with a wide range of settings to suit the cell line of choice. As with the two 
previous descriptions, the exact chemical / molecular mechanism by which electroporation 
functions is uncertain, but broadly, the applied electric field temporarily moves ions present both 
inside and outside the cells. This is believed to be the mechanism which increases membrane 
permeability to exogenous molecules through small “holes”. Once the electrical field is turned off, 
the cell membrane repair mechanisms will seal up the passages and restore membrane integrity. 
Although this is a relatively easy method to use, and applicable in the majority of cell lines, there is 
the potential disadvantage of cell mortality, particularly with adherent cell lines that need to 
recover immediately post-electroporation to allow cellular function in re-adhering to the cell 
culture surface.  
 
Other alternatives include, viral vectors, microprojectiles, microinjections, cationic polymers and 
magnetic nanoparticles, all of which have their advantages and disadvantages, but typically are 
not first-line (or even second-line) techniques. Additionally, this is not an exhaustive list as there 
are newer biotechnologies that also achieve cell transfection via different methods. 
 
2.19.2. Methods 




Studies with HEK293 and A10 cells were cultured as described in Section 2.1.5, with 
DMEM+10%FBS as the culture media. When subculturing the cells to proliferate, the cell culture 
surface did not require any gelatin coating. However, when utilising glass cover slips, the culture 
surface was pre-coated with 0.2% w/v gelatin (Sigma, G1890) to minimise cells detachment when 
undergoing multiple washes which is otherwise particularly noticeable with HEK293 cells with the 
immunocytochemistry (see Section 2.16) protocols. 
 
HEK293 and A10 cells for transfection experiments were grown on a gelatin pre-coated 16-mm 
coverslip within 6-well plates or 35-mm petri dishes. Once the cells reach the desired confluence 
(40%), the reaction mix was prepared. At this confluency, the cells are likely to be in their log-
growth phase, providing just enough cell-cell contact to help cell cultures grow, but not too much 
contact that results in contact inhibition, making cells resistant to uptake of DNA. The media was 
replaced prior to transfection, with 2ml of fresh DMEM+10%FBS media. 
 
All studies were conducted in parallel, where all four plasmids (vector, S1G, U1 and Z3A) were 
transfected in parallel to minimise potential variability in the baseline characteristics of the cells. 
 
Calcium phosphate transfection 
Calcium phosphate transfection was conducted using 2x HEPES buffered saline (50 mM HEPES, 10 
mM KCl, 12 mM dextrose, 280 mM NaCl, 1.5 mM Na2PO4, pH adjusted to 7.4 using HCl, and sterile 
filtered) and 2 M CaCl2 solution. Initially, a calcium chloride-plasmid mixture was made with 1 (up 
to 2) µg of plasmid and 24.4 µmol (12.2 µl of 2 M) CaCl2 made up to a final volume of 100 µl with 
sterile-filtered nuclease-free water. This mixture was then added drop-wise into 100 ul of 2x 
HEPES buffered saline and left to incubate for 10 minutes at room temperature. Following this 
incubation, the resultant mixture was added drop-wise into the well, aiming to cover the whole 
well. The cells were then incubated a humidified incubator kept at 37oC and 5% CO2. After 24 
hours, the media is replaced with fresh DMEM+10%FBS media. After a total of 24 to 72 hours after 
the start of transfection, the cells are suitable for further studies. This working volume of plasmids 
and reagents were optimized to a well in a 6-well plate (approx. cell growth area 10 cm2), and 
subsequent work is scaled up or down dependent on cell culture growth area. 
 




The liposome-based transfection with the proprietary X-tremeGENE reagent (Roche, 
06366244001) was conducted as per manufacturer’s recommendations 
(http://lifescience.roche.com/wcsstore/RASCatalogAssetStore/Articles/06989195001_03.13.pdf), 
as summarised below.  
 
For every well, 1 (up to 2) µg of plasmid is added to 200 µl of basal media, in the context of the 
work for this thesis, DMEM (Sigma, M4530). Following that, 3 µl of the X-tremeGENE reagent was 
added to the plasmid/DMEM mixture with pipette mixing, and allowed to incubate for 20 minutes 
at room temperature. Following incubation, the mixture was added drop-wise into the well, 
aiming to cover the whole well. The cells were then incubated a humidified incubator kept at 37oC 
and 5% CO2 for (24 to) 48 hours without the need to replace the culture media. This working 
volume of plasmids and reagents were optimized to a well in a 6-well plate (approx. cell growth 
area 10 cm2), and subsequent work is scaled up or down dependent on cell culture growth area. 
 
There is overexpression of RNA (as detected by RT-PCR) in A10 cells after 24 hours post-
transfection (Figure 42). 
 
 
Figure 42: RT-PCR for transfected of A10 cells 
End-point RT-PCR using 10 ng of reverse-transcribed RNA from transfected A10 cells and 
untransfected HUAMSC cells. Three primers (F, R1 and R2, see Section 2.21.2) were used 
concurrently. 1 ng of plasmid served as positive control marking appropriate product sizes. 
A10 cells were transfected with 1 ng plasmid per 10 cm2 cell culture surface (326E, 326K and Spl or 





These conditions produced an overexpression of NBCn1 of the appropriate sizes, with either 2 µg 




Figure 43: Protein immunoblots for transfected HEK293 and A10 cells 
HEK293 and A10 cells were transfected with 2 ng plasmid per 10 cm2 cell culture surface (326E, 




Figure 44: Protein immunoblots for transfected HEK293 with dose and time variation 
HEK293 cells in 6-well plates were transfected with 1 or 2 ng plasmid per 10 cm2 cell culture surface 
(326E, 326K and Spl or with vector control) for 24 or 48 hours. 
The short (30 seconds) and long (5 minutes) exposure of the autoradiograph film were done 
consecutively on the same ECL-treatment. The short exposure allows better differentiation of sizes 
of the products. The long exposure allows better differentiation of the degree of expression 





The overexpression was also confirmed by fluorescent immunocytochemistry (Figure 45). The 





Figure 45: Merged inverted fluorescent microscopy images for transfected A10 cells 
Representative images of A10 cells transfected with 2 µg of plasmid per 10 cm2 cell culture surface 




microscope (EVOS® FL Cell Imaging System, Life Technologies). Blue, DAPI; red, NBCn1. Scale bars 
represent 200 µm.  
Expression plasmids and the range of NBCn1 variants 
It should be recognised that there are several different variations to NBCn1 apart for Cassette II. 
The expression plasmids utilised here contain the MERF N-terminal sequence, and also contains 
Cassette I, III and IV.  Although the MERF sequence is classically regarded as “human” (as opposed 
to the “classically murine” MEAD sequence), it has been recently shown that both MERF and 
MEAD sequences are expressed in human cells. Additionally, with the other cassettes, there are 
now 10 known full length human NBCn1 variants, where the absence/presence of these cassettes 
may alter surface availability and intrinsic transporter function (Liu et al., 2013). It should be 
recognised that there is a theoretical possibility that the E326K amino acid change behaves 
differently in depending on the whole NBCn1 sequence. 
 
 
2.20. Intracellular pH (pHi), buffering capacity and Na
+/HCO3
--dependent pHi recovery  
2.20.1. Principles 
pHi measurement 
Early methods of measuring pHi initially involved direct use of pH electrodes. Originally, glass 
electrodes were used (Caldwell, 1954), but they were too large for most cells except for 
crustacean muscle fibers or cephalopod giant axons. This method progressed to smaller 
microelectrodes (Thomas, 1974), but were still limited by the size of the cell, technical difficulties 
and the inability to assess more than one cell at any one time.  This is now very much superseded 
by the use of pH-dependent fluorescent dyes. A commonly used dye is BCECF-AM ((2’,7’-bis-(2-
carboxyethyl)-5-(and-6)-carboxyfluorescein-acetoxymethyl ester), as first reported in 1982 (Rink et 
al., 1982), and it continues to be popular almost a quarter of a decade on as it has some key 
properties important for pHi assessment.  
 
Although its active moiety is BCECF, it is formulated as an AM ester to allow for easier usage. The 
ester derivative itself is non-fluorescent, and membrane permeant. This allows non-invasive 
loading of the cells. Additionally, intracellular non-specific esterases within viable cells are able to 
free up the BCECF molecule, thus producing a signal only when present within viable cells. When 
the hydrolysis of the ester bond occurs, the resultant BCECF with a pKa of approximately 7.0, has a 




worth noting that this property, results in BCECF having a buffering capacity of its own, thus it is 
important not to overload cells and distort the observed intracellular buffering capacity.  The key 
to the utility of BCECF as a pH indicator is that the fluorescence excitation profile is pH-dependent 
(Figure 46), allowing the implementation of ratiometric measurement techniques (see Section 
2.20.4.). Notably, these dyes have a frequency whereby the signal is dependent on, and preferably 
linearly correlated, to the pH. It also has an isobestic point, specific wavelength at which the 
absorbance of a sample does not change with the pH of the sample. This absorbance at the 
isobestic point accounts for dye loading, thus a ratio of the emitted light following excitation at the 
two wavelengths allows for calibration of the experiment and eliminates artefacts caused by 




Figure 46: pH-dependent fluorescence excitation spectra of BCECF  
Fixed emission wavelength of 535 nm with peak excitations near 490 nm and a pH-independent 
isosbestic point near 440 nm. (Adapted from 
https://tools.lifetechnologies.com/content/sfs/manuals/mp01150.pdf). The studies conducted here 
utilized excitation wavelengths of 495 and 440 nm. 
 
Carboxy SNARF-1-AM (Spiro[7H-benzo[c]xanthene-7,1'(3H)-isobenzofuran]-ar'-carboxylic acid, 3-




which like BCECF-AM easily loads into viable cells, and is retained after the non-specific esterases 
frees up carboxy SNARF-1 molecule. Carboxy SNARF-1 have both dual-emission and dual-
excitation properties, making them particularly useful for confocal laser-scanning microscopy, flow 
cytometry and microplate reader–based measurements. Additionally, the spectra of carboxy 
SNARF-1 are well resolved from those of multiple Ca2+ and Na+ indicators, permitting simultaneous 
measurements of pHi and Ca
2+ or Na+. 
 
Newer flourimetric microscope imaging systems now allow for assessment of multiple regions 
within one single microscopy field. With an adequately dye-loaded specimen, it is possible to 
obtain images with exposures of less than 500 milliseconds, allowing for an almost real-time, 
second-to-second measurement. This frequency of measurements is important for an accurate 
measurement of pHi recovery. Using more advanced systems, not used for the work in this thesis, 
it is even possible to combine with scanning confocal microscopy, although this would be limited 
by longer duration between full scans. 
 
Ammonium chloride pre-pulse and experimental protocols 
To induce intracellular acidification a pre-pulse of ammonium chloride is administered and later 
washed-out, of which an early version was described in 1974 but using microelectrodes and an 
external Ringer’s solution of pH 8.0 (Thomas, 1974). A protocol closer to current practice was 
described in 1977, with an external solution of pH 7.7 (Boron and De Weer, 1976), but this time 
with giant axons of live specimens of the squid Loligo pealei, with a relatively high (but not high 
relative to the squid) extracellular sodium content of 450 mM.   
 
After an initial period of baseline measurements (Figure 47, a), the addition of NH4Cl to the 
extracellular solution initially leads to the equilibrium of NH4
+ ↔ NH3 + H
+. As the plasma 
membrane is permeable to NH3, it rapidly diffuses intracellularly, where it can combine with H
+, 
resulting in abrupt intracellular alkalinisation (b). This is followed by a slower acidification as NH4
+ 
enters the cells and base extrustion (e.g. via Cl-/HCO3
—exchange) is activated. Upon washout of 
extracellular NH4Cl, the intracellular NH3 rapidly escapes the cell, leaving H
+ behind and causing 
intracellular acidification, and the recovery of pHi from this acidification is initially observed in the 
absence of sodium (c). In this step, the sodium content within the PSS (physiological salt solution) 
is replaced with either equimolar N-methyl-D-glucammonium (NMDG) chloride or choline 




which are relatively inert and largely impermeable to the plasma membrane. This combination 
allows the generation of an isotonic, but sodium-free solution. Following the period of exposure to 
sodium-free solution, the samples are re-introducted to sodium with the original PSS to determine 
sodium-dependent base uptake (d). The main variations on the initial experiment are conducted in 
the presence of an NHE inhibitor; or the absence of CO2/HCO3
- to identify a bicarbonate-
dependent component to pHi recovery (Figure 47).  
 
There are several options for NHE inhibitors, all with different inhibitory potencies and target 
specificities. An early option was amiloride, but is not as potent an inhibitor of NHE (IC50 of 84 µM) 
and also has the disadvantage of being non-specific at experimental conditions with a Na+-channel 
(ENaC) IC50 of 0.34 µM. EIPA (5-(N-Ethyl-N-isopropyl)amiloride), on the other hand, is a more 
potent inhibitor of NHE (IC50 0.33 µM) but relatively non-specific with regards to the Na
+/Ca2+ 
exchanger (NCX) IC50 of 129 µM. A potential compromise is that of dimethyl amiloride (DMA) with 
IC50 of 4.3 µM and 550 µM for NHE and NCX respectively (Lesburg et al., 1990). Utilising DMA, 
instead of EIPA, as the NHE inhibitor has the additional benefit of being easier to handle 
logistically, being able to be frozen in stock solutions.  
 
For CO2/HCO3
--free studies, the bicarbonate within the solution is replaced with equimolar sodium 
chloride (or NMDG chloride for sodium- and bicarbonate-free solution), once again maintaining 
isotonicity. Instead of bubbling CO2 gas into the solution, air (with the nominal absence of CO2) is 
used instead. HEPES is used as one of the pH buffering agents in these studies. It is an organic 
zwitterion with strong buffering capacity in the physiological range (6.8 to 8.2), and is typically 
independent of carbon dioxide for its buffering potential. This makes it an appropriate basis for 
the CO2/HCO3
--free buffers. It is notable that HEPES has been found to have inhibitory effects on 
ion channels, for example Cl- channels (Yamamoto and Suzuki, 1987) and to control for such 







Figure 47: Experimental protocol investigating influence of NHE (by DMA inhibition) and NBC (by 
removal of CO2
 and HCO3
-) in HUVECs and HUASMCs 
(a) Initial baseline pHi, (b) abrupt intracellular alkalinisation with ammonium chloride with initial 
rapid influx of NH3 and later slower acidification with NH4
+ entry, (c) washout of ammonium 
chloride results in intracellular NH3 rapidly escapes the cell, leaving H
+ behind and causing 
intracellular acidification, and the recovery of pHi from this acidification is initially observed in the 
absence of Na+ and (d) where the recovery is observed in the presence of Na+. 
Representative figure from HUASMCs, and reflects the format of representing results for the rest of 
the thesis. 
 
Separate to the above studies, HUASMCs were also cultured for 48 hours in serum-free media 
prior to experimentation attempting to limit any differences in cell cycle stages (Griffin, 1976). 
Notably, serum starvation has previously been shown to reduce sodium-dependent recovery from 
intracellular acidosis in Caco-2 human epithelial colorectal adenocarcinoma cells (Watson et al., 
1992). This study was conducted before the identification of NBCs, and therefore the finding was 
attributed to a post-translational effect on NHEs. However, studies were performed in the 
presence of CO2/HCO3
-, therefore could also be related to an effect on NBCs. This was not possible 
for HUVECs, as culture in serum-free media resulted in cell death, as reflecting previous studies 
(Karsan et al., 1997). 
 
Other variations for HUASMCs include the addition of 10 µM of the calcineurin inhibitor FK506 (or 
equivolume 2 µl DMSO vehicle control) at the point of ammonium chloride washout, with (or with 
equivolume 2 µl DMSO vehicle control) incubation with 30 µM of the intracellular calcium chelator 
1’,2’-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis-acetoxymethyl ester (BAPTA-




BAPTA-AM used were reflective of previous studies on VSMCs of rat mesenteric isolated arteries 
(Danielsen et al., 2013). Additionally, the effective concentration and loading duration was also 
confirmed to have a sufficient influence on intracellular calcium of HUASMCs by Fura-2 (F-1201, 
Fisher Scientific) studies (Figure 49). 
 
 
Figure 48: Experimental protocol investigating influence of calcineurin (by FK506 inhibition) and 




Figure 49: Free intracellular calcium in response to ammonium prepulse in HUASMCs with and 
without BAPTA-AM loading 
30 µM BAPTA-AM loading for 20 minutes is sufficient to attenuate increases in intracellular calcium 
in response to the alkalinisation, acidification and depolarisation of HUASMCs during ammonium 
chloride prepulse. The ratios were not calibrated to absolute values of intracellular free Ca2+ as this 
was not necessary to demonstrate an effect of BAPTA-AM. 
 
Of note, the studies demonstrate a sodium-independent component of pHi recovery (Figure 50), 
which is also independent of CO2/HCO3
- (Figure 50, lower panel). The potential mechanisms for 




monocarboxylate transporters (inhibited by its specific blocker α-cyano-4-hydroxycinnamate) have 
been demonstrated in an in vitro assessment of human radial artery smooth muscle cell explants 
(Lee et al., 2014). 
 
Figure 50: Na+-independent pHi recovery  
Paired experiments on HUVECs. Note the purple curves (denoting the absence of Na+ following 




Cell culture surface, culture substrate and cell type selection 
Experiments were initially conducted with cells cultured on 0.04% w/v gelatin-coated glass 
coverslips. Under these condition, cells were prone to detachment, particularly after ammonium 
chloride exposure. Furthermore, this is exacerbated with HUASMCs which retain their contractile 
abilities. Cell detachment is markedly reduced when using the cell culture surface of 0.1% w/v 
poly-lysine coated-polystyrene flasks. Further to improving cell attachment, NBC activity, as 
represented by pHi recovery in PSS (+DMA) buffer is more apparent with the poly-
lysine/polystyrene cell culture surface (Figure 51). Hence, all studies in this thesis are conducted 







Figure 51: Effect of cell culture surface and substrate on pHi recovery 
Representative results for 1 HUASMC, 2 HUVECs and 1 A10 cell cultures on different cell culture 
surfaces. The gelatin-coated glass coverslip culture surface consistently had lower resting pHi and 
rate of recovery as compared to poly-lysine-coated polystyrene flasks, across all cell types. 
 
Two experimental cell lines were not followed up for different reasons. HEK293 cells shunk 
significantly upon addition of the standard 20 mM NH4Cl prepulse. This was even observed with 
concentrations of NH4Cl as low as 5 mM. On top of this problem, HEK293 cells were not tolerant of 
the multiple washes that was required as part of this protocol. NIH3T3 fibroblasts did not have any 
less endogenous sodium- and bicarbonate-dependent recovery from intracellular acidosis as 
compared to A10 cells and thus not further utilised. 
 
Calibration curves for pHi 
Calibration of the initial fluorescence output (F495/F440 ratio) to a numerical pH value typically 
utilises nigericin, which acts as a K+/H+-exchanger, allowing equilibration of these ions across the 
plasma membrane (Harold and Baarda, 1968). In the presence of nigericin, bathing the sample 
with solutions of known pH will equilibrate with the intracellular space, and allows the dye-
measured ratio to equate to a known pH (Chaillet and Boron, 1985) (Figure 52).  
 
The presence of the high K+ concentration approximates to the intracellular [K+], which allows 
nigericin to mediate K+-H+ exchange until extracellular [H+] is equal to intracellular [H+], and 
therefore pHi equals pHo. The calibration curves for the work done for this thesis are further 







Figure 52: Example of nigericin and pH clamping calibration 
Adapted from Chaillet and Boron (1985). Note the difference from current protocol of the 
measured fluorescence ratio (due to use of different dye) and the concentration of extracellular K+ 
(due to different cell type), but the principle remains the same. It also refers to “lumen” as the 
sample assessed was a proximal tubule from a salamander. 
 
Limitations 
Perhaps the most important limitation of this methodology is the dependence on the relevance of 
the samples assayed. With an in vitro assay, there are always the concerns of extrapolating to in 
vivo situations (as explored in Section 2.1.1) and the lack of interactions between adjacent cell 
types (as explored in Section 1.6). The work in this thesis also found a major influence of the cell 
culture surface and substrate (Figure 51), indicating that different experimental conditions may 
influence pHi recovery. With that, consistency in conditions must be ensured, and particularly 
relevant when comparing results across studies/publications.  
 
2.20.2. Materials 
All solutions were warmed to 37oC and bubbled with the corresponding gas for 30 minutes prior to 
use. 
 
Physiological saline solution (PSS) had a final formulation of 116 mM NaCl, 2.82 mM KCl, 25 mM 
NaHCO3, 1.6 mM CaCl2, 1.2 mM MgSO4, 1.18 mM KH2PO4, 10 mM HEPES, 0.03 mM EDTA
 and 5.5 
mM glucose. The solution was adjusted to pH of 7.45 at 37oC while bubbled with 5% CO2 in air. 
Calcium chloride was the last to be added after achieving the desired pH. This provides a final 
concentration of 141 mM Na+, 122 mM Cl-, 25 mM HCO3
-, 10 mM HEPES, 5.5 mM glucose, 4 mM 
K+, 1.6 mM Ca2+, 1.2 mM Mg2+, 1.2 mM SO4
2-, 1.18 mM H2PO4





Bicarbonate-free physiological saline solution (-HCO3
- PSS) had a final formulation of 141 mM NaCl, 
2.82 mM KCl, 25 mM NaHCO3, 1.6 mM CaCl2, 1.2 mM MgSO4, 1.18 mM KH2PO4, 10 mM HEPES, 
0.03 mM EDTA and 5.5 mM glucose. The solution was adjusted to pH of 7.45 at 37oC while bubbled 
with air (nominally 0% CO2). Calcium chloride was the last to be added after achieving the desired 
pH. This provides a final concentration of 141 mM Na+, 147  mM Cl-, 10 mM HEPES, 5.5 mM 
glucose, 4 mM K+, 1.6 mM Ca2+, 1.2 mM Mg2+, 1.2 mM SO4
2-, 1.18 mM H2PO4
- and 0.03 mM EDTA.   
 
Sodium-free physiological saline solution (-Na+ PSS) had a final formulation of 116 mM NMDG (N-
methyl-D –glucamine), 2.82 mM KCl, 25 mM choline bicarbonate, 1.6 mM CaCl2, 1.2 mM MgSO4, 
1.18 mM KH2PO4, 10 mM HEPES, 0.03 mM EDTA
 and 5.5 mM glucose. The solution was adjusted to 
pH of 7.45 at 37oC while bubbled with 5% CO2 in air. Calcium chloride was the last to be added 
after achieving the desired pH. This provides a final concentration of 116 mM NMDG+, 25 mM 
choline+, 122 mM Cl- (in theory after titrating pH Cl), 25 mM HCO3
-, 10 mM HEPES, 5.5 mM glucose, 
4 mM K+, 1.6 mM Ca2+, 1.2 mM Mg2+, 1.2 mM SO4
2-, 1.18 mM H2PO4
- and 0.03 mM EDTA.   
 
Sodium- and bicarbonate-free physiological saline solution (-Na+/-HCO3
- PSS) had a final 
formulation of 141 mM NMDG, 2.82 mM KCl, 25 mM NaHCO3, 1.6 mM CaCl2, 1.2 mM MgSO4, 1.18 
mM KH2PO4, 10 mM HEPES, 0.03 mM EDTA
 and 5.5 mM glucose. The solution was adjusted to pH 
of 7.45 at 37oC while bubbled with air (nominally 0% CO2) with HCl. Calcium chloride was the last 
to be added after achieving the desired pH. This provides a final concentration of 141 mM NMDG+, 
147 mM Cl- (in theory after titrating pH Cl), 10 mM HEPES, 5.5 mM glucose, 4 mM K+, 1.6 mM Ca2+, 
1.2 mM Mg2+, 1.2 mM SO4
2-, 1.18 mM H2PO4
- and 0.03 mM EDTA. 
 
High-potassium physiological saline solution (High-K+ PSS) had a final formulation of 68.8 mM NaCl, 
50 mM KCl, 25 mM NaHCO3, 1.6 mM CaCl2, 1.2 mM MgSO4, 1.18 mM KH2PO4, 10 mM HEPES, 0.03 
mM EDTA and 5.5 mM glucose. The solution was adjusted to pH of 7.45 at 37oC while bubbled with 
5% CO2 in air. Calcium chloride was the last to be added after achieving the desired pH. This 
provides a final concentration of 93.8 mM Na+, 122 mM Cl-, 25 mM HCO3
-, 10 mM HEPES, 5.5 mM 
glucose, 51.2 mM K+, 1.6 mM Ca2+, 1.2 mM Mg2+, 1.2 mM SO4
2-, 1.18 mM H2PO4
- and 0.03 mM 
EDTA.   
 
Sodium-free, high-potassium physiological saline solution (-Na+/High-K+ PSS) had a final 




MgSO4, 1.18 mM KH2PO4, 10 mM HEPES, 0.03 mM EDTA
 and 5.5 mM glucose. The solution was 
adjusted to pH of 7.45 at 37oC while bubbled with air (nominally 0% CO2). Calcium chloride was the 
last to be added after achieving the desired pH. This provides a final concentration of 68.8 mM 
NMDG+, 25 mM choline+, 122 mM Cl-, 25 mM HCO3
-, 10 mM HEPES, 5.5 mM glucose, 51.2 mM K+, 
1.6 mM Ca2+, 1.2 mM Mg2+, 1.2 mM SO4
2-, 1.18 mM H2PO4
- and 0.03 mM EDTA.   
 
In calibrating the experiments, a range of bicarbonate-free, high-potassium PSS calibration 
calibration (Calibration PSS) were used. The buffers had a final formulation of 11 mM NaCl, 132.8 
mM KCl, 1.6 mM CaCl2, 1.2 mM MgSO4, 1.18 mM KH2PO4, 10 mM HEPES, 0.03 mM EDTA
 and 5.5 
mM glucose. The solution was adjusted to pH of a range between 6.0 and 8.0 at 37oC while 
bubbled with air (nominally 0% CO2). Calcium chloride was the last to be added after achieving the 
desired pH. Just before use, nigericin (N7143, Sigma) was added to achieve a final concentration of 
5 mg/l. This provides a final concentration of 11 mM Na+, 147 mM Cl-, 10 mM HEPES, 5.5 mM 
glucose, 134 mM K+, 1.6 mM Ca2+, 1.2 mM Mg2+, 1.2 mM SO4
2-, 1.18 mM H2PO4
- and 0.03 mM 
EDTA.   
 
Poly-L-lysine (P8920, Sigma) was used at a working concentration of 0.1% w/v, covering the cell 
culture surface at 0.5ml for each 12.5 cm2 cell culture flask. This was allowed to rest at room 
temperature for 5 minutes, before being aspirated. The flask was then washed with sterile distilled 
deionised water and aspirated to dryness. The flask was then left to dry at 37oC for 2 hours. 
 
In studies with the calcineurin inhibitor FK506 (F4679, Sigma), a final concentration of 10 µM is 
used. Additionally, to increase the intracellular calcium levels, a 50 mM K+ solution is used where 
the increased K+ is provided by KCl in direct equimolar replacement of NaCl (or NMDG). Dimethyl 
amiloride (A4562, Sigma) was used at a final concentration of 10 µM. 
 
In studies with transfected cells, transfection with the lipofectamine method is as previously 









Equilibration and set-up 
The desired cells were sub-cultured on polystyrene cell culture flasks with 12.5 cm2 cell culture 
surface (#353107, BD-Falcon) pre-coated with 0.1% w/v poly-l-lysine. Once at the desired 
confluence, the cultured cells were ready to be assayed.  
 
The experiments were conducted in a temperature controlled set-up with the stand and ambient 
air warmed up to 37oC for 30 minutes before initiation of experiments. Just before starting the 
experiments, two ports were created on the top of the culture flask, one to allow for aspiration 
and the other for bubbling of gasses (5% CO2 / 95% air or 100% air depending on study). The flask 
was then placed in a custom manufactured holder to ensure stability throughout the study.  Once 
in place the culture flask washed twice with PSS (or -HCO3
- PSS), and the relevant gas bubbled 
through at a constant rate. After the washes, the flask was filled with 2 ml of PSS (or -HCO3
- PSS) 
with 2 µl of 2mM stock BCECF-AM (B-1170, ThermoFisher) dissolved in DMSO, to reach a final 
concentration of 1 µM. 
 
The cells were incubated with the BCECF-AM for 20 minutes. After BCECF-AM loading, the 
adherent cells were washed twice with PSS (or -HCO3
- PSS), and the recordings were initiated 
(Visiview Version 3, Visitron Systems).  
 
Experimental protocols 
Experimental protocols for HUASMCs and HUVECs were otherwise as described in Section 2.20.1., 
and can be summarised as 20 mM ammonium chloride prepulse: 
- In PSS buffer, 
- In PSS buffer followed by 30 µM DMA (NHE inhibition), 
- In CO2/HCO3
—-free PSS (NBC inhibition), and 
- In CO2/HCO3
—-free PSS (NBC inhibition) followed by 30 µM DMA (NHE inhibition). 
 
For HUASMCs, additional studies can be summarised as 20 mM ammonium chloride prepulse: 
- In PSS buffer followed by 30 µM DMA (NHE inhibition) for cells cultured in serum-free media 
for 48 hours, 
- With 2 µl equivolume DMSO vehicle incubation for 20 minutes, in PSS buffer followed by 30 




- With 2 µl equivolume DMSO vehicle incubation for 20 minutes, in PSS buffer followed by 30 
µM DMA (NHE inhibition) and 10 µM FK506 (calcineurin inhibition), 
- With 30 µM BAPTA-AM loading for 20 minutes (intracellular calcium chelation), in PSS buffer 
followed by 30 µM DMA (NHE inhibition) and 2 µl equivolume DMSO vehicle, and 
- With 30 µM BAPTA-AM loading for 20 minutes (intracellular calcium chelation), in PSS buffer 
followed by 30 µM DMA (NHE inhibition) and 10 µM FK506 (calcineurin inhibition). 
 
Paired digital images at excitation wavelengths of 495 nm and 440 nm were obtained with 
exposure times of 800 and 1000 milliseconds respectively. These images and their corresponding 
fluorescence measurements were obtained every 3 seconds at times of interest, otherwise at 15 
second intervals. Paired videos for both 495 nm and 440 nm excitation wavelengths are shown in 
Appendix 8a and 8b. 
 
Experimental protocols for transfected A10 cells were otherwise as described in Section 2.20.1., 
and can be summarised as 20 mM ammonium chloride prepulse: 
- In PSS buffer followed by 30 µM DMA (NHE inhibition), and  
- In PSS buffer followed by 30 µM DMA (NHE inhibition) and 2 µl equivolume DMSO vehicle, 
and 




pHi calibration curves 
The calibration curves for the work done for this thesis follows a highly reproducible curve, with 







Figure 53: pHi calibration curve  
F495/F440 ratios (mean ± SEM, n=6 sets) at a range of pHi normalised to the ratio at pHi of 7.0. Error 
bars not easily visualized at datapoints between pH 6.0 and 7.4 due to the very small inter-
experiment variation. The curve axes were inverted to derive the cubic polynomial formula (pHi) = 
2.2855x3 – 7.2398x2 + 8.7642x + 3.194, where x = normalised F495/F440 ratio. The relationship is near 
linear between the pH ranges of 6.5 to 7.5. 
 
Baselines 
The initial resting baseline was recorded for 1 minute (20 timepoints at 3 seconds intervals) before 
the ammonium chloride prepulse. The end resting baseline was noted for studies with inhibitors 
(DMA or FK506) for 1 minute (20 timepoints at 3 seconds intervals) when the pHi trace plateaus.  
 
Buffering capacity, pHi
 recovery rate and net base uptake 
The buffering capacity (mmol/L) was calculated based on the response to wash-out of NH4Cl using 
the formula β= Δ[NH4
+]i / ΔpHi. The [NH4
+]i was calculated from the Henderson-Hasselbalch 
equation assuming equilibration of NH3 across the membrane and using a pKa of 9.2 (Equation 1 
below), and ΔpHi
 calculated by the difference in pHi before and after washout of NH4Cl (Boetkjer et 
al., 2006).  
 
Equation 1: Henderson-Hasselbalch equation 
 
The rate of net base uptake (mmol/L/min) during recovery from intracellular acidosis was 
calculated as the product of the rate of pHi gain (ΔpHi
 per minute calculated by linear regression 





2.21.1. KASPar genotyping primers 
SNP Primer type 
(reporter) 
Sequence 
rs13082711 C allele (VIC) GAAGGTCGGAGTCAACGGATTAAGATCTGTTTAAAAACAGCTCCCTAC 
T allele (FAM) GAAGGTGACCAAGTTCATGCTTAAAGATCTGTTTAAAAACAGCTCCCTAT 
Common primer AGTTTAGCAAAGCTACAGAACAAGGACAT 
rs13096477 C allele (VIC) GAAGGTCGGAGTCAACGGATTACACAAACATCACCACCGGAGG 
T allele (FAM) GAAGGTGACCAAGTTCATGCTGACACAAACATCACCACCGGAGA 
Common primer CCCGTCCATCTTCTTTATCTGATTCTTTA 
rs3755652 C allele (VIC) GAAGGTCGGAGTCAACGGATTCTGACCTCCAGAAGTTCCCAAG 
T allele (FAM) GAAGGTGACCAAGTTCATGCTCCTGACCTCCAGAAGTTCCCAAA 
Common primer TCACTGGCAGGTGAAACCAGTAGTT 
Table 20: KASPar genotyping primers 
 
2.21.2. End-point PCR primers 








genomic DNA  
Forward CCCAATACAATACATTCCCCATAC 57
o
C / 2mM 459 
Reverse TGGGCACAATATTCTGTGTAGTG 
rs13096477 
complementary DNA  
Forward CCTGGTCCTGATGAAGAAGC 57
o




primers in a 
single PCR) 
Forward CTGGCCAATTAGACGAGTCC(Exon 6) 57
o
C / 2mM Variable 
(see Figure 
42)         
Rev 1 TCAGCACCCGTAGGAATTTT(Exon 7) 
Rev 2 CGCTGACTCTTTTGGGAACT(Exon 8) 
SLC4A4 cDNA Forward GGCTTCTTCTCTCCCACAGT 57
o
C / 2mM 129 
Reverse TTCTTGGTTTGATGCCGGTG 
SLC9A1 cDNA Forward CGGTTCTGGCTGTCTTTGAG 57
o
C / 2mM 181 
Reverse ACCACGAAGAAGCTCAGGAA 
β-actin cDNA Forward TTCTACAATGAGCTGCGTGTG 57
o
C / 2mM 122 
Reverse GGGGTGTTGAAGGTCTCAAA 
EOMES cDNA Forward CCACTGCCCACTACAATGTG 55
o
C / 3mM 480 
Reverse GACCTCCAGGGACAATCTGA 
NEK10 cDNA Forward AATGGCCAATGAAGCTTTTG 57
o
C / 2mM 377 
Reverse TACGCTGAGGATGTTTGCTG 
PHOX2A cDNA Forward TTTCGCTGAGACCCACTACC 57
o
C / 2mM 216 
Reverse GACTCCTTGGAATCGTCGTC 
PLAGL1 cDNA Forward GGGACCATTGAAGAATTCCA 57
o
C / 2mM 2 variants 
(720 & 416) Reverse GGCTTTGAGGTGGTCCAGTA 
TFAP2C cDNA Forward CCCACTGAGGTCTTCTGCTC 57
o
C / 2mM 235 
Reverse AGAGTCACATGAGCGGCTTT 
TRMT1 cDNA Forward AGGAGAGAAGGACACGCAAA 57
o
C / 2mM 290 
Reverse CTAGGGCAAATCGAATGGAA 
Table 21: End-point PCR primers, annealing temperatures and predicted amplicon sizes 
 
2.21.3. SYBR Green® qRT-PCR primers 
Assay   Sequence 
SLC4A7 splice * Common Forward (Exon 6) CAGTCGGATTCCTCTTGTTCGA 
Reverse 1 (Exon 7) GACCTGTTCGCAAAGAGTGG 
Reverse 2 (Exon 8) TGTCCAAGTTTCCAGGAGCA 
18S Forward CCCAGTAAGTGCGGGTCATAA 
Reverse CCGAGGGCCTCACTAAACC 
Table 22: SYBR Green® qRT-PCR primers 




2.21.4. EMSA primers  
SNP Allele  Sequence 
rs13077400 A Forward GAAGATGACCAAGAAGAAGAG 
Reverse CTCTTCTTCTTGGTCATCTTC 
G Forward GAAGATGACCGAGAAGAAGAG 
Reverse CTCTTCTTCTCGGTCATCTTC 
rs13078798 A Forward CAACCTCACCAATGGAAACTG 
Reverse CAGTTTCCATTGGTGAGGTTG 
G Forward CAACCTCACCGATGGAAACTG 
Reverse CAGTTTCCATCGGTGAGGTTG 
rs13082711 C Forward CAGCTCCCTACGATGGGGGCC 
Reverse GGCCCCCATCGTAGGGAGCTG 
T Forward CAGCTCCCTATGATGGGGGCC 
Reverse GGCCCCCATCATAGGGAGCTG 
rs13096477 C Forward TATCTTTTCTCCTCCGGTGGT  
Reverse ACCACCGGAGGAGAAAAGATA 
T Forward TATCTTTTCTTCTCCGGTGGT  
Reverse ACCACCGGAGAAGAAAAGATA 
rs1309717 C Forward CTGCAACATCCGGAAAGAGTC 
Reverse GACTCTTTCCGGATGTTGCAG 
T Forward CTGCAACATCTGGAAAGAGTC 
Reverse GACTCTTTCCAGATGTTGCAG 
rs17019809 A Forward CCCGTAAAACAAATGGAAACC 
Reverse GGTTTCCATTTGTTTTACGGG 
G Forward CCCGTAAAACGAATGGAAACC 
Reverse GGTTTCCATTCGTTTTACGGG 
rs2003886 C Forward TGCGTCTCTGCGTCTGCAGCT 
Reverse AGCTGCAGACGCAGAGACGCA 
T Forward TGCGTCTCTGTGTCTGCAGCT 
Reverse AGCTGCAGACACAGAGACGCA 
rs2371065 A Forward TCCCACCTTCATAATTTTGTT 
Reverse AACAAAATTATGAAGGTGGGA 
C Forward TCCCACCTTCCTAATTTTGTT  
Reverse AACAAAATTAGGAAGGTGGGA 
rs35701251 A Forward TTCAGAATACATCCTGAGTAT 
Reverse ATACTCAGGATGTATTCTGAA 
T Forward TTCAGAATACTTCCTGAGTAT 
Reverse ATACTCAGGAAGTATTCTGAA 
rs3755652 C Forward CGCTGACTCTCTTGGGAACTT  
Reverse AAGTTCCCAAGAGAGTCAGCG 
T Forward CGCTGACTCTTTTGGGAACTT  
Reverse AAGTTCCCAAAAGAGTCAGCG 
Table 23: EMSA primers 








Competitor primers  Sequence 
Non-specific competitor Forward AGTACGGGGGTCCTCCCCAGA 
Reverse TCTGGGGAGGACCCCCGTACT 
TFAP2C Forward TCCCACCTTCCAAATTTTGTT 
Reverse AACAAAATTTGGAAGGTGGGA 
Elk1 Forward TCCCACCTTCCGGCTCTTGTT 
Reverse AACAAGAGCCGGAAGGTGGGA 
c-fos Forward TCCCACCTGACTCACTTTGTT 
Reverse AACAAAGTGAGTCAGGTGGGA 
TRMT1 Forward TCCCACCTTCATTTTTTTGTT 
Reverse AACAAAAAAATGAAGGTGGGA 
EBF1 (position 1) Forward TCCCACCTTCCCGTTTTTGTT 
Reverse AACAAAAACGGGAAGGTGGGA 
EBF1 (position 2) Forward TCCCACCTTCCCCGTTTTGTT 
Reverse AACAAAACGGGGAAGGTGGGA 




























Type Name Mono 
/ poly 
clonal 









Abcam ab82335 1 for IB / IP 





Rabbit Anti-SLC4A7 IgG 
antibody 
Poly Sigma HPA035857 1 
Primary IB Goat Anti-PPAR-Abeta 
(Calcineurin A) IgG antibody 
Poly Santa Cruz sc-6124 1 
Blocking peptide Immunizing peptide for sc-
6124 
N/A Santa Cruz sc-6214P 40 
2
o
ry IB Horse anti-mouse IgG, HRP-
linked Antibody 





ry IB Goat anti-rabbit IgG, HRP-
linked Antibody  





ry IB Donkey anti-goat IgG-HRP N/A Santa Cruz sc-2020 0.08 
Control antibody 
IP / ICC 
Normal mouse IgG Poly Santa Cruz sc-2025 Variable 
Control antibody 
IP / ICC 
Normal rabbit IgG Poly Santa Cruz sc-2027 Variable 
1
o
ry IB Mouse Anti-GAPDH IgG 
antibody 
Mono Santa Cruz sc-47724 0.1 
1
o
ry IB Mouse Anti-α Tubulin IgM 
antibody 
Mono Santa Cruz sc-53646 1 
IP Rabbit Anti-Pol II IgG 
antibody 




Rabbit anti-AP-2γ IgG 
Antibody 
Poly Santa Cruz sc-8977X 0.05 to 0.25 
EMSA Supershift Rabbit anti-ZAC1 IgG 
Antibody 
Poly Santa Cruz sc-22811X 0.05 to 0.25 
EMSA Supershift Goat anti-PHOX2A IgG 
antibody 
Poly Santa Cruz sc-13229X 0.05 to 0.25 
1
o
ry  IB / ICC Mouse IgG anti-human VE-
Cadherin 
Mono Abcam ab7047 10 for ICC,  
1 for IB 
1
o
ry  IB / ICC Mouse IgG anti-human N-
Cadherin 





Donkey anti-rabbit IgG - 
H&L Alexa Fluor® 594 





Goat anti-mouse IgG - H&L 
Alexa Fluor® 488 
Poly Abcam ab150113 2 
Table 25: List of antibodies used. 
1ory denotes primary; 2ory denotes secondary; IB denotes immunoblots; IP denotes 
immunoprecipitation; ICC denotes immunocytochemistry; EMSA denotes electrophoretic mobility 





Thesis section Reagent / mixture Formulation 
2.1 Tissue culture Cryopreservation media 70% v/v FBS 
20% v/v base media (M199 or DMEM) 
10% v/v dimethyl sulfoxide 
2.1 Tissue culture Hanks’ Balanced Salt 
Solution (HBSS) 
138 mM NaCl 
5.33 mM KCl 
4 mM NaHCO3 
1.26 mM CaCl2 
0.5 mM MgCl2 
0.44 mM KH2PO4 




5.6 mM glucose 
2.1 Tissue culture HUASMC media 
supplement 
Final concentration: 
0.5 ng/ml human epidermal growth factor 
2 ng/ml human fibroblast growth factor 
5 µg/ml human insulin 
2.1 Tissue culture HUVEC media supplement Final concentration: 
2.5 µg/ml human beta-endothelial cell growth 
factor 
2.25 mg/ml endothelial cell growth supplement 
from bovine neural tissue 
1.25 mg/ml thymidine 
5,000units/ml heparin from porcine intestinal 
mucosa 
2.2 DNA isolation  Lysis buffer for DNA 
isolation 
10 mM Tris pH 8.0 
10 mM EDTA pH 8.0 
100 mM NaCl 
0.5% w/v sodium dodecylsulfate 
If digesting tissue, 400 µg Proteinase K was added 
2.5 PCR 6x DNA Loading Buffer 60% v/v glycerol 
60 mM Tris-HCl pH 8.0 
6 mM EDTA pH 8.0 
0.06% w/v bromophenol blue 
2.8 Protein isolation Protease inhibitor (PI) 1 mM PMSF 
1 µg/ml Leupeptin 
1 µg/ml Aprotinin 
1 µg/ml Pepstatin 




(for membrane prep) 
10 mM Tris HCl pH 7.2, 1mM EDTA pH 8.0, 250 mM 
sucrose 
2.8 Protein isolation – 
nuclear extracts 
Hypotonic Lysis Buffer 
(Buffer A for nuclear 
extract isolation) 
10 mM HEPES pH 7.9 
10 mM KCl 
0.1 mM EDTA 




2.8 Protein isolation – 
nuclear extracts 
Nuclear Lysis Buffer 
(Buffer B for nuclear 
extract isolation) 
20 mM HEPES pH 7.9 
400 mM NaCl 
1 mM EDTA 
10% v/v glycerol 
2.8 Protein isolation – 
total cellular protein 
Radio-
Immunoprecipitation 
Assay (RIPA) lysis buffer 
50 mM Tris.HCl pH7.4 
150 mM NaCl 
0.5% w/v sodium deoxycholate 
1% v/v NP-40 
0.1% w/v sodium dodecylsulfate 
2.10 Immunoblotting 10x Tris-buffered saline 
(TBS) 
24 g Tris-HCl 
5.6 g Tris-base 
88 g NaCl 
Diluted into 1 L of ddH2O 
2.10 Immunoblotting Destaining Solution (for 
Ponceau) 
45% v/v isopropanol 
10% v/v acetic acid 
2.10 Immunoblotting Enhanced 
chemiluminescence (ECL) 
Solution 1: 
1 ml of 250 mM Luminol stock 
0.44 ml of 88 mM p-coumaric acid 
10 ml of 1 M Tris-base pH8.5 
88.56 ml of ddH2O 
 
Solution 2: 
64 µl of 30% v/v H2O2 
10 ml of 1 M Tris-base pH8.5 
90 ml of ddH2O 
 
Working solution (constitute before use):  
1 ml of each solution 
2.10 Immunoblotting Western blot (denaturing) 
6x loading buffer 
240 mM Tris pH 6.8 
12% w/v sodium dodecylsulfate 
24% v/v glycerol 
6% v/v beta-mercaptoethanol 
0.06% w/v bromophenol blue 
2.10 Immunoblotting Western blot 1x Running 
Buffer 
192 mM glycine  
25 mM Tris-base 
0.1% w/v sodium dodecyl sulphate 
2.10 Immunoblotting Western blot 1x Transfer 
(Towbin) Buffer 
192 mM glycine  
25 mM Tris-base 
20% v/v methanol 
2.10 Immunoblotting, 
2.11 DNA pull-down 
Ponceau Staining Solution 0.1% w/v Ponceau S 
40% v/v isopropanol 
10% v/v acetic acid 
2.11 DNA pull-down DNA pull-down Elution 
Buffer 
120 mM Tris pH 6.8 
20% w/v glycerol 
4% w/v sodium dodecylsulphate 
After elution, bromophenol blue added to reach 




2.11 DNA pull-down DNA pull-down Incubation 
Buffer 
50 mM Tris pH 7.0 
1 mM EDTA 
100 mM KCl 
5% v/v glycerol 
0.1% v/v Triton-X100 
2.11 DNA pull-down DNA pull-down Wash 
Buffer 
10 mM Tris pH 7.0 
1 mM EDTA 
2 M NaCl 
2.12 Co-
Immunoprecipitation  
IP Loading Buffer 62.5 mM Tris-HCl pH 6.8 
10% v/v glycerol 
10% w/v sodium dodecylsulfate 
100 mM dithiothreitol 
After elution, bromophenol blue added to reach 
final concentration of 0.02% w/v 
2.12 Co-
Immunoprecipitation 
IP Lysis Buffer 25 mM Tris HCl pH 7.2  
150 mM NaCl 
1 mM EDTA pH 8.0 
1% v/v NP-40 
2.12 Co-
Immunoprecipitation 
IP Wash Buffer 
 
25 mM Tris HCl pH 7.2 
150 mM NaCl 
1 mM EDTA pH 8.0 
2.14 EMSA EMSA (non-denaturing) 
loading buffer 
10 mM Tris pH 7.5 
1 mM EDTA 
50% v/v glycerol 
0.001% w/v bromophenol blue 
2.14 EMSA EMSA oligonucleotide 
annealing buffer 
10 mM Tris pH 8.0 
50 mM NaCl 














Wash Buffer  
1% FBS v/v in TBS 





141 mM NaCl  
2.82 mM KCl  
25 mM NaHCO3  
1.6 mM CaCl2  
1.2 mM MgSO4  
1.18 mM KH2PO4  
10 mM HEPES  
0.03 mM EDTA
  
5.5 mM glucose 







11 mM NaCl 
132.8 mM KCl 
1.6 mM CaCl2 




1.18 mM KH2PO4 
10 mM HEPES 
0.03 mM EDTA 
5.5 mM glucose 
2.20 Intracellular pH  Physiological saline 
solution (PSS) 
116 mM NaCl 
2.82 mM KCl  
25 mM NaHCO3  
1.6 mM CaCl2  
1.2 mM MgSO4  
1.18 mM KH2PO4  
10 mM HEPES  
0.03 mM EDTA
  
5.5 mM glucose 
2.20 Intracellular pH Sodium- and bicarbonate-






141 mM NMDG chloride 
2.82 mM KCl  
25 mM NaHCO3  
1.6 mM CaCl2 
1.2 mM MgSO4 
1.18 mM KH2PO4 
0.03 mM EDTA 
5.5 mM glucose 




116 mM NMDG chloride 
2.82 mM KCl  
25 mM choline bicarbonate  
1.6 mM CaCl2  
1.2 mM MgSO4  
1.18 mM KH2PO4  
10 mM HEPES  
0.03 mM EDTA
  
5.5 mM glucose 
Various 10x Phosphate-buffered 
saline (PBS) 
80 g NaCl 
2 g KCl 
14.4 g Na2HPO4  
2.4 g KH2PO4 
Diluted into 1 L of ddH2O 
Table 26: Reagents and formulations 
 
 
2.24. Statistical analyses 
Comparisons between two independent groups were conducted using two-sample t-test or the 
Mann-Whitney U-test for parametric and non-parametric distributions respectively. Comparisons 
between two paired groups were conducted using one-sample t-test or the Wilcoxon sign-ranked 
for parametric and non-parametric distributions respectively. Predicted linear relationships were 




Comparisons between multiple paired groups were conducted using repeated-measures analysis 
of variance (ANOVA). Examination of the influence of two different independent variables (e.g. 
genotype and dose) on one dependent variable was conducted using two-way ANOVA. 
 
Contingency tables (e.g. comparing observed and predicted genotype frequencies) were assessed 
by a chi-squared test, or the Fisher’s Exact Test, when at least one cell had a value of less than 5. 
 
Graphical presentation and statistical analyses other than power calculations were conducted 
using Prism v5 (GraphPad Software). Power calculations were conducted using G*Power v3.1.9.2 
(Universitӓt Kiel, Germany). Input parameters included an α-value of 0.05, and a sample size to 
obtain a power of 80%. Two-tailed comparisons were used when comparing two groups. 
 
Values were expressed as mean ± standard error of the mean, unless stated. When values 
expressed as a percentage, the total values may occasionally not add up to 100% due to rounding. 
A p-value of less than 0.05 was considered statistically significant. Multiple testing was further 






3. Analysis of single nucleotide polymorphisms (SNP) at the SLC4A7 locus 
using genomic prediction tools 
 
The complexity surrounding investigating the numerous SNPs in high LD with the lead SNP 
(rs13082711) in aforementioned genome-wide association study (Ehret et al., 2011) has already 
been visited in Section 1.2.  
 
There are many mechanisms whereby a polymorphism can theoretically impact on gene 
expression or protein function. The following sections sets out to utilize a range of prediction tools 
relating to the 93 polymorphisms of interest  - ranging from prediction of eSNPs (expression SNPs), 
transcription factor binding sites, properties of amino acid changes, post-translational 
modification, exonic splicing enhancer sites, miRNA (micro RNA) interactions and epigenetic 
influences. These sections will also aim to describe the potential flaws of the tools and what, if 
any, can be learnt from them. 
 
 
3.1. Genetic location of rs13082711 and other nearby genes – NEK10 and EOMES 
As genome-wide association studies are only able to identify genomic loci, as opposed to specific 
genes, it is necessary to consider the other genes near the locus, one of which is NEK10, encoding 
the NIMA (never in mitosis gene a)-related kinase 10. It has a low probability as a candidate gene 
by both positional and functional criteria. This gene is situated 255kb away from the sentinel 
blood-pressure associated SNP rs13082711 and does not have any SNPs in strong LD with (all 
r2<0.2). Furthermore, the gene product has no clear biological function related to blood pressure. 
Recently, NEK10 has been reported to play a role in the cellular response to ultraviolet irradiation 
(Moniz and Stambolic, 2011), and an nsSNP within NEK10 was found to be associated with risk of 
breast cancer (Milne et al., 2014).  
 
The other gene flanking SLC4A7 is EOMES, encoding eomesodermin. It is not a strong positional 
candidate being 232kb away from rs13082711, and the EOMES gene and its flanking regions do 
not contain any SNPs in LD with rs13082711, even when applying a markedly lowered threshold of 
r2>0.2. EOMES has in fact been implicated as a candidate gene in a GWAS for the haematological 




than 220kb from the SLC4A7 hypertension loci, with very weak linkage disequilibrium (r2 = 0.015, 




Figure 54: Linkage disequilibrium plots at the rs13082711 and rs3806624 SNPs 
Linkage disequilibrium plots at the blood pressure-associated (rs13082711) and Hodgkin’s 
lymphoma susceptibility-associated (rs3806624) SNPs based on HapMap3 (release 2) data for the 
CEU population (http://www.broadinstitute.org/mpg/snap/ldplot.php). Position along 
chromosome 3 is matched on both plots. An LD of r2 > 0.8 (dashed lines) is marked as strong 





Like NEK10, the gene product for EOMES does not appear to have any clear biological function 
related to blood pressure. Eomesodermin-deficiency in EOMES-/- knockout mice is embryonically 
lethal, and appears to be essential in trophoblast development and mesoderm formation (Russ et 
al., 2000). Whilst blood vessels are embryonically derived from the lateral plate of the mesoderm 
(Risau et al., 1988; Pardanaud et al., 1989), and nephrons from the intermediate mesoderm 
(Obara-Ishihara et al., 1999), this embryonically lethal knockout does not provide a direct 
biologically plausible link between EOMES and hypertension. 
 
Conditional EOMES knockout mice provide further insight into the potential function of its gene 
product, but currently it does not add much to the understanding of blood pressure regulation. 
Mice with haematopoetic-specific deficiency of both transcription factors EOMES and T-bet failed 
to develop NK cells (Gordon et al., 2009), and CD8+ T cells lacking EOMES compete poorly in 
contributing to the pool of Ag-specific central memory cells (Banerjee et al., 2010). There are 
currently no published murine models of conditional knockouts relating to the circulatory, renal or 
neurological systems.  
 
With this, NEK10 and EOMES do not seem to be strong candidate genes in terms of genomic 
position as well as known protein function. Adding to this hypothesis, the GTEx (Genotype-Tissue 
Expression project; http://www.gtexportal.org/home/) RNA-seq data demonstrates high transcript 
levels of SLC4A7, but low NEK10 and EOMES, in arteries. The results on renal samples are more 
difficult to interpret as the samples are from the renal cortex, whereas SLC4A7 is localized to the 
medulla. Nevertheless, the levels of NEK10 and EOMES in the renal cortex are still lower than 
SLC4A7 (Figure 55). Of course, care needs to be taken when using PRKM (reads per kilobase per 
million reads) as a comparator (Wagner et al., 2012). This is further supported by the finding of 
this thesis that NEK10 and EOMES transcripts were not found in a panel of tissues key to blood 







Figure 55: Genotype-Tissue Expression project (GTEx) SLC4A7, NEK10 and EOMES expression data 
on a panel of human tissue samples. 
PRKM denotes reads per kilobase per million reads, as a method of quantifying gene expression by 
normalizing for total read length and the number of sequencing reads. Coronary artery, tibial 





3.2. Predicted allele frequencies and genotype distributions 
In planning future experiments, it is important to consider the genotype distribution of the 
accessible samples. Based on HapMap data, the minor allele frequency ranges from 2.2% to 
20.2%, and a minor homozygote frequency of 0% to 9.6% ( 




Genotype frequency Allele frequency 
C/C C/T T/T C (risk 
allele) 
T 
HapMap-CEU 104 0.096 0.212 0.692 0.202 0.798 









HapMap-CHB 90 0.022 0.000 0.978 0.022 0.978 
HapMap-JPT 88 0.000 0.114 0.886 0.057 0.943 
HapMap-YRI 116 0.000 0.086 0.914 0.043 0.957 
 
Table 27: Genotype and allele frequency at rs13082711 
Genotype and allele frequency of HapMap populations, and from this study’s data at rs13082711 
in descending risk allele frequency. CEU denotes Utah residents with Northern and Western 
European ancestry from the CEPH (Centre d'Etude du Polymorphisme Humain) collection; CHB, Han 
Chinese in Beijing; JPT, Japanese in Tokyo; YRI, Yoruba in Ibadan, Nigeria. 
 
Although in high LD with the GWAS-associated rs13082711, the genotype frequency of the 
investigated nsSNP rs3755652 should also be considered ( 
Table 28). There is actually more data available for rs3755652 due to the nature of interest as an 


















Genotype frequency Allele frequency 
C/C C/T T/T C (risk 
allele) 
T 
HapMap-CEU 226 0.080 0.327 0.593 0.243 0.757 
HapMap-GIH 176 0.057 0.341 0.602 0.227 0.773 
CS Agilent 1137 0.047 0.350 0.603 0.222 0.778 
HapMap-MEX 100 0.020 0.400 0.580 0.220 0.780 
Study data (Genetically 
heterogeneous cohort) 
394 0.036 0.362 0.602 0.217 0.783 
HapMap-TSI 174 0.011 0.368 0.621 0.195 0.805 
ESP Cohort Populations 4552 0.037 0.293 0.669 0.184 0.816 
HapMap-MKK 286 0.021 0.189 0.790 0.115 0.885 
HapMap-JPT 170 0.000 0.106 0.894 0.053 0.947 
HapMap-ASW 96 0.000 0.083 0.917 0.042 0.958 
HapMap-LWK 178 0.000 0.079 0.921 0.039 0.961 
HapMap-YRI 226 0.000 0.115 0.885 0.037 0.942 
HapMap-CHD 170 0.000 0.071 0.929 0.035 0.965 
HapMap-CHB 86 0.023 0.000 0.977 0.023 0.977 
 
Table 28: Genotype and allele frequency at rs3755652 
Genotype and allele frequency of HapMap populations, and from this study’s data at rs3755652 in 
descending risk allele frequency. CEU denotes Utah residents with Northern and Western European 
ancestry from the CEPH (Centre d'Etude du Polymorphisme Humain) collection; GIH, Gujarati in 
Houston, Texas; MEX, Mexican ancestry in Los Angeles; TSI, Tuscans in Italy; MKK, Maasai in 
Kinyawa, Kenya; JPT, Japanese in Tokyo; ASW African ancestry in Southwest USA; LWK, Luhya in 
Webuye, Kenya; YRI, Yoruba in Ibadan, Nigeria; CHD, Chinese in Metropolitan Denver; CHB, Han 
Chinese in Beijing. 
CS Agilent denotes cohort of European descent with whole-genome sequencing. 
ESP denotes Exome Sequencing Project. 
 
The genotype frequency of the Chinese GWAS identified independent risk SNP rs820430 is also 
















Genotype frequency Allele frequency 
A/A A/G G/G A (risk 
allele) 
G 
Study data (Genetically 
heterogeneous cohort) 
383 0.439 0.439 0.123 0.658 0.342 
HapMap-CEU 116 0.414 0.448 0.138 0.638 0.361 
HapMap-CHB 90 0.178 0.442 0.400 0.389 0.611 
HapMap-JPT 90 0.156 0.489 0.356 0.400 0.600 
HapMap-YRI 120 1.000 0.000 0.000 0.000 0.000 
 
Table 29: Genotype and allele frequency at rs820430 
Genotype and allele frequency of HapMap populations, and from this study’s data at rs820430 in 
descending risk allele frequency. CEU denotes Utah residents with Northern and Western European 
ancestry from the CEPH (Centre d'Etude du Polymorphisme Humain) collection; CHB, Han Chinese 
in Beijing; JPT, Japanese in Tokyo; YRI, Yoruba in Ibadan, Nigeria. 
 
Also of note, the overall genotype distribution of our samples does not readily approximate into 
one particular dataset of HapMap ancestry. This in part reflects the significant ethnicity admixture 
in the Borough of Tower Hamlets, London, from where the samples are obtained. According to the 
latest 2011 census (Tower Hamlets Council, 2012) the two largest self-reported ethnic groups are 
Bangladeshi (32%, not covered by HapMap data), and White British (31%, which in itself is a 
genetically heterogeneous population). Additionally, 21% of households are multi-ethnic, 
indicating a large proportion of our samples is derived from mixed ancestry. Importantly, it must 
also be recognised that each of the CEU, YRI, JPT and CHB datasets represent a very specific 
population, and commonly misused terminologies such as “Caucasian”, “Asian”, “East Asian”, 
“Sub-Saharan African”, “West African”, “Nigerian”, or “East Asian” are inaccurate (International 
HapMap Project, 2005).  
 
3.3.  eSNPs (expression single nucleotide polymorphisms) prediction 
A potential objective of this thesis is to determine whether the SNPs of interest impacts on SLC4A7 
gene expression. There is already a limited amount of data publically available via the GENEVAR 
(GENe Expression VARiation) database from the Sanger Institute 
(http://www.sanger.ac.uk/resources/software/genevar/) (Yang et al., 2010), which the public 
datasets allow interrogation from four different published studies (Grundberg et al., 2012, 





Out of these datasets, none were found to be an eQTL (expression quantitative trait loci) at the 
default significance level of P<0.001. However, there were several SNPs that were associated with 
gene expression at a P<0.01 level (Appendix 9). However, these findings seemingly appear to be 
present in only certain populations (correlation with SLC4A7 expression in CEU population, and 
with NEK10 in the GIH population). If we are to consider the multiple testing conducted, these 
associations need to be interpreted with caution. 
 
The limited support from these datasets on our SNPs of interest having an impact on SLC4A7 gene 
expression however may not be sufficiently sensitive for several reasons. Most of all, these 
datasets are derived from relatively small sample size (n = 60 to 856). Furthermore, the tissues are 
of limited relevance in the context of blood pressure regulation – lymphoblastoid cells, skin, 
adipose tissue, fibroblasts, and mainly from healthy populations or umbilical samples. Additionally, 
lymphoblastoid cell lines, which forms a large proportion of the samples, are Epstein Barr virus 
(EBV)-transformed lymphocytes, which in itself alters gene expression profiles (Carter et al., 2002), 
and even mosaicism (Shirley et al., 2012), limiting its relevance in gene expression studies. Finally, 
these studies only consider the relationship between SNPs and RNA/cDNA levels; whereas the 
overall impact on gene expression is far more than gene transcription or RNA stability alone. 
 
A separate source of information on eQTL mapping of SNPs to gene expression comes from 
SCANdb (SNP and CNV Annotation Database, http://www.scandb.org). It utilises data from SNPs 
and RNA/cDNA from EBV-transformed B-lymphocytes in HapMap CEU and YRI samples (Gamazon 
et al., 2010). Table 30 shows SCANdb predicting trans-eQTLs (altered gene expression located on 
different chromosome from SNP of interest) for 9 gene and 2 likely pseudogenes with a pre-set 
significance level of P<0.0001. Once again, the caveats regarding EBV-transformation on gene 






Table 30: SCANdb output for gene transcripts that vary with each SNP  
Summarised SCANdb (http://www.scandb.org) output identifying gene transcripts that vary with 
each SNP (one row each, and rs13082711 identified in grey). Each column represents the gene or 
pseudogene with altered expression levels. Green cells denotes SNP-dependent expression 
P<0.0001 (but none P<0.00001), blank cells denote no SNP-expression associated found. The SNP 




Whilst this may pique interest, there are several caveats to remember. All of the proposed trans-
eQTLs had a significance level of P <0.0001 (10-4), but >0.00001 (10-5). It could be argued that for a 
significant trans-eQTL with an even larger number of multiple testing conducted, the uncorrected 
significance level should be much lower. There should also be caution exercised with the limited 
range of populations used. Last of all, the concerns of using lymphoblastoid cell lines as 
highlighted above also applies. 
 
More recently, the Genotype-Tissue Expression (GTEx) project (http://www.gtexportal.org/home) 
aimed to provide gene expression data (mRNA/cDNA, not protein) across multiple human tissues. 
The tissue type with most samples at this stage (n = 60 to 120) include subcutaneous adipose 
tissue, tibial artery, blood, cardiac left ventricle, lung, skeletal muscle, tibial nerve, skin (sun 
exposed) and thyroid tissue. As exemplified in Figure 56 there were no significant effect of the 
rs13082711 SNP on SLC4A7 and NEK10 gene expression after considering the Bonferroni 
correction for multiple (200,000) hypotheses as set out by the project (GTEx Consortium, 2013). 
Additionally, the potential direction of effect on NEK10 is conflicting, being in opposite directions 
for the tibial artery and left ventricle. Furthermore, all the other tissues studied did not reveal an 
impact of the polymorphism on neither SLC4A7 nor NEK10 expression. An additional caveat to 






Figure 56: Genotype-Tissue Expression project (GTEx) SLC4A7 and NEK10 expression data of 
selected tissues for the rs13082711 SNP 





Although the attempt to provide a panel of expression data from different tissues is highly 
laudable, there are significant issues with the interpretation. As an indication of the population 
that the samples were derived, the pilot phase demographics (GTEx Project,  
http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000424.v1.p1) show 
they were 65% male, median age 53, >80% white, and with a median BMI 26.7. Importantly, 94.3% 
of samples were derived following deaths (the remaining from surgical samples), of which 41.4% 
were from deaths relating to intracranial haemorrhage or ischaemic strokes, and 30% from 
myocardial infraction. There is also other significant cardiovascular past medical history that 
includes hypertension (51.4%), type II diabetes (22.7%) and renal failure (10.1%). This means the 
impact of the environment is significant, and potentially outweighs that of the initial genetic 
influence on gene expression. These subjects also had their (based on their past medical history, 
likely to be non-inconsequential) drug history collected, but this was not available publicly. Even if 
medications data were available, it would be near impossible to tease out the effect of 
medications vs environment vs genetics based on this sample size (pilot n=214, eventual target 
n=750).  
 
Further consideration should also be given to the choices of tissue samples. Most of them are not 
a uniform cell type, for example, the tibial artery is likely to contain vascular smooth muscle cells, 
endothelial cells, fibroblasts and any other surrounding connective tissue. Also notably, the 
magnitude of genotype-related NEK10 mRNA levels is far smaller as compared to the magnitude of 
detected SLC4A7 mRNA levels. It is worth recognising that statistically significant results are not 
necessarily biologically significant. These predictions should be taken in context of a recent meta-
analysis of identifying 34 gene differentially expressed in treatment-naïve hypertensives (Huan et 
al., 2015). SLC4A7 was not identified as being differentially expressed, but the main limitation of 
this study is that it centres on the RNA expression in samples of whole blood. 
 
Therefore, a lack of observed relationship between SLC4A7 genotype and its expression may be 
related to multiple environmental confounders, or in this context of increased noise, an 






3.4. TFBS (transcription factor binding site) prediction 
If a SNP occurs at the consensus binding site of transcription factors, the nucleotide change may 
increase or decrease the probability of binding and thus up- or down-regulating RNA transcription 
(the direction of action depending on the interacting nuclear protein itself). It follows that these 
particular SNPs may have an overall effect on gene expression. There are several online prediction 
tools that use position weight matrices to predict possible TFBS, which includes AliBaba2 (Grabe, 
2002), JASPAR (Bryne et al., 2008) and P-Match (Chekmenev et al., 2005). Using these tools, the 
four SNPs within 5000 bp of the start of transcription were assessed for allele-dependent potential 
transcription factor binding sites – in other words, where the predicted scores change with the 







































































N/A N/A N/A N/A 
 
Table 31: Transcription factors with different allele-specific scores for binding sequences 
The polymorphism with preferential binding scores is listed in parentheses. SNPs are listed together 




predicted, only the top 6 hits are listed. N/A denotes transcription factor binding was not predicted 
to be different based on the two alleles. 
Whilst these predictions may be helpful as a starting point, there are several limitations to these 
tools. One striking observation is the inconsistencies between the four prediction tools utilised. 
This not just limits the utility of using the predictions as a starting point, but also raises concerns of 
its positive predictive value. 
 
These prediction tools utilize position weight matrices from databases such as TRANSFAC (Matys 
et al., 2003) and JASPAR (Bryne et al., 2008). Thus, the predictions are only as generalizable as 
their input databases. The experimental evidence that inform these databases include gel shift 
assays, footprinting analysis and ChIP-seq studies, and is based on a range of cell types. With all of 
these experimental methods, there are some limitations to the generalizability from in vitro assays 
to in vivo function, as well as across cell types. Whilst the TRANSFAC database provides a “quality 
value” to describe the confidence of the observed DNA-binding activity, this continuous variable 
can sometimes be difficult to interpret in terms of an in vivo probability. 
 
With these caveats in mind, a recent study has identified a false positive rate of 0.13 and 0.64 for 
P-Match and JASPAR respectively (Fazius et al., 2011), based on the re-identification of twenty-two 
hidden true sites in random sequences. This however may not fully reflect the low positive 




3.5. Nucleosome occupancy prediction 
A separate mechanism of DNA-nuclear protein interaction controlling gene expression involves the 
organization of DNA into nucleosomes. Nucleosomes are 147 base pair segments of DNA, wrapped 
around an octamer of histone proteins, which in turn can be connected together by the linker 
histone H1. The presence of histone binding and nucleosome structures can influence and reduce 
the accessibility of DNA to other proteins such as transcription factors. In turn, if a SNP sufficiently 
changes the DNA sequence to result in differences in affinity for histone octamers; this may result 
in an overall change in gene expression. 
 
An online nucleosome occupancy prediction tool (http://bio.physics.leidenuniv.nl/~noort/cgi-




the periodic occurrence of the dinucleotides TA, TT, AA, and GC found in regions of high 
nucleosome affinity (van der Heijden et al., 2012). The authors calculated a Pearson’s correlation 
coefficient (r) of 0.66 between their predictions and in vivo (yeast) experiments. However, there is 
no direct evidence of the strength of correlation between these prediction and human 
nucleosomes in vivo. With the proviso that the tool is not designed to predict changes in 
nucleosome occupancy relating to SNPs, it did highlight some interesting results. Out of the 93 
SNPs of interest, up to 18 SNPs were predicted to change the probability of the nucleotide being at 
a nucleosome dyad (Appendix 11), introducing an interesting possibility of blood pressure 
associated SNPs exerting epigenetic effects. However, only rs3755652 (Figure 57) produced a 




Figure 57: Prediction of nucleosome occupancy with the respective alleles at rs3755652  
 
It is important to recognize that whilst some of the changes in predicted probabilities of 
nucleosome binding may appear relatively large (up to 100% increase in numerical value), the 
biological relevance is uncertain. Additionally, the algorithm is unable to consider any impact of 





3.6. Predicting the functional impact of non-synonymous single nucleotide polymorphisms 
(nsSNP) and the resultant amino acid change  
Only one of the 93 SNPs of interest (rs3755652) results in a non-synonymous coding substitution. 
The guanine to adenine (G1047A) polymorphism produces an amino acid change from glutamic 
acid to lysine at position 326 (E326K), and has some potential for impact on the function of the 
encoded NBCn1 protein.  
 
Taken in the wider context, the presence of glutamic acid or lysine at that position is not 
commonly found in the animal kingdom. With a BLAST search of the 30 most similar NBCn1 
Cassette II from other species (Appendix 12), only the common chimpanzee (Pan troglodyte) is 
predicted to have a glutamic acid (E) residue, the same as humans. The common marmoset 
(Callithrix jacchus) is predicted to have a histidine (H) residue there. Of the 28 remaining, of which 
7 are primates, all are predicted to have a glutamine (Q) residue in that position. None are 
predicted to have the rarer human risk-allele amino acid lysine (K) residue there. Whilst potentially 
interesting, this does not provide further evidence on whether (or not) the E326K amino acid 
substitution has any functional significance.   
 
The main difference between glutamic acid and lysine amino acid residues is that the former has a 
negative charge; whist the latter has a positive charge. Apart from their charges, they are 
otherwise relatively similar - having similar molecular weights (147.13 kDa and 146.19 kDa 
respectively), both being hydrophilic, and neither are bulky enough to classically result in steric 
hindrance and changes in secondary structures. This is reflected by the early analysis by Grantham 
(1974), noting that the difference between the two amino acids based on composition, polarity 
and molecular volume to be relatively small. Set out in alphabetical order,  
Table 32 shows the predictions by eight different online tools on the effect of the amino acid 
change. Three other prediction tools Panther 
(http://www.pantherdb.org/tools/csnpScoreForm.jsp), SNPs3D (http://www.snps3d.org/) and 
nsSNP analyser (http://snpanalyzer.uthsc.edu/) did not return any results as they admit to a lack 










Reference Prediction (Score)  From Bromberg and 
Rost, 2007; Thusberg et 
al., 2011; Frousios et 
al., 2013 
Calculated 
from Sens and 
Spec 
Sens Spec FN* LR+ LR- 
Grantham  Grantham, 1974 Moderately conservative 
AA change (56)  




Destabilising mutation  
(-0.80 kcal/mol at 37C, 
pH 7.4) 









No hypothesis (0.332).   
Leading features: 
 Gain of MoRF 
binding  
(P = 0.0041) 
 Gain of methylation 
at E326 (P = 0.044)  





































Table 32: Predicted functional impact of the E326K polymorphism by online tools. 
Sens denotes sensitivity; Spec, sensitivity; FN, false negative rate; LR+, likelihood ratio for positive 
result; LR-, likelihood ratio for negative result; N/A, not available.  
* indicates false negative rates reported using benchmarking set by Frousios et al., 2013 and not 
general population, see text for discussion.  







Whilst some tools were unable to provide a prediction based on their respective algorithms and 
training sets, all but one predicted that he amino acid change would be tolerated. Only SNAP and 
i-Mutant hinted at a potential change in function relating to the nsSNP. SNAP returned a result of 
2, from a range of -100 to 100, where anything below 0 is regarded as neutral, and those above 0 
are regarded as having an effect. It however does not provide any guidance on the degree of 
confidence based on the numerical value. A similar issue is present with the i-Mutant prediction. It 
suggested the E326K amino acid change results in a “destabilizing” mutation. However, it should 
be noted that prediction (-0.80 kcal/mol) is difficult to put in physiological context. Furthermore, a 
dataset comparing the predicted and experimentally obtained protein stability, identified only a 
modest correlation coefficient (r = 0.62), and a relatively large standard error (1.45 kcal/mol). This 
indicates the signal-to-noise ratio of this prediction is low. 
 
This might initially be interpreted as the E326K polymorphism would not have an impact on the 
function of the NBCn1 protein. However, caution should be exercised with these predictions, as 
exemplified by the E6V mutation in the β-globin gene. This common beta-globin mutation results 
in the abnormal HbS responsible for sickle cell disease and results in a significant change in protein 
behavior in vivo but was predicted to benign by PolyPhen. The likely reason for this is that most 
prediction tools are unable to take into account the wide variety of macromolecule-
macromolecule interactions that occur in vivo. The same study identified that PolyPhen and SIFT 
only correctly identified approximately 70% of mutations causing the clinical manifestation of 
G6PD (Glucose-6-phosphate dehydrogenase) deficiency (Tchernitchko et al., 2004). Further studies 
identified the sensitivity and specificities of these tools mainly ranges from 70% to 85%, as 
summarised in  
Table 32 (Bromberg and Rost, 2007; Thusverg et al., 2011; Frousios et al., 2013). However, as the 
studies utilize datasets enriched with well-characterised (and presumably mostly high-impact 
Mandelian) mutations, these parameters may be overestimated. Additionally, sensitivities and 
specificities may not be the ideal parameter, as the positive and negative predictive values are 
dependent on the underlying population prevalence. Alternatively, the utility of these data sets 
may be viewed in terms of their likelihood ratios. The tools have calculated likelihood ratio for 
negative results ranging from 0.11 to 0.44. This highlights the difficulty of interpreting results from 
prediction tools on their own, as the pre-test odds for whether an nsSNP alters protein function is 





In addition, these tools often utilize overlapping algorithms and training sets of experimental data. 
This would lead to often comparable predictions, and the consistency across the different tools 
may be falsely reassuring. Furthermore, the training sets for these algorithms are unlikely to have 
encountered sequences that resemble the area of interest, particularly as the sequence of the 124 
amino acid Cassette II does not contain any putative conserved domains, and bares minimal 
similarities to other known human proteins ( 
Figure 58). The E (Expect)-value reflects the number of expected hits purely by chance in that size 
of database, and are 0.7, 1.2 and 5.4 for the three hits respectively. In other words, the low 




Figure 58: BLAST protein query of the human NBCn1 Cassette II 
BLAST (Basic Local Alignment Search Tool; http://blast.ncbi.nlm.nih.gov/Blast.cgi, NCBI) protein 
query with the NBCn1 Cassette II using the protein-protein BLAST algorithm limited to Homo sapien 
proteins only. Black bars indicate low alignment scores, limited to the default maximum E-value of 
10. 
 
The lack of sequence alignments within the libraries of prediction tools should be of concern, as 
most tools provide a prediction output irrespective of confidence of predictive ability. This is 
further exacerbated by a false dichotomy, where the prediction is often presented as a definitive 
categorical variable. A good example is provided by MutationAssessor (Figure 59), whereby a cut-
off is placed at the score where the prevalence of false negative will equal that of false positives 







Figure 59: Example of prediction tools converting continuous scores to categorical outputs 
Adapted from http://mutationassessor.org/howitworks.php 
 
Another consideration of the algorithm training sets is that they are predominantly derived from 
distinct and unambiguous cases of deleterious mutations, as seen in monogenetic conditions. This 
may not be powerful enough to determine potentially subtle changes that may be identified from 
GWAS hits. 
 
Finally, these tools are also usually unable to consider the impact of nearby regulatory elements or 
post-translational modifications. The potential of nearby regulatory elements may still be relevant 
to NBCn1, as the E326K polymorphism lie near to postulated protein kinase C phosphorylation 
sites of Ser324 and Ser327 (Pushkin et al., 1999). Similarly, the E326K amino acid change lies only 6 
amino acids away from a likely calcineurin binding site (Danielsen et al., 2013), which would not be 
accredited by the prediction tools. 
 
 
3.7. Predicting the functional impact of nsSNP on 3-dimensional structure of protein 
Another way of considering potential impacts of amino acid changes is via 3-dimensional 
modelling of the protein variants. One such tool is SWISS-MODEL (http://swissmodel.expasy.org/), 




model of a protein of interest based on sequence homology. The quality of the computed model is 
estimated to indicate the expected quality of the obtained model (Biasini et al., 2014). This model 
predicted structures that on first glance appeared to vary at the intracellular N-terminus, where 
the 326K variant may have a more open conformation compared to the 326E variant (Figure 60). 
However, it is essential to recognize that both predictions were provided together with very low 
GMQE (Global Model Quality Estimate) and QMEAN4 scores, indicating poor prediction quality. 
This is often due to the queried sequence having insufficient homology with sequences of known 





Figure 60: SWISS-MODEL predicted 3-dimensional representation of native conformational changes 
with the E326K variants 
 
An alternative tool is PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/) which concentrates on the 
secondary structure. This tool reports a Q3 score (percentage of correct predictions of the three 
states – helix, sheet and coil) of 73.4%. These predictions are based on a window of 15 amino acids 
to predict the central residue using an artificial neural network linking the input sequence with 
known protein structures (McGuffin et al., 2000). The summary data ( 
Figure 61) initially suggests that the E326K changes the secondary structure of the NBCn1 protein. 




sequences are modest at best. Once again, the result is perhaps unreliable for forming any further 
hypotheses on its own. 
 
 
Figure 61: PSIPRED prediction of 3-dimensional conformation with the E326K variants 
Highlighted are the predicted helices (purple boxes), predicted sheets (yellow boxes) and the E326K 
amino acid change (red circle). 
 
Another tool that predicts secondary structures is I-TASSER 
(http://zhanglab.ccmb.med.umich.edu/I-TASSER/) (Roy et al., 2010), one of the highest ranking 
3D-model prediction servers (Critical Assessment of Techniques for Protein Structure Prediction, 
2012). Similar to PSIPRED, I-TASSER predicts that the 326E variant results in a protein that has a 
helical secondary structure at the 326 residue, but not with the 326K variant ( 
Figure 62). Like the previous tool, I-TASSER also provides a global estimate of quality of predicted 







Figure 62: I-TASSER prediction of 3-dimensional conformation with the E326K variants 
Identified are the predicted helices (red H), predicted sheets (blue S) and the E326K amino acid 
change (yellow highlight). 
 
Accepting that these results are inconclusive, it should also be recognised that even if the non-
synonymous polymorphism does result in a change in 3-dimensional structure, this does not 
necessarily lead in a change in protein function, localization or abundance. 
 
 
3.8. Predicting the potential impact of the nsSNP on post-translational modifications  
Post-translational modifications are common, and there are predicted to be more than 500,000 
potential phosphorylation sites on serine (S), threonine (T), tyrosine (Y) residues within the human 




sodium-bicarbonate co-transporters was previously discussed in Section 1.10, and polymorphisms 
that have an effect on the propensity to these modifications may in turn impact on protein 
function.  
 
One of the commonly used phosphorylation site prediction tools is PhosphoBase 
(http://phospho.elm.eu.org/), first released in 1999 (Blom et al., 1999) and is regularly updated 
(Dinkel et al., 2010). It utilises position weight matrices based on experimentally verified 
phosphorylation sites. The sensitivity of the prediction tool was recorded to range from 69% to 
96%. However it was also noted that there were false positives, resulting in positive predictive 
value between 65% and 89% (Blom et al., 1999). PhosphoBase does not predict any differences in 













S 84 KESDKEDGRESPSYDTPSQRV 0.91 0.76 Medium 
S 382 LTPGILASPQSAPGNLDNSKS 0.81 0.71 Medium 
S 400 SKSGEIKGNGSGGSRENSTVD 0.04 0.76 Medium 
S 403 GEIKGNGSGGSRENSTVDFSK 0.89 0.68 Medium 
S 407 GNGSGGSRENSTVDFSKVDMN 0.89 0.6 Medium 
T 1167 AERMLQDDDDTVHLPFEGGSL 0.31 0.29 Medium 
S 1176 DTVHLPFEGGSLLQIPVKALK 0.04 0.12 Medium 
S 1213 PRKKYVDAETSL          - 0.32 Medium 
 
Table 33: Phospho.ELM predictions on possible sites of post-translation phosphorylation. 
There were no differences noted as relevant when considering the E326K amino acid change. 
Conservation score quantifies the conservation of each phosphor-site with scores from 0 to 1, 
where 1 indicates highest conservation. IUPRED score is a prediction of disordered amino acids 
(where disorder better allows modification) with scores from 0 to 1, where scores greater than 0.5 
are considered as disordered. Phospho3D score is the prediction of surface accessibility by kinases.  
 
This limited impact of E326K is also reported by DISPHOS v1.3 (DISorder-Enhanced 
PHOSphorylation Sites Predictor, http://www.dabi.temple.edu/disphos/) ( 
Table 34) a prediction tool trained on over 2000 non-redundant experimentally confirmed protein 
phosphorylation sites as well as Phospho.ELM ( 
Table 33) outputs. Both these tools utilize the observation that intrinsically unstructured / 




state, which in turn affords the flexibility for post-translational modification (Iakoucheva et al., 
2004). 
 
Position Residue 326E 326K 
55 S 0.846 FSKESRRRH 0.846 FSKESRRRH 
76 S 0.913 KDKESDKED 0.913 KDKESDKED 
84 S 0.949 DGRESPSYD 0.949 DGRESPSYD 
86 S 0.606 RESPSYDTP 0.606 RESPSYDTP 
87 Y 0.624 ESPSYDTPS 0.624 ESPSYDTPS 
89 T 0.675 PSYDTPSQR 0.675 PSYDTPSQR 
91 S 0.545 YDTPSQRVQ 0.545 YDTPSQRVQ 
257 S 0.519 GLSASRHSL 0.519 GLSASRHSL 
260 S 0.738 ASRHSLRTG 0.738 ASRHSLRTG 
271 S 0.629 ASNLSLRGE 0.629 ASNLSLRGE 
276 S 0.749 LRGESPLSL 0.749 LRGESPLSL 
293 T 0.536 SRAGTPAGS 0.535 SRAGTPAGS 
297 S 0.598 TPAGSRCTT 0.596 TPAGSRCTT 
301 T 0.812 SRCTTPVPT 0.811 SRCTTPVPT 
309 S 0.798 TPQNSPPSS 0.795 TPQNSPPSS 
312 S 0.779 NSPPSSPSI 0.776 NSPPSSPSI 
313 S 0.843 SPPSSPSIS 0.839 SPPSSPSIS 
315 S 0.887 PSSPSISRL 0.884 PSSPSISRL 
317 S 0.902 SPSISRLTS 0.892 SPSISRLTS 
321 S 0.919 SRLTSRSSQ 0.922 SRLTSRSSQ 
323 S 0.834 LTSRSSQES 0.801 LTSRSSQKS 
324 S 0.928 TSRSSQESQ 0.916 TSRSSQKSQ 
327 S 0.741 SSQESQRQA 0.723 SSQKSQRQA 
392 S 0.509 DNSKSGEIK 0.509 DNSKSGEIK 
403 S 0.605 GSGGSRENS 0.605 GSGGSRENS 
407 S 0.63 SRENSTVDF 0.63 SRENSTVDF 
532 S 0.534 EWDPSIRIE 0.534 EWDPSIRIE 
540 S 0.561 EPPKSVPSQ 0.561 EPPKSVPSQ 
1132 S 0.518 KRELSWLDD 0.518 KRELSWLDD 
1141 S 0.854 LMPESKKKK 0.854 LMPESKKKK 
 
Table 34: DISPHOS v1.3 predictions on possible post-translation phosphorylation. 
Position of the E326K change is underlined in the 323Ser, 324Ser and 327Ser sequences. There were no 
differences in scores noted as relevant when considering the E326K amino acid change. 
Phosphorylation scores ranges from 0 to 1, where 1 indicates highest probability and residues with 
the score >0.5 are considered as likely phosphorylation sites. 
 
On the other hand, these results conflict with a third tool, PhosphoNet 
(http://www.phosphonet.ca/). PhosphoNet also utilises position weight matrices, but predicted a 
difference in the propensity to phosphorylation at the 323Ser residue; there the 326E amino acid 
increases the probability, whilst 326K reduces it ( 
Table 35). This introduces an interesting possibility of the non-synonymous polymorphism at 







Table 35: PhosphoNet predictions of post-translational phosphorylation sites 
The predicted change due to the E326K amino acid change is highlighted in green (increased 
probability), red (decreased probability). Yellow denotes minimal change. Scores range from 0 to 1, 
where 1 indicates highest probability, and scores >0.5 are considered as likely phosphorylation 
sites. 
 
Of note, another commonly used phosphorylation prediction tool, ScanSite3 (Massachusetts 
Institute of Technology, http://scansite3.mit.edu) also predicted an impact of the E326K non-
synonymous polymorphism on phosphorylation, but in this case, on the 324Ser residue instead ( 
Table 36).  
 
Position Residue Sequence Score Sequence Score Position Residue Sequence Score Sequence Score
26 S GKTSSTVNT 0.678 GKTSSTVNT 0.678 323 S LTSRSSQES 0.945 LTSRSSQKS 0.243
30 T STVNTKFEK 0.923 STVNTKFEK 0.923 324 S TSRSSQESQ 0.997 TSRSSQKSQ 0.998
39 S EELESHRAV 0.824 EELESHRAV 0.824 327 S SSQESQRQA 0.996 SSQKSQRQA 0.997
52 S HVPFSKESR 0.966 HVPFSKESR 0.966 337 S ELLVSPASD 0.81 ELLVSPASD 0.81
55 S FSKESRRRH 0.994 FSKESRRRH 0.994 390 S NLDNSKSGE 0.861 NLDNSKSGE 0.861
76 S KDKESDKED 0.998 KDKESDKED 0.998 400 S KGNGSGGSR 0.819 KGNGSGGSR 0.819
84 S DGRESPSYD 0.995 DGRESPSYD 0.995 403 S GSGGSRENS 0.92 GSGGSRENS 0.92
86 S RESPSYDTP 0.777 RESPSYDTP 0.777 407 S SRENSTVDF 0.996 SRENSTVDF 0.996
87 Y ESPSYDTPS 0.953 ESPSYDTPS 0.953 412 S TVDFSKVDM 0.971 TVDFSKVDM 0.971
89 T PSYDTPSQR 0.893 PSYDTPSQR 0.893 424 T RKIPTGAEA 0.563 RKIPTGAEA 0.563
91 S YDTPSQRVQ 0.953 YDTPSQRVQ 0.953 459 T LTGLTEVPV 0.522 LTGLTEVPV 0.522
121 Y DELCYRDGE 0.695 DELCYRDGE 0.695 481 Y KAPQYHEIG 0.942 KAPQYHEIG 0.942
127 Y DGEEYEWKE 0.943 DGEEYEWKE 0.943 502 Y HDVAYKAKD 0.567 HDVAYKAKD 0.567
132 T EWKETARWL 0.792 EWKETARWL 0.792 512 S NDLLSGIDE 0.997 NDLLSGIDE 0.997
161 S LSLHSLFEL 0.988 LSLHSLFEL 0.988 540 S EPPKSVPSQ 0.988 EPPKSVPSQ 0.988
181 S DMRASTLDE 0.981 DMRASTLDE 0.981 543 S KSVPSQEKR 0.988 KSVPSQEKR 0.988
182 T MRASTLDEI 0.914 MRASTLDEI 0.914 559 T GSTPTLGET 0.815 GSTPTLGET 0.815
203 S QLDESIREN 0.996 QLDESIREN 0.996 563 T TLGETPKEA 0.971 TLGETPKEA 0.971
225 T EKRFTSRIP 0.947 EKRFTSRIP 0.947 639 S EGRISAIES 0.997 EGRISAIES 0.997
226 S KRFTSRIPL 0.947 KRFTSRIPL 0.947 695 S SLRTSIGLW 0.543 SLRTSIGLW 0.543
233 S PLVRSFADI 0.703 PLVRSFADI 0.703 723 T ITRFTEEAF 0.744 ITRFTEEAF 0.744
242 S GKKHSDPHL 0.59 GKKHSDPHL 0.59 793 S AHNISWRNL 0.977 AHNISWRNL 0.977
255 S GEGLSASRH 0.51 GEGLSASRH 0.51 798 T WRNLTVSEC 0.813 WRNLTVSEC 0.813
260 S ASRHSLRTG 0.996 ASRHSLRTG 0.996 800 S NLTVSECKK 0.508 NLTVSECKK 0.508
271 S ASNLSLRGE 0.932 ASNLSLRGE 0.932 847 T KQFKTKRYF 0.509 KQFKTKRYF 0.509
276 S LRGESPLSL 0.973 LRGESPLSL 0.973 857 S TKVRSTISD 0.938 TKVRSTISD 0.938
288 S HLLPSSRAG 0.652 HLLPSSRAG 0.652 858 T KVRSTISDF 0.902 KVRSTISDF 0.902
293 T SRAGTPAGS 0.974 SRAGTPAGS 0.974 882 S VGVPSPKLH 0.949 VGVPSPKLH 0.949
297 S TPAGSRCTT 0.818 TPAGSRCTT 0.818 894 T KFEPTHPER 0.553 KFEPTHPER 0.553
300 T GSRCTTPVP 0.509 GSRCTTPVP 0.509 982 S VLSISHVNS 0.885 VLSISHVNS 0.885
301 T SRCTTPVPT 0.994 SRCTTPVPT 0.994 986 S SHVNSLKVE 0.937 SHVNSLKVE 0.937
309 S TPQNSPPSS 0.956 TPQNSPPSS 0.956 991 S LKVESECSA 0.931 LKVESECSA 0.931
312 S NSPPSSPSI 0.551 NSPPSSPSI 0.551 1127 T DLCFTKREL 0.869 DLCFTKREL 0.869
313 S SPPSSPSIS 0.98 SPPSSPSIS 0.98 1132 S KRELSWLDD 0.997 KRELSWLDD 0.997
315 S PSSPSISRL 0.932 PSSPSISRL 0.932 1141 S LMPESKKKK 0.97 LMPESKKKK 0.97
317 S SPSISRLTS 0.547 SPSISRLTS 0.547 1188 S ALKYSPDKP 0.886 ALKYSPDKP 0.886
320 T ISRLTSRSS 0.988 ISRLTSRSS 0.988 1194 S DKPVSVKIS 0.992 DKPVSVKIS 0.992
321 S SRLTSRSSQ 0.996 SRLTSRSSQ 0.996 1198 S SVKISFEDE 0.996 SVKISFEDE 0.996
1207 Y PRKKYVDAE 0.906 PRKKYVDAE 0.906






Table 36: ScanSite3 predictions of post-translational phosphylation sites 
The predicted change due to the E326K amino acid change is highlighted in green (increased 
probability), red (decreased probability). Scores are expressed as percentiles ranking the best fit 
compared to all other ScanSite records, and those at 0.2% or lower are considered as likely 
phosphorylation sites. 
 
Glycosylation is another post-translational modification that may impact on protein function. 
However, compared to phosphorylation, the amount of protein glycosylation data is limited and its 
annotation in databases is scarce, thus having relatively lower predictive values.  
 
NetOGlyc 4.0 (http://www.cbs.dtu.dk/services/NetOGlyc/) is a predictor of O-glycosylation trained 
on a mass spectrometry-based dataset of genetically engineered human cell lines (Steentoft et al., 
2013). It predicts that the 317Ser and 337Ser residues are more likely to be O-glycosylated with the 
polymorphism resulting in 326E, as opposed to 326K ( 
Table 37). This introduces the possibility, albeit low in context of limited prior relevant examples, 
of the non-synonymous polymorphism at rs3755652 resulting in a change in protein function by 
altering post-translational glycosylation.  
 
Percentile Sequence Percentile Sequence
Y87 0.11% DGRESPSyDTPSQRV 0.11% DGRESPSyDTPSQRV
Y87 0.15% DGRESPSyDTPSQRV 0.15% DGRESPSyDTPSQRV
Y87 0.03% DGRESPSyDTPSQRV 0.03% DGRESPSyDTPSQRV
T305 0.18% RCTTPVPtPQNSPPS 0.18% RCTTPVPtPQNSPPS
S309 0.02% PVPTPQNsPPSSPSI 0.02% PVPTPQNsPPSSPSI
S309 0.05% PVPTPQNsPPSSPSI 0.05% PVPTPQNsPPSSPSI
S313 0.09% PQNSPPSsPSISRLT 0.09% PQNSPPSsPSISRLT
S313 0.16% PQNSPPSsPSISRLT 0.16% PQNSPPSsPSISRLT
S317 0.16% PPSSPSIsRLTSRSS 0.16% PPSSPSIsRLTSRSS
S317 0.11% PPSSPSIsRLTSRSS 0.11% PPSSPSIsRLTSRSS
S324 0.18% SRLTSRSsQESQRQA 0.76% SRLTSRSsQKSQRQA
T459 0.09% AVLLTGLtEVPVPTR 0.09% AVLLTGLtEVPVPTR








Table 37: Net-O-Glyc v4.0 predictions of possible sites of post-translational O-glycosylation. 
The differences in scores resulting from the E326K amino acid change is highlighted in green 
(increased probability), red (decreased probability). Scores range from 0 to 1, where 1 indicates 
highest probability, and scores above 0.5 is regarded as potential glycosylation sites. 
 
NetOGlyc 4.0 has an estimated sensitivity of approximately 80% (Steentoft et al., 2013), but 
positive and negative predictive values of this tool are likely to be low in context of an amino acid 
sequence with no a priori hypothesis, as applies in the case of NBCn1. Additionally, the use of the 
(arbitrary) cut-off of 0.5 may provide a false impression of a definitive prediction, where on a 
continuous scale of probability, the change may not be that definitive. 
 
Another sequence-based prediction program, OGlcNAcScan 
(http://cbsb.lombardi.georgetown.edu/hulab/OGAP.html), predicted only 6 O-glycosylation sites, 
none of which are affected by the E326K amino acid change.  However, this result should be taken 
in context of an estimated sensitivity of only 30% (Jochmann et al., 2014). 
 
Position Position
24 0.918 Positive 0.918 Positive 305 0.803 Positive 0.847 Positive
25 0.836 Positive 0.839 Positive 309 0.718 Positive 0.771 Positive
26 0.918 Positive 0.919 Positive 312 0.738 Positive 0.734 Positive
27 0.919 Positive 0.916 Positive 313 0.898 Positive 0.845 Positive
52 0.763 Positive 0.744 Positive 315 0.622 Positive 0.596 Positive
55 0.938 Positive 0.935 Positive 317 0.576 Positive 0.408 Negative
76 0.868 Positive 0.871 Positive 321 0.773 Positive 0.577 Positive
84 0.915 Positive 0.920 Positive 323 0.632 Positive 0.527 Positive
86 0.904 Positive 0.905 Positive 324 0.641 Positive 0.577 Positive
89 0.573 Positive 0.580 Positive 327 0.747 Positive 0.659 Positive
91 0.796 Positive 0.794 Positive 337 0.538 Positive 0.395 Negative
100 0.528 Positive 0.518 Positive 379 0.897 Positive 0.844 Positive
225 0.735 Positive 0.733 Positive 382 0.852 Positive 0.784 Positive
226 0.847 Positive 0.844 Positive 390 0.821 Positive 0.765 Positive
233 0.820 Positive 0.831 Positive 392 0.885 Positive 0.846 Positive
242 0.853 Positive 0.852 Positive 400 0.803 Positive 0.778 Positive
255 0.923 Positive 0.906 Positive 403 0.651 Positive 0.618 Positive
257 0.916 Positive 0.910 Positive 407 0.774 Positive 0.773 Positive
260 0.863 Positive 0.811 Positive 408 0.514 Positive 0.528 Positive
263 0.827 Positive 0.678 Positive 412 0.520 Positive 0.556 Positive
266 0.848 Positive 0.708 Positive 532 0.747 Positive 0.726 Positive
268 0.724 Positive 0.609 Positive 540 0.856 Positive 0.843 Positive
288 0.743 Positive 0.736 Positive 543 0.789 Positive 0.748 Positive
289 0.876 Positive 0.865 Positive 556 0.958 Positive 0.949 Positive
293 0.841 Positive 0.839 Positive 557 0.966 Positive 0.960 Positive
297 0.791 Positive 0.870 Positive 559 0.902 Positive 0.887 Positive
300 0.892 Positive 0.916 Positive 563 0.929 Positive 0.918 Positive
301 0.930 Positive 0.942 Positive




A different form of glycosylation, N-glycosylation, is predicted to occur at 10 potential N-
glycosylation sites by NetNGlyc (http://www.cbs.dtu.dk/services/NetNGlyc/), but similarly, none of 
them are affected by the non-synonymous polymorphism. 
 
Although these tools may appear to suggest the possibility of the rs3755652 non-synonymous 
polymorphism altering post-translational modifications, and potentially resulting in a change in 
protein function, it has to be interpreted with caution in context of limitations of the training sets, 
conflicting results, modest predictive values, or limited prior evidence to suggest biological 
plausibility. Additionally, as will all prediction tools, there are complexities that cannot be factored 
in; particularly that in silico analyses may not reflect the in vivo milieu, with varying 
macromolecule interactions, unknown 3D protein conformations, as well as varying levels of 
enzymatic activity to result in the post-translational modification. 
 
 
3.9. Predicting the impact of the nsSNP on the isoelectric point (pI)  
While there are limited predictions on a functional change in the protein, there is a notable 
difference in the individual pI (isoelectric points) of the negatively charged glutamic acid and 
positively charged lysine amino acids (3.08 and 9.47 respectively). This potentially influences the 
overall pI of the protein. Although there are slightly different predictions for the pI of the glutamic 
acid and lysine variants, the latter consistently has a pI 0.1 larger than the former ( 
Table 38). Caution should be exercised when extrapolating these predictions to in vivo situations 
as they are unable to account for protein folding and post-translational modifications. 
 
Prediction tool Reference pI (326E) pI (326K) 




ExPSPy, SIB Swiss 
Institute of 
Bioinformatics 
http://web.expasy.org/compute_pi/ 6.26 6.35 
Scripps Research 
Institute 
http://www.scripps.edu/~cdputnam/protcalc.html 6.71 6.81 
ScanSite, Massachusets 
Institute of Technology 
http://scansite.mit.edu/calc_mw_pi.html 6.26 6.35 
 





Whilst this difference in pI may not be sufficient to result in a physiological impact on the protein 
function, it should be sufficient to produce a difference in experiments utilizing isoelectric focusing 
to separate proteins. 
 
 
3.10. Predicting the impact of the nsSNP on enzymatic protein digestion and potential 
differences in mass spectrometry signals  
Another potential method of utilizing the non-synonymous polymorphism in assessing the relative 
expression of the two alleles is by mass spectrometry. As the two amino acid residues, lysine and 
glutamic acid have similar molecular masses, this would be difficult to differentiate by overall mass 
alone. However, the change of amino acid may change its behavior under tryptic digestion. This 
utilises the enzymatic property of trypsin cleaving peptide chains mainly at the carboxyl side of the 
amino acids lysine or arginine, except when either is followed by proline.  
 
As the E326K polymorphism results in one of the amino acids having a propensity to be cleaved 
(lysine, K), and the other does not (glutamic acid, E), the online tool MS-Digest 
(http://prospector.ucsf.edu/prospector/cgi-bin/msform.cgi?form=msdigest) predicts different 
sized fragments produced after tryptic digestion with the two different amino acids (Appendix 14). 
These differences in fragment sizes would allow relative quantification of the respective proteins 
by mass spectrometry in heterozygotes for the non-synonymous (E326K) rs3755652 




3.11. ESE (exonic splicing enhancer) site prediction 
In view of the recent findings that NBCn1 splice variants demonstrated difference in activity (see 
Section 1.9 for details, Yang et al., 2009; Danielsen et al., 2013; Liu et al., 2013), any impact of 
SLC4A7 genotype on mRNA splicing may contribute to the blood pressure effects. Out of the 93 
SNPs of interest, four are exonic. Using the online ESEfinder prediction tool (Cold Harbour Spring 
Laboratories; http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=home), all four exonic 
SNPs are predicted to be in potential exonic splicing enhancer sites, and the nucleotide change 
potentially alters the probability of a splicing event (example  






Figure 63: Representative output of ESE scores from ESEFinder 
ESE scores above threshold at rs13077400 for the A (left) and G allele (right), from ESEFinder 
(http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=home). Bars represent scores for 
binding of SF2/ASF (red), SF2/ASF - IgM-BRCA1 (pink), SRp40 (green). No hits for SC35 and SRp55 
detected in these sequences. Similar changes at rs13096477 and rs3736312. 
 
The tool utilises position weight matrices to score potential exonic splicing enhancer sequences 
(Cartegeni et al., 2003). As with other prediction tools utilising position weight matrices, these 
predictions may lack specificity, and have already been clearly identified by the authors as a caveat 
in its use. This is emphasised by a later study on the positive predictive value of ESEfinder in 
predicting allele-dependent splicing was 0%, or 0 out of 42 predictions (El Sharwary et al., 2009). 
Again, tools like ESEfinder that use cut-offs may provide a false impression of a definitive 
prediction, where on a continuous scale of probability, the change may not be that definitive. On 
the other hand, the study was conducted on a total of 92 samples, based on a combination of 25 
whole blood samples, 57 lymphoblastoid cell lines and 10 operative brain tissue biopsies from 
patients with pharmacoresistant temporal lobe epilepsy. In view of this heterogenous sample and 
limited size, it could be argued that it may have lacked the power to detect allele-dependent 
splicing. Nevertheless, this is not encouraging.  
 
A newer tool, Human Splicing Finder (http://www.umd.be/HSF/) was developed with updated 
position weight matrices, not just for the spliceosome, but also includes exonic splicing silencing 
sequences, hnRNP (heterogeneous ribonucleoprotein particle) and branch sites (Desmet et al., 
2009). As summarized in  
Table 39 below, both rs13077400 and rs3755652 polymorphisms may have an effect on 
components important for mRNA splicing. As our SNPs of interest around Cassette II are exonic, 




program also evaluated the algorithms using a set of mutations known to alter splicing, and 
another set of control polymorphisms thought to be unrelated to splicing. This returned a positive 
predictive value ranging from 22 to 56%, and a negative predictive value of 76 to 95% (Desmet et 




Table 39: Predicted splicing changes by Human Splicing Finder 
Predicted changes by Human Splicing Finder (http://www.umd.be/HSF/), relating to the two exonic 
SNPs located within Cassette II (rs13077400 and rs3755652).  “-“ denotes results below significance 



















912 - - SRp40 cttctcg (86.35) New site
1041 SRp40 tcccaag (82.22) - - Site broken
1042 SF2/ASF cccaaga (77.85) - - Site broken
1042 SF2/ASF cccaaga (75.31) - - Site broken














































1045 hnRNP A1 aagaga (73.33) - - Site broken
-














An alternative online prediction tool, RESCUE-ESE (Massachusets Institute of Technology; 
http://genes.mit.edu/burgelab/rescue-ese/), found that only one (rs13077400) of the four exonic 
SNPs was predicted to potentially affect interactions with exonic splicing enhancers (Fairbrother et 
al., 2002) (Appendix 16). 
 
There is some consistency of the rs13077400 SNP being predicted to have an increase the 
probability of functioning as an exonic splicing enhance, as well as reducing  probability in being a 
splicing silencer. This is interesting as the nearest identified splice cassette is known to be an 
important region of protein-protein interaction (Section 1.9). There is less consistency in the 
predictions for the other SNPs. Once again, caveats already discussed with position weight 
matrices also apply here. Additionally, these predictions do not consider the distance from known 
splice sites, which is important for in vivo mRNA splicing. 
 
 
3.12. miRNA (micro RNA)-mRNA interaction prediction 
miRNAs are small non-coding mRNAs that typically interact with the 3’ UTR of mRNA, usually to 
silence gene expression, but can rarely stabilize the mRNA and promote gene expression. Of the 
93 SNPs examined, none lie within this classical region of action. This is supported by the 
prediction tools mirBase (http://www.mirbase.org/), miRDB (http://mirdb.org/miRDB/index.html) 
and TargetScan (http://www.targetscan.org/). The lack of predicted miRNA interaction sequences 
is particularly important to be considered with the low specificity of these tools. Out of a range of 
prediction tools, the best positive predictive value is around 10%, and most lie between 0 to 5% 
(Ben-Moshe et al., 2012). Although the negative predictive values of these tools are not 










3.13. Epigenomic predictions - ENCODE (Encyclopedia Of DNA Elements), NIH Roadmap and 
the Multiple Tissue Human Expression Resource (MuTHER) 
In recent years, there is an increasing drive towards exploring the epigenomic control of gene 
expression. One major international collaborative effort formed the ENCODE Consortium, which 
aims to identify functional elements in the human genome. Currently, there is data available from 
experimental assays exploring DNA methylation, open chromatin status, RNA-binding proteins, 
RNA profiling, transcription factor binding and histone binding, together with others such as 
known genetic polymorphisms and nucleosome status.  
 
The data relevant to SLC4A7 and hypertension is summarized in (Figure 64 and Appendix  17), 
where 15 of the 93 SNPs of potential interest was noted to be in genomic regions that had signals 
for DNase hypersensitivity, transcription factor binding (typically by ChIP), CpG islands or 
nucleosome interactions. Like the rest of this chapter, the summarized data from ENCODE is 
presented as is, and should only be interpreted with caution. The reproducibility of the ENCODE 
outputs across cell types and experimental methods is not yet known, as is whether it has any 
predictive value (both positive and negative) when extrapolating to human diseases. These issues 








Figure 64: ENCODE outputs for the 93 SNPs of interest 
ENCODE outputs for the 93 SNPs of interest (top), and various results for DNase hypersensitivity, 





Although the dataset is continuously expanding, data is concentrated on the “Tier 1” cell lines, 
GM12878 (lymphoblastoid cell line produced by EBV transformation), K562 (immortalized cell line 
produced from a patient with chronic myelogenous leukemia) and H1 human embryonic stem cells 
(obtained commercially from Cellular Dynamics International) (ENCODE Experiment Matrix, 2012), 
which are experimental cell lines with little relevance to blood pressure regulation.  
 
“Tier 2” cell lines, the next level of cell types with less experimental data available, are typically 
cancer cell lines, for example HeLa-S3 (immortalized cervical cancer cell line), HepG2 (cell line 
derived from liver carcinoma) and MCF-7 (epithelial cell line derived from the metastatic pleural 
effusion of human breast adenocarcinoma), and healthy white blood cells from donors, such as 
monocytes and B-cells. The only remotely relevant cell type to hypertension in this tier are 
HUVECs (obtained commercially from Lonza Biosciences) (ENCODE Experiment Matrix, 2012).  
Although HUVECs do have biological relevance to the study of blood pressure regulation, the use 
from a commercial source results in an inability to assess the impact of genotype. 
 
“Tier 3” with even less experimental data includes most of the primary cell lines (ENCODE 
Experiment Matrix, 2012). Of these primary cell lines, not many are directly relevant to blood 
pressure control. At a stretch, AoSMC (aortic smooth muscle cells), HAoEC (thoracic aortic 
endothelial cells pooled from two individuals), HBMEC (brain microvascular endothelial cells), 
HBVSMC (brain vascular smooth muscle cells), HPAEC (pulmonary artery endothelial cells) and 
HSaVEC (saphenous vein endothelial cells pooled from two individuals) may show some relevance. 
However, data from these cell lines are sparse. Other tissue of potential relevance (Fetal Adrenal 
Gland, BC_Adrenal_Gland_H12803N, BC_Brain_H11058N, BC_Kidney_01-11002, Cerebellum_OC, 
Cerebrum_frontal_OC, Fetal Kidney, Kidney Adult, Kidney_OC) in addition to having limited 
experimental data, are derived from heterogeneous tissues, and sometimes derived from multiple 
subjects. Thus these samples cannot attribute any observations to one particular cell type. The 
current information available does not allow for delineation of which cell type within the tissue is 
responsible for the accessible data. 
 
Whilst these datasets can hint at the epigenomic control in blood pressure regulation, the lack of 
information from relevant cells is a severely limiting factor. A further barrier to utilizing ENCODE 
data for the purpose of this thesis stems from the fact that the data is predominantly derived from 




applies to one genotype / haplotype, and thus cannot provide any information on whether a 
polymorphism may alter the phenotype. There are also skeptics of the interpretation of this large 
epigenomic dataset. They argue that it may inappropriately attribute a causal role to observational 
findings, is prone to analytical methods that yield biased errors and inflate estimates of 
functionality, favours statistical sensitivity over specificity, and emphasizes statistical significance 
rather than the magnitude of the effect (Graur et al., 2013). 
 
A separate collaboration has resulted in the NIH Roadmap Epigenomics Program also with the aim 
of developing a community, freely-accessible resource of genome-wide epigenetic maps in a range 
of human primary cells and tissues (Chadwick, 2012). The two datasets are now possible to view in 
one combined site, the UCSC Genome Browser website (http://www.epigenomebrowser.org/). 
However, the caveats expressed regarding utilizing ENCODE data would also apply to that of the 
Roadmap Epigenomics Program. 
 
Another consideration of epigenetic influences would be that of DNA methylation. This is the 
process of adding a methyl group onto cytosine or adenine DNA nucleotides. DNA methylation 
occurs mainly in CpG islands (string of cytosine-guanine repeats) at the C5 position, and is carried 
out by the enzyme DNA methyltransferase. Physiologically, this phenomenon is typically age-
dependent (Bell et al., 2012). With methylated nucleotides in promoter regions, this typically 
reduces gene expression. On the other hand, hypomethylation increases gene expression as seen 
with some oncogenes and cancers. However, a recent GWAS aiming to detect enrichment of CpG 
island methylation in blood pressure associated-SNPs found 35 SNPs associated with methylation 
markers, but none of them relating to SLC4A7 (Kato et al., 2015). 
 
Recently, the Multiple Tissue Human Expression Resource (MuTHER) was used to generate 
methylome data from subcutaneous adipose tissue punch biopsies from 648 twins. In turn, a 
metQTL (methylation-quantitative trait loci) analysis between DNA methylation levels and 
probabilities of genotypes (minor allele frequency > 5%, info > 0.8) was conducted. This was 
considered a step forward from previous analyses typically used either whole-blood-derived 
samples or arrays only targeting promoter regions, which may reveal only a portion of DNA 






Although the results summarised in Table 40 shows multiple SNPs associated with three main CpG 
islands in different patterns, it should be recalled that this is an observational association and that 
these SNPs are in strong LD. With this, it is still possible that any of the 93 SNPs may be causal, 
although those positioned closer to the CpG islands would be stronger candidates. This brings up 
the interesting possibility of the SNP affecting gene expression by the propensity to methylation. 
On the other hand, similar to other results on the GENEVar database, the pre-set cut off of 
P<0.0001 might not be stringent enough, noting that the majority of these observed associations 
were between P = 10-4 and 10-5. 
 
 
Table 40: Summarised met-QTL data from the MuTHER / GENEVar database. 
Summarised met-QTL data from the MuTHER / GENEVar database (http://www.scandb.org) 
output identifying gene transcripts that vary with each SNP (one row each, and rs13082711 
identified in grey). Each column indicates region of CpG island. Green cells denotes SNP-dependent 
DNA methylation P<0.0001, black cells denote no SNP-expression associated found, open cells 
denote no SNP information available. The SNP IDs are not intended to be read in this format, as full 




3.14. Potential inducibility of SLC4A7 expression 
While most of the above predictions are based on the impact of genotype on gene expression in 
an unstimulated state, it should also be considered if the genetic polymorphism has a functional 
impact in a stimulated state. It has previously been identified that acid-base regulating 
transporters are subject to endocrine stimulation, and particularly relevant to blood pressure 
control, the renin-angiotensin-aldosterone axis (Section 1.12). 
 
To consider the impact of a hormonal or pharmacological challenge on NBCn1 expression, some 
limited clues may be gained from the online dataset, Connectivity Map (Broad Institute; 
http://www.broadinstitute.org/cmap/). This is an online interface allowing access to collection of 
genome-wide transcriptional expression data from cultured human cells treated with bioactive 
small molecules (Lamb et al., 2006).  
 
Based on the data on NBCn1 expression, there does not appear to be strong support for the 
hypothesis of angiotensin II or aldosterone inducing NBCn1 expression ( 
Figure 65), with gluco- and mineralocorticoids being as equally spread out along the Connectivity 
Score spectrum as the renin-angiotensin-aldosterone axis antagonists. Tacrolimus, a calcineurin 
inhibitor, was also highlighted as the potential interaction between NBCn1 and calcineurin 
inhibitors have been discussed in Section 1.9. In Connectivity Map data, tacrolimus appears to 
reduce NBCn1 expression, which the direction of action is at least congruent with the finding that 
tacrolimus also attenuated NBCn1 activity in murine mesenteric arteries (Danielsen et al., 2013). 







Figure 65: Connectivity Score output for NBCn1 
(Left) Ranking of small molecules and their effect on NBCn1 expression, with Connectivity Scores of 
-1 (decreased expression) to 1 (increased expression). Bars on the left of the scores indicated gluco- 
and mineralo- corticoids (red), renin-angiotensin-aldosterone axis antagonists (blue) and other 
anti-hypertensive medications (grey). Small molecules of particular interest are listed in the colour 
of their grouping. (Right) Mean Connectivity Score based on small molecule classification, 
represented as mean ± SEM. See Appendix 19 for full results. 
 
However, this lack of supportive information should be considered with several caveats. All of the 
experiments are conducted on cancer cell lines - MCF7 (breast cancer), PC3 (prostate cancer) and 
HL60 (promyelocytic leukaemia). These experimental models may have only limited biological 
relevance to blood pressure regulation. Additionally, for approximately 70% of the 
pharmacological agents tested, the overall result was an amalgamation of 4 or less experiments, 




Perhaps most importantly, most of the pharmacological antagonism is conducted in the absence 
of their physiological agonist or substrate while in an in vitro cell culture system - for example an 
angiotensin converting enzyme inhibitor (ramipril) in absence of its substrate (angiotensin I). 
 
 
3.15. Other theoretical molecular mechanisms not assessed by prediction tools 
Whilst the above already provides quite a large amount of information to carefully interpret, it 
should be noted that there are other potential molecular mechanisms where an SNP may lead to 
changes in gene expression or product function. This may relate to mRNA conformation and 




3.16. Limited supportive bioinformatics evidence at rs820430 
Although this chapter has already explored the myriad of pitfalls that bioinformatics tools may 
provide, it is worth discussing these prediction tools in context of rs820430. As previously shown 
in Figure 10, rs820430 is in high LD with 10 other SNPs, all clustered within 16kb of each other, of 
which none are within 140kb from the start of SLC4A7. As none of these SNPs are near SLC4A7, 
there is no scope for impact of protein function (by amino acid substitution), splicing (by exonic 
splicing enhancers) or miRNA interactions (within the 3’-UTR). This leaves the potential impacts on 
transcription factor binding, and epigenetic impact of nucleosome interactions. 
 
In short, the only finding of note was that the GeneVar database indicated that rs820430 was 
weakly associated with SLC4A7 (P<0.05) only with the JPT, but not the CHB population. This makes 
the interpretation in context of the Lu et al., Chinese GWAS difficult. However, the caveats as 
outlined in Section 3.3 remains. Outputs from other eQTL databases (ScanDB), tissue-specific 
eQTLs (GTEx), methylation and CpG islands (MuTHER) and nucleosome occupancy (Leiden 








3.17. Summary of prediction tool analyses 
Prediction tools may occasionally be helpful in prioritizing lines of investigations. However, several 
key limitations should always be remembered, in that: 
- the algorithms are often derived from experimental models that are not always relevant to 
blood pressure regulation (or any other investigated disease), 
- the insufficient specificity can readily result in false positives, especially if multiple predictions 
are undertaken,  
- the achievement of statistical significance (or a “cut-off score”) is not necessarily biologically 
significant, and provides an artificial dichotomy when in reality at best represents a 
continuum of likelihood, 
- the observational nature of the data means any observed correlation is not necessarily a 
causative relationship, 
- there are occasions where a multitude of tools may provide conflicting outputs for the same 
prediction, or in other cases where these tools provide concurring outputs based on similar 
training datasets may be falsely reassuring, 
- the “black box” nature of the algorithms lacks transparency,  
- with the primary data often inaccessible to confirm appropriateness of data and relevance to 
algorithm, and last but not least,  
- it often neglects the underlying pre-test probability as derived from known physiological 
understanding of the proteins of interest. 
 








4.1. SLC4A7 genotyping 
229 HUASMC and 178 HUVEC samples were genotyped by the KASP method for the lead SNP at 
the SLC4A7 loci (rs13082711; Ehret et al., 2011) and two others in high LD (rs13096477 and 
rs3755652), and the results are in  
Table 41,  
Table 42 and  
Table 43. 
 






































Unclassified 2 1 2 N/A 
Insufficient 
sample 





80.2% 79.4% 78.0% 81.1% 
Minor allele 
frequency 

































Table 41: Genotyping of HUASMC samples 
Genotypes, allele frequencies and Hardy-Weinberg predicted distributions at rs13082711, 
rs13096477 and rs3755652 of 229 HUASMC samples. “Haplotype” for heterozygotes refers to a 
concordance of heterozygosity across all three SNPs, as it is technically impossible to be certain 
that they form the same haplotype without sequencing. “Unclassified” denotes an inability to call 










































Unclassified 1 2 6 N/A 
Insufficient 
sample 





80.2% 79.5% 78.7% 79.6% 
Minor allele 
frequency 

































Table 42: Genotyping of HUVEC samples 
Genotypes, allele frequencies and Hardy-Weinberg predicted distributions at rs13082711, 
rs13096477 and rs3755652 of 178 HUVEC samples. “Haplotype” for heterozygotes refers to a 
concordance of heterozygosity across all three SNPs, as it is technically impossible to be certain 
that they form the same haplotype without sequencing.  “Unclassified” denotes an inability to call 
genotype by KASP assay. Not all columns add to exactly 100% as numbers are rounded to one 
decimal place. 
 
The genotype distributions for both HUASMCs and HUVECs were in Hardy-Weinberg equilibrium 
(P>0.05 for deviation from equilibrium by chi-squared test).  
 
All 6 genotyping runs had a call rate of >95%. As there were multiple genotyping runs, there were 
samples that were present in more than one genotyping batch. Inter-assay concordance of 97.8% 
(88/90), 97.9% (94/96) and 96.1% (73/76) for the rs13082711, rs13096477 and rs3755652 
respectively. Where there are discordant results from two runs, the samples are “unclassified”. 




100% (14/14 HUASMCs, 16/16 HUVECs and 9/9 renal biopsies) concordance with gold standard 
DNA sequencing. In 14 paired samples with HUASMCs and HUVECs from single donors, all three 
SNPs had 100% matching genotype by KASP assay. With the SNPs in high LD, haplotypes were also 


































Table 43: Haplotypes at rs13082711, rs13096477 and rs3755652, for HUASMCs and HUVECs  
 “Haplotype” for heterozygotes refers to a concordance of heterozygosity across all three SNPs, 
while it is impossible to be certain that they form the same haplotype without sequencing.   
 
The genotype distributions for both HUASMCs and HUVECs were in Hardy-Weinberg equilibrium 
when considering the three main haplotypes (P>0.05 for deviation from equilibrium chi-squared 
test), and there were no differences in the distribution between these two sample groups 
(P>0.05). Notably there was no difference in the proportion of samples with incomplete datasets 
(HUASMCs 3.9%, 9/229; HUVECs 5.6%, 10/178; P>0.05).  
 
213 HUASMC and 174 HUVEC samples were genotyped by the KASP method for the Chinese GWAS 
















  HUASMC HUVEC 












Unclassified 1 3 
Calculated 
frequency 
Major allele frequency 66.3% 65.2% 
Minor allele frequency 33.7% 34.8% 
Hardy-Weinberg 
predicted 













Table 44: Genotyping of HUASMC and HUVEC samples at rs820430 
Genotypes, allele frequencies and Hardy-Weinberg predicted distributions at rs820430 of 213 
HUASMC and 174 HUVEC samples. “Unclassified” denotes an inability to call genotype by KASP 
assay. Not all columns add to exactly 100% as numbers are rounded to one decimal place. 
 
 
4.2. Gene expression 
4.2.1. End-point reverse-transcriptase polymerase chain reaction (RT-PCR) 
In a panel of HUASMCs, HUVECs and biopsies of non-diseased poles of cancer nephrectomies, 
SLC4A7 mRNA was detected by end-point RT-PCR, but not of the surrounding genes NEK10 and 
EOMES (Figure 66). Primers for SLC4A7 spanned exons 2 to 5, and therefore detected the majority 







Figure 66: End-point RT-PCR (SLC4A7, NEK10 and EOMES) for HUASMCs, HUVECs and nephrectomy 
biopsies 
MCF7 and human T-lymphocytes were positive controls.  
Input of 20ng reverse-transcribed RNA for each reaction / lane.  
 
 
4.2.2. Allelic imbalance analysis  
Known heterozygotes at three SNPs rs13082711, rs13096477 and rs3755652 (which are all in high 
LD) were selected for allelic imbalance analysis. The PCR amplicon surrounding the SNP was 
sequenced and analysed by PeakPicker. In HUASMCs, HUVECs and nephrectomy biopsies, the risk 
(minor) allele C at rs13096477 was preferentially detected as compared to the protective T (major) 







Figure 67: Allelic imbalance analyses using heterozygote samples at the exonic SNP rs13096477 
Allelic imbalance analyses using heterozygotes at an exonic SNP (rs13096477), which is in high LD 
with the GWAS lead SNP (rs13082711). (a) Representative chromatographs of genomic DNA 
(gDNA) and complementary DNA (cDNA) for the same sample, with the C/T SNP rs13096477 
highlighted in blue. (b) Bar chart of normalized C/T peak height ratios calculated using PeakPicker, 
where the C allele is preferentially observed in cDNA of HUASMC and renal biopsies.  
* P<0.05, ** P<0.01, paired t-test. 
 
4.2.3. Quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR)  
173 HUASMC and 145 HUVEC cDNA samples were successfully assayed in the qRT-PCR 
experiment. Quality control criteria were set for with Ct standard deviation of replicates >1 for at 
least one of the three probes used (18S, SLC4A7 long transcript and SLC4A7 short transcript). The 
samples were obtained between 2010 and 2014. All samples shown were concordant for 
genotypes at rs13082711, rs13096477 and rs3755652. There were no statistically significant 
differences in ddCt values between the genotypes in either long or short transcripts in both cell 







Figure 68: qRT-PCR of HUASMC and HUVEC cDNA stratified by rs13082711 genotype 
ddCt was calculated by subtracting the corresponding Ct values of the 18S control probe from Ct 
values of the text probe (dCt), and later referenced to the population mean. Positive value denotes 
increased transcript levels. 
No difference between genotypes for each variant by one-way ANOVA.  
 
When considering the difference between HUASMC and HUVEC samples, HUVECs have a larger 
number of transcripts for both the long variant (difference in dCt of 1.73 ± 1.58) and short variant 
(difference in dCt of 3.79 ± 1.33) (14 paired samples,  
Figure 69a). The difference in dCt may extrapolate to a fold difference of 4.3x and 14.9x for the 
long and short variants respectively. There is no genotype impact on the ratio of long to short 
variants, but there is a cell type difference, where HUASMCs have a larger proportion (despite 
lower overall expression) levels of long variant transcripts (difference in dCt of 3.45 ± 0.18, 








Figure 69: qRT-PCR of HUASMC and HUVEC cDNA, stratified by rs13082711 genotype or cell type 
(a) 14 pairs of HUASMC and HUVEC samples from the same umbilical cord were assessed for 
SLC4A7 mRNA expression, expressed as the difference in Ct of SLC4A7 and 18S transcripts. Positive 
value denotes increased transcript levels. (b) Ratio of long and short transcripts in HUASMCs and 
HUVECs, expressed as the difference of Ct of the two variants. Positive value denotes greater 
proportion of short variants. 
* P<0.05, *** P<0.001. Groups in (A) compared by paired t-test. Groups in (B) compared by 
unpaired t-test.  
No difference between genotypes for each variant by one-way ANOVA. 
 
It is not possible to directly compare the Ct of the long and short variants as to determine which is 
more prevalent, as there may be different PCR efficiencies, and it should be recalled that the 
primers of the short variant could also technically detect that of the long variant, despite the single 
end-point PCR product as seen in the Methods Section 2.7.4. 
 
From Figure 68, it is apparent that there is a large distribution of ddCt values, regardless of 
genotype for both HUASMCs and HUVECs (although larger in HUASMCs). This is expressed in dCt 
values in  
Figure 70a. There is an apparent range of Ct of up to 12, even when excluding outliers, 
approximating to 212-fold (4096x) difference. Even with more conservative estimates of PCR 
efficiency (e.g. 80%), this still equates to differences in the magnitude of thousand-fold. A 
histogram showing the distribution of ddCt (by definition a mean of 0) shows a positively skewed 
distribution ( 
Figure 70b and c) with interquartile ranges that are large ( 






Figure 70: qRT-PCR results demonstrating a skewed distribution with a long tail 
(a) qRT-PCR of HUASMC and HUVEC cDNA expressed as dCt by subtracting the corresponding Ct 
values of the 18S control probe from Ct values of the text probe. Smaller value denotes increased 
transcript levels. No difference between genotypes for each variant by one-way ANOVA.  







Long variant Short variant Long variant Short variant 
Standard deviation ddCt*
 3.313 2.395 1.503 0.949 
Lower quartile ddCt -2.200 -1.689 -0.852 -0.528 
Median ddCt -0.938 -0.372 -0.242 0.017 
Upper quartile ddCt 0.862 1.075 0.396 0.457 
IQR (ddCt) 3.062 2.764 1.248 0.985 
IQR (fold difference in 
transcript)** 
9.351 7.792 3.375 2.979 
 
Table 45: Distribution statistics  
* For illustrative purposes, accepting that standard deviations are not ideal representations of 
variance in non-normally distributed datasets 
** Fold difference calculated as equal to “1+2IQR”. As before this carries the caveat that it assumes 
100% PCR efficiency which is improbable. 
 
Similar to the results for rs13082711, there were no statistically significant differences in qRT-PCR 
Ct values between the rs820430 genotypes ( 





Figure 71: qRT-PCR of HUASMC and HUVEC cDNA stratified by rs820430 genotype 
ddCt was calculated by subtracting the corresponding Ct values of the 18S control probe from Ct 
values of the text probe (dCt), and later referenced to the population mean. Positive value denotes 
increased transcript levels. 






4.2.4. NBCn1 protein immunoblots for total cellular protein  
Samples with known genotypes at rs13082711 were assessed for protein expression by protein 
immunoblots. There is an allele-dose effect, with the greatest signal with minor homozygotes, 
followed by heterozygotes and lowest signal with major homozygotes ( 




Figure 72: Protein immunoblots for NBCn1 with HUASMC samples stratified by genotype at 
rs13082711 
(a) Immunoblots for samples with genotype at all three SNPs. The two bands for NBCn1 
approximate to the 136kDa and 127kDa predicted larger and smaller isoforms (with and without 
Cassette II). (b) Bar graph for the signal intensities normalized to β-actin signal.  
Comparisons across the three genotypes by one-way ANOVA. 
*P<0.05 after correcting for multiple comparisons 
 
There were no statistical differences between percentage of overall signal represented by the 






Unlike HUASMCs, HUVECs did not show a genotype-dependent NBCn1 total protein expression ( 
Figure 73, NBCn1:β-actin ratio C/T 1.00 ± 0.13; T/T 1.00 ± 0.15). 
 
 
Figure 73: Protein immunoblots for NBCn1 with HUVEC samples stratified by genotype at 
rs13082711 
There are two signals for NBCn1 present. 
 
4.2.5. Isoelectric focusing 
HUASMC samples representing the different genotypes at the non-synonymous SNP rs3755652, 
resulting in the E326K amino acid, was examined by isoelectric focusing. There were no differences 
in the isoelectric focusing of NBCn1 based on genotype (Figure 74). 
 
 




Isoelectric focusing of whole cell lysates of HUASMCs did not reveal the predicted changes (Section 
3.9) in mobility for the different E326K variants. The pH gradient is identified on the right. 
Representative blot of three experiments, all showing no difference in electrophoretic mobility. 
4.3. Studies into molecular mechanisms underlying differences in gene expression 
Following the identification of a genotype-associated effect on SLC4A7 gene transcription in both 
the assessed cell types (Section 4.2.2), and total cellular NBCn1 expression at least in HUASMCs 
(Section 4.2.4), the next set of experiments aimed to explore the underlying molecular genetic 
mechanisms. 
 
4.3.1. Chromatin immunoprecipitation (ChIP)  
A ChIP assay using HUASMCs was initially conducted attempting to identify which, if any, 
allele/haplotype is preferentially transcribed. To do this, 2 ng of anti-RNA polymerase II (Pol II) was 
used to immunoprecipitate sections of DNA that were being actively transcribed by RNA 
polymerase. Allelic imbalance with heterozygotes was used to improve the sensitivity and reduce 
external confounders by having a system where both alleles/haplotypes are exposed to the same 
environment.  
 
There was no significant difference between the input chromatin and the immunoprecipitated 
sample (Figure 75). However, there was a striking reduction in the C allele : T allele ratio in the 
chromatin samples as compared to what would be expected if there were no preferential 
chromatin binding. This finding cannot be interpreted without further experiments as due to the 
chemistry of Sanger sequencing (see Section 2.6.1), there may be differences in the C and T 
chromatograph signals purely due to experimental conditions. With this, the study progressed to 
the formaldehyde-assisted isolation of regulatory elements (FAIRE) assays to determine if the T 






Figure 75: Chromatin immunoprecipitation (ChIP) assay with anti-Pol II antibody 
Allelic imbalance at rs13096477 of ChIP products. rs13096477 was chosen as a marker for the 93 
SNPs in high LD. 
No significant difference between input chromatin and anti-Pol II. It was not appropriate to 




4.3.2. Formaldehyde-assisted isolation of regulatory elements (FAIRE) assays  
To continue from the ChIP studies (Section 4.3.1), FAIRE assays in both HUASMCs and HUVECs 
were conducted to identify sections of DNA that are protein-bound (chromatin) within a cellular 
environment. At rs13096477, the major/protective (T) allele is preferentially chromatin-bound in 






Figure 76: Formaldehyde-assisted isolation of regulatory elements assays at rs13096477 
Heterozygotes at rs13096477 were used to obtain chromatin-associated DNA, and paired with the 
respective genomic DNA.  
*P<0.05, Wilcoxon signed-rank test. 
 
4.3.3. Electrophoretic mobility shift assays (EMSA) 
In order to utilize electrophoretic mobility shift assays in investigating the potential SNPs of 
interest, a decision was made to prioritise the initial list of 93 SNPs down to 10 SNPs. The decision-
making rationale included the position of the SNPs relative to start of transcription, predictions of 
transcription factor binding, ENCODE and RegulomeDB predictions (Figure 77), of which the 






Figure 77: Rationale in selecting 10 SNPs (out of 93) for further investigation with EMSA 
Arrows to left indicate SNPs selected, and arrows to the right indicate SNPs with lower priority. 
 
With the 10 SNPs to be investigated by EMSA, the scanning panel shows that the electrophoretic 
mobility of labelled double-stranded oligonucleotides representing both the alleles of rs13096477, 
the minor alleles of rs2371065 and rs13077400, were retarded in the presence of 10 ng HUASMC 
nuclear extracts (Figure 78). The doublet of the signal shift for the rs2371065 probe is consistent 
throughout all EMSA studies, and even the DNA-pulldown assay shown later (Figure 85). It should 
be highlighted that the GWAS blood pressure-associated index SNP rs13082711 did not 







Figure 78: EMSA with labelled-probes corresponding to both alleles of 10 SNPs 
For each SNP, the minor allele is listed first; solid black line indicates GWAS-lead SNP, red lines 
indicate predicted TFBS, broken black lines indicate intronic, green lines indicate synonymous 
exonic SNPs, blue lines indicate non-synonymous SNP. All lanes had 10 ng HUASMC nuclear 
extracts added to 10 pmol of labelled double-stranded oligonucleotide probe. Unbound probes as 
visualized at bottom of autoradiograph. Red boxes denote observed electrophoretic mobility shifts, 
indicating protein-oligonucleotide interaction. Representative of n=2 sets. 
 
To test for consistency of the potential cell-type dependent effect of DNA-nuclear protein 
interaction as seen in the FAIRE studies above (Figure 76), further EMSA studies were conducted 
comparing HAUSMC and HUVEC nuclear extracts with regards to the rs2371065, rs13096477 and 






Figure 79: EMSA comparing HUVEC and HUASMC nuclear extracts for three SNPs 
For each SNP, the minor (risk) allele is listed first. All lanes had 10 ng HUVEC or HUASMC nuclear 
extracts added to 10 pmol of labelled double-stranded oligonucleotide probe. Unbound probes as 
visualized at bottom of autoradiograph.  
 
With all three SNPs, HUVEC nuclear extracts did not retard the mobility of the biotin-labelled 
oligonucleotide probes. HUASMC nuclear extracts continue to indicate in vitro DNA-nuclear 
protein interaction consistent with previous FAIRE results (Figure 76). 
 
The apparent allele-dependence of the electrophoretic mobility shifts was further assessed by a 
dose-dependent assay for the sequences surrounding rs2371065, rs13096477 and rs13077400 
using HUASMC nuclear extracts (Figure 80). The shifted signals for rs2371065 and rs13096477 
continue to be persistently strong, whereas the signals for rs13077400 were often faint. These sets 









Figure 80: EMSA studies at rs2371065, rs13096477 and rs13077400 
Dose-response of the double-stranded oligonucleotide probes for minor (first 5 lanes on gel, red on 
chart) or major (last 5 lanes on gel, green on graph) alleles at rs2371065, rs13096477 and 
rs13077400, shifting to increasing quantities of HUASMC nuclear extract. 
ANOVA denotes two-ways repeated measures ANOVA for interaction.  
* P<0.05, ***P<0.001 for comparison between alleles at each concentration of nuclear extract 
after Bonferroni correction for multiple comparisons. 
 
Initial attempts at to identify the interacting nuclear protein was using the C allele at rs2371065, 
due to strong shifted signal, and the large difference when compared against the T allele. To 
narrow down the list of potential nuclear proteins that may interact with the rs2371065 double-
stranded oligonucleotide, databases from Match, Patch and Wilmer, together with data from the 




with the rs2371065 SNP are listed in Table 46. Unlabelled double-stranded oligonucleotides were 




Table 46: Oligonucleotide sequences of EMSA competitor probes 
The sense strand is shown, and a reverse complimentary strand is used to construct double-
stranded oligonucleotides. The reference SLC4A7 sequence is shown on the first row, with the 
rs2371065 SNP at position 11. The competitor probe representing PHOX2A and PLAGL1 is the same 
as the C allele probe due to the shared sequence. Coloured boxes are proposed consensus 
sequences; green, no change from refernce sequence; red, different from consensus sequence; 
large font, proposed key sequences. See Section 3.4 for description of prediction sources and 
sequence references. 
 
Using competitor assays, the initally obsvered shift is reduced and almost amiliorated by the 
competitor probes corresponding to PHOX2A, PLAGL1, TFAP2C and TRMT1 (Figure 81). Of note, 
the competitor corresponding to the SLC4A7 C allele sequence reduced the shifted signal more 






Figure 81: Unlabeled double-stranded oligonucleotide competitor EMSA studies 
Effect of 200 pmol unlabelled double-stranded oligonucleotide competitor probes on the previously 
seen protein-labelled oliginucleotide (rs2371065 (C) dsOligo) shifted signal. 
ANOVA denotes one-way repeated measures ANOVA for interaction.  




Antibodies targeted against the most promising nuclear proteins (PHOX2A, PLAGL1 and TFAP2C) 
were used in supershift assays. TRMT1 was not assessed as it functions primarily to bind tRNA 
(transfer RNA). In two separate studies, there were no supershifts observed with two different 




Figure 82: Supershift assays at rs2371065 targeted against PHOX2A, PLAGL1 and TFAP2C 
Controls included normal IgG and gelatin / NaN3 (sodium azide) as they can potentially interference 
with the protein-oligonucleotide interaction. Representative of n=2. 
No consistent pattern observed. 
 
As supershift assays are highly dependent on antibody-protein interactions that may be difficult to 
achieve in vitro, a Western-EMSA (see Section 2.14.2) was conducted. With a native 
polyacrylamide gel, the nuclear proteins normally migrate slowly. However, if there were protein-
oligonucleotide binding, this would increase the charge-to-mass ratio and accelerate the mobility, 







Figure 83: Western-EMSA (WEMSA) at rs2371065 
Western-EMSA (WEMSA) with HEK293 nuclear extracts and double-stranded oligonucleotides 
corresponding to the sequence surrounding rs2371065. No shift of AP2γ (the gene product of 
TFAP2C) was detected. Representative of n=2. HEK293 nuclear extracts were chosen due to the 
higher expression levels.  
 
No PHOX2A and PLAGL1 signal was detected when replicating this study with the respective 
antibodies. In addition, a ChIP assay using 2ng anti-AP2γ antibodies did not identify the sequence 
around rs2371065 as interacting with AP2γ. 
 
These negative results were followed up with end-point RT-PCR to determine if there was at least 
mRNA expression of PHOX2A, PLAGL1 or TFAP2C in tissues of interest. Out of the three, only 






Figure 84: End-point RT-PCR for PHOX2A, PLAGL1, TFAP2C and TRMT1 
End-point RT-PCR (10ng input RNA) of a panel of cell lines for PHOX2A, PLAGL1, TFAP2C and 
TRMT1. β-actin shown as control. MCF7 and H1299 cells were used as possible positive controls. 
 
As the attempts at identifying the protein responsible for the EMSA shift with rs2371065 probes 
via supershift assays were unproductive, a DNA pull-down assay was conducted (see Section 
4.3.4).  
 
Due to the limited success of the supershift (Figure 82) and DNA pull-down assay (Section 4.3.4), 
this result of an allele-preferential nuclear protein binding with the sequences surrounding 







4.3.4. DNA pull-down assay 
A DNA pull-down assay was conducted with biotin-labelled double stranded oligonucleotides 
targeted against the 21 bp sequence centered on rs2371065 (with the C allele in position 11; 
forward strand 5’-TCCCACCTTCCTAATTTTGTT-3’). It identified two specific bands of proteins, 
neither present in the final (2nd) wash and the negative (no oligo, but with agarose beads) control 
(Figure 85). The presence of two signals was reassuringly consistent with previous EMSA studies. 
These bands were excised and sent for N-terminal protein sequencing commercially by Alta 
Bioscience (Cambridge, UK). 
 
 
Figure 85: DNA-pull down with double-stranded oligonucleotide centering on rs2371065 
Digital image of a Ponceau S-stained PVDF membrane demonstrating the different banding 
patterns. The boxes indicate bands that is neither present in the final wash nor the negative 





The commercial service was unable to return any sequenced amino acids despite a successful 




Figure 86: N-terminal amino acid sequencing chromatographs of DNA-pull down products 
N-terminal amino acid sequencing chromatographs of the two excised bands (top and middle), and 




4.4. Impact of non-synonymous SNP rs3755652 
4.4.1. Co-immunoprecipitation and calcineurin A (CnA)  
In studies using A10 cells transfected with SLC4A7 variants (326E, 326K or splice variant without 
Cassette II) or vector control, there was no co-immunoprecipitation of NBCn1 with calcineurin A 
detected (Figure 87). The presence of calcineurin A signal in lanes 1 to 4 acts as a positive control 
for the system to detect calcineurin A. The absence of NBCn1 signal in lanes 5 to 8 act as a 
negative control to confirm immunoprecipitation of NBCn1 in lanes 9 to 12. The absence of 
calcineurin A signal in lanes 9 to 12 indicates that despite the immunoprecipitation of NBCn1, it 




Figure 87: Calcineurin A does not co-immunoprecipitate with NBCn1 in transfected A10 cells 
Input total protein from A10 cells transfected with 1 ng plasmid (vector control, 326E, 326K or Spl) 
per 10 cm2 cell culture surface for 24 hours (lanes 1 to 4). Eluates from immunoprecipitating 500 µg 
of protein using 2 ng of the negative control, normal rabbit IgG (lanes 5 to 8) or using 2 ng of rabbit 
anti-NBCn1 polyclonal IgG (lanes 9 to 12).  
 
Studies repeated with HUASMC primary cell cultures also did not show calcineurin A to co-






Immunocytochemistry identified NBCn1 present in both the membrane and cytosol, in HUVECs 
(Figure 88) and HUASMCs (Figure 89). Similarly, transfection with A10 cells were as initially shown 
in Section 2.19 (Figure 45). Negative controls IgG (normal mouse IgG, Santa Cruz sc-2025; normal 
rabbit IgG, Santa Cruz sc-2027) did not produce any detectable signal with the same exposure. It is 
apparent that in all three cell models, with the different variants, the is NBCn1 signal present in 
both the plasma membrane, as well as intracellularly. The signal ratio calculated from the mean 
NBCn1 signals within the membrane (corresponding VE-Cadherin peaks) and cytoplasmic areas it 
encompasses were similar in the two genotypes. 
 
As intracellular organelle markers were not used, it is difficult to localise the intracellular signal, 
but the perinuclear pattern might suggest presence within the Golgi apparatus. However, the 
quantification of the relative presence in membrane or cytosol is fraught with difficulties as 








Figure 88: Confocal microscopy staining for VE-cadherin and NBCn1 in HUVECs  
Confocal microscopy (63x objective) of HUVECs of rare and common homozygotes at the nsSNP 






Figure 89: Inverted fluorescent microscopy images staining for NBCn1 in HUASMCs  
Representative images of HUASMCs of rare and common homozygotes at the nsSNP rs3755652. 
Cells grown to high confluence for 4x objective images, solitary cells for 40x objective images. Scale 
bars represent 1000 µm (4x objective) and 100 µm (40x objective). Histograms show profile plots of 
the respective signals across the yellow line of 40x objective images (ImageJ). 
 
4.4.3. Subcellular fractionation and localization of NBCn1  
With the differential centrifugation method of subcellular fractionation (Section 2.8.1), one 
fraction was discarded, and three others were obtained. The first centrifugation pellet (at 1,000g) 
was discarded as it would have contained a mixture of nuclei as well as whole unlysed cells, 
making interpretation difficult. The second centrifugation pellet (at 10,000g) would contain a 
mixture of cellular organelles, the third centrifugation pellet (at 100,000g) would predominantly 
contain the plasma membrane-bound proteins and the resultant supernatant reflects the content 




In both HUASMCs and HUVECs, there was a greater amount of NBCn1 in the “membrane” 
(100,000 g) fraction in the cells encoding NBCn1 proteins with the risk Lys/Glu variants (G/A at 
rs3755652) compared to the protective Glu/Glu variant (A/A at rs3755652) (Figure 90). Notably, 
there were no differences between the genotypes in the “organelle” (10,000 g) fraction. There 





Figure 90: Subcellular fractionation samples from HUASMCs and HUVECs 
Samples paired for E326K variants in each immunoblot. 2 ng protein of each cellular fraction, 
grouped by cell sample, was loaded for each lane.  
n = 9 each group for HUASMCs, 8 each group for HUVECs.  
*P<0.05 by Mann-Whitney U-test 
 
4.4.4. Total cellular NBCn1 in transfected A10 cells 
Transfecting equimolar quantities of the two 326E and 326K SLC4A7 plasmids for 48 hours 







Figure 91: NBCn1 expression in transfected A10 cells 
HEK293 and A10 cells were transfected with 1 ng plasmid per 10 cm2 cell culture surface (326E, 
326K and Spl or with vector control) for 48 hours.  




Treating HUASMCs with 10-9 M angiotensin II in a serum-starved culture system over 3 days 
increased total NBCn1 expression as compared to vehicle control (Figure 92a). Treatment with a 
dose-range of angiotensin II over 12 hours changed the mRNA/cDNA allelic imbalance of the two 
polymorphic alleles, where there is a return from a imbalance from favouring the minor (C) alele 




Figure 92: Inducibility of NCBn1 by angiotensin II, and the relevance of genotype 
Samples were exposed to varying concentrations of angiotensin II or vehicle in an unsupplemented 
culture system. (a) Protein immunoblots indicate an induction of NBCn1 by angiotensin II, (b) allelic 




These studies could not be replicated in HUVECs particularly as they demonstrated an apoptotic 
phenotype in unsupplemented media (Figure 93). This need for media supplementation would 
likely negate the effect of angiotensin II due to its short half-life in serum (Al-Merani et al., 1978). 
Whilst some reports utilise “low serum” supplementation, it is still likely to impact on the 




Figure 93: Digital light microscopy images (10x objective) of serum-starved HUVECs over 48 hours. 
Digital images taken from the same position over the time course.  
Marked reduction in cell numbers observed, as compared to paired cultures in serum-
supplemented conditions 
Red arrows denote detached cells; blue arrows denote cell shrinkage; black arrows denote clumps 






4.6. In vitro cellular function  
4.6.1. Collagen contractility gel 
An initial trial of collagen contractility gel assays revealed the optimal cell density of 1.25x106 
cells/ml gel. Following this, a time-course was assessed for untreated, serum-supplemented and 
angiotensin II-stimulated contraction. It showed that maximal contraction is achieved by 72 hours 
( 
Figure 94). On top of the unstimulated contraction, addition of serum-supplementation produces a 
further contraction that is not added to by 10-8 M angiotensin II. This lack of additive effect is not 
unexpected, as previously mentioned, the half-life of angiotensin II is markedly reduced in the 
presence of serum (Al-Merani et al., 1978). With this, all further studies are conducted over 72 




Figure 94: Time series for collagen contractility gels 
Time series for collagen contractility gels (1.25x106 cells/ml gel) with various conditions.  
“SFM” denotes serum-free DMEM media as overlay, “Serum” denotes 15% FBS-supplemented 
DMEM media as overlay.  
 
Having established a contractile system, the replicability was assessed, showing good correlation 
between replicates (Figure 95a). For appropriate quantification, an imaging system had to be 
established. This involved initially assessing the difference between colour and black-and-white 
digital images. The independent measurements of the two image formats were well correlated 
(Figure 95b). Anecdotally, the black-and-white images showed clearer borders, as it is not 




Observer 2 (Dr AD Moore) and Observer 3 (Dr K Witkowska). With this, all further images were 
taken in black-and-white. 
 
 
Figure 95: Collagen contractility gels intra-sample replicability and measurement optimisation 
(a) Replicates of collagen contractility gels demonstrating low variability. (b) Correlation between 
independent measurements of the same gel surface areas, either in colour or black-and-white 
digital images (n=24). 
 
The variability of the measurements itself needed to be assessed. Intra-observer variability was 
good (Figure 96; P<0.001, r2 > 0.9, CV < 0.05), and inter-observer variability was reasonable and 
was again confirmed to be better with black-and-white images (Figure 97; P<0.001, r2 > 0.7, CV < 
0.15). With this, future analysis would be conducted by three independent blinded observers with 
black-and-white digital images. 
 
 




Intra-observer variability between a first and second measurement of the same digital image, with 
three days separating the measurements (n=24). 
 
 
Figure 97: Inter-observer variability of collagen gel contractility assays measurements 
Inter-observer variability between a three independent observers of the same digital image, with 
all observers blinded to the identity of the image (n=24). With gratitude to Dr AD Moore (Observer 
2) and Dr K Witkowska (Observer 3). 
 
However, after establishing the methodology, it became apparent that collagen contractility gels 
were not suitable for analyzing the impact of intracellular acidosis. The ammonium chloride pre-
pulse method was not deemed appropriate due to the multiple washes that is necessary and 
would disturb the positioning of the collagen gel. With this, noradrenaline (as adrenergic receptor 
agonist), sodium acetate as weak base that results in intracellular acidosis and extracellular 
acidosis using a monovalent strong acid (HCl) were use, in comparison to vehicle control.  
 
Unsurprisingly, 10-5 M noradrenaline resulted in a smaller collagen gel, reflecting vascular smooth 
muscle contraction, whereas 40 mM sodium acetate did not produce a clear shift in gel size as 
opposed to vehicle control (Figure 98). However, upon introducing an overlying culture media with 
an acidotic pH of 6.8, the structural integrity of the collagen gels notably changes with blurring of 
the edges (Figure 99). This is likely due to the alkaline pH that is necessary for collagen 
polymerization. This is also apparent in the methodology of extracting collagen from rat tails 






Figure 98: Time series for collagen contractility gels with various pharmacological stimuli 
Time series for collagen contractility gels (1.25x106 cells/ml gel) with various conditions. NAd, 
noradrenaline; NaAce, sodium acetate. Experiments conducted with unsupplemented DMEM as 




Figure 99: Digital images of collagen gels exposed to pHo 6.8 
 
With this, attempts to establish an in vitro system of investigating the influence of SLC4A7 
genotype on vascular smooth muscle contractility under acidic conditions were unsuccessful. 
 
4.6.2. Na+/HCO3
--dependent, DMA-insensitive pHi recovery following ammonium chloride 
prepulse-induced intracellular acidosis - HUASMCs 
With in vitro studies of 19 HUASMC samples (9 C/T heterozygotes and 10 T/T major/protective 
allele homozygotes at rs13082711), any potential difference in pHi recovery following intracellular 
acidosis was not detected by repeated measures two-way ANOVA (Figure 100). This was despite 
the apparent divergence of curves in cells exposed to NHE inhibition (DMA) in the presence of 
CO2/HCO3






Figure 100: HUASMC pHi recovery following intracellular acidosis, with and without CO2/HCO3
- or 
DMA 
rs13082711 genotypes: C/T (yellow, n=9) and T/T (green, n=10). Grey error bars denotes SEM. 
All P >0.05 when comparing the two genotypes by repeated measures two-way ANOVA over the 
280 time points between 60 seconds to 900 seconds after re-introduction of Na+-containing buffer. 
 
To minimize the potential effects of variances in cell cycles by returning the cells into a quiescent 
state, HUASMCs were serum-starved for 48 hours (Pardee, 1974). In this synchronised state, they 
were then assessed for pHi recovery in the presence of CO2/HCO3
- and DMA, thus mainly isolating 
NBC activity. There was a markedly reduced rate of pHi recovery in serum starved cells (Figure 
101a). As with the standard cultures (Figure 100b), any potential differences in genotypes were 








Figure 101: Serum-starved HUASMC pHi recovery following intracellular acidosis, with CO2/HCO3
- 
and DMA 
(A) n=19 paired HUASMCs. (B) rs13082711 genotypes: C/T (yellow, n=9) and T/T (green, n=10). 
Grey error bars denotes SEM. 
Groups compared by repeated measures two-way ANOVA over the 280 time points between 60 
seconds to 900 seconds after re-introduction of Na+-containing buffer. 
 
When comparing the initial rate of net base uptake (for the first 15 recorded seconds after 
reintroduction of sodium-containing buffer), there were no differences between the genotypes in 
either standard serum-containing or serum-starved culture systems (Figure 102). Notably, there 
was a reduced (but non-statistically significant for the sample size) initial net base uptake when 




Figure 102: Initial net base uptake of HUASMCs in sodium-free and sodium-containing PSS in 
presence of CO2/HCO3
- and DMA 
rs13082711 genotypes: C/T (yellow, n=9) and T/T (green, n=10).  




Although there were no differences in the initial rate of net base uptake across the genoytpes, it is 
apparent that there is a large range of initial “starting” pHi (Figure 103). Although there was no 
overall difference between the groups, the standard deviation and range were large for the both 
serum-containing (SD 0.23 and range 0.79) and serum-starved (SD 0.17 and range 0.68) cultures.  
 
 
Figure 103: pHi at which initial base flux measurements were obtained 
P>0.05 for comparisons across genotype by Mann-Whitney U-test. 
 
As activities of acid-base transporters are regulated by pHi, these varying pHi points from which 
the initial rates of net base uptake were assessed introduces marked variation in the net base 
uptake values of Figure 102. This could disguise any potential differences in HCO3
- transport as 
suggested by the diverging curves in Figure 100b and Figure 101b. With this, the rate of net base 
uptake was determined at regular pHi intervals (Figure 104). There is a genotype effect reflective 
of the aforementioned divergent pHi recovery curves, where the C/T genotypes have a steeper 
slope when plotting net base uptake against each pHi in both serum-treated and serum starved 






Figure 104: Rates of net base uptake at pHi intervals for HUASMC following intracellular acidosis, 
with CO2/HCO3
- and DMA 
(A) n=19 paired HUASMCs. (B and C) rs13082711 genotypes: C/T (yellow, n=9) and T/T (green, 
n=10).  
Groups were compared by linear regression.  
 
In addition to differences in net base uptake rates, there is also a genotype effect on final plateau 
pHi after recovery from intracellular acidosis that is revealed in the presence of DMA (ΔpHi = 0.087 
± 0.027, P<0.01), which is replicated with the serum-starved cells (ΔpHi = 0.108 ± 0.035, P<0.01) 
(Figure 105). Notably, 48-hour serum starvation resulted in a reduction in final plateau pHi in the 
presence of CO2/HCO3
- and DMA (ΔpHi = 0.070 ± 0.015, n=19 pairs, P<0.001). On the other hand, 







Figure 105: Final plateau pHi after recovery from intracellular acidosis 
rs13082711 genotypes: C/T (yellow, n=9) and T/T (green, n=10).  
**P<0.01 by Mann-Whitney U-test. 
 
These observed genetic influence in net base flux (Figure 104) and resting pHi (Figure 105) was 
confirmed to be CO2/HCO3
–-dependent as the differences disappear in CO2/HCO3





Figure 106: HUASMC pHi recovery following intracellular acidosis, without CO2/HCO3
-, and in the 
presence of DMA 
rs13082711 genotypes: C/T (yellow, n=9) and T/T (green, n=10). Grey error bars denotes SEM. 
Groups in (A) compared by repeated measures two-way ANOVA over the 280 time points between 
60 seconds to 900 seconds after re-introduction of Na+-containing buffer. Groups in (B) compared 




As expected, the buffering capacity of the cells was higher in the presence of CO2/HCO3
-, as 
compared to its nominal absence. The buffering capacity is similarly low regardless of the presence 
or absence of CO2/HCO3
- at the lower ranges pHi, relating to the lower intracellular HCO3
- 
concentrations. The difference was particularly evident at the pHi ranges closer to physiological 
levels where lower intracellular HCO3
- concentrations are high and adds substantially to the 
buffering power (Figure 107). There were no differences in buffering capacity between cells of the 
two assessed genotypes in the presence or absence of CO2/HCO3, indicating that any genetic 
influence on NBCn1 function does not occur via changes in buffering capacities. Serum-starvation 
for 48 hours did not alter buffering capacity in the presence of CO2/HCO3
- (n=19 pairs; with serum, 





Figure 107: Buffering capacity of HUASMCs in the presence and absence of CO2/HCO3
- 
Buffering capacity in the presence / absence of CO2/HCO3
- as a function of mid-washout pHi 
n=19 paired HUASMCs. ***P<0.001 by Wilcoxon sign-ranked test. 




--dependent, DMA-insensitive pHi recovery following ammonium chloride 
prepulse-induced intracellular acidosis – HUASMCs (by cell morphologies) 
Of the 19 HUASMCs assessed, it was apparent that it was divisible into two different macroscopic 
morphologies and cell culture surface confluencies. One group has a higher proliferation rate, 
achieves cell culture surface confluency and has an elongated spindle-shaped morphology (Figure 




confluency, and has a larger surface area per cell. It is important to consider these differences as it 
poses potential confounding factors such as the cells that achieve confluency: 
- will have a larger surface area-to-volume ratio, allowing for greater transporter density, 
- may have higher cell-cell interactions,  
- may be in different stages of the cell cycle, and 




Figure 108: Representative images of two different HUASMC morphologies 
Fluorescence images of BCECF-loaded cultures. Typical appearance of HAUSMC primary cultures 
reaching confluence appearing elongated (left); and not those not reaching confluence even after 
two week’s culture appearing to occupy a larger culture surface area (right). Same magnification 
for both images. 
 
The digital images were categorized by two independent assessors (Dr AD Moore and Dr FL Ng) 
blinded to the other characteristics of the samples. There were no statistical differences in the 
distribution of the two different morphologies when separated by rs13082711 genotype ( 













 rs13082711 genotype 
C/T T/T 
Confluent 5 7 
Non-confluent 4 3 
 
Table 47: Distribution of HUASMC morphology by rs13082711 genotype 
P>0.05 by Fisher’s exact test. 
 
The cells from the two different morphological groups had markedly different pHi recovery profiles 
( 
Figure 109), particularly that of studies conducted in CO2/HCO3
--free conditions ( 
Figure 109C), predominantly reflecting the NHE component. Although there was no statistical 
difference in the p pHi recovery in cells studied in the presence of CO2/HCO3
- and DMA (isolating 
the NBC component, 








Figure 109: HUASMC pHi recovery following intracellular acidosis, with and without CO2/HCO3
- or 
DMA, or in 48 hour serum-starved cultures 
Confluent (orange, n=12) and non-confluent subgroup (grey, n=7). Grey error bars denotes SEM. 
Groups compared by repeated measures two-way ANOVA over the 280 time points between 60 
seconds to 900 seconds after re-introduction of Na+-containing buffer. 
 
The presence of two morphologically different groups that behave differently with regards to pHi 
recovery necessitates a further assessment of the subgroups, as it would have potentially 
introduced a degree of variability of results in Figure 100. Most of the following will only consider 
the confluent subgroup, as there is a larger sample size and is more likely to reflect healthier 





When considering this subgroup, the differences between the two genotypes are even more 
apparent than before. The genotypic effect on Na+/HCO3
--dependent net base flux and resting pHi 
persists ( 
Figure 110A-C), and is also continues in the growth-arrested serum-starved cells ( 
Figure 110D-F), although as with the unstartifed group, there were no statistically difference at 
each pHi. The difference in pHi plateau after recovery from intracellular acidosis revealed in the 
presence of DMA is 0.079 ± 0.024 (P<0.01), which is replicated with the serum-starved exposed to 
DMA (ΔpHi = 0.118 ± 0.043, P<0.05). These observed genetic influence in net base flux and resting 
pHi was confirmed to be CO2/HCO3






Figure 110: HUASMC pHi recovery following intracellular acidosis, with and without CO2/HCO3
-, 




rs13082711 genotypes: C/T (yellow, n=5) and T/T (green, n=7). Grey error bars denotes SEM. 
Groups in (A, D and G) compared by repeated measures two-way ANOVA over the 280 time points 
between 60 seconds to 900 seconds. Groups in (B, E and H) compared by linear regression. Groups 
in (C, F and I) compared by Mann-Whitney U-test. 
The non-confluent subgroup is not further investigated due to the low numbers after further 
stratification by genotype (4 vs 3).  
 
4.6.4. Na+/HCO3
--dependent, DMA-insensitive pHi recovery following ammonium chloride 
prepulse-induced intracellular acidosis – HUASMCs and responses to FK506 and BAPTA 
In 11 matched experiments (rs13082711 genotype: C/T n=4, T/T n=7), cells from four concurrent 
cultures of the same cell lineage were assessed for Na+/HCO3
--dependent, DMA-insensitive pHi 
recovery following ammonium chloride prepulse-induced intracellular acidosis while being 
exposed to (A) DMSO vehicle, (B) 10 µM FK506, (C) 30 µM BAPTA-AM loading, or (D) both FK506 
and BAPTA-AM as previously represented in Figure 48.  
 
There was no effect of 10 µM FK506 on Na+/HCO3
--dependent, DMA-insensitive pHi recovery ( 
Figure 111b), but a marked effect with BAPTA-AM incubation ( 







Figure 111: HUASMC pHi recovery following intracellular acidosis, with CO2/HCO3
- and DMA, ± 
FK506 or BAPTA-AM 
N=11 sets of matched quadruplets. Grey error bars denotes SEM. 
(A) only shows mean of all four matched experiments, whereas (B-D) shows mean ± SEM of a pair. 
Groups compared by repeated measures two-way ANOVA over the 280 time points between 60 
seconds to 900 seconds after re-introduction of Na+-containing buffer. 
 
When considering the rate of net base uptake at each specified pHi, the absence of an effect of 10 
µM FK506 is confirmed, as is the notable impact of pre- incubation with 30 µM BAPTA-AM for 20 




Figure 112: Rates of net base uptake at pHi intervals for HUASMC following intracellular acidosis, 
with CO2/HCO3
- and DMA, ± FK506 or BAPTA-AM 
n=12 sets of matched quadruplets. 
*** P<0.0001 Vehicle vs. BAPTA-AM for slope by linear regression.  
P<0.05 Vehicle vs BAPTA-AM at pHi of 6.6 and 6.7, after Bonferroni correction for multiple 
comparisons. 
N.S. no significant difference Vehicle vs. FK506. 
 
Similar to net base flux, FK506 also did not have an effect on plateau pHi. However, intracellular 
calcium chelation with 30 µM BAPTA-AM loading significantly reduced plateau pHi (ΔpHi = 0.094 ± 






Figure 113: Final plateau pHi after recovery from intracellular acidosis with CO2/HCO3
- and DMA, ± 
FK506 or BAPTA-AM  
n=12 sets of matched quadruplets. 
Bonferroni correction for multiple testing applied. *P<0.05, **P<0.01 by Wilcoxon sign-ranked test. 
N.S. no significant difference Vehicle vs. FK506.  
 
 
It is unsurprising that as 10 µM FK506 did not have an effect on Na+/HCO3
--dependent, DMA-
insensitive pHi recovery, the SLC4A7 genotypic effect persists during calcineurin inhibition by 




Figure 114: HUASMC pHi recovery following intracellular acidosis, with CO2/HCO3
-, DMA and FK506 
rs13082711 genotypes: C/T (n=4) and T/T (n=7). Grey error bars denotes SEM. 
Groups in (A) compared by repeated measures two-way ANOVA over the 280 time points between 
60 seconds to 900 seconds after re-introduction of Na+-containing buffer. Groups in (B) compared 





--dependent, DMA-insensitive pHi recovery following ammonium chloride 
prepulse-induced intracellular acidosis - HUVECs 
With in vitro studies of 20 HUVECs samples (10 C/T heterozygotes and 10 T/T major/protective 
allele homozygotes at rs13082711), any potential difference in pHi recovery following intracellular 
acidosis was not detected by repeated measures two-way ANOVA (Figure 115). This was despite 
the apparent divergence of curves in cells exposed to NHE inhibition (DMA) in the presence of 
CO2/HCO3
- (Figure 115b). 
 
 
Figure 115: HUVEC pHi recovery following intracellular acidosis, with and without CO2/HCO3
- or 
DMA 
rs13082711 genotypes: C/T (yellow, n=10) and T/T (green, n=10). Grey error bars denotes SEM.  
Groups compared by repeated measures two-way ANOVA over the 280 time points between 60 
seconds to 900 seconds after re-introduction of Na+-containing buffer. 
 
 
When comparing the initial rates of net base uptake (for the first 15 recorded seconds after 
reintroduction of sodium-containing buffer), there was a larger rate of net base uptake in 






Figure 116: Initial net base uptake of HUVECs in sodium-free and sodium-containing PSS in 
presence of CO2/HCO3
- and DMA 
rs13082711 genotypes: C/T (yellow, n=10) and T/T (green, n=10).  
*P<0.05 by Mann-Whitney U-test. 
 
Similar to the finding in HUASMCs, there is a large range of pHi where the “initial” base uptake was 
measured (Figure 117), with a large standard deviation (0.21) and range (0.73).  
 
Figure 117: pHi at which initial base flux measurements were obtained 
P>0.05 for comparisons across genotype by Mann-Whitney U-test. 
 
Just like with HUASMCs, the varying pHi points from which the initial rates of net base uptake were 
obtained would introduce marked variation in the net base uptake values. Once again, the rates of 




effect reflective of the aforementioned divergent pHi recovery curves, where the rs13082711 C/T 
genotypes have a steeper slope when plotting net base uptake against each pHi, although there 
were no statistically difference at each pHi. This is consistent with the HUASMC results (Figure 
104). 
 
Figure 118: Net base uptake at pHi intervals for HUVECs following intracellular acidosis, with 
CO2/HCO3
- and DMA 
rs13082711 genotypes: C/T (yellow, n=10) and T/T (green, n=10).  
Groups compared by linear regression. 
 
 
In addition to differences in rates of net base uptake, it is worth considering any potential 
genotype-dependent effect on final plateau pHi after recovery from intracellular acidosis that is 
revealed in the presence of DMA. In a similar direction to HUASMCs, the final plateau pHi in C/T 
samples were higher (statistically non-significant) as compared to T/T samples (ΔpHi = 0.082, 95% 
CI -0.020 to 0.185, P=0.10,  
Figure 119). This is a similar magnitude of that of HUASMCs, but due to the larger confidence 
interval, did not reach statistical significance. Of note, there is no difference when the cells were 
assessed under CO2/HCO3






Figure 119: Final plateau pHi after recovery from intracellular acidosis 
rs13082711 genotypes: C/T (yellow, n=10) and T/T (green, n=10).  
No statistical differences between genotypes by Mann-Whitney U-test. 
 
Just like that of HUASMCs, these observed genetic influence in net base flux and resting pHi was 
confirmed to be CO2/HCO3
–-dependent as the differences disappear in CO2/HCO3





Figure 120: HUVEC pHi recovery following intracellular acidosis, without CO2/HCO3
-, and in the 
presence of DMA 
rs13082711 genotypes: C/T (yellow, n=10) and T/T (green, n=10). Grey error bars denotes SEM. 
Groups in (A) compared by repeated measures two-way ANOVA over the 280 time points between 
60 seconds to 900 seconds after re-introduction of Na+-containing buffer. Groups in (B) compared 
by linear regression. Groups in (C) compared by Mann-Whitney U-test. 
 
Similar to HUASMCs, the buffering capacity of the cells was higher in the presence of CO2/HCO3
-, 




regardless of the presence or absence of CO2/HCO3
- at the lower ranges pHi. At higher pHi there is 
still the divergence of the curves where the presence of CO2/HCO3
- is associated with higher 
buffering capacities (Figure 121). There were no differences in buffering capacity for the two 
assessed genotypes in the presence and absence of CO2/HCO3
-, indicating that any genetic 
influence on NBCn1 function does not occur via changes in buffering capacities. 
 
 
Figure 121: Buffering capacity of HUASMCs in the presence and absence of CO2/HCO3
- 
Buffering capacity in the presence / absence of  CO2/HCO3
- as a function of mid-washout pHi 
n=20 paired HUVECs.  




--dependent, DMA-insensitive pHi recovery following ammonium chloride 
prepulse-induced intracellular acidosis – comparing HUASMCs and HUVECs 
To fully interpret the HUASMCs and HUVECs results, they should also be considered in relation to 
each other. It should be noted that none of the samples were paired for arterial and venous 
samples from the same umbilical cord, thus all comparisons were based on unpaired statistical 
tests.  
 
HUVECs demonstrated faster pHi recovery as compared to HUASMCs in CO2/HCO3
--containing 
buffer (Figure 122a), CO2/HCO3
--containing buffer with NHE inhibition by DMA (Figure 122b) and 
removal of NBC activity in CO2/HCO3
--free buffer (Figure 122c). It is notable that the difference is 
absent following the inhibition of both NHEs and NBCs, during studies with CO2/HCO3
--free buffer 







Figure 122: HUASMC and HUVEC pHi recovery following intracellular acidosis 
HUASMC (red, n=19), HUVEC (blue, n=20). Grey error bars denotes SEM. 
Groups compared by repeated measures two-way ANOVA over the 280 time points between 60 
seconds to 900 seconds after re-introduction of Na+-containing buffer. 
 





The net base uptake measured in the 15 recorded seconds before and after re-introduction of 
sodium-containing solutions is markedly different between the two cell types. HUVECs 
demonstrated higher net base uptake as compared to HUASMCs, in both the Na+-independent 
(+0.94 ± 0.15 mmol/L/min, P<0.0001) and Na+-containing conditions (+3.81 ± 0.54 mmol/L/min, 
P<0.0001) (Figure 123a). These initial rates of base uptake were obtained at a large range of pHi 
values, which were also significantly different between the two cell types (Figure 123b). HUVECs 
also continue to show an increased net base uptake at regular pHi intervals in Na
+-containing 







Figure 123: HUASMC and HUVEC net base uptake in presence of CO2/HCO3
- and DMA 
(A) Net base uptake in the last 15 seconds in Na+-free buffer (+DMA) and the first 15 recorded 
seconds in Na+-containing PSS (+DMA), (B) pHi at point of assessing Na
+-dependent base uptake, 
(C) net base uptake at regular pHi intervals.  
HUASMC (red, n=19), HUVEC (blue, n=20). 
**P<0.01. ***P<0.001 by Mann-Whitney U-test. 
P<0.001 HUASMC vs HUVEC at pHi of 6.6 to 6.8, after Bonferroni correction for multiple 
comparisons. 
 
In addition to the increased pHi recovery, HUVECs also have a higher plateau baseline after 
recovery from intracellular acidosis in both CO2/HCO3
--containing (ΔpHi = 0.064 ± 0.030, P<0.05 by 
Mann-Whitney U-test) and CO2/HCO3
--free conditions (ΔpHi = 0.080 ± 0.033, P<0.05 by Mann-
Whitney U-test). However, despite the increased Na+/HCO3
--dependent, DMA-insensitive net base 
uptake in HUVECs, there were no statistically significant difference in the plateau baseline (ΔpHi = 







Figure 124: Final plateau pHi after recovery from intracellular acidosis 
HUASMC (red, n=19), HUVEC (blue, n=20). 
*P<0.05 by Mann-Whitney U-test. 
 
HUVECs appear to have a larger population variance as compared to HUASMCs. The standard 
deviation of the HUVEC samples are larger than that of HUASMCs in the three main Na+/HCO3
--
dependent, DMA-insensitive characteristics assessed ( 
Table 48). Of note, and as hypothesized, serum-starved HUASMCs had a generally lower variance 
as compared to serum-treated HUASMCs. 
 
   Standard deviation 











Initial net base uptake 
(mmol/L/min) 
1.14 1.43 1.89 
Net base uptake at pHi 6.6 
(mmol/L/min) 
1.05 1.22 2.04 
Plateau pHi 0.09 0.07 0.11 
 




HUASMCs have consistently smaller standard deviations than HUVECs with regards to Na+/HCO3
--
dependent, DMA-insensitive net base uptake and final plateau pHi. 
 
4.6.7. Na+/HCO3
--dependent, DMA-insensitive pHi recovery following ammonium chloride 
prepulse-induced intracellular acidosis – overexpression models in A10 cells 
A10 cells were transfected with 1 ng plasmid per 10 cm2 cell culture surface (326E, 326K, Spl or 
vector control) for 48 hours. The transfected A10 cells were assessed for their pHi recovery 
following ammonium-induced intracellular acidosis in the presence of CO2/HCO3
- and DMA. The 
three overexpressing plasmids were different from that of the vector plasmid, but there were no 





Figure 125: SLC4A7-expression plasmid-transfected A10 cells pHi recovery following intracellular 
acidosis with CO2/HCO3
- and DMA 
(Left) only shows the mean at each timepoint. (Right) zoomed view of mean ± SEM of the first 600 
seconds after reintroduction of Na+-containing buffer. 
Groups compared by repeated measures two-way ANOVA over the 190 time points between 30 
seconds to 600 seconds after re-introduction of Na+-containing buffer. 
Blue, Vector; Brown, 326K; Black, 326E; Yellow, without Cassette II.  
n = 6 sets of transfections. 
 
The buffering capacities in the presence of CO2/HCO3
- in the four different plasmid-transfected 
A10 cells were not different (Vector 20.4 ± 1.6 mmol/L, 326K 21.5 ± 1.7 mmol/L, 326E 19.4 ± 1.8 
mmol/L, without Cassette II 22.9 ± 1.2 mmol/L; one-way ANOVA).  
 
The net Na+-dependent base uptake measured based on the 15 recorded seconds before and after 
re-introduction of sodium-containing solutions is elevated in A10 cells transfected with SLC4A7-
overexpressing plasmids as compared to vector plasmid (326K vs Vec +2.4 ± 1.1 mmol/L/min; 326E 
vs Vec 3.2 ± 1.2 mmol/L/min; w/o Cassette II vs Vec 3.0 ± 0.9 mmol/L/min), but with no difference 




Figure 126a). Like that of HUASMCs and HUVECs, initial rates of net base uptake were obtained at 
a large range of pHi values, which was also significantly different between the overexpression 
plasmids and vector ( 
Figure 126b). The analysis that accounted for net base uptake at regular pHi intervals also show a 
higher rate of net base uptake in Na+-containing buffer for the expression plasmids as compared to 





Figure 126: Net base uptake of transfected A10 cells in presence of CO2/HCO3
- and DMA 
(A) Net base uptake in the last 15 seconds in Na+-free buffer (+DMA) and the first 15 recorded 
seconds in Na+-containing PSS (+DMA), (B) pHi at point of assessing Na
+-dependent net base 
uptake, (C) net base uptake at regular pHi intervals, where groups were compared by linear 
regression. 
n=6 sets of parallel transfections.  
*P<0.05, **P<0.01 by repeated measures one-way ANOVA with Bonferroni correction. 
(C) P<0.05 by two-way ANOVA. 
 
In addition to the increased pHi recovery, A10 cells transfected with overexpression plasmids also 
have a higher plateau baseline after recovery from intracellular acidosis as compared to vector 
(326K vs Vec ΔpHi = 0.085 ± 0.016; 326E vs Vec ΔpHi = 0.087 ± 0.023; w/o Cassette II vs Vec ΔpHi = 






Figure 127: Final plateau pHi after recovery from intracellular acidosis 
n=6 sets of parallel transfections.  
**P<0.01 by repeated measures one-way ANOVA. 
 
In these studies with transfected A10 cells, the overexpression plasmids produced more NBCn1 
signal as compared to transfection with vector. There were no differences between the three 
overexpression plasmids ( 
Figure 128). Care should be taken with the numerical values of the y-axis, as there can be inter-
blot variability in signal (although all sets of transfections were assessed in one blot), and 




Figure 128: NBCn1 immunoblot signals in transfected A10 cells 




*P<0.05 by repeated measures one-way ANOVA. 
 
4.6.8. Na+/HCO3
--dependent, DMA-insensitive pHi recovery following ammonium chloride 
prepulse-induced intracellular acidosis – responses to FK506 in A10 overexpression 
models  
A10 cells transfected with the three overexpression plasmids (326K, 326E and splice variant 
without Cassette II) were assessed for their Na+/HCO3
--dependent, DMA-insensitive pHi recovery 
following ammonia-induced intracellular acidosis. Any potential difference in pHi recovery was not 
detected by repeated measures two-way ANOVA ( 
Figure 129). This was despite the apparent divergence of curves in cells transfected with 326K and 




Figure 129: Transfected A10 cells pHi recovery following intracellular acidosis, with CO2/HCO3
- and 
DMA ± FK506 
Blue denotes vehicle; brown denotes FK506. n=4 parallel transfections and paired experiments. 
Grey error bars denotes SEM. 
Groups compared by repeated measures two-way ANOVA over the 280 time points between 60 
seconds to 900 seconds after re-introduction of Na+-containing buffer, all P>0.05. 
 
Similar to HUASMCs, A10 cells treated with 10 μM FK506 did not reveal a statistically significant 




0.028, P=0.09), 326E-transfected (ΔpHi = -0.065 ± 0.028, P=0.06), splice variant-transfected (ΔpHi = 
-0.022 ± 0.023, P=0.38) cells ( 




Figure 130: Final plateau pHi after recovery from intracellular acidosis 
Blue denotes vehicle; brown denotes FK506.  
n=4 parallel transfections and paired experiments. 








5.1. SLC4A7 genotyping 
5.1.1. rs13082711, rs13096477 and rs3755652 genotype distribution in Hardy-Weinberg 
equilibrium 
The quality control parameters for the genotyping assay were adequate, with call rates and inter-
assay concordance of greater than 95%, as is the 100% concordance with the gold standard DNA 
sequencing (Section 4.1). 
 
The genotype distribution of the three SNPs is in Hardy-Weinberg equilibrium ( 
Table 27 and  
Table 28), which is consistent with public databases (Section 3.2). The absence of a deviation from 
Hardy-Weinberg equilibrium implies (although does not absolutely confirm) that there is no large 
selection effect of the genetic variation. As previously discussed, the genotype distribution is not 
expected to closely approximate that of public databases, as regional differences would be 
important, and particularly the local sample pool is more heterogeneous as compared to those 
databases. 
 
There were also no differences in the genotype, haplotype distribution and rate of incomplete 
datasets between HUASMCs and HUVECs ( 
Table 43) suggesting there were no systematic errors in genotyping across samples.   
 
5.1.2.  rs820430 genotype distribution in Hardy-Weinberg equilibrium 
Similar to the results in Section 5.1.1 above, the rs820430 genotyping assay demonstrated 
adequate quality control parameters, and the genotype distribution was in Hardy-Weinberg 
equilibrium ( 
Table 44). Although the genotype distribution is not expected to directly approximate to public 
databases, it does appear close to that of HapMap-CEU ( 
Table 29). 
 





5.2. Gene expression 
5.2.1. SLC4A7 (but not NEK10 and EOMES) mRNA detected in a selection of samples 
An expression panel with end-point RT-PCR identified SLC4A7 mRNA in all HUASMCs, HUVECs and 
renal biopsy samples selected (Figure 66). On the other hand, mRNA of the flanking genes (see 
Section 3.1), NEK10 and EOMES were not detected. This supports the hypothesis that SLC4A7 is 
the most likely gene, if any, that the genome-wide associated SNP rs13082711 has a functional 
impact on. This is compatible with publically available data, where the GTEx (Genotype-Tissue 
Expression project; http://www.gtexportal.org/home/) RNA-seq data demonstrates high transcript 
levels of SLC4A7, but low NEK10 and EOMES, in arteries. The results on renal samples are more 
difficult to interpret as the sample is from the renal cortex, whereas SLC4A7 is localized to the 
medulla. Nevertheless, the levels of NEK10 and EOMES in the renal cortex are still lower than 
SLC4A7 (Figure 55). 
 
Whilst it is unlikely that NEK10 or EOMES have an important role in blood pressure regulation 
through these tissues, a few caveats should be recalled: 
- End-point RT-PCR has lower sensitivity, and may not detect low copy numbers. It could also 
be argued, that very low copy numbers of cell-cycle regulators (NEK10) and transcription 
factors (EOMES) could still be physiologically relevant. 
- Blood pressure regulation occurs in concert with many different organs (see Section 1.8), and 
the absence of expression in vascular smooth muscle cells, endothelial cells and kidneys does 
not necessarily exclude a role in blood pressure regulation. 
- That from a generalisability viewpoint, HUASMCs and HUVECs are not derived from resistance 
vessels (see Section 2.1.1) and that the nephrectomy biopsies are sampled from cancerous 
kidneys, even if they are from the non-cancer pole. It could be argued that they are not 
representative samples of tissues regulating blood pressure. 
On balance, these are weak counter-arguments, and SLC4A7 remains as the best candidate at this 
genomic locus. 
 
A final theoretical point for consideration is that the blood pressure-associated SNP may actually 
have long-ranging effects, past the local region, or even trans-chromosomes. While theoretically 
possible, the results set out in this thesis where there is a genotypic effect on SLC4A7 gene 





5.2.2. Allelic imbalance analysis identifies the risk (minor) allele at rs13096477 as being more 
prevalent in mRNA  
The allelic imbalance in the cDNA chromatographs of rs13096477 heterozygotes (Figure 67) 
implies that there is more C (minor) allele mRNA as compared to the T (major) allele in HUASMC, 
HUVEC and nephrectomy biopsies. The method has the advantage that both alleles are exposed to 
the same cellular environment thus is unlikely to be due to an external factor. 
 
As the exonic SNP rs13096477 is in high LD with 92 other SNPs, it should be emphasized that it is 
not necessarily the causative polymorphism, and could have been a result of any other the other 
SNPs in high LD. 
 
In theory, the increased presence of the C allele mRNA could be due to either differences in mRNA 
transcription (i.e. increased C allele or decreased T allele transcription), or reduced mRNA turnover 
/ degradation (i.e. the converse, decreased C allele or increased T allele degradation). In the 
absence of a nonsense mutation or an SNP of interest in the 3’-UTR nor predicted to interact with 
miRNAs, the more likely explanation for the difference between the alleles is that of differential 
transcription rather than degradation.  
 
The consistency of effect across the three assessed sample types suggests that this is a common 
mechanism across multiple cell types. Also reassuringly, a combined analysis of the samples of all 
three cell types, the C allele appears to have 50% more transcript levels compared to T allele 
(n=27, P<0.0001). 
 
A limitation of the allelic imbalance analysis methodology is the inability to discriminate between 
isoforms. As the exonic rs13096477 is placed in exon 3, outside of Cassette II, the assay will detect 
the differences as a total of both long and short isoforms. With this, it is unable to determine 
whether if (or not) either isoform is dominant in its effect.  
 
5.2.3. qRT-PCR did not demonstrate an allele-dependent association with SLC4A7 mRNA/cDNA 
levels or splicing, but did demonstrate a large inter-sample variability 
Unlike allelic imbalance studies (Section 5.2.2), qRT-PCR did not demonstrate an allele-dependent 
association with SLC4A7 transcript levels (Figure 68). Whilst this could be true result, it should be 
recalled SLC4A7 is prone to up- and down-regulation (Section 1.12), dependent on pH, other 




cell states when using cell culture systems with supplemented culture media and not cell cycle-
synchronised before mRNA isolation. Additionally, although mRNA isolation was conducted at 
passage number 1 for each primary culture, the initial number of seeded cells may vary and thus 
the number of cell divisions to reach confluency and its phenotypic state may also be variable. 
 
However, the qRT-PCR studies indicate a smaller dCt (SLC4A7 – 18S) in HUVECs as compared to 
HUASMCs in paired samples ( 
Figure 69a). There are two main interpretations which will be considered in turn. Firstly, this may 
reflect that HUVECs have a higher SLC4A7 expression, which would also be consistent with 
measurements of NBCn1 function (Section 4.6.6). The alternative explanation is that the 
expression levels of 18S mRNA per cell is not equal between the two cell types, and therefore the 
dCt (SLC4A7 – 18S) would not be an appropriate housekeeping control across cell types. 
 
In addition to the potential increased SLC4A7 mRNA levels in HUVECs, there also appears to be a 
difference in relative proportions of long and short variants. HUASMCs had a higher proportion of 
long variants as compared to HUVECs ( 
Figure 69b). Although the Ct values of the short variant were consistently lower than those of the 
longer variant, this does not necessarily indicate there is more of the shorter variant mRNA 
present. As previously discussed, it may be differences in PCR efficiency, and in addition probes for 
the short variant can also detect that of the longer variant. More relevant to the study of the 
genetic polymorphism, there was no genetic effect of rs13082711 on splicing. 
 
Another striking result of the qRT-PCR results is the inter-sample variability ( 
Figure 70). The positively skewed distribution, particularly in HUASMCs, may imply that there is a 
baseline level of expression, but can be induced. Additionally, the smaller interquartile ranges of 
HUVECs may be related to the finding above that they have a larger overall transcript levels, 
perhaps already being in an induced state. It should be noted that this is unlikely to be related to 
intra-sample variability as an exclusion criteria for a successful assay includes any sample with 
replicates greater than 1 Ct apart is excluded, even for just one of the three (SLC4A7long, SLC4A7short 
and 18S) probes. 
 
Based on the population standard deviation, an expected difference between C/T and T/T 




by the allelic imbalance method, equating to a ddCt of 1.322) and a 1:2 ratio of genotype 
distribution, around 400 HUVECs and 1900 HUASMCs would be required to achieve a power of 
80% with an α-value of 0.05. As previously addressed, the caution for this power calculation is that 
it relies on a standard deviation value in the presence of a non-parametric distribution, together 
with the assumption of a 100% PCR efficiency. 
 
Nephrectomy biopsy samples were not assessed by qRT-PCR. This is owing to SLC4A7/NBCn1 
expression being localized to the mTAL, and non-selective biopsies will obtain highly heterogenous 
samples with varying proportions of mTAL. This will mean the main determinant of the quantity of 
SLC4A7 mRNA within a sample is the biopsy contents rather than any genotype influence. Once 
again, this highlights the advantage of allelic imbalance analyses over qRT-PCR. 
 
With all these caveats to qRT-PCR analysis, the allelic imbalance analysis would appear to be a 
better reflection of allele-dependent mRNA/cDNA levels. 
 
5.2.4. NBCn1 protein immunoblots identifies the risk (minor) allele as having a higher 
expression in total cell protein of HUASMCs but not HUVECs 
Consistent with the allelic imbalance analyses findings, the minor allele is dose-dependently 
associated with increased quantity of total cellular NBCn1 protein detected ( 
Figure 72). The two bands present on the immunoblot may potentially reflect the two main 
isoforms (predicted sizes 136kDa and 127kDa), with and without Cassette II. In the absence of an 
antibody raised against Cassette II, or utilising highly-specialised studies such as protein 
sequencing / mass spectrometry, it is not possible to be certain whether these reflect two 
different variants or differences in post-translational modification.  
 
Like the notable variability in the HUASMC SLC4A7 mRNA levels, there was also a corresponding 
large variability in the β-actin normalised immunoblot signals. Accepting the significant caveat of 
the lack of linearity at the extremes of signal detection, arithmetically there is up to 70-fold signal 
difference comparing the maximum and minimum signals. This was despite culturing in serum-free 
media after reaching confluency. This is consistent with the findings of a large range of mRNA 





The presence of increased total protein, does not imply functionality, and can theoretically 
potentially reflect sequestration in non-functioning regions of the cell. This will be explored later in 
Section 5.4. 
 
On the other hand, HUVEC samples did not show a genotype-dependent NBCn1 total protein 
expression ( 
Figure 73). It should be noted that the probability of a false negative appears low. Another notable 
difference is that immunoblots for HUVECs show much lower variability in NBCn1 expression 
levels, just over a 3.5-fold signal difference between the maximum and minimum signal intensities 
of the 14 sample panel, as compared to the HUASMCs. This is consistent with the lower variability 
in HUVEC SLC4A7 mRNA transcript levels.  
 
To explain the difference in the HUASMC and HUVEC results, it can be argued that the higher 
transcript levels of HUVECs may saturate the translation mechanism, and therefore eliminates any 
potential differences in total protein expression. The lower expression and increased variability in 
HUASMCs opens up the possibility of a larger impact of genotype on regulating gene expression 
and protein function. 
 
5.2.5. SLC4A7 E326K variation does not impact on isoelectric focusing 
In attempt to reduce the influence of cell culture conditions, isoelectric focusing was attempted 
under the initial prediction that the 326E and 326K variants based on the rs3755652 non-
synonymous polymorphism (Section 3.9). If the two variants produced separate signals, it would 
be possible to assess the impact of both alleles in the same intracellular environment in 
heterozygotes, in a manner like allelic imbalance analysis for RNA (Section 5.2.2).  
 
However, isoelectric focusing did not reveal any separation of the 326E or 326K variants (Figure 
74). This could be: 
 A true result in the E326K amino acid change does not influence the isoelectric point of 
NBCn1.  
 Alternatively, it should be recalled that the difference in predicted isoelectric point only 
applies to the full length protein that includes Cassette II. The splicing variant without 
Cassette II (amino acid 253-375, including E326K), would mean that the non-synonymous 




predominant isoform of NBCn1 in the samples assayed are that of the shorter variant, the 
results would be expected.  
As the antibody is raised against the C-terminus, the antibody itself is unable to differentiate 
between these isoforms.  
 
 
5.3. Molecular mechanisms underlying gene transcription 
Following the identification of a genotype-associated effect on SLC4A7 gene transcription in both 
assessed cell types, and the total cellular NBCn1 expression at least in HUASMCs (Section 5.2), the 
next set of experiments aimed to determine the underlying molecular genetic mechanisms driving 
these processes. 
 
5.3.1. Chromatin immunoprecipitation (ChIP) suggested an allele-dependent chromatin 
interaction at rs13096477 
There was no observed statistical significance in the allelic balance of chromatin 
immunoprecipitation outputs using anti-Pol II antibodies (Figure 75).  
 
There are two main potential explanations for the negative finding.  
- The main hypothesis is related to the striking difference in the allelic balance in chromatin-
associated DNA inputs (C:T ratio 0.15 ± 0.07), whereas it would have been expected to be 
closer to 1 in heterozygotes. In context of a marked allelic imbalance in the ChIP inputs, it 
would be difficult to identify any further imbalances related to the immunoprecipitation. 
However, this observed difference cannot be adequately interpreted without further 
experiments due to the chemistry of Sanger sequencing (see Section 2.6.1). With this, the 
study progressed to the formaldehyde-assisted isolation of regulatory elements (FAIRE) 
assays (Section 5.3.2). 
- The second explanation is based on the use of anti-Pol II antibodies. This methodology is 
dependent on active transcription at the ~400 bp sequence around rs13096477. Binding of 
transcription factors to DNA may not be consistent but may be transient. This transient 
nature may reduce the probability of capturing the interaction. 
It should also be considered that this may be a true negative result where there is no allelic-
dependence on binding of the transcription initiation complex. However, this conflicts with 




5.3.2. Formaldehyde-assisted isolation of regulatory elements (FAIRE) assays identified the 
protective (major / T) allele at rs13096477 as preferentially chromatin-bound in 
HUASMCs but not HUVECs 
FAIRE assays at rs13096477 identified the T (major) allele as being preferentially chromatin bound 
in HUASMCs (Figure 76). These results are consistent with those of the allelic imbalance between 
genomic DNA and cDNA (Section 4.2.2). In the previous study, the C (minor/risk) allele was 
associated with increased mRNA/cDNA levels. In turn, the T (major/protective) allele is associated 
with increased chromatin-binding, suggesting that at baseline, the transcription of SLC4A7 may be 
limited by the T allele and its interaction with nuclear proteins. However, it is not possible with 
FAIRE to determine the protein species that has caused the interaction. This could potentially be 
addressed by either EMSA (Section 5.3.3) or DNA pull-down assays (Section 5.3.4). 
 
Notably, the FAIRE result is also only positive in HUASMCs, but not HUVECs. The sample size for 
HUVEC studies should be sufficiently powered (98%) to detect a difference. The potential for this 
tissue-specific effect could be due to: 
 The potentially higher baseline expression with lower inter-sample variation in HUVECs 
(Section 5.2.3) suggests an overall higher probability being in an open chromatin 
conformation. As the allelic imbalance studies only detects a relative difference between 
the alleles, a near absence of rs13096477 in HUVEC closed chromatin would not show any 
differences in the alleles. This hypothesis is consistent with the EMSA results (Figure 80, 
middle panels), and further supported by the lower variability in the HUVEC chromatin 
sample C:T ratios (standard deviation 0.07) as compared to HUASMC chromatin sample 
C:T ratios (standard deviation 0.57).  
 Alternatively, the results for the HUASMC samples could be a false positive. Although this 
should always be considered, the consistency of positive results in the same allelic 
direction for HUASMCs, suggests that this is less likely. 
 
5.3.3. Electrophoretic mobility shift assays (EMSA) indicate allele-dependent in vitro nuclear 
protein binding at rs13096477, rs2371065 and rs13077400 
There was an early need to narrow down the number of SNPs to be investigated, as the study of 
the blood pressure associated SNP, together with all 92 SNPs in high LD is logistically near 
impossible, particularly this means assessing 186 different alleles. Furthermore, with multiple 
testing of 93 independent SNPs, the risk of a false positive is markedly increased (or the need to 





The prioritization of the 10 SNPs (Figure 77) to investigate was conducted in a stepwise manner. 
The first priority was the GWAS associated SNP followed by SNPs in the classical positions of TFBS 
with predicted differences in transcription factor binding ( 
Table 31). This is followed by prediction tools, with ENCODE and RegulomeDB. Of course, as 
indicated in Section 3.13, there are limitations to these prediction tools particularly with the 
paucity of input data, notably with 40% (37/93) of the SNPs of interest having no data within 
RegulomeDB. However, this is still the only information available to aid the decision. With that, the 
pragmatic view would be to accept these limitations, and accept that the true (if any) causative 
SNP(s) may lay outside of the 10 investigated SNPs.  
 
Of the 10 SNPs investigated in the panel (Figure 78), 3 SNPs (intronic SNP rs2371065, synonymous 
exonic SNPs rs13096477 and rs13077400) demonstrated electrophoretic mobility shifts, 
interacting with HUASMC nuclear extracts. Notably, in a paired study, nuclear extracts from 
HUVECs did not retard the electrophoretic mobilities of those oligonucleotides (Figure 79). This 
can be interpreted as consistent with the previous qRT-PCR results (Section 5.2.3). As SLC4A7 
mRNA appears to be more prevalent in HUVECs as compared to HUASMCs, this might suggest 
their respective nuclear extracts may have different levels of the proteins responsible for the DNA-
nuclear protein interaction. This interpretation should be taken with the caveats of being an in 
vitro experiment and does not account for potential epigenetic modifications. 
 
The three SNPs (rs2371065, rs13096477 and rs13077400) were further investigated to confirm 
allelic-dependent oligonucleotide-protein interactions (Figure 80). The result for rs13096477 
emphasises the consistency of results across methodologies where the protective major (T) allele 
preferentially binds nuclear extracts as compared to the risk (C) allele, just as demonstrated in the 
FAIRE studies (Section 4.3.2). 
 
Having identified a DNA-nuclear protein interaction, it would be interesting to identify the protein 
responsible for the observed shift. With this, competitor studies were performed. Unlabeled 
competitors designed to reflect the consensus binding sequences of transcription factors 
predicted to bind the sequence on and around rs2371065 (Table 46) suggested that PHOX2A, 
PLAGL1, TFAP2C and TRMT1 may be good candidates by significantly reducing the shifted signal 




against PHOX2A, PLAGL1 and TFAP2C. TRMT1 was not assessed as it functions primarily to bind 
tRNA. However, there were no supershifts noted in these experiments (Figure 82). This was 
confirmed by an absence of shift in the WEMSA (Figure 83). This failure to identify the responsible 
protein led to DNA pull-down assays (see Section 5.3.4).  
 
5.3.4. DNA pull-down showed in vitro nuclear protein interaction with sequence centered on 
rs2371065, but unable to reveal identity of protein 
A DNA pull-down assay with biotin-labelled double stranded oligonucleotides representing the 21 
bp sequence centered on rs2371065 was successful in obtaining two specific protein bands as 
identified by Ponceau S staining (Figure 85). The specificity of the bands is supported by their 
absence in the final wash and the negative control. The presence of two bands with the DNA pull-
down reflects the findings of two shifted bands in EMSAs (Figure 78). Just like EMSAs, the results 
have to be taken with the caveat that it is an in vitro system that may not always reflect an in vivo 
cellular environment. 
 
With this colloidal stain’s lower detection limit of 250 ng, the bands were of a sufficient quantity 
for commercial protein sequencing 
(http://www.altabioscience.com/media/repo/Protein_sequencing_Technical_Brochure.pdf). The 
commercial service (AltaBioscience, UK) was unable to return a protein sequence read, not even 
position 1. The most likely cause is N-terminal blockage, which is present in ~50% of eukaryotic 
proteins as a result of glycosylation or pyroglu-cyclisation. There is no method of determining this 
prior to sequencing. Other potential causes of altered protein structure during processing that 
impedes protein sequencing chemistry include processing at elevated pH (>9.0), inferior grade 
reagents and water, exposure to elevated temperatures if glutamine is the N-terminal residue, 
protease inhibitors interacting with terminal amino groups or the use of formic acid or urea; all of 
which were known to be present. 
 
Potential remedies include fragmenting the protein into smaller components, but this makes the 
interpretation of the sequence more difficult or requires HPLC (high-performance liquid 
chromatography) purification, which in turn increases the initial protein yield required. 
Acidification of the protein sample may (but rarely) remove the blockage. However, it should be 




vivo biology. As these potential remedies are logistically complicated, expensive and still unlikely 
to yield useful results, DNA pull-down was not further pursued.  
5.4. Impact of non-synonymous SNP on protein behavior and function 
Although Section 5.3 has already discussed the impact of SLC4A7 genotype on gene expression, it 
should be recalled that the GWAS lead SNP rs13082711 is in high LD with a non-synonymous SNP 
(rs3755652). This section explores the potential impact of the E326K (glutamic acid to lysine at 
position 326) amino acid change.   
 
5.4.1. Calcineurin A did not co-immunoprecipitate with NBCn1 in HUASMCs 
There has been previously reported interactions between NBCn1 and calcineurin A in mice 
(Danielsen et al., 2013) and experimental in vitro models (Gill et al., 2014), but not yet with human 
NBCn1. There is also an increasing body of evidence, albeit again in animal models, that those co-
transporters that regulate pHi can be modulated by kinases and phosphatases ( 
Table 2). Coupled with the presence of postulated calcineurin binding sites close to the E326K 
amino acid change (Danielsen et al., 2013), it was important to consider whether there is an 
interaction between calcineurin A and NBCn1. Co-immunoprecipitation would show only a 
temporal and spatial physical relationship, whereas a physiological relationship, as assayed by 
pharmacological inhibition will be examined later (Section 5.6.2). 
 
There was an absence of co-immunoprecipitation of NBCn1 and calcineurin A together in 
transfected A10 cells as well as HUAMSC primary cultures (Figure 87). This was initially surprising 
as application of the same protocol for murine NBCn1 as conducted by Danielsen et al (2013) 
yielded positive results. However, there are several potential explanations for this: 
 This could be a true negative result.  
o The lack of consistency with other studies could potentially be explained by the 
difference in human and mouse NBCn1 amino acid sequences (Figure 5). It may well 
be that the relevance of calcineurin is lower in human NBCn1 than murine NBCn1. 
o Another explanation that accepts the lack of interaction as a true negative relates to 
the in vitro nature of this study. Positive co-immunoprecipitation in murine arteries 
(Danielsen et al., 2013) was performed in freshly dissected vessels, and under 
conditions that elevated intracellular calcium concentrations. An in vitro primary cell 




the finding that different cell culture surfaces significantly impacted on NBCn1 co-
transport activity (Figure 51). 
o Alternatively, this result could relate to the cell type used. HUASMCs, being from 
embryonic, conduit arteries that carry deoxygenated blood, do not reflect the adult 
resistance arteries, as previously expanded when discussing the limitations of the cell 
type in Section 2.1.1. Additionally, it may be possible that the combination of the 
transfected human NBCn1 and the endogenous murine (A10 cells) calcineurin does 
not interact across species. 
 In view of the absence of a positive co-immunoprecipitation, this could be a false negative 
result. 
o It could be that the interaction between calcineurin A and NBCn1 is transient, and 
therefore it would be difficult to capture the interaction. 
o On a similar note, the detection limit of protein immunoblots may not be sensitive 
enough to detect low levels of co-immunoprecipitation. Theoretically, a higher 
sensitivity detection system such as ELISA (enzyme-linked immunosorbent assay), 
HPLC (high-performance liquid chromatography) or mass spectrometry may be an 
alternative assay. 
o There is still a possibility that the co-immunoprecipitation conditions that were 
successful for murine NBCn1 are not optimized for human NBCn1.  
 
This system was interrogated again in a cell physiology setting with tacrolimus, a calcineurin 
inhibitor, and its impact on NBCn1 Na+/HCO3
- transport function (Section 5.6.2). 
 
5.4.2. Immunocytochemistry revealed NBCn1 position both on the nuclear membrane, and also 
intracellularly 
Immunocytochemistry studies of HUVECs and HUASMCs were stained for NBCn1. This was 
conducted together with VE-cadherin as a membrane marker for HUVECs, but as a preliminary 
study, a membrane marker such as N-cadherin for HUASMCs was not used. The 
immunocytochemistry on HUVECs demonstrates a significant proportion of NBCn1 signal that does 
not appear to be membrane-bound (Figure 45, Figure 88 and Figure 89). Based on appearance, 
this may be representative of Golgi or endoplasmic reticulum, but cannot be determined without 




(1) in vitro preparations, (2) embryonic conduit vessels and (3) the importance of cell culture 
surfaces should also be considered in the context of these “negative” results.  
 
The appearance of NBCn1 intracellularly may initially appear counterintuitive, but reflects previous 
literature where it is detected both along the plasma membrane, as well as intracellularly, even if 
not clearly localised to any particular organelle (Lauritzen et al., 2010; Namkoong et al., 2015).  
 
Although there are well recognised methods of quantifying membrane vs. non-membrane 
proteins (such as in Figure 88), there is the possibility of bias. In the absence of a categorical 
(yes/no) difference between the genotypes, any difference would be on a continuous scale. This 
means selection of cells to analyze (out of tens of thousands on a slide) and the direction of the 
slice (infinite possibilities) are subject to selection bias. With the difficulties in quantification, the 
attempt to determine differences in cellular localization, in particular the proportion of NBCn1 
that appears membrane-bound, prompted the use of subcellular fractionation by differential 
centrifugation method (Section 5.4.3). 
 
5.4.3. Subcellular protein fractionation identified protein variant (326E) associated with the 
protective (major / T) allele at rs13096477 as preferentially abundant in the membrane 
fraction 
To reduce the impact of inter-experiment variation, immunoblots were run in pairs (Lys/Glu, G/A 
at rs3755652 and Glu/Glu, A/A at rs3755652), and if possible as two pairs on one blot. Due to the 
limited number of rare homozygotes (Lys/Lys, G/G at rs3755652), they were not used for this set 
of studies. The cadherins (N- and VE-) were used as a loading control as their relative expressions 
should reflect the quantity of membrane proteins loaded. Of note, there was no difference in total 
cellular expression of VE-cadherin comparing 7 G/A and 7 A/A HUVEC samples (normalized ratio 
G/A 0.97 ± 0.08, A/A 1.03 ± 0.05; P>0.05), supporting its suitability as a loading control.  
 
Heterozygotes HUASMCs and HUVECs carrying the risk variant (Lys/Gly) had a higher NBCn1 signal 
in the “membrane” fraction as compared to the homozygotes for the protective variant (Gly/Gly) 
(Figure 90). This was despite a similar NBCn1 signal in the “organelle” fraction. The statistically 
significant difference remains even when taking a ratio of “membrane”:”organelle” fractions. 
These results are consistent with the hypothesis that the risk allele, has a higher level of NBCn1 






It is interesting to note that HUVECs have a higher expression of NBCn1 in the “membrane 
fraction” for this set of studies, but not as previously detected on a panel of total cellular protein ( 
Figure 73). This perhaps relates to the relative presence of NBCn1 in each compartment. 
Anecdotally, a confluent 25 cm2 cell culture flask provides on average 5 ng of “membrane fraction” 
proteins, 20 ng “organelle fraction” proteins and 200 ng “cytosolic fraction” proteins. As 2 ng is 
loaded for immunoblots of each fraction, this accounts for 40%, 10% and 1% of the fractions 
respectively. Considering this complexity, it would be safe to conclude that the cells carrying the 
risk allele has more abundance of NBCn1 at the cell membrane, but not enough evidence to 
suggest that it affects trafficking to the cell membrane. If there is a subtle effect on trafficking to 
be detected, perhaps protein quantification using membrane biotinylation would be the next step 
to pursue. However, as the probability that NBCn1 trafficking is the mechanism whereby the 
GWAS-associated polymorphism exerts its effect appears low, it has not been prioritized. 
 
5.4.4. Transfection of overexpression plasmids suggests that the E326K NBCn1 variation is 
unlikely to impact on NBCn1 degradation 
In SLC4A7 overexpression studies in A10 mouse aortic smooth muscle cells, there was a consistent 
increase in total cellular NBCn1 expression of either 326E or 326K variants when compared with 
control vector, but with no difference between the two variants (Figure 91). This suggests that 
over the 48 hour period, there is no difference in protein production or degradation.  
 
This provides some evidence that the E326K amino acid change may not play a role in total cellular 
protein levels. However, it should be emphasized that experimental confirmation of equal mRNA 
translation and protein degradation of the two variants would require further investigation with 




5.5. Impact of SLC4A7 genotype on inducibility 
Consistent with the findings in other acid-base regulators, such as NHE1 and NHE3 (see Section 
1.12), angiotensin II induced NCBn1 expression in vascular smooth muscle (Figure 92a). This also 




vitro. Of note, the concentration of 10-8 M used was at a physiologically relevant level (Bergeron et 
al., 2001).  
 
The allelic imbalance method was used due to the previously discussed marked inter-sample 
variability in HUASMCs (Section 5.2.3), which showed an allele-dependent effect of AngII-related 
upregulation. The allelic imbalance observed at baseline returns to parity upon induction (Figure 
92b). This suggests that the C (minor) allele being more transcribed at baseline, indicating 
constitutive transcription, whereas expression of the T (major) allele may be inhibited at rest, but 
could be induced upon stimulation. This interpretation can also be consistent with the findings of 




5.6. Impact of SLC4A7 genotype on cell function 
5.6.1. Collagen gel contractility assays – lacks the rapid response required and is unable to 
withstand the necessary pH range 
The initial optimization of the collagen gel contractility was successful, with the cell density and 
time course ( 
Figure 94), replicability (Figure 95), inter-assay (Figure 95), intra-observer (Figure 96) and inter-
observer (Figure 97) variability established for primary HUASMC contractility gels. 
 
However, three main issues have limited the utility of this assay as an indicator of vascular smooth 
muscle cell function in terms of contractility, which would have relevance to blood pressure 
regulation. The time course to achieve maximal contraction in such as set up is near 72 hours ( 
Figure 94), which is not reflective of the rapid recovery of intracellular acidosis by NCBn1 (in 
magnitudes of minutes, see Figure 2) and other acid-base regulating transporters and channels. 
This delayed contraction is likely to mask any effect of genotype on pHi and vascular smooth 
muscle contractility. 
 
A separate concern is that the collagen gel is not resistant to lower pH values. In the methodology, 
the gel polymerises at a pH higher than 8.0 (see Section 2.17.1), and conversely, acidification is the 
common method of dissolving collagen from rat tails (Rajan et al., 2006). This is reflected by fact 




was difficult to quantify, and more importantly unable to guarantee a connective tissue matrix for 
the vascular smooth muscles to anchor and produce a quantifiable contraction of the gel. 
 
The final caveat, as previously expressed for HUASMCs, is that there is significant inter-sample 
variability in terms of NBCn1 expression, perhaps reflecting state in cell cycle or cellular phenotype 
of each studies sample. This would markedly increase the overall numbers that are required to 
detect potential genotype-associated differences. 
 
With these three concerns, it appears that collagen gel contractility assays may not provide the 
quality of evidence required to identify any differences in cell function based on SLC4A7 genotype. 
In the subsequent studies, cellular function was predominantly assessed with pHi recovery 




--dependent DMA-insensitive pHi recovery from intracellular acidosis 
Thus far, the data presented shows the SLC4A7 genotype at rs13082711 impacting on gene 
expression, where the risk allele is associated with increased NBCn1 expression in terms of mRNA 
and protein, and subsequently availability at the plasma membrane. This section aims to explore 
whether this translates to differences in protein function in terms of Na+/HCO3
--dependent, DMA-
insensitive pHi recovery following ammonium-induced intracellular acidosis. This would reveal NBC 
activity, although it should be recognised that it would not differentiate between NBCn1 and 
NBCe1 or even other sodium-bicarbonate co-transporters. Overall, there is a consistent trend 
where the risk allele, associated with higher NBCn1 expression, demonstrates increased protein 
activity as defined by Na+/HCO3
--dependent, DMA-insensitive net base uptake and final plateau 
pHi. This appears to be independent of the co-inherited non-synonymous polymorphism 
rs3755652 and the subsequent E326K amino acid change. The differing strengths of evidence may 
be dependent on relative protein expression levels of the three investigated cell lines. 
 
HUASMCs - The protective (major / T) allele at rs13096477 is associated with greater Na+/HCO3
--
dependent, DMA-insensitive net base uptake and resting pHi  
Based purely on the Na+/HCO3
--dependent, DMA-insensitive pHi recovery curves (Figure 100) and 
initial net base uptake (Figure 102), there was no statistically significant differences between the 




became apparent that there was significant inter-sample variability, which led to a large range of 
pHi start points from which recovery was measured (Figure 103). This is a potential confounder as 
net base uptake is pHi-dependent. When taking this into account, it showed that rs13082711 
genotype was likely to be associated with NBC activity, where the higher-expressing risk allele is 
associated with a steeper slope when plotting net base uptake against each pHi (Figure 104b), 
although they were not statistically different at each pHi, and final resting pHi (Figure 105). 
 
Serum-starvation of 48 hours, intending to reflect the expression levels of quiescent cells resulted 
in lower protein expression (Figure 131, P=0.15, n=16 pairs). As hypothesised, this also reduced 
the variability potentially introduced by having cells in different phases of the cell cycle. With the 
lower expression levels, this reduced Na+/HCO3
--dependent, DMA-insensitive pHi recovery curves 
(Figure 101a), although once again, no statistically difference at each pHi,  and final resting pHi 
(Figure 105). In this context of quiescent HUASMCs, the genotypic effect of rs13082711 persists, 
where the higher-expressing risk allele continues to be associated a steeper Na+/HCO3
--dependent, 




Figure 131: NBCn1 protein expression in serum-treated and -starved HUASMC samples undergoing 
pHi studies 






Following completion of the studies, it became apparent that the HUASMCs could be classified 
into two different morphological categories (Figure 108). In a post-hoc analysis, it was seen that 
the confluent subgroup was associated with higher NHE and NBC activity. As the confluent 
subgroup is more likely to be reflective of healthier and more proliferative cells, with a 
morphology that appears more “contractile”, this subgroup was further assessed. The rs13082711 
genotype-associated differences in Na+/HCO3
--dependent, DMA-insensitive net base uptake and 
final resting pHi ( 
Figure 110) was even greater in this subgroup. However, it is interesting that despite the 
differences in Na+/HCO3
--dependent, DMA-insensitive net base uptake, there does not appear to 
be an influence of the morphological groups on total cellular NBCn1 protein expression by 




Figure 132: NBCn1 protein expression in serum-treated and -starved HUASMC samples undergoing 
pHi studies 
Confluent, n=12; non-confluent n=5; confluent subgroup rs13082711 genotype C/T, n=5; T/T, n=7. 
Paired samples for serum-treated and -starved.  
**P<0.05 
 
It is worth noting that although SLC4A7 genotype and its associated variation on expression levels 
may influence Na+/HCO3




does not have an impact on the cell’s buffering capacities. This is not unexpected, as buffering 
capacities were not different between SLC4A7 knockout mice lacking NBCn1 as compared to 
wildtype controls; both in the presence and absence of CO2/HCO3
- (Boedtkjer et al., 2011). Thus, 
the genotypic effect on NBC activity is not related to changes in buffering capacity. 
HUASMCs – calcineurin inhibition (by FK506) did not alter net base uptake, whereas intracellular 
calcium chelation (by BAPTA-AM) decreased net base uptake and and resting pHi, but was not 
dependent on rs13096477 genotype 
As previously discussed in Section 1.9, there has been reported physical interaction between 
calcineurin A together with Cassette II of NBCn1 (Danielsent et al., 2013; Gill et al., 2014). In turn, 
calcineurin inhibitors were able to attenuate the expected activity of NBCn1 in rat mesenteric 
arteries, after either depolarization or norepinephrine-induced contractions (Danielsen et al., 
2013). The hypothesis that calcineurin, and intracellular Ca2+, may have a role in NBCn1 function of 
HUASMCs and HUVECs was also tested here. In 12 matched experiments (rs13082711 genotype: 
C/T n=4, T/T n=8), cells from four concurrent cultures of the same cell lineage were assessed for 
Na+/HCO3
--dependent, DMA-insensitive pHi recovery following ammonium chloride prepulse-
induced intracellular acidosis while being exposed to (A) DMSO vehicle, (B) 10 µM FK506, (C) 30 
µM BAPTA-AM loading, or (D) both FK506 and BAPTA-AM. 
 
Na+/HCO3
--dependent, DMA-insensitive pHi recovery and net base uptake was not changed in the 
presence of 10 µM FK506 ( 
Figure 111b and Figure 112). Considering how the “vehicle” and “FK” curves practically overlap, 
the lack of a difference detected is unlikely to be a false negative. This is also true when stratified 
into SLC4A7 genotype subgroups (Figure 114). Potential reasons for a lack of an effect could be 
that: 
1. Calcineurin and NBC proteins can interact, but the 10 µM exposure of FK506 is too low. 
Differing cell preparations (ex vivo vessels vs. in vitro cell culture) can feasibly have differing 
IC50s, but this is perhaps a less likely explanation. However, it would be typical to expect 
higher sensitivities in cell cultures as compared to intact vessels due to difficulties in 
penetrating the layers of intact vessels, combined with potential local degradation. If there 
were more opportunities, perhaps a dose-range study could be conducted, but however this 
will massively expand the workload for unlikely gain.  
2. Calcineurin and NBC proteins can interact, but calcineurin has already exerted its phosphatase 




dephosphorylated state, where inhibition of calcineurin A phosphatase activity does not 
change the phosphorylation status. It is for instance possible that the culture conditions alter 
the expression or activity of counteracting kinases and therefore changes the phosphorylation 
state even under resting conditions. 
3. Calcineurin and NBC proteins can interact, but the intracellular conditions (e.g. intracellular 
Ca2+) may be insufficient to appropriately activate calcineurin A. It is worth recollecting the 
study by Danielsen et al. (2013) assessed the impact of FK506 in a high-K+-depolarized state 
which activates Ca2+ influx via voltage-gated Ca2+-channels. If there were more opportunities, 
the cells could be exposed to an initial high-K+ environment. However with a preliminary study 
of n=4 pairs, exposure to a 60 mM K+ (replacing Na+) throughout the study did not notably 
alter the pHi recovery of HUASMCs after ammonium-prepulse washout. 
 
This study is unable to differentiate between the three hypotheses above, and any of the three 
may be potential explanations, either on their own or in combination. Nonetheless, our data show 
that NBCn1 activity is possibly increased in VSMCs carrying the BP risk allele also after inhibition of 
calcineurin activity (Figure 133). 
 
Figure 133: HUASMC pHi recovery following intracellular acidosis, with CO2/HCO3
-, and in the 
presence of DMA and FK506 
rs13082711 genotypes: C/T (yellow, n=4) and T/T (green, n=7). Grey error bars denotes SEM. 
Groups in (A) compared by repeated measures two-way ANOVA over the 280 time points between 
60 seconds to 900 seconds after re-introduction of Na+-containing buffer.  Groups in (B) compared 
by linear regression.  
 
The impact of intracellular Ca2+ chelation was however much clearer. 30 µM BAPTA-AM loading for 
20 minutes significantly reduced Na+/HCO3
--dependent, DMA-insensitive pHi recovery and net 




Figure 111d and Figure 112). The BAPTA-AM-attenuated NBC activity in HUASMCs reflects the 
findings in rat mesenteric arteries where the depolarisation (50 mM KCl)-stimulated NBC activity 
was greatly attenuated by BAPTA-AM (Danielsen et al., 2013). It should be noted that the Ca2+ 
chelation was deemed to be successful with this specific concentration and duration of initial 
loading, based on the marked attenuation of the Ca2+-spike of intracellular acidosis following 
washout of ammonium (Figure 49). In the context of markedly reduced Na+/HCO3
--dependent, 
DMA-insensitive pHi recovery, it is unsurprising that 30 µM BAPTA-AM also decreased final resting 
pHi (Figure 113a). However, this is in the absence of a significant change in buffering capacity 
(Vehicle 16.7 ± 1.0 mmol/L, BAPTA 15.7 ± 1.0 mmol/L, difference 1.0 ± 1.3 mmol/L, n = 12 pairs). 
 
While these results may support the hypothesis that Na+/HCO3
--dependent, DMA-insensitive pHi 
recovery was reduced by directly influencing Ca2+-dependent signaling pathways, it was apparent 
that the morphology of the HUASMCs changes in a manner that is not noted with the vehicle 
control. Over the course of the 45 minute recordings, the cells begin to detach from the cell 
culture surface and appear to shorten, particularly after the washout of ammonium. Therefore, 
the change in Na+/HCO3
--dependent, DMA-insensitive pHi recovery is likely to be relating to a 
change in overall cellular phenotype.  
 
HUVECs - The protective (major / T) allele at rs13096477 is associated with greater Na+/HCO3
--
dependent, DMA-insensitive net base uptake  
The findings from the studies on HUVECs and their Na+/HCO3
--dependent, DMA-insensitive 
recovery from intracellular acidosis largely reflects the observations made with HUASMCs, which 
provides reassuring consistency. 
 
As with HUASMCs, based purely on the Na+/HCO3
--dependent, DMA-insensitive pHi recovery 
curves (Figure 115b), there were no statistically significant differences between the two 
genotypes. However, there is a divergence in the curves that merited further analysis. Despite the 
large inter-sample variability in pHi at the first recording when Na
+-containing buffer is 
reintroduced, there is an increased Na+/HCO3
--dependent, DMA-insensitive net base uptake 
carried by the risk allele (Figure 116). This is reiterated by showing that rs13082711 genotype was 
associated with NBC activity, where the risk allele is associated with stonger relationship between 
Na+/HCO3





Figure 119, albeit non-statistically significant P=0.10). The consistency of direction and magnitude 
of effect on final resting pHi opens up the possibility of a false negative. Despite the same 
magnitude of difference and similar sample numbers, the larger standard deviation from the 
HUVEC samples as compared to HUASMCs (Figure 124,  
Table 48), results in the study having only a statistical power of 58%, and the needs n=30 for each 
genotype to reach a power of 80%. 
 
As with HUASMCs, SLC4A7 genotype did not influence the cell’s buffering capacities, both in the 
presence and absence of CO2/HCO3
-, which is unsurprising given the knowledge gained from the 
aforementioned knockout mouse model (Boedtkjer et al., 2011). Thus, the genotypic effect on 
NBC activity is not related to changes in buffering capacity. 
 
Unlike HUASMCs, the assessment of HUVECs in the thesis did not include serum-starved cells, 
stratification by cellular morphology or use of calcineurin inhibition. This is due to HUVECs: 
- not tolerating serum-starvation for any significant duration of time (Figure 93), 
- not revealing any notable difference in morphology, and 
- not regarded as having a large contribution of calcineurin signaling to its cellular function. 
 
HUASMCs vs HUVECs - HUASMCs have a comparable contribution from NBCs and NHEs to pHi 
recovery from intracellular acidosis, but HUVECs with a much faster recovery has a dominant 
NHE activity 
As mentioned in Sections 1.3 to 1.8, NBCn1 is widely expressed in a range of tissues. The work for 
this thesis has predominantly explored vascular smooth muscle cells and endothelial cells. As there 
appears to be opposing effects of these cell types on blood pressure as demonstrated by the 
SLC4A7 knockout mouse (Boedtkjer et al., 2011), this section attempts to highlight the similarities 
and differences between the two cell types. 
 
From Figure 122, it is apparent that HUVECs have a faster recovery from intracellular acidosis as 
compared to HUASMCs. This is in addition to a higher final plateau pHi (Figure 124). The absence 
of a statistically significant difference in the final plateau pHi of the two cell types in CO2/HCO3
--
buffer with DMA treatment (predominantly isolating the NBC component) is likely to be due to an 
underpowered sample size (power 26%, requiring a n=89 each group sample size to reach a power 




larger than that of HUASMCs. This may reflect the activity of Na+-independent pHi regulators such 
as monocarboxylate/H+ co-transporter or H+-ATPase, but was not within the scope for this thesis.  
 
Taken together, this indicates that HUVECs have higher overall ability to recover from intracellular 
acidosis (Figure 122a), which comprises mainly of higher activity for both NBCs (Figure 122b) and 
NHEs (Figure 122c). In the absence of CO2/HCO3
- (inhibiting NBCs) and the presence of DMA 
(inhibiting NHEs), the pHi recovery was slow and similar in the two cell types, suggesting that non-




Figure 134: pHi recovery rates of HUASMCs and HUVECs in different conditions 
Each data point reflects one of the 290 timepoints, plotted for the average pHi and recovery rate.  






Although not easily quantifiable, it appears that the relative contributions of NHE and NBC may be 
closer to each other in HUASMCs as compared to HUVECs, especially in the pHi ranges from around 
6.7 upwards ( 
Figure 134). Also of note, there is less variability in the HUASMCs as compared to HUVECs in three 
key Na+/HCO3
--dependent, DMA-insensitive characteristics assessed ( 
Table 48). Taken in combination, the higher overall contribution and lower population variability 
may mean that any genotypic differences in NBCn1 activity in HUASMCs could play a larger role in 
the overall pHi regulation as compared to HUVECs.  
 
These results should be taken in relation to expression of other pHi regulators (Figure 135). This 
end-point RT-PCR panel of HUASMC and HUVEC samples paired from the same donor, shows 
inter-sample variability is present not just for SLC4A7 short and long isoforms (confirming the 
previous qRT-PCR and immunoblot results), but also SLC4A4 (NBCe1) and SLC9A1 (NHE1). 
Accepting that this is not qRT-PCR or immunoblot results, it is apparent that in these paired 
samples the overall signal for SLC4A7 and SLC9A1 is stronger in HUVECs compared to HUASMCs. 




Figure 135: End-point RT-PCR of selected pHi regulators 
End-point RT-PCR (10 ng of reverse transcribed RNA) for the long and short variants of SLC4A7, 
together with other pHi regulators SLC4A4 (NBCe1) and SLC9A1 (NHE1). β-actin included as positive 
control. 0.1 ng of plasmids for the full length and variant without Cassette II was also underwent 





It is worth recollecting the Na+/HCO3
--dependent, DMA-insensitive pHi recovery and baseline 
would be composed of the actions of all NBCs (with likely minor contribution from non-NHE co-
transporters), that also includes SLC4A4/NBCe1. Notably, NBCn1 KO appears to abolish all 
Na+/HCO3
- co-transport. Additionally, despite the observation of mRNA expression of multiple 
SLC4-family Na+/HCO3
- co-transporters has also been identified in mouse carotid arteries, NBCn1 
has been found to functionally dominate net acid extrusion ex vivo (Boedtkjer et al., 2016). 
However, after culture by explants, there is a remaining 40% NBC-activity in NBCn1 KO cells, 
suggesting that other NBCs may play a functional role in cell culture conditions (Boedtkjer, 
unpublished data). This means that the genotype-effect on HUASMC Na+/HCO3
--dependent, DMA-
insensitive net base uptake and end pHi is potentially to be in addition to baseline NBCe1 
contribution. There is currently no small molecule pharmacological inhibition of the different NBC 
isoforms available. 
 
A10 mouse aortic smooth muscle cells - SLC4A7 overexpression increased Na+/HCO3
--dependent, 
DMA-insensitive net base uptake, but is not related to the E326K variation or the 
presence/absence of Cassette II  
Overexpression models were used to test two main research questions – (1) whether increased 
SLC4A7/NBCn1 expression affects Na+/HCO3
--dependent, DMA-insensitive baseline pHi and 
recovery from intracellular acidosis, and (2) whether the non-synonymous polymorphism and the 
subsequent E326K amino acid change or the splice variant alters NBCn1 function, which is difficult 
to assess in the primary cell lines as there is a genotype-associated difference in gene expression. 
In summary, there is an effect of expression on Na+/HCO3
--dependent, DMA-insensitive baseline 
pHi and recovery, but independent of the E326K or splice variations.  
 
From  
Figure 125, there is a clear difference between the overexpression plasmids (326E, 326K and w/o 
Cassette II) and vector, although there is no statistically significant difference between the three 
overexpression plasmids. This is further supported by assessing the net base uptake, both at the 
initial phase, or at fixed pHi intervals ( 
Figure 126). In concordance with the increased Na+/HCO3
--dependent, DMA-insensitive base 
uptake in the three overexpression plasmids, there is also an associate increased in baseline pHi 
(Figure 127). The resting pHi for the short splice variant is difficult to interpret. It occupies an 




each other. However, when considering additional SLC4A7 transfection studies in the next section 
(total n=10 sets of parallel transfections), there is no difference between the three overexpression 
plasmids (end pHi: 326K 7.247 ± 0.020, 326E 7.252 ± 0.016, w/o Cassette II 7.227 ± 0.015). 
 
As with the primary cell line studies, NBCn1 expression levels and E326K variation did not 
influence buffering capacities. 
 
Throughout these overexpression studies, all three plasmids showed similar levels of 
overexpression on immunoblot signals ( 
Figure 128). Additionally, there appears to be equal efficiency in uptake of plasmids, or at least as 
identified by qRT-PCR (Figure 42). This suggests findings that the three variants are similar to each 
other in Na+/HCO3
--dependent, DMA-insensitive net base uptake and resting pHi are true 
negatives, and not confounded by differences in expression levels. However, a caveat to consider 
is the possibility of overexpression studies saturating the system, which disguises any potential 
subtle differences between the variants. 
 
A10 mouse aortic smooth muscle cells - Calcineurin inhibition (by FK506) did not alter net base 
uptake in SLC4A7 overexpressed cells, regardless of E326K variation or the presence/absence of 
Cassette II  
Similar to that of the findings with HUASMC primary cultures, Na+/HCO3
--dependent, DMA-
insensitive pHi recovery and net base uptake was not changed in the presence of 10 µM FK506 ( 
Figure 129). Potential reasons for a lack of an effect are similar to that explored earlier in this 
section, with the additional factor that in this setting it relies on interaction between human 
NBCn1 and rat calcineurin A. A potential method of overcoming this is to co-transfect another 
plasmid that overexpresses human calcineurin A, but this is likely to introduce even more noise in 
to the system, and makes detecting a signal even more difficult. 
 
When assessing the final plateau pHi, it is interesting to note that there is an overall pattern (by 
repeated-measures ANOVA) where calcineurin inhibition lowers plateau pHi in both variants with 
Cassette II but not with the plasmid that lacks Cassette II. It would be tempting to suggest that this 
supports the hypothesis of calcineurin A interacting with Cassette II. However, the main caveats to 
this are that the individual paired comparisons between “Vehicle” and “FK506” do not reach 




as with the HUASMC studies, when considering the reduction of pHi from the start of the 
experiment, to the end following introduction of DMA and FK506, the differences between the 
treatment groups is less apparent. With this, it is likely that there is no true effect of calcineurin 
inhibition in this experimental model. 
 
Does the use of DMA to inhibit NHEs produce an artificial result? 
When considering overall (NBC and NHE) pHi recovery from acidosis, the protective (major / T) 
allele at rs13096477 is associated with greater net base uptake and resting pHi only in HUASMCs, 
but not HUVECs 
These studies exploring NBC activity utilises 10 μM DMA to inhibit NHE transporters, with the aim 
to leave NBCs as the major pHi regulator of the cells assessed. This provides an appropriate 
experimental protocol to assess the specific effect of SLC4A7 genotype on NBC function, but 
however, does not provide a true representation of in vivo pHi regulation. This is particularly as 
NHE function appears to dominate in HUVECs but not as much in HAUSMCs ( 
Figure 134). This opens up the possibility that variations in NBC activity may have a relevant 
impact on overall pHi regulation for HAUSMCs, but not HUVECs. This is particularly relevant as the 
SLC4A7 knockout mouse model demonstrates an increased HCO3
--independent, amiloride-
sensitive (NHE) base uptake, suggesting some degree of compensatory effect between the 
different pHi regulators. With this, it is worth revisiting studies conducted without NHE inhibition 
(HUASMCs, Figure 100a; HUVECs, Figure 115a). 
 
With HUASMCs (Figure 100a), there is a pHi recovery curve that appears to diverge with 
rs13082711 heterozygotes (C/T) recovering faster than common homozygotes (T/T), even in the 
presence of uninhibited NHE. This is better represented when considering the net base uptake at 
regular pHi intervals ( 
Figure 136). When grouping by cell morphology, as previously discussed, there is a marked 
difference in pHi recovery ( 
Figure 136a). In both subgroups, the genotypic effect on HUASMC NBCn1 activity does not appear 







Figure 136: HUASMC pHi recovery following intracellular acidosis, in the presence of CO2/HCO3
-  
Confluent subgroup (orange, n=12) and non-confluent subgroup (grey, n=7) (A-C).  
rs13082711 genotypes in confluent subgroup: C/T (yellow, n=5) and T/T (green, n=7) (D-F).  
rs13082711 genotypes in non-confluent subgroup: C/T (yellow, n=4) and T/T (green, n=3) (G-I). 
Grey error bars denote SEM. 
Groups in (A, D and G) compared by repeated measures two-way ANOVA over the 280 time points 
between 60 seconds to 900 seconds after re-introduction of Na+-containing buffer. Groups in (B, E 
and H) compared by linear regression. Groups in (C, F and I) compared by Mann-Whitney U-test. 
 
The genotype effect on final plateau pHi is also observed in the confluent subgroup (Figure 137), 
although the non-confluent subgroup was underpowered to detect the difference. The difference 
in pHi plateau after recovery from intracellular acidosis in the presence of CO2/HCO3
- and absence 




DMA (Figure 136), potentially suggesting that NHEs may have only a relatively low, if at all, 
contribution to the difference. 
 
Figure 137: Final plateau pHi after recovery from intracellular acidosis 
Confluent (orange, n=12) and non-confluent subgroup (grey, n=7).  
rs13082711 genotypes in confluent subgroup: C/T (yellow, n=5) and T/T (green, n=7). 
**P<0.01, ***P<0.001, by Mann-Whitney U-test. 
 
On the other hand, the pHi recovery curves for HUVECs in CO2/HCO3
--containing conditions are 
practically overlapping (Figure 138). This suggests that genotypic effects on NBCn1 in HUVECs 
(Figure 118) can be overcome by the proportionally larger contribution of NHEs to HUVEC pHi 




Figure 138: HUVEC pHi recovery following intracellular acidosis, with CO2/HCO3
-  
rs13082711 genotypes: C/T (yellow, n=10) and T/T (green, n=10).Grey error bars denote SEM.  
Groups in (A) compared by repeated measures two-way ANOVA over the 280 time points between 
60 seconds to 900 seconds after re-introduction of Na+-containing buffer.  Groups in (B) compared 
by linear regression. Groups in (C) compared by Mann-Whitney U-test. Note differing y-axis scale in 





This difference between HUASMCs and HUVECs should also be considered with the qRT-PCR 
results (Section 5.2.3) where the inter-sample variability in HUASMC is higher. This suggests that 
the expression differences in genotype have the potential to be of a larger range, hence more 
likely to be detected on a cellular function level. This view on pHi regulation, without inhibition of 
any acid-base transporters, may reveal that the genotypic effect of rs13082711 on blood pressure 
may have a larger role in HUASMCs than in HUVECs. 
 
 
Is the pHi recovery or resting pHi that is important? Or neither? Or both? Does it matter? 
As already explored in Sections 1.4 to 1.8, steady state pHi has the potential to alter cellular 
function in a variety of tissues that may affect blood pressure. In summary, this could be via pH-
dependent changes in enzyme activity, channel activity and receptor activity. Similarly, different 
transport activities may cause Na+ overload and secondary Ca2+-overload with consequent effects 
on cellular behaviour. However, the effect may be related not just to resting pHi, but also to the 
rate from which pHi recovers from intracellular acidosis; particularly as pHi is not constant and pHi 
recovery rates are important in response to a variety of in vivo vasoconstrictive stimuli such as 
angiotensin II, noradrenaline, endothelin-1 and cellular depolarization (Hatori et al., 1987; Aalkjaer 
and Cragoe, 1988; Touyz and Schiffrin, 1993; Austin and Wray; 1993). 
 
It is hitherto unknown whether it is the baseline pHi, or the ability to return towards its set-point 
that predominantly influences the overall in vivo phenotype. However, these results indicate a 
genotypic effect on both the rate of recovery and resting levels of pHi. Thus, although the exact 
mechanism is not yet clear, the genetic link is still present. 
 
 
Is this clinically significant? 
This is a much more difficult question to answer.  
 
As discussed in Sections 1.7 and 1.8, the role of NBCn1 in influencing blood pressure is unlikely to 
be limited to the vasculature, but is not further explored in this thesis. It is very much feasible that 
genetic variants in SLC4A7 may influence renal, gastrointestinal, cardiac or neuronal tissue 
function and subsequently blood pressure. However, regardless of this possibility, the work shown 





As discussed in Section 1.13, there has been some observational data from hypertensive arterial 
segments suggesting pHi regulation may play a role in blood pressure regulation. Accepting the 
caveats and complexities of comparing different inbred animal strains, the pHi in mesenteric artery 
segments of spontaneously hypertensive rats were only 0.03 higher than Wistar-Kyoto controls, 
with approximately 70% increased rate of pHi recovery (Foster et al., 1992). In human studies, the 
difference between the pHi of arterial segments after noradrenaline contraction from 
hypertensive subjects were protected from intracellular acidosis by about 0.04 as compared to 
those from normotensive subjects (Izzard et al., 1991). Furthermore, non-selective 
pharmacological inhibition of all NBCs with S0859 reduces the pHi of cat myocytes by 0.2 (De 
Giusti et al., 2010), and the blood vessels of SLC4A7 knockout mice had resting pHi that were 0.14 
lower than their wildtype littermates (Boedtkjer et al., 2011).  
 
In the data presented in this thesis, the difference between the genotypes in resting pHi (between 
0.08 and 0.12) and pHi recovery rates (between 15 and 55%), with both parameters higher in 
rs13082711 risk allele carriers as compared to the protective allele homozygotes. This should be 
regarded in the context the studies explored in Section 1.4 – in rat mesenteric artery studies, a fall 
of pHi by 0.1 was associated with a decreased ex vivo contractility by around 10%, with the 
converse also true with the increase in pHi (Austin and Wray, 1993a), and in SLC4A7 knockout 
mice, a fall in pHi of 0.1 was associated with a decreased in vitro cell proliferation by around 10% 
and in vivo medial hypertrophy by around 5%. With this, it could be argued that if the observed in 




6. Conclusions: summary, key limitations, future studies and implications 
of results 
 
GWAS have identified multiple genetic loci associated with blood pressure, each with a modest 
contributory effect to overall blood pressure levels, one of these was found to be encompase 
SLC4A7/NBCn1. The function of NBCn1 was well described prior to the work conducted for this 
thesis. It is known to regulate pHi by the electroneutral symport of sodium and bicarbonate into 
the cell. Reduction of NCBn1 activity, by knockdown or knockout markedly reduces, but does not 
abolish recovery from intracellular acidosis. The SLC4A7-/- knockout mouse demonstrates a 
complicated blood pressure phenotype where they were modestly hypertensive at rest, but 
significantly resistant to hypertensive stressors such as angiotensin II nitric oxide synthase 
inhibition (Boedtkjer et al., 2011). As NBCn1 is expressed in various tissues, it is unclear which one 
(or more) contributes to blood pressure regulation.  
 
There is a relative large literature base regarding other sodium-dependent pHi regulators, such as 
NHE1 and NHE3. Less is known about NBCn1, and how subtle genetic variations might affect its 
function, and potentially lead to blood pressure changes. Based on other co-transporters, various 
hypotheses could be proposed to explain the impact of genetic changes on NBCn1 expression 
and/or function. These include effects on baseline expression or inducibility, splice variants, 
protein trafficking, post-translational modifications and intracellular protein-protein interactions. 
This is complicated by the understanding that the blood pressure-associated SNP rs13082711 is in 
a linkage disequilibrium block with 92 other SNPs. With this, rs13082711 could merely be a 
marker, and theoretically could be any (or none, or more) of these polymorphisms that is the true 
causative SNP.  
 
The work presented here has identified that the blood pressure risk allele rs13082711 is 
associated with: 
- Allele-dependent DNA-nuclear protein interactions  
- greater transcription levels,  
- NBCn1 protein expression and cell membrane availability, particularly in vascular smooth 
muscle cells, but perhaps also in endothelial cells, and  
- increased Na+/HCO3
--dependent, DMA-insensitive pHi recovery, base uptake and resting pHi, 




Notably, due to the large contribution of NHE in HUVEC pHi regulation, the small genotypic effect 
is removed when NHE function is present. This is not the case for HUASMCs, where the genotypic 
effect persists even in the absence of DMA. This effect was independent of the associated E326K 
amino acid change, suggesting that the genotypic influence on function is predominantly related 
to overall expression levels.  
 
In terms of negative findings, significant efforts attempting to identify the underlying molecular 
mechanism for this genotype-associated difference in expression were unsuccessful, despite the 
initial promise of FAIRE and EMSA results. In assessing potential impact on protein behavior, the 
studies did not reveal any clear evidence of the polymorphism influencing gene splicing, protein 
trafficking or interaction with calcineurin A. 
 
 
6.1. Key limitations 
One of the limitations of the current work is the restricted number of rare homozygotes, with a 
genotype frequency of less than 4% in this population. To feasibly conduct all the studies, while 
maintaining primary cultures to a low passage number, this would require a minimum of 12 rare 
homozygotes and even higher for assays with higher variability such as qRT-PCR. This suggests that 
an overall sample size of 532 provides a 95% chance of having sufficient rare homozygotes 
(calculated using binomial distributions with event probability of 3.4%, also accounting for 
unclassified genotype calls, see  
Table 41). This would cost approximately £36,700 if both HUASMCs and HUVECs are required, or 
£19,700 and £18,400 for HUASMCs or HUVECs alone, respectively. Furthermore, this calculation 
merely estimates the costs for cell culture to get to a state of being able to conduct the necessary 
assays, and not the cost of the studies themselves. This needs to be considered against a 
consumables budget of £30,000 for the duration of the PhD as provided by the kind support of the 
British Heart Foundation. In addition to monetary cost, this endeavor would take up to an 
estimated 1,200 researcher-hours, which approximates to 1/5th of the allocated PhD time. Perhaps 








Figure 139: Estimate costings for increasing sample size 
Total costs (left) and cost per unit (right) with increasing sample sizes of deriving primary cell 
cultures of both HUASMCs and HUVECs (green), HUASMCs only (blue) and HUVECs only (red). Full 
costings available in Appendix 20. 
 
To circumvent the need for a large repository of cells due to the low prevalence of rare 
homozygotes, some may suggest the use of the CRISPR (clustered regularly-interspaced short 
palindromic repeats)/Cas9 technology. It is often argued that this would allow the investigation of 
an isolated region, with less noise from the variation in other genetic and environmental (in vitro 
cell culture) factors. There are several counter-arguments against this suggestion. The most 
relevant is that CRISPR/Cas9 technology is not able to replace the whole LD block. Thus it would be 
impossible to investigate all 93 SNPs in high LD individually. Next, despite the rapidly improving 
methodology, the off-target indels introduced by the technique is still being quoted at around 
0.1% (Kim et al., 2015), which equates to thousands of undesired changes in the genetic code. Last 
of all, there are already genotype-associated differences in protein expression and function with 
limited access to rare homozygotes. In the absence of evidence (or a strong hypothesis) that there 
is a dominant/recessive effect, the pursuit of rare homozygotic samples is unnecessary. 
 
The failure to identify the molecular mechanism underlying the allele-associated changes in gene 
expression has been frustrating. This is especially as FAIRE and EMSA studies have potentially 
narrowed down to a few candidate SNPs from the large LD block. An alternative to the attempted 
protein sequencing would require specific antibodies for immunoblots, and this is very difficult as 
prediction tools have been seen to be poor in this setting. With this, it is perhaps not a time- and 
cost-effective pursuit.  
 
Although there are exciting results with regards to an genotypic effect on gene expression and 
overall protein function, it should always be taken with the caution (as previously indicated) that 




blood and lower arterial pressures) conduit vessels. This may not represent fully the function in 
adult resistance vessels. Additionally, the work conducted here, like all in vitro cell culture work, is 
based on isolated cells, and not in an whole organism setting, with complicated interactions, 
either by cell-cell contact, paracrine, endocrine and neurogenic factors.  
 
Potential further studies (some more feasible than others) to further the understanding on SLC4A7 




6.2. Possible future studies 
Possible future studies that have been considered, or sometime kindly suggested elsewhere, can 
be split into (1) animal studies, (2) in vitro studies on other cell types, (3) ex vivo studies on human 
blood vessels or (4) in vivo studies with healthy volunteers. The limitations of pharmacological 
inhibition of NBCn1 as an experimental tool will also be discussed, although this may be an area of 
interest for the future. 
 
To take a step away from human studies, some have suggested a return to animal models. It is 
now possible to introduce point mutations in mouse models which in theory would be able to 
assess a single polymorphism. This has two main (and fatal) drawbacks. The first have been 
previously discussed with suggestions of CRISPR/Cas on human cells. Due to the large LD block, 
there are multiple potential causative (if at all) SNPs to explore – too many to realistically do so by 
single point mutations. The second consideration is that although the final NBCn1 sequence of 
humans and mouse are similar, there are 80 amino acid differences (11 within Cassette II itself), 
including that of the E326K human variation (where the murine NBCn1 has Glutamine/Q in the 
326 position). Therefore, introducing the point mutation changing residue to E or K may not be 
appropriate. Additionally, work for this study has suggested that genotype-associated variation in 
expression levels is more likely the mechanism action rather than the amino acid change. 
 
The work here has already sampled human adult kidneys, identifying a genotype-associated level 
of mRNA expression by allelic imbalance. However, due to the heterogenous nature of renal 
biopsies, it would be difficult to determine protein expression by immunoblots as there will be no 
appropriate control for the relative quantity of cells from the thick ascending loop of Henle (where 




samples of other tissue types that may play a role in blood pressure regulation, such as the brain 
and GI tract. One possible sample is from gluteal biopsies for resistance vessels. This would be a 
potential source to confirm these results in adult resistance vessels. Of course, the previous 
caution with sample sizes and costs should be considered, and may be prohibitive. Additionally, 
the task of recruiting large numbers of healthy volunteers for an invasive tissue biopsy may also be 
logistically difficult. The final consideration of adult vessels is that environmental factors would 
also have a large effect to potentially overcome subtle genetic effects (as reflected by the huge 
cohorts required for GWASs). 
 
Perhaps the most interesting possibility lies with ex vivo wire myograph studies of arterial 
segments. The arteries could either be from umbilical cords or gluteal biopsies, for which the 
relative advantages and disadvantages have been discussed above. The attraction of this set-up is 
that it progresses on the current knowledge that SLC4A7 genotype influences NBCn1 expression 
and pHi regulation onto whole arterial function (with both vascular smooth muscle and endothelial 
contributions). Arterial segments could be studies in a various combination of settings – with or 
without CO2/HCO3
-, at external pH of 6.8 or 7.4, with or without NHE inhibition, exposure to a 
range of vasoconstrictors or vasodilators and with or without endothelial contribution 
(pharmacologically or mechanically). This would be able to determine whether there is a 
genotype-associated difference in vascular function overall, and in isolated settings.  
 
In vivo healthy volunteer studies would be interesting if there were a clear mechanism of assessing 
NBCn1. There are two main considerations, either (1) local vascular beds in the short term, or (2) 
whole person in the medium term. The first proposal would take the form of forearm 
plethysmography. As there are currently no licensed NBC inhibitors of human use, the closest 
pharmacological challenge could be in the form of amiloride. As previously discussed, local 
amiloride infusion reduced the angiotensin II-induced vasoconstriction in healthy volunteers, and 
was vasodilatory in high concentrations (Pickkers et al., 1999). This could be reproduced to 
identify any genotype-associated changes in response to amiloride. In theory, this short-lived local 
infusion would mainly have an effect on the vasculature, and not due to its renal diuretic effects, 
and can reveal the contribution of NBCs, as NHEs could be inhibited by the amiloride.  
 
Studies on the whole person is even more difficult. The dominant effects of oral, long-term 




attribute any (if at all) differences to NBC. However, there is the possibility (although currently 
untested even in the knockout mouse model) that NBCs can play a role in salt-and-water 
regulation due to its expression in the ascending loop of Henle. A potential study is to salt-load 
and -restrict healthy volunteers, with end-points being 24-hour ambulatory blood pressure 
measurements and 24-hour urinary electrolyte excretion. Although a potentially interesting, there 
is perhaps not enough supportive evidence yet of NBCn1 contributing to salt-and-water regulation 
to justify this time- and cost-heavy study. 
 
The lack of NBCn1 inhibitors is currently a limiting factor in exploring its function. However, there 
is a possibility of advancing the small molecule strategy (currently S0859 as the best candidate, but 
is not suitable for in vivo use due to its high albumin binding, and also non-specificity for NBC 
isoforms). Alternatively, there is a possibility of inhibitory monoclonal antibodies, although there is 
none close to fruition as yet. 
 
 
6.3. Implications of results 
At the end of this thesis, it is worth considering what clinical implications may follow from this 
study. As previously discussed, this is an in vitro study, for which there are still several hurdles to 
identify the genotypic effect on hypertension patients in vivo. Three main questions that might be 
posed are (1) is this work transferable to other conditions, (2)  whether this work aid personalized 
medicine, and (3) does this work bring any potential new therapeutics closer to reality? Personally, 
the answers are yes, no and maybe (but only by a slight amount).  
 
As indicated in Section 1.17, a separate SNP at the 3’-UTR SLC4A7 also demonstrates an 
association with breast cancer susceptibility (Ahmed et al., 2009; Chen et al., 2012). Additionally, 
intracellular alkalosis, or a resistance to intracellular acidosis, has already been associated with 
cancer cell growth and survival in vitro (Pedersen et al., 2006). The results here could stimulate a 
similar study on breast cancer cells, but with the rs4973768 SNP instead. 
 
It is the opinion of the author that personalized medicines based on genotype, or even a panel of 
SNPs is far from reality when capplied to complex diseases such as hypertension. 
Pharmacogenetics studies in hypertension has generally not been able to show clinically significant 




range of therapeutic options. The knowledge gained from this study does not take this further; 
particularly there were no proven impact of calcineurin inhibition. 
 
Although the responsible mechanism that results in genotype-associated expression levels was not 
ascertained it may be postulated that this study adds weight of evidence (albeit very small) to 
suggest that NBCn1 is a potential target. All previous work on NBCn1 in blood pressure regulation 
was based on animal models and, for the first time, the work presented here indicates a link 
between genotype to human SLC4A7 expression and NBCn1 protein function. This may stimulate 
progress on developing an NBCn1 inhibitor that may be appropriate for in vivo use. However, the 
author is fully aware that the attrition rate from candidate target to actual marketed 
pharmacological agent is in the order of thousands to one. Additionally, there is a lower desire for 
pharmaceutical development of drugs for hypertension due to a flooded marketplace with older 
off-patent drugs. The most likely path for NBCn1 inhibitors to reach the cardiovascular market is 
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